Quantcast
Channel: AGINGSCIENCES™ – Anti-Aging Firewalls™
Viewing all 150 articles
Browse latest View live

CHRONOBIOLOGY OF TISSUE REGENERATION

$
0
0

By Vince Giuliano

We have discussed important aspects of cell tissue regeneration in previous blog entries.  In particular see AGING, CELL AND TISSUE REPAIR, RENEWAL AND REGENERATION, INFLAMMATION AND THE SASP.  The present blog entry deals with circadian regulation; in particular with regulation of cell tissue regeneration.  Circadian regulation is of very great importance both for understanding the mechanisms involved and determining the patterns of rest and sleep that are essential if effective repair and renewal are to take place.  Further, I explore some practical things we can do to make sure our body clocks are fully supportive of initiatives we may take to further cell and tissue renewal and regeneration.  I include timing suggestions for exercise, meals and taking supplements, and assuring nightly periods of restorative deep and REM sleep.     Image source

We have previously published two blog entries related to this one, the 2014 entry Shedding new light on circadian rhythms, and the 2012 entry by Victor Circadian Regulation,NMN, Preventing Diabetes, and Longevity.  This was a very prescient publication, pointing out the probable relevancy of NAD+ augmentation years before this subject became popular.  These publications contain much background information relevant to this blog entry.

I proceed by reviewing:

  1. Relevance of circadian regulation of cell and tissue repair, renewal and regeneration processes.
  2. Basic circadian regulatory processes – how they work and their complexities
  3. Consequences of improper circadian clock functioning: diseases and aging
  4. Some opinions about how older people can best respect the circadian regulatory processes in the interests of their health and longevity
  5. A bit on sleep monitoring with wearables
  6. An update on key actions of a traditional circadian regulator – Melatonin

HOW IMPORTANT IS CIRCADIAN REGULATION?

Very.  Most mammals – us humans included – have evolved in circumstances of day-night cycles, and many of our internal operations have been optimized during our long periods of evolution to function differently during periods of the daily cycle.  Sleepiness, alertness, hunger, endurance strength, muscle coordination, sexual arousal and mental acuity are among the list of matters we have learned to be so regulated.  And we have learned about the importance of sleep and rest.  But behind the obvious effects are hundreds of pathways affected by circadian cycle signaling, in one way or another.

There are two master body clocks and numerous peripheral ones.   As explained in the introduction to the May 2019 publication Circadian Regulation in Tissue Regeneration: “Earth’s 24 h rotation around its axis has influenced organismal development to be centered around cyclic patterns of day- and night-time function. Circadian systems are determined by environmental zeitgebers, or time givers, that entrain clock rhythmicity. In mammals, the most prominent zeitgebers are the onset of light and darkness, though other factors such as food intake and temperature can influence clock mechanisms [1,2]. The circadian system consists of both central and peripheral clocks. The central clock in mammals stems from a network of neurons in the suprachiasmatic nucleus (SCN); these neurons, in addition to maintaining their own cell-intrinsic clock, receive photic cues from the retina to synchronize peripheral day and night cycles throughout the body using a variety of mechanisms, including nervous system signaling, body temperature regulation, hormonal signaling, and regulation of metabolism [2,3]. Peripheral tissue circadian rhythms are synchronized by the central clock, but they also contain their own cell-intrinsic circadian rhythms [4]. As evidence, cells in culture also retain cell-autonomous 24 h rhythmicity, although synchronization is required for detection at the whole culture level [5]. — In mammalian cells, peripheral clocks are maintained by two major auto-regulatory feedback loops that involve transcription of master regulator genes Clock and Bmal1. Clock and Bmal1 proteins heterodimerize and bind to enhancer E-box regions that promote transcription of thousands of genes throughout the body; 43% of protein encoding genes show circadian oscillations in expression in at least one organ [6,7,8,9]. Transcriptional targets include negative circadian master regulator genes Per1Per2Per3Cry1, and Cry2 [6,10]. The first auto-regulatory feedback loop is formed when Per and Cry proteins accumulate in the cytoplasm. Eventually, Cry/Per heterodimers translocate to the nucleus and bind the Clock/Bmal1 complex, inhibiting further Cry/Per transcription as well as the transcription of other genes regulated by the Clock/Bmal1 complex [7,8,11,12,13]. Cry and Per proteins are eventually ubiquitinated and degraded, allowing for another rise in Clock/Bmal1 activity [14,15].”  OK.  This is starting to get complicated.  Welcome to the real world of biology!

Here are some diagrams listing what might be expected to go on during a day of circadian regulation.

Image source

Here is an

other model of what might typically be expected to go on around the clock:

Image source

Here is yet another portrayal of chronobiological events.  You will note that each clock portrays different things.

Image source

If you want to see many-more body processes that are circadian-regulated, here is a large additional collection of relevant images.

History of circadian regulation

Circadian regulation of biological species is extremely ancient, apparently going back to the times when the heavy cloud cover over all of the earth started to lift and day and night started to become distinct  from each other.  The first oxygen-synthesizing bacteria appeared in our oceans between 3 and 4 billion years ago.  Before that we had no oxygen in the atmosphere(ref).  But is was not until approximately a billion years ago that we started to see circadian regulation, initially in cyanobacteria and related species.  The 2003 publication Origin and evolution of circadian clock genes in prokaryotes discusses this early history: “Circadian clock genes are a vital and essential feature of eukaryotes (1). Cyanobacteria were the first prokaryotes reported to have the circadian clock regulated by a cluster of three genes: kaiAkaiB, and kaiC (2). Cyanobacteria are among the oldest organisms on the earth, and they are among the most successful in terms of ecological plasticity and adaptability (3). In adaptation strategy of cyanobacteria, circadian clock genes are of particular importance, because they underlie fundamental physiological processes such as the regulation of nitrogen fixation, cell division, and photosynthesis (4).  The clock genes are ubiquitous in cyanobacteria (5). In most cyanobacteria, these genes were reported as a single copy (25), although some of them (kaiB; ref. 6) or even a whole cluster (7) may be duplicated. They were shown to operate as a single unit and to follow a feedback model of regulation: kaiA positively affects kaiBC promoter, whereas overexpression of kaiC represses it (28). Among these genes, kaiC is a crucial component of clock precession in cyanobacteria (911). — In this study we reconstruct the origin and evolutionary patterns of the circadian clock genes in prokaryotes. Using available sequences from the public databases, we performed extensive phylogenetic analysis of the kai genes. The results suggest that the three prokaryotic circadian pacemakers have quite different evolutionary histories, and two of them, kaiA and kaiB, originated in cyanobacteria. The three-gene kaiABC cluster itself evolved ≈1,000 Mya.”

(Image source).  Cyanobacteria bloom on lake

 

 

So that’s how it got started, and the circadian regulatory genes evolved as did species.  Fast forwarding to mammals starting a mere 300 million years ago or so, we find that our circadian regulatory genes are virtually the same as the ones operating in mice, skunks and zebras.  The 2003 publication Clocks, genes and sleep reports:In mammals, circadian rhythms are governed by a paired master oscillator in the suprachiasmatic nuclei (SCN), which controls slave oscillators throughout the body.2,3 The SCN determines the individual’s free-running circadian period, τ,4 which in man is reported to average 24.2 h in the absence of light cues.5 Our laboratory has observed a range of 23.83-25.00 h in blind individuals.6 Variability within the species, whereby individuals reach peak performance at different times of day, may have conveyed an evolutionary advantage to early human societies. In a normal individual the phase of the SCN oscillator is entrained each day to the external light/dark cycle by information relayed through the retinohypothalamic tract.7,8In vertebrates, sleep has evolved as a sustained period of physical inactivity during a specific part of the circadian cycle.9 The distribution of rest and activity between the night and the day varies between taxa. Our reptilian ancestors, being exothermic, were active during the day (diurnal), but the endothermic mammals that radiated from these species were nocturnal. From there, various mammals (including most primates) reverted to diurnality through secondary modifications, notably in the visual system. The retina was recolonized by color-sensitive cones (not required for night vision) and the higher visual canters were rewired.913  — The parameters within the circadian system that define nocturnality and diurnality are only partly understood.14 As a general rule, nocturnal species have a τ<24 hours, diurnal species have a τ>24 hours.15 In addition, the composition of visual photoreceptors seems important. People who are color blind through complete lack of cone photoreceptors tend to be photophobic, and on the Micronesian island of Pingelap, where the condition is common, some affected individuals specialize in night fishing.16

Image sourceSleep and circadian brain circuitry in mammals — The SCN is the central circadian pacemaker, entraining other brain regions as well as peripheral tissues. The SCN projects directly to the wake-promoting LH, which contains hypocretin neurons, and to the DMH. The DMH projects broadly to sleep and arousal centers. Abbreviations: SCN: suprachiasmatic nucleus; DMH: dorsomedial hypothalamus; LH: lateral hypothalamus; LC: locus coeruleus; VLPO: ventrolateral preoptic area”

 CIRCADIAN REGULATION OF REGENERATIVE PROCESSES

Many key regenerative processes are subject to circadian regulation.  The May 2019 publication Circadian Regulation in Tissue Regeneration states the case in point.  “Circadian rhythms regulate over 40% of protein-coding genes in at least one organ in the body through mechanisms tied to the central circadian clock and to cell-intrinsic auto-regulatory feedback loops. Distinct diurnal differences in regulation of regeneration have been found in several organs, including skin, intestinal, and hematopoietic systems. Each regenerating system contains a complex network of cell types with different circadian mechanisms contributing to regeneration. In this review, we elucidate circadian regeneration mechanisms in the three representative systems. We also suggest circadian regulation of global translational activity as an understudied global regulator of regenerative capacity. A more detailed understanding of the molecular mechanisms underlying circadian regulation of tissue regeneration would accelerate the development of new regenerative therapies.  — Circadian rhythms from both central and peripheral clock mechanisms have been found to influence efficacy of regeneration of many different tissues. Among the many cell types involved in regeneration, stem cells have varied circadian rhythmicity depending on differentiation state, with an extreme example being the lack of master regulator rhythmicity in pluripotent stem cells. Reflecting the current interest in stem cell biology, circadian regulation of stem cell activity has been comprehensively reviewed in recent articles [18,19]. Another widely studied area, circadian gating of cell cycle progression at multiple checkpoints, including the G1-S and the G2-M transitions, has also been extensively studied and reviewed, both in physiological tissues and in the context of carcinogenesis [20,21,22,23,24,25,26]. Therefore, in this review, we highlight circadian regulation of stem cell biology, cell cycle, and other cellular functions from the perspective of regeneration in three specific organs: skin, intestine, and blood (Figure 1). These representative tissues demonstrate time of day-dependent differences in regenerative capacity, an understudied but important contributor during wound healing. We also propose that circadian fluctuations of global translational activity may affect the regenerative capacity at any given time of day and should be taken into consideration in future studies of regeneration.”

The 2017 publication Circadian clocks: from stem cells to tissue homeostasis and regeneration provides another partial summary:  “The circadian clock is an evolutionarily conserved timekeeper that adapts body physiology to diurnal cycles of around 24 h by influencing a wide variety of processes such as sleep‐to‐wake transitions, feeding and fasting patterns, body temperature, and hormone regulation. The molecular clock machinery comprises a pathway that is driven by rhythmic docking of the transcription factors BMAL1 and CLOCK on clock‐controlled output genes, which results in tissue‐specific oscillatory gene expression programs. Genetic as well as environmental perturbation of the circadian clock has been implicated in various diseases ranging from sleep to metabolic disorders and cancer development. Here, we review the origination of circadian rhythms in stem cells and their function in differentiated cells and organs. We describe how clocks influence stem cell maintenance and organ physiology, as well as how rhythmicity affects lineage commitment, tissue regeneration, and aging.”

Continuing with material from the May 2019 publication Circadian Regulation in Tissue Regeneration: “Levels of the Clock/Bmal1 complex are regulated by a second auto-regulatory feedback loop that affects transcription of Bmal1. Clock/Bmal1 complexes induce expression of nuclear receptor transcriptional activators RORα (retinoic acid receptor-related orphan receptor α) and RORβ, and repressors Rev-ErbAα (reverse c-erbAα) and Rev-ErbAβBmal1 transcription is affected by competitive binding of these two nuclear receptors to Rev-ErbA/ROR response elements (RREs) in the Bmal1 promoter region. Rev-Erbs inhibit Bmal1 expression, while RORs promote Bmal1 expression as essential components to stabilize circadian rhythmicity [7,8,16,17]. A variety of chromatin-modifying enzymes, kinases, phosphatases, and RNA-binding factors also modify these core master regulators to ensure circadian rhythmicity [7,8].  Circadian rhythms from both central and peripheral clock mechanisms have been found to influence efficacy of regeneration of many different tissues. Among the many cell types involved in regeneration, stem cells have varied circadian rhythmicity depending on differentiation state, with an extreme example being the lack of master regulator rhythmicity in pluripotent stem cells. Reflecting the current interest in stem cell biology, circadian regulation of stem cell activity has been comprehensively reviewed in recent articles [18,19]. Another widely studied area, circadian gating of cell cycle progression at multiple checkpoints, including the G1-S and the G2-M transitions, has also been extensively studied and reviewed, both in physiological tissues and in the context of carcinogenesis [20,21,22,23,24,25,26]. Therefore, in this review, we highlight circadian regulation of stem cell biology, cell cycle, and other cellular functions from the perspective of regeneration in three specific organs: skin, intestine, and blood (Figure 1). These representative tissues demonstrate time of day-dependent differences in regenerative capacity, an understudied but important contributor during wound healing. We also propose that circadian fluctuations of global translational activity may affect the regenerative capacity at any given time of day and should be taken into consideration in future studies of regeneration.”

 

 

 

 

 

 

 

 

 

Common elements shared by biological clocks and cell cycle. Image source.  Myc is a broadly acting regulator of transcriptional activities of families of genes involved in both healthy and cancer processes. Myc binds to something like 25,000 gene sites, and there  is much literature related to it(ref).

If you are interested in the molecular biology of clock regulation and the multiple pathways involved, I suggest you delve into the above publications and others they link to.

CIRCADIAN REGULATION AND THE NAD WORLD

Jim Watson and I have devoted a series of blog entries to metabolic events in the “NAD WORLD.”  (ref)(ref)(ref)(ref)(ref). These outline the compelling story of how expression of NAD+ declines with age, the numerous deleterious consequential effects, and what might be done to counter some of them in the interest of health and longevity.  You can  also view my 2018 PowerPoint presentation TALES OF NAD+.   And again, relevant to NAD and circadian regulation, you can review Victor’s 2012 blog entry  Circadian Regulation,NMN, Preventing Diabetes, and Longevity.

Relevant in the present context is the fact that events in the NAD salvage cycle are under circadian regulation, and also that these NAD salvage cycle events in turn impact on the circadian cycle.  The 2010 publication “Clocks” in the NAD World: NAD as a metabolic oscillator for the regulation of metabolism and aging tells a part of the story: “SIR2 (silent information regulator 2) proteins, now called “sirtuins,” are an evolutionarily conserved family of NAD-dependent protein deacetylases/ADP-ribosyltransferases. Sirtuins have recently attracted major attention in the field of aging research, and it has been demonstrated that SIR2 and its orthologs regulate aging and longevity in yeast, worms, and flies. In mammals, the SIR2 ortholog SIRT1 coordinates important metabolic responses to nutritional availability in multiple tissues. Most recently, it has been demonstrated that SIRT1 regulates the amplitude and the duration of circadian gene expression through the interaction and the deacetylation of key circadian clock regulators, such as BMAL1 and PER2. More strikingly, we and others have discovered a novel circadian clock feedback loop in which both the rate-limiting enzyme in mammalian NAD biosynthesis, nicotinamide phosphoribosyltransferase (NAMPT), and NAD levels display circadian oscillations and modulate CLOCK:BMAL1-mediated circadian transcriptional regulation through SIRT1, demonstrating a new function of NAD as a “metabolic oscillator.” These findings reveal a novel system dynamics of a recently proposed systemic regulatory network regulated by NAMPT-mediated NAD biosynthesis and SIRT1, namely, the NAD World. In the light of this concept, a new connection between physiological rhythmicity, metabolism, and aging will be discussed.”

Regular readers of this blog may note that SIRT1 exercises a number of important functions related to health and longevity including in DNA repair, mitochondrial health and the control of chronic inflammation, so the close interaction of circadian events and the NAD salvage cycle (which impacts on the expression of SIRT1) is extremely important.

ORGAN SPECIFICITY OF CIRCADIAN RENEWAL PROCESSES

As mentioned above, there are numerous secondary and tertiary organ and cell-level clocks that roughly synchronize to the master clocks.  Likewise, there are overall body circadian impacts and ones that are specific to particular organs and ones that are applicable to specific cell types.  I can’t cover these all here but will refer to publications related to the intestinal track and the cornea of eyes as examples.

Gastrointestinal Track

Regenerative events in the gastrointestinal track are subject to strong circadian regulation, no surprise given the relative regularity of our eating and movement patterns.  The 2017 publication The Circadian Clock Gene BMAL1 Coordinates Intestinal Regeneration offers this image and reports in summary:

“BACKGROUND & AIMS:  The gastrointestinal syndrome is an illness of the intestine caused by high levels of radiation. It is characterized by extensive loss of epithelial tissue integrity, which initiates a regenerative response by intestinal stem and precursor cells. The intestine has 24-hour rhythms in many physiological functions that are believed to be outputs of the circadian clock: a molecular system that produces 24-hour rhythms in transcription/translation. Certain gastrointestinal illnesses are worsened when the circadian rhythms are disrupted, but the role of the circadian clock in gastrointestinal regeneration has not been studied. — METHODS: We tested the timing of regeneration in the mouse intestine during the gastrointestinal syndrome. The role of the circadian clock was tested genetically using the BMAL1 loss of function mouse mutanj in vivo, and in vitro using intestinal organoid culture. — RESULTS: The proliferation of the intestinal epithelium follows a 24-hour rhythm during the gastrointestinal syndrome.  The circadian clock runs in the intestinal epithelium during this pathologic state, and the loss of the core clock gene, BMAL1, disrupts both the circadian clock and rhythmic proliferation.  Circadian activity in the intestine involves a rhythmic production of inflammatory cytokines and subsequent rhythmic activation of the JNK stress response pathway. — CONCLUSIONS: Our results show that a circadian rhythm in inflammation and regeneration occurs during the gastrointestinal syndrome. The study and treatment of radiation-induced illnesses, and other gastrointestinal illnesses, should consider 24-hour timing in physiology and pathology.”

Stem cell activities are also to various extents regulated by circadian factors.  Again, in the case of intestines the 2019 publication Time after time: circadian clock regulation of intestinal stem cells reports: “Daily fluctuations in animal physiology, known as circadian rhythms, are orchestrated by a conserved molecular timekeeper, known as the circadian clock.  The circadian clock forms a transcription-translation feedback loop that has emerged as a central biological regulator of many 24-h processes.  Early studies of the intestine discovered that many digestive functions have a daily rhythm and that intestinal cell production was similarly time-dependent.  As genetic methods in model organisms have become available, it has become apparent that the circadian clock regulates many basic cellular functions, including growth, proliferation, and differentiation, as well as cell signaling and stem cell self-renewal.  Recent connections between circadian rhythms and immune system function, and between circadian rhythms and microbiome dynamics, have also been revealed in the intestine. These processes are highly relevant in understanding intestinal stem cell biology. Here we describe the circadian clock regulation of intestinal stem cells primarily in two model organisms: Drosophila melanogaster and mice.  Like all cells in the body, intestinal stem cells are subject to circadian timing, and both cell-intrinsic and cell-extrinsic circadian processes contribute to their function.”

The Eye – Corneal Epithelium

The eye is another organ where issue renewal is understandably very susceptible to circadian regulation.  Sensible, since we are not using our eyes while sleeping making that a good time for repair and renewal.  The 2018 publication Ocular Clocks: Adapting Mechanisms for Eye Functions and Health reports; “Vision is a highly rhythmic function adapted to the extensive changes in light intensity occurring over the 24-hour day.  This adaptation relies on rhythms in cellular and molecular processes, which are orchestrated by a network of circadian clocks located within the retina and in the eye, synchronized to the day/night cycle and which, together, fine-tune detection and processing of light information over the 24-hour period and ensure retinal homeostasis.  Systematic or high throughput studies revealed a series of genes rhythmically expressed in the retina, pointing at specific functions or pathways under circadian control.  Conversely, knockout studies demonstrated that the circadian clock regulates retinal processing of light information.  In addition, recent data revealed that it also plays a role in development as well as in aging of the retina.  Regarding synchronization by the light/dark cycle, the retina displays the unique property of bringing together light sensitivity, clock machinery, and a wide range of rhythmic outputs.  Melatonin and dopamine play a particular role in this system, being both outputs and inputs for clocks.  The retinal cellular complexity suggests that mechanisms of regulation by light are diverse and intricate.  In the context of the whole eye, the retina looks like a major determinant of phase resetting for other tissues such as the retinal pigmented epithelium or cornea.  Understanding the pathways linking the cell-specific molecular machineries to their cognate outputs will be one of the major challenges for the future.”

The 2017 publication Modulation of Circadian Rhythms Affects Corneal Epithelium Renewal and Repair in Mice reports: “PURPOSE:  In mammalian corneal epithelium, mitosis shows a distinct circadian pattern.  However, how this circadian pattern is maintained, and how it or its disruption influence renewal and regeneration remain unclear. — METHODS:  C57BL/6 mice were maintained under 12-hour light/12-hour dark (LD), 12-hour light/12-hour light (LL), 12-hour dark/12-hour dark (DD), or reversed LD (DL, 12-hour dark/12-hour light; jet-lag defined as a shift of 12 hours) conditions.  Mitotic cells in corneal epithelium were enumerated and analyzed via immunofluorescence at different zeitgeber times (ZTs).  Expression of core clock genes (Clock, Bmal1, Period2, Cry1, and Rev-erbα) was qualified via quantitative RT-PCR.  The rate and quality of healing at different ZT times and after administration of two small-molecule modifiers of the circadian clock, KL001 and SR8278, was evaluated. — RESULTS:  In this study, photic cues were found to influence the 24-hour rhythm of corneal clock gene expression and epithelial cell mitosis in mice.  Disruption of the circadian clock by exposure to constant light, constant dark, or jet-lag conditions modified the normal 24-hour patterns of corneal epithelial mitosis and corneal clock gene expression.  The time of day of wound occurrence affected the rate and quality of corneal healing, with both of these parameters peaking during the more mitotically active hours of the morning.  The two small-molecule modifiers of the circadian clock, KL001 and SR8278, had negative and positive effects on corneal wound healing, respectively.  — CONCLUSIONS: Circadian rhythms significantly influence corneal epithelium renewal and repair in mice. Our findings reveal possible opportunities for biological rhythm-based interventional strategies to control corneal healing and restore corneal homeostasis.”

THE CIRCADIAN CLOCK AND INFLAMMATION

I have written extensively about the jmportance of controlling chronic inflammation for general health and longevity.  But what are the chronobiological properties of inflammation?  When in the course of 25 hours is it most and least likely to be manifest?.  And specifically, if one  takes anti-inflammatory herbs or our liposomal herbal product 4 Herb Synergy to control inflammation, when is the best time of day to do this?  Some applicable insights can be found in the 2016 publication  The circadian clock regulates inflammatory arthritis“There is strong diurnal variation in the symptoms and severity of chronic inflammatory diseases, such as rheumatoid arthritis. In addition, disruption of the circadian clock is an aggravating factor associated with a range of human inflammatory diseases.  To investigate mechanistic links between the biological clock and pathways underlying inflammatory arthritis, mice were administered collagen (or saline as a control) to induce arthritis.  The treatment provoked an inflammatory response within the limbs, which showed robust daily variation in paw swelling and inflammatory cytokine expression.  Inflammatory markers were significantly repressed during the dark phase.  Further work demonstrated an active molecular clock within the inflamed limbs and highlighted the resident inflammatory cells, fibroblast-like synoviocytes (FLSs), as a potential source of the rhythmic inflammatory signal.  Exposure of mice to constant light disrupted the clock in peripheral tissues, causing loss of the nighttime repression of local inflammation.  Finally, the results show that the core clock proteins cryptochrome (CRY) 1 and 2 repressed inflammation within the FLSs, and provide novel evidence that a CRY activator has anti-inflammatory properties in human cells.  We conclude that under chronic inflammatory conditions, the clock actively represses inflammatory pathways during the dark phase.  This interaction has exciting potential as a therapeutic avenue for treatment of inflammatory disease.— The circadian clock is an internal timing mechanism that enables organisms to anticipate rhythmic daily changes in the environment and adapt their physiology accordingly.  At a molecular level, 24-h oscillations are created by a transcriptional–translational feedback loop ().  Within this loop, the positive transcriptional regulators CLOCK and BMAL drive the transcription of the negative regulators period (per) and cryptochrome (cry). The PER and CRY proteins dimerize and inhibit CLOCK/BMAL-mediated transcription.  The PER/CRY complex is subsequently degraded, releasing this inhibitory effect and allowing a new cycle of transcription to begin.  Immune system function and activity are strongly influenced by the circadian clock, under both homeostatic conditions and during inflammatory challenge (). Much of this temporal control of immune responses is orchestrated by peripheral clocks—timers within individual cellular components of the immune system that confer rhythmicity to their functionality. –’

“Rheumatoid arthritis (RA) is a debilitating autoimmune condition, characterized by inflammation and swelling within the joints.  Inflammation within the joint is driven both by resident synovial cells [fibroblast-like synoviocytes (FLSs)] and by infiltrating immune cells (including monocytes, macrophages and T cells). I n addition to acute swelling and pain, this chronic inflammatory state leads to joint remodelling, causing severe disability.  RA shows daily variations in symptom and sign severity ().  Clinical studies dating back to the 1960s document patients with RA exhibiting increased joint stiffness in the morning (), and it is well established that immunologic disease markers associated with RA show time-of-day variation.  In particular, IL6 has been identified as strongly rhythmic in patients with RA, with elevated levels in the morning ().  However, despite this clear clinical evidence of rhythmic disease presentation, little is known about how the pathophysiology of RA is governed by the circadian clock.”

So, circadian activation of CRY proteins minimize the inflammatory state at night.  The FLS cells are most clock-active in the day, leading to the swelling, joint siffness, disability, pain and tissue remodeling mischief characteristic of RA inflammation.  I infer therefore that the best time to take anti-inflammatory supplements like 4 Herb Synergy to avoid such damage is morning, and that is what I personally do.

WHEN OUR CLOCKS GO SCREWY, WHAT CAN HAPPEN?

Our circadian rhythms are subject to disruption by a number of lifestyle factors including late or irregular shift working, travel across multiple time zones, irregular meal times, large ill-timed meals, excess alcohol, exposure to bright lights at night, disturbing news at bedtime, and late partying.  This 2018 review article identifies the major risks and associated factors related with disruption in circadian system and sleep: Health risks associated with genetic alterations in internal clock system by external factors.  “ — Adverse impacts of circadian dysrhythmia on body and mind are linked with lifestyle or routines such as frequently flying, working in repeatedly changing shifts and exposure to irregular light-dark conditions.  Working around the clock and jetting around the globe are becoming necessary in our globalized world in some high-profile services. C rossing multiple time zones results in “jet lag,” a circadian rhythm disorder, that disturbs spatial cognition and hippocampal neurogenesis.  Jet lag immediately causes fatigue and indigestion while chronic exposure to jet lag has strong impacts on spatial cognition and temporal lobe5.  Externally induced disruption in natural sleep-wake cycles6and circadian rhythms is associated with neuronal dysfunction7,, increased risk for psychiatric, cardiovascular and metabolic diseases3, and affects bone health9.  — Long-term exposure to irregular dark-light cycles increases the risk of sleep disorders, metabolic disorders, mental abnormalities, depressive disorders, and hormonal abnormalities, that further develop cancer, gastrointestinal, and reproductive disorders10.  Trans meridian travel may develop general malaise, headaches, insomnia, daytime sleepiness, impaired cognitive or physical performance and gastrointestinal disturbances. Impacts of shift-work on sleep duration quality can disrupt the physiological rhythms via desynchronization between hormonal rhythms, metabolic function and sleep cycle4.  Physiological clock alterations  increase the risk of peptic ulcer and diabetes12.

Some of the problems are directly sleep-related, as illustrated here.

(Image source)

Five stages of normal sleep are shown along with how long they may typically last.  All of these stages are needed for best rest and regeneration.  My Oura ring, as described below, will tell me every morning how much time I spent in light sleep, deep sleep and REM sleep.  So will my Fitbit Charge 3 smartwatch, although with less accuracy

In addition, numerous other negative consequences can be associated with circadian dysregulation as portrayed in this diagram.

Image source

In addition, there are of course also numerous internal factors that can contribute to clock dysregulation, including conditions that can lead to insomnia(ref):

“Examples of medical conditions that can cause insomnia are:

  • Nasal/sinus allergies
  • Gastrointestinal problems such as reflux
  • Endocrine problems such as hyperthyroidism
  • Arthritis
  • Asthma
  • Neurological conditions such as Parkinson’s disease
  • Chronic pain
  • Low back pain
  • Some medications such as those taken for the common cold and nasal allergies, high blood pressure, heart disease, thyroid disease, birth control, asthma, and depression can also cause insomnia.
  • Restless legs syndrome”

SIMPLE THINGS TO DO TO KEEP OUR CLOCKS RUNNING WALL

The common-sense suggestion for those of us who are elderly or beset  with diseases that disrupt our chronobiological patterns is of course a) develop awareness of our daily rhythms, b) try to the greatest extent possible to maintain consistent daily patterns as relate to sleep and awakeness, exercise and meals, and c) seek to schedule our activities at optimal times during the day given the operation of our natural clocks, d) avoid known disruptors of circadian thythms like bright or blue lights at night or late meals, and e) recognize that there are many different inputs we can make to the circadian clocks to give us better results.

  1. c) Scheduling our activities at optimal times.

There appears to be much conventional wisdom at to timing, but relatively little actual research.  Morning is often thought to be best for learning by the elderly,  This publication which appeared last month suggests that for motor skills, evening training is better;  A Delayed Advantage: Multi-Session Training at Evening Hours Leads to Better Long-Term Retention of Motor Skill in the Elderly.  “The acquisition and retention of motor skills is necessary for everyday functioning in the elderly and may be critical in the context of motor rehabilitation.  Recent studies indicate that motor training closely followed by sleep may result in better engagement of procedural (“how to”) memory consolidation processes in the elderly.  Nevertheless, elderly individuals are mostly morning oriented and a common practice is to time rehabilitation programs to morning hours.  Here, we tested whether the time-of-day wherein training is afforded (morning, 8-10:30 a.m., or evening, 6-9 p.m.) affects the long-term outcome of a multi-session motor practice program (10 sessions across 3-4 weeks) in healthy elderly participants.  Twenty-nine (15 women) older adults (60-75 years) practiced an explicitly instructed five-element key-press sequence by repeatedly generating the sequence “as fast and accurately as possible.”  The groups did not differ in terms of sleep habits and quality (1-week long actigraphy); all were morning-oriented individuals.  All participants gained robustly from the intervention, shortening sequence tapping duration and retaining the gains (> 90%) at 1-month post-intervention, irrespective of the time-of-day of training.  However, retesting at 7-months post-intervention showed that the attrition of the training induced gains was more pronounced in the morning trained group compared to the evening group (76 and 56.5% loss in sequence tapping time; 7/14 and 3/14 participants showed a > 5% decline in accuracy relative to end of training, respectively). Altogether, the results show that morning-oriented older adults effectively acquired skill in the performance of a sequence of finger movements, in both morning and evening practice sessions.  However, evening training leads to a significant advantage, over morning training, in the long-term retention of the skill. Evening training should be considered an appropriate time window for motor skill learning in older adults, even in individuals with morning chronotype. The results are in line with the notion that motor training preceding a sleep interval may be better consolidated into long-term memory in the elderly, and thus result in lower forgetting rates.”  As a personal observation, I have observed the same for myself for intellectual learning.  I think I can better retain new information related to quantum physics or to molecular biology, for example, if I seek to digest it after supper.

Best time for wound healing

Limited research suggests that if are going to get a skin wound, the best time for that to happen from a healing perspective is during the day rather than at night.  The 2017 publication Circadian actin dynamics drive rhythmic fibroblast mobilization during wound healing reports: “Fibroblasts are primary cellular protagonists of wound healing.  They also exhibit circadian timekeeping, which imparts an approximately 24-hour rhythm to their biological function.  We interrogated the functional consequences of the cell-autonomous clockwork in fibroblasts using a proteome-wide screen for rhythmically expressed proteins.  We observed temporal coordination of actin regulators that drives cell-intrinsic rhythms in actin dynamics. In consequence, the cellular clock modulates the efficiency of actin-dependent processes such as cell migration and adhesion, which ultimately affect the efficacy of wound healing.  Accordingly, skin wounds incurred during a mouse’s active phase exhibited increased fibroblast invasion in vivo and ex vivo, as well as in cultured fibroblasts and keratinocytes.  Our experimental results correlate with the observation that the time of injury significantly affects healing after burns in humans, with daytime wounds healing ~60% faster than nighttime wounds.   We suggest that circadian regulation of the cytoskeleton influences wound-healing efficacy from the cellular to the organismal scale.”

Note that this study is with mice as are many of the other circadian-impact studies, and that a significant proportion of the studies are with drosophila or other insects.  The similarity of clock gene operation is so great, however, that conditionally, many of the results of these lower-species studies probably apply to us.

Best times to take anti-inflammatory dietary supplements

Research cited above suggest that inflammatory and wound healing processes are most active during daytimes, least active during dark hours of rest.  The best approach for avoidance of inflammation-related damage as potentiated by daytime-active FLS genes, I infer, is therefore first thing in the morning.  I take 4-Herb Synergy, Lion’s Mane and Turkey Tail mushroom extracts and a number of anti-inflammatory NF-kB inhibiting and Nrf2-promoting  herbs extracts then.  I also take smaller quantities of these substances just before going to bed to help stiffness and pain from emerging overnight.  I believe these strategies are working for me.

Simple practical inputs to circadian clocks

  • To help us get to sleep at night, No caffeine after noon, last meal of day at least 3 hours before bedtime, schedule heavy exercising in late morning or afternoon, avoid bright blue light and no fighting with relatives for 3 hours before bedtime, 3-5 mg of melatonin before bedtime. GABA supplements at bedtime might help too.
  • To shake off grogginess in morning when getting up, expose yourself to bright natural daylight, using “daylight” artificial lights if necessary.  Go outside for a while and move around If you can.  Start day with at least moderate exercise, and a cup of coffee of course.

TRACKING SLEEP WITH WEARABLES

Several wrist, ring and other wearable devices on the market now allow for fairly extensive sleep and circadian pattern tracking, tracking that was formerly available only via staying overnight at sleep labs.  I briefly characterize only two of these devices here, ones that I personally wear and use.

The Fitbit Charge 3 is a relatively low-cost multifunction watch-type activity tracker $125 to $150).   It does a fairly good job at tracking steps, floors climbed swimming and various other exercises.  It tracks total sleep, occurrences and lengths of sleep stages (light, deep and REM) during the night and pattern of resting heart rate. Just touch your device to see the time, your heart rate at the time, notifications, steps you have taken or other features.  Summary daily data are available on an online or cell phone display.  While accuracy of sleep measurements have been questioned in some reviews, I have found comparisons of one night with other nights to be sometimes valuable.  A number of other useful parameters are displayed.  Synchs automatically with my Android phone.  Waterproof, having a clear screen, providing notifications and other smart-watch features, and having a 7 day battery life between recharging.  Charging itself is very rapid, taking perhaps 40 minutes. I find the Charge 3 to be a highly reliable and practical device.

My Oura Ring looks like a wedding band, has no display of its own, but is purported to have significantly greater accuracy for measuring pulse and sleep events and even a version of heart rate variability.    This is because pulse and circulation are less-masked by body tissues and more measurable at the base of a finger than on the wrist.  The Oura Ring tracks almost all the same things the Fitbit Charge 3 does (measures body temperature in addition but not flights of steps climbed).  However, my own experience and several independent reviews support Oura’s claims to enhanced accuracy when it comes to sleep and heart events.  Below are a few of many screens available on the Oura app.  Like the Fitbit Charge 3, the ring synchronizes to my Android phone via Bluetooth.  The Android display for the ring provides greater detail related to sleep than does the display for the Fitbit.  The Oura Ring currently goes for $299 for silver or black.  I think it is worth the money for people interested in 24-7 monitoring their heart-rate, HRV or sleep parameters.  If you just want to monitor your steps and exercise , the Fitbit is probably all you need. “Oura is more than just intelligent technology. It’s a philosophy to guide you to understand how your body responds to your activities, daily choices and rhythms.“

How do the Fitbit Charge 3 and Oura Ring data compare for the same night of sleep?  They generally agree to within 80% or so.  When in doubt I tend to trust the Oura Ring numbers.  Downsides for the Oura Ring are that the battery must be recharged every 3 days and that takes a couple of hours.  And it is usually a struggle to get the ring off past a bulge in my finger so it can be recharged.  Finally, I sometime have trouble getting Bluetooth to synchronize between my phone and ring.  That does not happen automatically as it does with the Fitbit device.

NEW FINDINGS ON OUR OLD FRIEND – MELATONIN

Melatonin is a hormone that is naturally expressed around bedtime to facilitate sleep.  I have long used melatonin, 3-5 mg, to reset my body clock at bedtime and help assure a night of sound sleep. I started doing this back in the 60s and 70s when I frequently traveled to Europe or the Middle East for work, and found it helpful for quickly resetting my master clocks – in a day or two instead of a week or more required if I just let them reset themselves for a 5-10 hour time shift.

The 2018 publication New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation reports: “In mammals, a central circadian clock, located in the suprachiasmatic nuclei (SCN) of the hypothalamus, tunes the innate circadian physiological rhythms to the ambient 24 h light–dark cycle to invigorate and optimize the internal temporal order.  The SCN‐activated, light‐inhibited production of melatonin conveys the message of darkness to the clock and induces night‐state physiological functions, for example, sleep/wake blood pressure and metabolism.  Clinically meaningful effects of melatonin treatment have been demonstrated in placebo‐controlled trials in humans, particularly in disorders associated with diminished or misaligned melatonin rhythms, for example, circadian rhythm‐related sleep disorders, jet lag and shift work, insomnia in children with neurodevelopmental disorders, poor (non‐restorative) sleep quality, non‐dipping nocturnal blood pressure (nocturnal hypertension) and Alzheimer’s disease (AD).  The diminished production of melatonin at the very early stages of AD, the role of melatonin in the restorative value of sleep (perceived sleep quality) and its sleep‐anticipating effects resulting in attenuated activation of certain brain networks are gaining a new perspective as the role of poor sleep quality in the build‐up of β amyloid, particularly in the precuneus, is unraveled.  As a result of the recently discovered relationship between circadian clock, sleep and neurodegeneration, new prospects of using melatonin for early intervention, to promote healthy physical and mental ageing, are of prime interest in view of the emerging link to the etiology of Alzheimer’s disease.”

Endogenous production of melotonin is regulated by light incident on the retina.  That is why clearing out a “foggy head” due to high presence of melatonin in mornings can be greatly assisted by exposure to bright daylight.

Image source: Ocular Clocks: Adapting Mechanisms for Eye Functions and Health    “Overview of photoreceptor gap junction coupling and the melatonin/dopamine pathway.  Gap junctions are located at photoreceptor terminals.  Melatonin production is under the control of a clock within the photoreceptor layer and high at night.  Melatonin suppresses dopamine release, and it is the nocturnal decrease in dopamine release and the subsequent decrease in activity of dopamine D2/4 receptors on photoreceptors that increases photoreceptor coupling. SD, subjective day; SN, subjective night.”

It is now 9:23PM, and time for me to publish this article before I start disrupting tonight’s circadian cycle.  Although research in the field of chronobiology goes back to the 18th century, my feeling is that we still have very much to learn about this area, and we will discover more related practical health and longevity-promoting interventions.  So, please stand by for more blogs related to this area.


My Thoughts on How to Live My Longest Healthy Life (Healthspan). Part one

$
0
0

Stan Goldfarb

Introduction by Vince Giuliano

Stan Goldfarb is a friend and a colleague who often contributes to online longevity discussions, particularly ones concerned with dietary supplements.  Although not a scientist he has strong and sometimes unique views on what makes for longevity, and I invited him to write one or more guest blog posts expressing them.  Here are Stan’s first-post comments, only lightly edited by me.  What Stan writes and how he writes are quite different than what you might expect from me.  I agree strongly with some of Stan’s points, agree less with others, and find a few new to me. 

——————————————————————————————

I am not a scientist.  Simply a person who wants to live the longest healthy life I can.  I’m 76 chronological years old and everything I currently do, I do to slow down my biological aging and make me healthier.

In the years that I have known Vince, I have found that most of our views are the same or similar.  When I finally got to meet him face to face, the time flew by.  He asked me to write a blog for him and I was flattered.

What I write might not be for most of the people who are currently reading Vince’s blog.  It will be mainly for people who want to start on this both wonderful and sometimes frustrating journey.  To feel that we now can partly control aging is exciting to me.  I have also largely geared my advice here for people who have a limited budget.

You will hear all sorts of claims if you start on this journey so you need to arm yourself with as much knowledge as possible.  Always remember that this is a young field and we’re continually learning new things about our amazingly complicated bodies.  If any product claims huge benefits, be very skeptical.

Go online and key in various terms; such as, “supplements”, “things to do for better health” etc. Also, go to https://www.longecity.org/forum/wrapper/184  where you will find more than enough topics to keep you busy.  Many but not all people have varying degrees of knowledge and you will soon learn to gravitate to certain ones.

While I don’t use the popular term “reverse aging” – it’s way overused – I do believe many people who do what I will eventually be talking about will have a good chance of living past 100 years of age and be in better shape than many younger people who are not pursuing “anti-aging” now.

I will try to build you up to what I am going and this will take time.  If you try to do too many anti-aging interventions too fast, your body will let you know (it may do that anyway as mine did).

You’ve all heard not to eat too much – and I’m going to add protein to the list.  At 5’8’’ 137lbs, I try to eat around 35-45 grams of protein per day.  When you hit puberty, you had a growth spurt and needed more but once you reach 30-35 too much stimulates your IGF-1 pathway (Insulin Growth Factor) and does shorten lifespan (yes, it does help build muscle).  All the supplements in the world don’t take the place of a good diet rich in vegetables and fruits as they have micronutrients and roughage not found in supplements that are important – vital in fact.

I even maintain one day weekly where, in a 38 hour period, I only eat a total of 500 healthy calories.  For those who care, after an early supper and sleep, I eat at around noon, two scrambled (or sunny side up) eggs with lots of broccoli (just cook for a minute).  I also eat two tiny bits of powdered mustard to enhance the benefit – you don’t need to use more than that.  For dinner it’s tilapia with lots of green and yellow squash.  I drink 3-4 cups of green tea daily and my use warm water with my supplements.  At first, the ghrelin waves (Hunger) will test you but after a few months this lessens.  This regimen also induces slight starvation and makes the body more efficient up to a point which I probably don’t reach.  Broccoli by itself is also believed to induce such slight starvation. When an insect bites into the top part of a broccoli plant, a chemical signal tells the broccoli stalk to produce Sulforaphane.  This can kill a small insect but induces slight starvation in us.

I drink 3-4 cups of green tea decaf tea a day and add an Erythritol sweetener.

It’s important to know how to swallow pills when you are taking a bunch (take one at a time unless they are small – forget what you might see on TV).  Use water or tea that is lukewarm but not cold or hot.  This will relax your throat.  If the supplement doesn’t go all the way down don’t panic.  Just take a larger gulp and “push” the water down.  Always have extra water, etc, than you think you will need.  Drink 1-2 swallows before taking anything to relax and clear your throat (I learned this the hard way in the beginning).  I’ll discuss taking powders in a later blog.

I’m going to mention a few dietary supplements to start with and will include some of the notes I’ve gathered over the years:

D3 – 5000iu (telomerase activator)(helps clear cells of ROS) the most important thing about taking vitamin D is not whether it’s dry or in oil, but that you take it with a meal, as that can increase absorption by about 30 to 50%.  Improves bone health, reduced risk of heart attacks, reduced inflammation.  May reduce aging in bones.  Plays an important role in the body’s utilization of carbohydrates and fats and in the synthesis of protein for the growth, maintenance, and repair of cells and tissues.  It is also crucial for the production of ATP a molecule the body uses for energy.  Take with meal that contains fats. ALL BRANDS ARE PROBABLY ABOUT AS GOOD.  I take this daily

DHA – Your brain loves this fat. Take it for breakfast and dinner with food. The findings, in mice, underscore a role for the body’s fat tissue in controlling the brain’s response to food scarcity, and suggest there is an optimal amount of body fat for maximizing health and longevity.

Vitamin C500mg – Vitamin C is an essential micronutrient, a free radical scavenger; while it has functions such as blocking oncogenic transformation induced by carcinogens. Deficiency in vitamin C is seen in cancer patients frequently, thus, adequate dietary vitamin C in these patients is needed increasingly. This novel epigenetic function of vitamin C needs to become recognized by the general public.  Future studies needs be done for greater understanding of vitamin C impact upon TET and the epigenome which have medicinal relevance in cancer and other diseases.

A multivitamin

These are all very easy to buy.

Next time I’ll discuss some specific supplements I take and why. Also, how I stack (group) them for maximum benefit.

Remember, it’s not just what you take but how much you take them, when, how often and with what (nobody said that this would be easy but it’s worth it).

I love life!  Here’s why I’m showing this picture: 1) Many of the supplements I take are pluripotent (they have more than one action and in several that is to act as “diet mimics” so I have to eat more food just to keep my weight – 5’8″ at 137 lbs). I weighed 197 forty years ago and was putting on weight a few pounds each year. 2) I also believe that you need to treat yourself well so once in a while I do this – shows I am human.

Stan

 

 

Longevity Views, — Did I have a COVID-19 infection?

$
0
0

By Vince Giuliano

I am writing this at a time when like tens of millions throughout the world I am shuttered at home as protection against the COVID-19 pandemic.  On November 17, 2019, I turned 90.  Because of my age and because my wife has an autoimmune condition, we could be very vulnerable if we became infected.  However, I think I may have already had and have recovered from that virus.  I tell the story of that here.

Because, I personally practice many of the health and longevity interventions that I have discussed in this Blog, from time to time I have reported here on the state of my own health.  Recent blog entries discussing my state of health and energy and some of my conditions of life are Funny Things Are Happening To Me On The Way To 100 written in August 2019 and UPDATE ON LONGEVITY INTERVENTIONS – MAINLY PERSONAL, written in April 2019.  I stand by most all of what I have said in these entries, expanding on some contextual aspects here.

As to the COVID-19 Corona Virus, we seem to be free of it in my family and have isolated ourselves in our house.  But is possible that I had and am recovered from an early US case of it.  I may never know for sure.

I could have contracted it on a long packed airline flight from Phoenix to Boston on February 15, a West to East flight on an international carrier on a plane with passengers that could have originated in Asia.  The following weeks, I had the typical kinds if symptom of COVID-19 so-often reported in the press.  It started an inflamed sinus and sinus discharge, followed with sore throat/chronic compulsive cough, low-grade fever, fatigue, lassitude, sleepiness, lack of energy and feeling lousy, finally with cough from deep in my chest, coughing up pus discharges.

Image source.  I had every symptom on this list except Kidney failure.

My situation got worse and worse,  On Feb 25 I saw an Urgent Care PA who ordered a lung X-ray that showed a pneumonia spot in the posterior right upper lobe. I was immediately put on Azithromycin and Cefdinir pills, for a 5-day course.

Neither I nor my healthcare providers were concerned at the time that I had COVID-19.  Perhaps wrongly, because I had not traveled outside the US, nor had knowingly been exposed to anyone who has done so.  At that time community transmission of the disease was not believed in.  Back then COVID-19 was seen as mostly a problem in China with only a handful of cases in the US.  And no tests for it were available except possibly through the CDC.  So I do not in fact know if my pneumonia originated with a COVID-19 infection.  There is, however, good reason to think it did start with some kind of viral infection.  Resting at home I slowly got better, although it took me about a month to completely recover.  Now, my energy and vitality are back.

What other evidence besides how I felt and the lung x-ray exists that I was sick and am now better? – Four key body indicators measured 24-7 by my Oura ring were irregular for the worst 4-5 days of my illness (the pneumonia phase) but have been back to normal ever since. They are:

  • Body temperature which normally and now varies around 97.1, but which ran 98.7 to over 100.4 during the worst sickness days
  • Resting heart rate which normally and now runs around 49- 53bpm. Ran 66-68 bpm during the worst sickness days.
  • Heart Rate Variability which today is 42ms but ran about 17ms during the worst sickness days. The higher the better, of course.
  • Readiness score – a composite index of instantaneous health condition calculated by the Oura software. Today it is 87 My readiness Score averages at 76 and can go up into the 90s,  During my sickest days it was 43-45.

The daily graphs of each of these are automatically recorded by my Oura Ring and most of these measures also by my FitBit Charge 3, and are online.  They convey the same message – I was sick and now am back to normal, at a time when cases of the virus pandemic are multiplying around me and warnings are everywhere to stay at home and avoid people.

In the case that the cause of this sickness was indeed COVID-19, I have some conjectures as to why my recovery was so speedy and uneventful despite my age, and happening at home without ventilator or hospital support of any kind  These are:

  • Simply, I am part of the population demographic segment not seriously sickened by the virus. About half of people tested positive for the virus are asymptomatic, and as I understand it only about 20% get really seriously sick.  Also, I have none of the comorbidities for the disease like diabetes, cardiac or pulmonary problems.
  • I have for years been on a low dose of hydroxychloroquinine, 200 mg every other day. A traditional anti-malarial and anti-arthritic drug now subject to much political controversy because the President is advocating its widespread use to treat COVID-19, but prominent physicians say its use for this purpose is unwarranted until its efficacy for this purpose is established by a large clinical trial.  The government database clinicaltrials.gov lists 68 studies testing the clinical effectiveness of hydroxychloroquinine against COVID-19.  Despite the fact that a major clinical trial for the effectiveness of this drug against is still to be reported, there are at least 3 small clinical studies so far in France(ref) and China suggesting that this drug typically shortens the time and lessens the severity of a covid-19 infection.  I think this could possibly have happened for me. Further, there is an understanding of its probable molecular mechanisms of action against the COVID-19 virus(ref). And last week, the FDA authorized its emergency use for someone with the virus(ref).
  • A frequent and major dangerous event in COVID-19 infection is described in the literature as “a pro-inflammatory cytokine storm” that materially contributes to the damage done by the disease(ref). I believe that the anti-inflammatory 4 Herb Synergy supplement I have been regularly taking might have protected me from the worst effects of such a storm(ref).  At least I do not think I experienced such a storm.  (Note that this is a personal conjecture, not a claim I can responsibly make for our product without an appropriate clinical trial.)
  • One of the drugs prescribed for my pneumonia treatment was azithromycin. Limited clinical evidence also suggests that this drug has been useful in reducing the severity and time course of COVID-19 infections.  The green line in the lower graph below shows the effectiveness of azithromycin and hydroxychlorquinine ln combination in reducing patient viral load in a small French study.

 

 

 

 

 

Image source: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

It could be that this green line shows what happened to me.

 

 

 

 

 

  • I have all along been taking a number of other dietary supplements reputed by some to have anti-viral impacts, including Lion’s Mane and Turkey Tail mushroom extracts, l-carnosine, olive leaf extract, melatonin, and ashwagandha.

I don’t know which of any of these may have helped me.  Neither I nor my healthcare providers are much concerned with the potential deadliness of pneumonia infections in my case – 30% 1-year mortality probability for normal 90 year-olds.  Nor is anybody in my medical care cadre besides me concerned that my pneumonia may have been kicked off by COVID-19

If and when an antibody test becomes available that reliably indicates whether I have had COVID-19, I will take it and resolve the main mystery of this blog entry.  Meanwhile, I see this as just another of the many bugs I have gotten in my life.  It will be the 4th or 5th encounter with pneumonia, and for some of the others I had to be hospitalized.  I have been comfortably at home all along during and after this latest illness episode, writing this and other draft blog entries in my study, staying in good communication with family, friends and colleagues, and taking it easy.  I am looking forward to the next decade of my life leading up to 100, and to keeping myself going fully participating in this hurley-burley life with health and vitality, continuing to contribute strongly all along.

THE COVID-19 PANDEMIC – A THIRD WAY TO GO – CALL FOR ACTION

$
0
0

By Vince Giuliano and Steve Buss

Version4-28-2020

Intro by Vince

With the COVID-19 pandemic, the human species faces the greatest crisis it has faced in 80 years. Since my own possible encounter with COVID-19 as outlined in the previous blog entry, I have been puzzled with how to orient my thinking, writing or research so as to make the largest difference I could.  Is there any way I could arise to the challenge of the situation?  The more I learned about the virus and its spread, the more I appeared impotent to do anything significant about ut.  Then about 10 days ago, Steve Buss called me.  There emerged the bright spark of a new and different societal and scientific approach.  We have interacted furiously since, and I now join Steve in believing that a possible breakthrough avenue exists, the Third Way that we outline here.  We think it is different than almost everything we have seen yet in public discourse.  Steve and I have been exchanging draft versions of this blog entry for several days now, and we always have seen ways to improve it.  Still, because vast numbers of people are getting sick and facing death every day, we want to get our ideas out to others ASAP.  So I am publishing this version to my Blog without Steve having reviewed it.  We may therefore update what is written here one or several times in the coming few days.  And we intend to expand on and further these ideas in a series of additional blog entries very soon to follow. 

———————————————————————————————

THE CURRENT SITUATION

Our public information channels are consistently telling us that the COVID-19 pandemic situation is dire, that it will likely get worse, and that it not likely to go away for years.  As of right now the official confirmed number of people in the United States killed by COVID-19 has reached about 60,000, and more than 210,000 people have died from the coronavirus globally, and case totals have reached over 3.0 million.  Rest assured that by the time you read this these numbers will have worsened considerably.  This blog entry is concerned with what we could do about it beyond the options being hotly contested in public.

Society desperately needs a better alternative than the two main currently-advocated approaches to the Covid-19 Pandemic.  Both these approaches have compelling reasons both for and against them.

The two approaches are basically 1. Open society and the economy up again now and go back to normal, get people back out there working and playing again so the economy can recover,   We can close society  back down again in the future if we need to; and 2: keep the society mainly shut down and slowly let it open up smartly region-by region and function-by function, and perhaps individual by individual.  Use massive testing to assess safety at each point and contact tracing to identify infectious hot spots.

The first “start re-opening our society now” approach is advocated by a number of southern and rural-state Governers: to encourage businesses to resume operations, shops to re-open and healthy people to go out and start participating again like they used to.  Some of our States never shut down, others are being encouraged by their leaders to re-open; people should be free to go out and participate, whether at work, at church, in a bar or restaurant or being in the grandstand at a demolition derby.  They say failing to do so puts the country at risk of: businesses failing, tens of millions unemployed, vulnerable marginal subpopulations suffering incredibly, society collapsing, and a worldwide depression that could last a half a century.  And the worst that could happen is that a 1% to 5% of the population would get sick enough to die while the population in general slowly gains herd immunity.  We think they may be correct about all this.  Most medical people, scientists and liberals say NO, NOT YET.  Up to 30 million Americans could get so sick as to require hospitalization.  Our health care system would collapse under this weight and perhaps 10 million or more Americans would die as a result.  We think they are probably right too.

A CNN screenshot today.

 

The second approach, “be smart about re-opening society carefully” is advocated by most health professionals.  It involves using massive testing to assess safety at each point and contact tracing to identify infectious hot spots.  May be that parts of the country don’t fully open up till mid or late summer or even winter.  Proponents say this is necessary to minimize deaths and keep the health care system operational.  We think they are right.  Opponents say the economic and personal damage could be worse than damage from the virus, and institutions and business and families could be destroyed.  Further, not opening up now is likely to result in subsequent even-worse waves of the pandemic.  We think they might be right too.  And “massive testing” – it does not exist for the US and won’t for some time.  There ain’t no such thing as a standardized and definitive testfor the virus  There are multiple kinds and brands of PCR tests for presence of the virus used in the US.  And the tests we have been using are crummy, giving high percentages of false positives and false negatives.  The tests are so bad that many emergency room doctors view them as only secondary evidence when deciding whether a very sick patient actually has COVID-19 or not.  As Michael Osterholm and Mark Olshaker write in a new Op-Ed in the New York Times: “Far too few tests are available in the United States. Some are shoddy. Even the ones that are precise aren’t designed to produce the kind of definitive yes-no results that people expect. “– “Governments throughout the world and the research, medical-supply and clinical-lab industries must unite to vastly increase global production of reagents and sampling equipment. Achieving this will take months and require building new capacity, presumably with public subsidies. The time and costs involved will be considerable, but such an effort is the only way to test large populations for this infection (and for others in the future).”

Both approaches have the same fundamental problem.  The virus reappears in multiple contexts.  It is out in our free society and the genie can’t be stuffed back in the bottle.  We won’t have a reliable way of knowing who has it for some time.  We could open the society up some and then shut it down again, so the pandemic is experienced in waves.  It doesn’t matter.  “flattening the curve” of infections means postponing cases of it, not averting them.  The virus is clever and unstoppable, and is likely to lie in wait until it affects everybody.  There is no normal to go back to.  And by itself government can’t solve the problem.  A governor can force a major shopping mall or racetrack or meat packing plant to re-open and tell people it’s safe to go and hangout or work there.  But shops in the mall or the racetrack can’t stay in business unless a lot of people decide to go there, which is unlikely.  Same for big sporting events, scientific meetings, restaurants, salons, religious services and bowling and knitting clubs.

The 1918 viral pandemic  Image source

We think the Third Way outlined here may well be the best way to go from here.  We need a must faster way of implementing the Immunity Passports idea, not requiring a vaccine.  It requires us to be we are willing to think outside of the box a bit and use new technical and knowledge resources in new ways.  You never thought of machine learning in connection with health?  Well, please fasten your seat belt and read on.

THE THIRD WAY PROPOSAL

We desperately need a way that gets the society and economy running at full speed again as soon as possible.  And at the same time we must act so that those most vulnerable face minimal risk of serious sicknesses and death from COVID-19 infection.  

We think a key part of the solution is to find a way for individuals to know their personal vulnerability if they are infected by the virus.  If people are to start again hanging out with relative strangers, it is important that they are confident about what their actual safety from COVID-19 harm status is.  Most in our society are unlikely to accept a government-authority proclamation that contradicts their personal experience.  A significant percentage of us now know of a relative, colleague or friend who has been or is now struggling for life in an ICU with a COVID-19 infection.  Or who is now hospitalized and might soon be put on a ventilator.  Or who is already dead.  And we follow the local news.  Therefore we are unlikely to accept a government spokesperson assuring us now that “All is now clear; it is now safe for you to go back out and work and play.”

We believe a COVID-19 Hazard Score (CoHS) can probably be calculated for individuals (for everyone) with a high degree of accuracy which would indicate the probability of getting seriously sick or dying upon coronavirus infection.  That is the novelty-essence of our proposal

A CoHS would range from 1 to 100. And if yours was 0.2 or less, you would know with high certainty that if you contracted the virus, you would have less than one chance in 500 of getting seriously sick or dying. From a personal safety point of view, you could go back out into active participation at work, church, meetings, restaurants, bowling, etc. with that confidence. On the other hand, if you had a score of 30, you would know that you had a 30% chance of getting seriously sick or dying if you contracted the virus, so you would probably want to keep yourself safe closeted up at home.  And if government authorities and businesspersons have the same data, they will know who can safely be encouraged to go back to work and participate with others to re-boot the economy.

If we had a good CoHS system, existing data suggests that something greater than 95% of the population would be found invulnerable to serious sickness from COVID-19, and could go back out and re-open the society.  Medical and social efforts would focus then on the 5% or so of the population tested to be probably vulnerable. Instead of sequestering everybody, only these vulnerable people in the society would have to be sequestered to protect them, standing the present approach where everybody is sequestered on its head.

Note that our focus in CoHS is on safety from serious illness or death, not on immunity which is extremely difficult to measure reliably and which might come and go.

The stakes for an approach like this to be realized are enormous – hundreds of thousands or millions of deaths averted, tens of millions of jobs recovered, trillions of dollars in economic benefits, years cut off the time for world recovery from the pandemic, and probably avoiding a worldwide depression or worse.

We can imagine a CoHS for individuals to evolve to yield summarized information that would look something like the data in the table below in some future phase.  (Data shown is invented, not to be taken for real.)

 

 

 

 

 

 

 

 

This kind of CoHS system does not yet exist, but we think:

  • It’s inevitable that something like it will eventually be created,
  • We know how to go about creating it, and
  • it can be created relatively quickly. (See the brief discussion below)

We think the suggested CoHS system can be based on analytical studies and machine learning applied to existing actual-data sets.  We further think the CoHS system could be made “hard” and statistically reliable by incorporating actual experience data for tens and hundreds of thousands of individuals. 

We think the approach will work because we already know that there is great variability of consequences for most people who contract the COVID-10 virus.  Several studies have indicted that around 95% of infected people don’t get seriously sick and that around 50% don’t have symptoms or know they are infected.  It is a highly personal difference that we think can be much more precisely nailed down by studying personal health-characteristics of infected people.  That is how we will get to the CoHS scoring system.  Look at the real data.

As a prime source, data bases worldwide specifically related to COVID-19. We suspect hundreds of such collections are being developed worldwide now.  Many of these will result in publications.

Also, among the kinds of data we are thinking about are ones routinely included in individual clinical records, such as

    • Disease history data (like kidney, heart, pneumonia, hypertension, obesity, etc)
    • Demographic data (like age, gender, and race)
    • Biological markers in the blood circulation data (IL-6, TNF, IL-1B, etc.)
    • Individual blood type – known to be influential for assessing susceptibility to Noroviruses
    • Individual inflammatory indices – such as CRP and levels of some cytokines like IL-6 and IL-1beta
    • Markers of obesity
    • Blood profiles on file including lipids
    • History of other chronic viral infections, HPV, HIV, EBV, CMV, etc.
    • History of certain diseases, such as pneumonia or kidney diseases
    • Smoking history
    • Plasma antibody COVID-19 test results if available
    • Previous COVID-19 test results if available
    • Allergy history
    • Measures of frailty, such as loss of body mass in old age

There is 24-7 data individuals gather using smart-watch and smart ring wearables such as body temperature, resting heart rate, and HRV.

Our approach to data heterogeneity is to start out being very be inclusive, that is, to start out including a number of data types as exemplified above that we think could possibly be relevant TO A CoHS. Then narrow the list down to data types established to be relevant based on data analysis,  And finally to compute CoHS scores based those data types for extremely large numbers of people.  Major issues are identifying relevant data bases, respecting personal confidentiality and data integration from different studies.

We will go into these further in blog posts to follow.  Among the Data Science Methodologies we see as potentially applicable are

  • Multi-variable regression analysis
  • Principle-axis data analysis
  • Data clustering techniques
  • In particular, many new approaches to machine learning

Ready-to-use software is available for each of these techniques and they are known well to those who practise them..

We think there is strong epidemiological evidence to support the third-way approach outlined here

A significant example is the Chinese study cited above Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China.  Many biological variables were measured and documented in the study; some we had never heard of but are now intrigued by. It is a study we are extremely interested in, and we would like to include it in our Phase 1 analysis. We think you will find it important too once you see a couple of their study images.

Background – With evidence of sustained transmission in more than 190 countries, coronavirus disease 2019 (COVID-19) has been declared a global pandemic. As such, data are urgently needed about risk factors associated with clinical outcomes.

Methods – A retrospective chart review of 323 hospitalized patients with COVID-19 in Wuhan was conducted. Patients were classified into three disease severity groups (non-severe, severe, and critical), based on their initial clinical presentation. Clinical outcomes were designated as favorable and unfavorable, based on disease progression and response to treatments. Logistic regression models were performed to identify factors associated with clinical outcomes, and logrank test was conducted for the association with clinical progression.

Results – Current standard treatments did not show significant improvement on patient outcomes in the study. By univariate logistic regression model, 27 risk factors were significantly associated with clinical outcomes. Further, multivariate regression indicated that age over 65 years, smoking, critical disease status, diabetes, high hypersensitive troponin I (>0.04 pg/mL), leukocytosis (>10 x 109/L) and neutrophilia (>75 x 109/L) predicted unfavorable clinical outcomes. By contrast, the use of hypnotics was significantly associated with favorable outcomes. Survival analysis also confirmed that patients receiving hypnotics had significantly better survival.  (Steve and Vince to comment on this point in a later blog entry)

Conclusions – To our knowledge, this is the first indication that hypnotics could be an effective ancillary treatment for COVID-19. We also found that novel risk factors, such as higher hypersensitive troponin I, predicted poor clinical outcomes. Overall, our study provides useful data to guide early clinical decision making to reduce mortality and improve clinical outcomes of COVID-19.

Most people will have relatively low vulnerability scores

We think the majority will score so they will be able to get back into work and social participation: Studies of people who test positive for the virus indicate that…

  1. A large portion of them – 50% is a usual estimate – have no symptoms and don’t know they are sick.
  2. 10% to 30% will feel sick but not sick enough to seek medical attention.
  3. 5% to 20% will get sick and seek medical attention.
  4. A tiny percentage – estimates range between 0.5% and 3% — will get so ill that they die despite medical attention, depending on the population and the study.

We think the higher percentages mentioned for A & B and the lower percentages mentioned for C & D are probably the more accurate because of existing shortcomings of testing scope and bias in testing studies. Most people tested so far were tested because they were already sick to start with. This suggests that we start out knowing that the average vulnerability score for everybody is not above the very low digits.  Hopefully, machine learning applied to large data collections will indicate far more-accurate low numbers for most individuals.

DEVELOPING THE COVID-19 HAZARD SCORING APPLICATION, Phase 1

Developing a high-accuracy scoring system is important because people need to have confidence in it to bet their lives on it. Several Phases will be required to develop the processes and software required for the vision we have expressed above.

Several key process steps are implicated in the Phase 1 application, and these steps are summarized in the text and image below.

  1. Identify, contact, and gather anonymous COVID-19 patient data from scientific teams and health institutions.
  2. Transform and integrate that anonymous patient data into the CoHS application database. Rationalizing inputs from multiple sources which use different criteria for the same measurement is likely to be the biggest challenge associated with the project.
  3. Leverage com’s Machine/Deep Learning Competitions feature to get many smart and skilled data scientists to participate. Support them while they compete to create the best Machine/Deep Learning Agents to analyze the CoHS application data and provide COVID-19 CoHS Risk Evaluations by significant scientific study variables. (Follow this link for info about Kaggle and this link about Kaggle Machine Learning Competitions.)
  4. In Phase 1, we would write a report that summarizes the results of the Kaggle.com COVID-19 CoHS application competition.
  5. Our hope is that future studies will leverage what we learn as they create new COVID-19-related studies.

We estimate that it will take at least two months to deliver the Results and Interpretation Report from the date we have enough scientific study data sets to begin. So if we have data by the end of May, we might be finished with Phase 1 by August 1st.

Who does all this?  As it forms, a tentative name for the group could be The Covid-19 Data Science and Machine Learning Consortium.  Steve and Vince would want to call ourselves IN this group

SIMILAR PROPOSALS THAT HAVE BEEN MADE

A vaccine and Immunity Passports?

There is the idea of developing a vaccine against the virus, which would protect people and of issuing covid-19 “Immunity Passports” to people who have antibodies to the virus and are safe to send out back into the society.  Terrific idea in that it has less-vulnerable people moving back into re-opening the society.  But as it has stood so far it can’t have a big impact for years because it requires a good test for such immunity and a plurality of people to have such immunity which in turn requires availability of a reliable vaccine.  At least a year and a half wait we are told.  And perhaps never.  We have been trying to get an effective vaccine for the HIV virus for three decades now, and success at that still eludes us.   We need a must faster ay of implementing the Immunity Passports idea, not requiring a vaccine.  We think the Third Way as we outline here might be that.

We think our suggested machine learning approach is a good way to start nowWe could have our first rough Hazard Score system up and running in a couple months and this could reveal very large numbers of safe individuals for going back out and rebooting V2 of US society.  And the system could be continuously improved after that.  And modifications of the Third Way could be used to protect us from pandemics yet to come

CORONAVIRUS #TOTALHARMMINIMIZATION

Dr. David Katz has proposed an approach very aligned to what we are proposing in terms of opening up the society.  We like what he has said and written about the pandemic.  He rightly points out “If all we do is flatten the curve, you don’t prevent deaths, you just change the dates.”  We arrived at the ideas presented here independently.   The further  contributions of our proposal is that we are suggesting 1. the use of massive application of machine learning approaches to existing and emerging databases to significantly speed up the process of deciding who is safe to go back 0ut in society, 2. Computation of Hazard Scores which indicate probabilities of becoming seriously sick if people get the virus, 3. Development of a personal app for cell phones and computers which tell individuals their hazard scores and possibly consul them of how to reduce their hazard scores and 4. use of aggregated Hazard Score data to drive public policy as well as private instutions as to how and when it is safe to re-open.

We would like to join with Dr. Katz and with the Immunity Passport advocates for moving forward at this point.  We need build on each other’s contributions if we are going to effectively take on the challenge of this and future viral pandemics.

We would like to join with Dr. Katz and with the Immunity Passport advocates for moving forward at this point.  We need build on each other’s contributions if we are going to effectively take on the challenge of this and future viral pandemics.

More detail and discussion is yet to come in future blog entries.

 

Possible Covid-19 Coronavirus (SARS-CoV-2) Infection in the UK in mid-December 2019

$
0
0

Intro by Vince Giuliano

It is a good guess that the earliest COVID-19 cases in many if not most countries were thought to reflect some other disease and never properly diagnosed.  Because no testing was done and the medical establishments were completely unprepared for the pandemic, we shall never know for sure.  I reported my having such a possible early case in the blog entry Longevity Views, — Did I have a COVID-19 infection?  My case, assuming it indeed was COVID-19, was contracted in  a crowded West to East airline flight on February 15. 2020. A member of my extended family Peter Mitchell put me in touch with Neil and Susan Johnson, UK medical science reporters who told a story remarkably similar to my own.  In their case, almost like mine, COVID-19 was not thought to exist in the country until long afterwards.  Their sickness harkens back to December 2019 and was contracted in airliners in Italy.  Their story  as they have written it follows.

Guest blog entry by Neil Johnson and Susan Johnson

According to a bulletin issued on 27 April by the WHO, the first recorded case of Covid-19 outside China was reported in Thailand on 13th January.  On 29 January two Chinese nationals became the first recorded cases of the coronavirus infection in the UK.  A week later, on 6 February, the first British national was diagnosed with the virus, though the infection was said to have been contracted in Singapore.  It was not until 28 February that a British national was reported to have been infected within the UK.

This timeline, which is widely regarded as crucial to a proper understanding of exactly how and when the Covid-19 pandemic struck the UK, also underpins the epidemiological models determining UK government policy on minimizing the spread of the disease.  If, however, evidence were to be produced that cases of Covid-19 had been present in the UK before the dates of the “officially” recognized cases, the reasoning behind both the epidemiological models and the disease-containment policies would need to be reviewed.  It is in this context that we present the following account of our own illnesses which occurred in December 2019.

The nature and duration of the symptoms

Between mid- and late-December in 2019, we both became ill with all the symptoms which are now regarded as characteristic of Covid-19 and which are generally accepted as being retrospectively diagnostic of infection with SARS-CoV-2 when a person has died before a test could be carried out for the presence of the virus – as has frequently happened amongst residents of care homes.

On Wednesday 18 December, Susan was the first of us to fall ill, initially with vomiting and diarrhoea, followed rapidly by total exhaustion, very high temperatures leading to drenching sweating, and the development of respiratory symptoms: these latter began with irritation at the back of the throat which then progressed rapidly downwards into the lungs, leading to a severe and debilitating cough which lasted for more than two weeks and led to her taking to bed for the next three to four days.  Though by Sunday 23 December Susan had recovered from the worst of her illness, and was just about well enough to collect some pre-ordered food for our Christmas dinner, her general exhaustion, high temperatures and cough persisted for several days, and the planned Christmas celebrations were all cancelled.

Neil’s illness began on Monday 23 December, five days after the commencement of Susan’s digestive problems.  Whilst Neil did not experience either vomiting or diarrhoea, the exhaustion and drenching temperatures set in rapidly, followed by severe and sustained coughing and infection of the lungs, rapid breathing (over thirty breaths per minute), and low oxygen levels in the blood.

Both of us also suffered from various other symptoms, some of which which were not included in the early descriptions as being characteristic of SARS-CoV-2 infection, but which have more-recently been accepted as important components of the symptom spectrum:

  • severe, itching conjunctivitis and blepharitis, with the accompanying redness and swelling of the tissues around the eyes, which we managed eventually to bring under control by the topical application of chloramphenicol ointment;
  • loss of taste and smell, these being aspects of Susan’s illness in particular; the return of these senses to normality are still, at the time of writing, by no means complete in her case. Whilst Neil did not lose either sense entirely, he did experience a change in taste, being unable to countenance some foods which he had previously liked – as in Susan’s case this has reversed, but only slowly;
  • loss of appetite, being the more obvious in Neil’s case, and resulting in his eating nothing for over a week, with consequent considerable loss of weight.

In the days after the symptoms of his illness first appeared, Neil’s condition deteriorated rapidly and he is sure that the close attention and care which Susan was able to give him were major elements in his eventual recovery, as she plied him with small amounts of water and food almost every five minutes, keeping up his level of hydration and energy reserves.  Despite this, the worsening of Neil’s condition was so rapid and marked that on Friday 29 December we decided to telephone 111.  We were referred to an out-of-hours general practitioner who, clearly alarmed by Neil’s red-eyed, grey-faced, gaunt and generally exhausted appearance, wavered on the edge of sending him to hospital; finally, however, and evidently reassured that he would continue to receive excellent care at home, the doctor prescribed a course of antibiotics (amoxicillin).

Neil’s condition remained more or less the same for the next week, at which point, on Friday 3 January, his GP prescribed a further week’s treatment with a different antibiotic (clarithromycin), and sent him for an X-ray that same day at the nearby hospital.   The X-ray confirmed changes in the lungs characteristic of pneumonia. By Thursday 9 January, Neil gradually recovered his strength: whether or not the clarithromycin had proved effective, or whether his own immune system had eventually risen to the challenge, is not clear, but his improvement was such that a review by his GP led to the decision that no further antibiotic treatment was required. T he racking cough, though, persisted, eventually subsiding after three more weeks.

In view of Neil’s recovery following the prescription of a one-week course of clarithromycin, it is, perhaps, worthy of note that it has been known for at least a decade that some of the macrolide antibiotics (which include, in addition to clarithromycin, erythromycin, roxithromycin and azithromycin) possess antiviral potency, in part by way of inhibiting cytokine production, an effect specifically noticeable in bronchial epithelial cells.  Such findings are particularly interesting in view of the recent suggestion by Professor Michael Lisanti and his co-workers at the University of Salford that azithromycin might well have a protective effect against SARS-CoV-2 virus infection if administered to doctors, nurses, paramedics and other health workers having direct contact with patients showing symptoms of Covid-19.

We find it curious that, with a few exceptions, the doctors to whom we have subsequently described our experience have seemed unwilling to acknowledge the possibility that we could have been infected with the SARS-CoV-2 virus.  The usual response that we received was that this was just not possible because the virus was not present in the UK until late January.  Our reply that, whilst that might be so, it was nevertheless possible that we had been infected by the virus outside the UK, was usually met with silence.

Travelling to and from Italy in mid-December

In fact, we had just returned from a short visit to Sardinia. Our outward journey on Wednesday 11 December had involved three separate flights – from Manchester to Amsterdam, Amsterdam to Rome, and Rome to Cagliari in Sardinia – with the reverse sequence of flights occurring on the return leg.

Although we had intended to spend a full day in Rome on the outward journey, a strike by Alitalia aircrew planned for two days later meant that we spent only one night there, catching the flight to Cagliari the next morning, Thursday 12 December.  There were many others who, like us, had found it necessary to bring their journey forward one day because of the Alitalia strike and, as a result, the plane was so tightly packed that there was no room for all the passengers’ hand luggage, which had to be put into the hold instead.  We both remarked on the number of passengers with very bad coughs, and we were concerned that we found ourselves seated right at the back of the plane from Rome to Cagliari (as, indeed, had been the case on both flights the previous day); we were therefore among the last to get off the plane when it landed at Cagliari, and we expressed to each other our concern that this involved our having to plod slowly through the same air that had been breathed in and out by the coughing passengers.  Our seating at the back of the aircraft was, to our great discomfort, repeated on each of the three return flights – Cagliari to Rome, Rome to Amsterdam and Amsterdam to Manchester – five days later, on Tuesday 17 December.

The upshot of all this is that we had not only been through, and passed a night in, the country that was to be the first in Europe to be devastated by Covid-19, but we had spent the best part of two whole days breathing recycled air in aeroplanes containing many people who, to judge by the widespread coughing amongst them, could well have been infected with the SARS-CoV-2 virus.  Moreover, we had spent several hours, on both outward and return journeys, waiting for our flight transfers in crowded airports where we were surrounded by people of many nationalities, including a high proportion of Chinese.

Implications for the currently accepted timeline for the appearance of Covid-19

If the symptoms of the illness to which we had both succumbed shortly after mid-December 2019 are – as they certainly appear to be — those which are now generally accepted as definitive of SARS-CoV-2 infection, then the conclusion that this virus was present, and possibly even widespread, in Europe by that time seems inescapable.  If so, it would seem also to be inevitable that SARS-CoV-2 would have been brought into this country in December 2019, or perhaps even earlier, by those who, like ourselves, were asymptomatic at the time of entry into the UK, or who were displaying symptoms which, at that time, were attributed to the common cold or influenza.  This would have been well before the report of the Wuhan Municipal Health Commission was issued on 31 December 2019, in which it was stated that a substantial number of cases of pneumonia had recently occurred in Wuhan, in the Chinese province of Hubei.

The conclusion that the SARS-CoV-2 virus was already circulating amongst sections of the population in Europe well before the Chinese report appeared, is in line with information recently provided by Dr Yves Cohen, Head of Resuscitation at the Avicenne and Jean Verdier Hospitals in Paris.  Dr Cohen and his colleagues retested samples from 24 pneumonia patients who had received treatment in December 2019 and January 2020 with suspected influenza but whose tests had, at that time, proved negative for any influenza virus: one of these samples, from a man whose test had first been carried out on 27 December 2019, gave a positive result for SARS-CoV-2.  Up to that point, it had been thought that the first three cases of Covid-19 in France had appeared on 24 January 2020. The patient, later identified as Amirouche Hammar, whose sample taken on 27 December 2019 had subsequently proved positive for SARSCoV-2 would not only have been ill for a while before the sample had been taken, but would have contracted the SARS-CoV-2 infection some time before his symptoms appeared.  Assuming that the total period of infection prior to his being tested was of the order of two weeks, that would suggest that the SARS-CoV-2 virus had been present in France, and perhaps in other parts of Europe, too, at least as early as 13th December, and most probably before that date – before, in fact, we commenced our series of flights from the UK to Italy, and well before the first report of the infection was issued by China.  This conclusion is supported by the fact that Monsieur Hammar had not travelled beyond the borders of France.

How and when the SARS-CoV-2 virus arrived in that country remain open questions, though suggestions are already being put forward.  For example, on 25 March French pentathlete Elodie Clouvel, who had taken part in the World Military Games in Wuhan in October 2019, reported that whilst in Wuhan she had fallen ill with symptoms now accepted as indicative of Covid-19; she suggested that she, as well as several of her fellow athletes who had attended the games and had also reported similar symptoms, may have been responsible for bringing the SARS-CoV-2 virus into France on their return from China.

We have no doubt that, as time progresses, we shall all hear of many more cases of Covid-19-like illnesses having been reported in the weeks, and possibly months, before the Chinese report was made public.  Such information will be crucial in understanding where and when (and, perhaps, how and why) the SARS-CoV-2 virus first entered the human population, as well as helping to elucidate the person-to-person transmission process (or processes) which allowed the illness to spread so rapidly throughout the world.

 N. Johnson PhD, FBPsS, FRSB,   S. Johnson PhD

About the authors

We are both retired and live just south of the English Lake District. Susan has a first degree in Zoology from Notingham Universityand took her PhD in Cancer Research in the Birmingham University Medical School before we moved to Lancaster where she became Managing Editor of Medical Science Research. I have two first degrees, the first in Chemistry & Zoology and the second in Psychology, and took my PhD, also in the Birmingham Medical School, in Experimental Neuropharmacology. I became a Lecturer in Psychology at Birmingham University before we moved to Lancaster where I became a Reader in Neuropharmacology in the Psychology, and eventually Head of Psychology, in the University of Lancaster. In late 2019 Susan started her own publishing house, which I later joined. We published and co-edited a clinical pharmacology journal, Reviews in Contemporary Pharmacotherapy, and published other medical and biomedical texts. We are both Fellows of the Royal Society of Medicine, and I am also a Fellow of the British Psychological Society, the Royal Society of Biology, and the International College of Neuro-psychopharmacology.

C0VID-19 myths, truths, commentary and updates

$
0
0

 

 

 

 

 

 

Image source

5-23-2020  By Vince Giuliano with strong support from Steve Buss

This blog entry combines links to new viewpoints on the COVID-19 pandemic with interesting news, comments and strong opinions of my own.

The key points I will amplify here are:

  1. We – members of our species – are at war with an alien enemy species
  2. We are fighting that war with ancient defenses from millennia in the past
  3. We are losing that war which is not at all ending
  4. The US response to the pandemic has been particularly ineffective
  5. The economic damage of our approach to the Pandemic may be driving us into an economic situation as bad as or worse than the Great Depression of the 1930s
  6. What we have been doing about the pandemic so far has not worked well
  7. We have crummy tests, crummy contact tracing, and crummy control of the virus
  8. While the enemy virus is waging war against our species, our responses have been fragmented, different among nations, different among states in the US
  9. The solution to the Pandemic societal dilemma is not primarily medical
  10. Superb medical facilities don’t help prevent spread of the virus and the sickness and deaths which follow
    1. The medically-sanctioned approaches to the pandemic are not practical and are not being followed
  11. Tribal politics seems to dominate the public discourse Our paralysis seems to be driven by noise connected with a conflict between two major viewpoints, neither of which can work well.
  12. The conflict is political as well as scientific, so much as to obfuscate fact from fiction. Many special interests are involved.
  13. There is a better way to go
    1. One the key is shifting from sweeping stay shut down vs open up policies that affect everybody to focusing instead on special and intense provisions for the relatively small population of people likely to be vulnerable to the virus enemy.
    2. The other key is to use the tools of big-data and machine learning to find out as much as we can about ourselves to protect us against the virus.
  14. There are ways you can protect yourselves as an individual in the face of the pandemic
  15. A few relevant new research findings
  16. FINAL COMMENTS
  1. We Are At War With An Alien Enemy Species

The enemy species is of course the COVID-19 virus which is alien because it is invisible, so new and strange for us, and we are not sure where it came from.  The enemy is very clever and employs stealth as a major strategy.  It is hard to fight an enemy you can’t see.  It is not possible reliably to tell who is infected with the virus and therefore know who to avoid to gain personal protection.  The virus is highly infectious and during its incubation period infected people don’t even know they have it.  A person cannot tell whether someone who seems healthy has the virus and is passing it on to him or her.

  • One of these alien enemy species is real, dangerous, and strangest.
         
  • 2.  We are fighting that war with ancient defenses from past millennia

Our primary public health response has been EVERYBODY SHOULD AVOID EVERYBODY ELSE.  This strategy is embodied in the strategies of social distancing, isolation and shutting down institutions and events where people interact with other people.  This is a very ancient pandemic response going back to times of the Egyptian, Persian, Greek and Roman empires.  One solution fits all.  When in doubt, hide out.  While-time honored it is a very inefficient response that does not work well with this particular COVID-19 enemy.  While this approach has been widely implemented and has been used “to flatten the curve,” I think it is dumb to rely on it permanently as our main approach while we have other powerful tools available.  It doesn’t work well.  And it is completely toxic to our economy.

Another ancient political response to disease is denial, deliberate not-knowing.  At various times, the Roman Empire used this response to deal with smallpox pandemics which devastated its armies and contributed to its ultimate demise.  A good way not to register any new COVID-19 cases is simply not to test for it and pretend the Pandemic has gone away.

  1. We Are Losing That War Which Is Not At All Ending

Is the pandemic going away?

The answer is clear from this chart, which is confirmed cases and number of deaths in the US.  As superman used to say, “Up. up and away.”

Image as of 5/19/2020

As of 5/23/2020 there were 5.2 million confirmed cases worldwide and 1.6 million in the US.(ref)  Confirmed deaths from the pandemic yesterday were 383,979 worldwide and 94,722 in the US.  And without doubt actual numbers of cases and deaths are much larger.  By the time you read this the reported numbers will be significantly larger.  At this time, the number of new cases worldwide appears to be still increasing while that in the US shows a slight tendency of leveling.

  1. The US response to the pandemic has been particularly ineffective

That observation is clear from looking at this chart for confirmed cases.  Top green line is for the US.  Lines for other countries are along the bottom  See the legend shown next to the graph.

Image as of 5/19/2020

On the optimistic side we might possibly just now be peaking in death toll

But don’t be fooled by the curved look of this graph.  The vertical scale is logarithmic and the actual rising death curve is still is a lot like a straight line

 

Image source

It is too soon to tell whether and when he virus infections will let up.  Infection and death rates vary widely by country and State and from week to week.   We are told additional waves of the pandemic are to be expected. A time in a war when death rates are maximal and the number of deaths is still shooting up is not a good time to declare victory. “Model Shows Increased US Deaths as Restrictions Continue to Lift.  A key model used to project COVID-19 deaths in the US is now predicting more than 137,000 people in the US could die by August from the novel coronavirus.  Researchers claim the augmented death toll is due to more people leaving their homes as governors relax social distancing restrictions.  IHME Director Dr. Christopher Murray said in a press release that: “Unless and until we see accelerated testing, contact tracing, isolating people who test positive, and widespread use of masks in public, there is a significant likelihood of new infections.(ref)”

Renewed fears of second wave:

‘New clusters in South Korea, Germany and China show the continued risk of reopening — even in countries that are seen to have managed their outbreaks well. New surge in cases: There was a surge of coronavirus cases over the weekend in some of the nations around the world where stay-at-home measures and other restrictions were lifted, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus said Monday.(ref)”

On a very personal level, I just learned that my eldest son who is in a Massachusetts nursing home has been isolated because his routine lab tests indicate a possible COVID-19 infection.

  1. The economic damage of our approach may be driving us into a situation as bad as or worse than the Great Depression of the 1930s?

Economically ,we are not doing well at all in the US.  We have close to 40 million unemployed people now.  Perhaps many more given that informal economy numbers are not counted.  See US job losses due to COVID-19 highest since Great DepressionSo far the banking system as held solid, but there have been many bankruptcies with many more to come.  It is one thing to tell, airlines, hotels, shopping malls, cruise ships, churches, restaurants, and barbershops that they can now re-open and resume business as normal.  But it remains to be seen if enough people patronize them that they can stay in business.  So it may be some time before we know the extent of already-done economic damage.

 

  1. What we have been doing about the pandemic so far has not worked well

This is a basic message of current data as can be seen in these and many many other current charts.  Our policies have simultaneously resulted in extraordinary large number of covid-19 cases and deaths AND economic havoc.

It is generally agreed that reported case as well as death numbers are probably far below actual.  The numbers of people tested for the virus who show positive in the US is probably a small fraction of those who have it or have had it.   Even if someone has been tested negative, they may test positive in a few days.  For the US as a whole the number of reported cases is now doubling every month, although that number varies widely by State.  For Kentucky, Alabama, California, Virginia and Illinois, for example, number of cases is doubling every 3 weeks.  In New York they are doubling every 3 months. (ref).  But please don’t be lulled by the lower numbers; in every case they represent exponential growth, not leveling, not declining.

  1. We have crummy tests, crummy contact tracing, and crummy control of the virus

For months now, political leaders and media voices have been telling us that the key to controlling the virus is more and more and more tests.  These tests combined with effective contact tracing for infected people should tell us who is infected and who is not.  Everybody should be tested.  There has been much consternation over a continuing lack of tests.   But only very few people in the public sphere have been telling us about the test’s deep flaws which result in them having quite limited practical utility.  Dr. Sanjay Gupta finally broke through that wall of silence this week with an article in CNN Health.  There is no such thing as a standard test for COVID-19.  Perhaps upwards of 100 different kinds of PCR-RT throat swab test kits are on the market, from companies in the US and around the world.  Only some  of these have been impartially tested and validated.  Some of these produce results only after 5 days, others in a few hours, a few in 5 minutes.

The biggest problem with these tests is false negatives, where people who are in fact infected yield negative test results.  False negatives can result because of improper throat swab administration, because the virus in an infected person has not yet replicated enough to show on the test, or because of flaws in the test itself.  I am told by practicing clinicians that a false negative rate of 20% to 40% is not unusual.  This means that 1 out of 3 or 4 tested and therefore declared to be “safe from infecting others” is in fact not safe that way at all.  No wonder that a locked-down nursing home may test everybody and find one positive case who is then isolated, and test everybody again in a week and find 15 positive cases who are also quickly isolated, and the week after that test again and find 75 positive cases among patients and staff.

The serum antibody tests are completely different but also have their own problems.  They are designed to look for antibodies in the blood expected to be present if a person has been infected with the virus.  The antibodies are produced as part of the body’s immune system response to the virus.  Mostly so, but not necessarily for everybody who has been infected.  Therefore the tests are thought to possibly give us low-bound estimates of the number who have been infected.  It is conjectured but not known for sure that the presence of the antibodies indicates some degree of immunity to the virus.  There are also several of these tests under development and coming on the market, but some of these may also not provide reliable results.  I was told by a practitioner that an imported batch of such tests showed strong positive results for people who had COVID-19 infections.  But alas, the tests also showed false positive results for people who had earlier infections with other viruses like CMV, EBV and HPV.  So again, you can’t conclude that a person testing positive is immune to COVID-19, because the test and presumed immunity might relate to a completely different infectious agent.  And you cannot conclude that a person who has tested negative has not had the virus.

Let me be clear, I support doing a lot more testing.  I think that doing widespread testing can be important for helping us guess more accurately who is vulnerable to infection with the virus and who is not.  But the tests too-often don’t give correct results and mostly can’t be relied on by themselves for effective decision making.

  1. While the enemy virus is waging war against our species, our responses have been fragmented, different among nations, different among States in the US

While I am concentrating here on the situation in the US the Pandemic is worldwide. The virus is a war against our species although the responses to the war lacks coherency and joint international initiative.  Imagine the world is under attack by a fleet of enemy spaceships and our reaction is that every nation needs defend its own citizens.   And in the US, it is up to each individual State to defend itself.  That is our current situation.  The World Health Organization in a relatively weak voice, lacking political clout.  The same can be said for the CDC in the US.  Yes, medical practice seems to be international in scope and there are important philanthropies devoted to world health like the Bill and Melinda Gates Foundation.  But governments seem to be the major public health actors responding to the virus in various ways and degrees.

Of course there is one major advantage to this fragmentation, and that is opportunity for learning and innovation as different approaches are being pursued and different results obtained.  The value of this should not be underestimated.

  1. The solution to the Pandemic societal dilemma is not primarily medical

Medicine and health care is perhaps the largest sector or the US economy.  However the overwhelming focus of medicine has always been the treatment of medical problems in individuals, and this usually only after symptoms of such problems have appeared.  While there has been increased discussion of “preventative medicine” recently this has been secondary to what most doctors and other health care workers do.  In the current Pandemic, medicine and the health care industry are only some of the key players involved -along with international meat-packing companies, nursing home operators, business owners, prison operators, cruise ship and sports team owners and politicians at every level.

Doctors and hospitals have played important roles in treating the very sick and saving a certain number of lives that would be otherwise lost.  They also maintain COVID-19 patient records, conduct research studies, and disseminate medical knowledge as it is accumulated to colleagues and via research publications  I believe these activities could play a very important R&D functions to help us defeat the virus.  Not only potentially by creating a vaccine for COVID-19, but also by helping us understand what existing pharmaceuticals might be mobilized to blunt its deadliness.  And most important of all in my mind, by helping identify biophysical  properties of individuals that make them particularly more or less vulnerable in case of COVID-19 infection,  More on this in Section 13  below

  1. Superb Medical facilities don’t help prevent spread of the virus and the sickness and deaths which follow

In health matters Massachusetts is a highly enlightened state, with hospitals, medical resources and health research programs among the very best in the world.  Yet, Massachusetts had the third-highest infection and death rates from the virus in the country on a population-adjusted bases   Northern Italy has one of the best medical systems in the world.  Yet, the existence of that system did not prevent the wildfire spread of the virus there and the associated death rates.  And statistics of death rates from the virus suggests that it sickens and kills everywhere, where there are first-class medical facilities and where such facilities don’t exist.  Of course for some individuals in critical condition and threatened by death from the virus, being in a first-rate hospital might make a life-or-death difference.  But from the worldwide numbers rolling in, availability of high-quality medical care does not seem to make much if any of a statistical difference.  The Roman Army could not conquer smallpox, despite some Roman Emperors having ordered the Army Generals to do so.  And an excellent health care system can’t conquer COVID-19, though it may contribute to saving the lives of a few of the most seriously sick.

  1. The medically-sanctioned approach to the pandemic are not practical and are not being followed

The central current “enlightened” proposed approach to our dilemma lacks both feasibility and imaginationFor the US, that proposed solution is to double down on the conventional public health measures:  My understanding is that the essence of these guidelines is:

  • Vastly expand testing for the virus, to healthy but possibly exposed populations
  • Get serious about 100% contacting tracing,
  • Enforce strict respect social distancing,
  • Keep society things closed down long and hard enough, until new cases and deaths drop down to low values
  • Promulgate specific rules to be followed by specific kinds of institutions, like nursing homes, restaurants, and meat packing plants
  • Fine and punish those who offend the rules,
  • make sure everyone wears face masks in public, and
  • accelerate work on a vaccine for the virus. And
  • accept that until or unless such a vaccine is developed, the pandemic may to a significant extent be with us.

These are great ideas, and some of them seemed to have worked so far in China.  But for us now in the US, they are collectively rather unrealistic – the tests are not available, sometimes require a week to get test results and often have a 30% false negative  rate.  Contact tracing won’t work because of possibly millions off already-infected people who we can’t identify to start with.  A very large numbers  of people who should know better offend the social distancing rules and won’t wear face masks.  And while many companies are working hard on a vaccine for COVID-19 and here are many optimistic press releases, the best realistic scenario says this will take at least 18 months, and it may never happen.  Decades of work have gone into attempting to develop a vaccine for HIV, and that has not happened yet.  And the political processes and social dynamics of the moment are leading us in the opposite direction, to re-open the society.  Most US States that have partially shut down are now re-opening, although they cannot assure following the guidelines for re-opening recently promulgated by the CDC.  Please, we desperately need additional creativity

  1. Tribal politics seems to dominate the public discourse Our paralysis seems to be driven by noise connected with a conflict between two major viewpoints, neither of which can work well. 

The societal shut downs in the US have of course caused economic paralysis on many fronts, leading to a political standoff that seems to me to be tribal in nature.  Our paralysis seems to be driven by noise connected with a conflict between two major viewpoints, neither of which can work well.  One tribe says we should keep the society mainly shut down for now to minimize deaths.  And opening up social interactions too fast could lead to disastrous new virus outbreaks and much additional sickness and very many new deaths.  The other tribe says not opening up our society and economy quickly and immediately could lead to massive unemployment, economic collapse and much associated suffering.  I believe both sides are right in their objections.  We seem to be heading to a compromise that could lead to the worst consequences of both of the two approaches.

The conflict blinds us to the fact that we, the human species, don’t have to depend only on the ancient tools of sequestering and social isolation to fight the virus.  We have other very powerful tools in our tool kits, ones that most politicians and public commentators don’t realize that we have.  I am talking about vast database records of the millions who have been infected by the virus and proven machine-learning software that could be applied to those database records – hopefully to enable us to predict with high certainty who among us are likely to be not vulnerable to the virus.

The conflict is political as well as scientific and commercial, so much as to obfuscate fact from fiction.  many special interests are involved.  An example is saliva testing kits for personal detection of infection with the virus.  Early in the game the CDC was offered the option to buy such kits from several offshore suppliers.  The CDC decided instead to go with a domestic supplier, knowing among other matters that a tens-of-billion dollar market was involved.  The test that CDC was backing turned out not to work, so the US lost 2-3 months lead time in testing.  If the pillars of our strategy is “test and isolate those who can infect others,” we had no tools to do this.  And basically, we still don’t.  To be clear, I don’t know what went into those early CDC decisions.  But the impact may be seen in our runaway US infection rates.

  1. There is a better way to go – the key is shifting from sweeping stay shut down vs open up policies that affect everybody to focusing instead on special and intense provisions for the relatively small population of people likely to be vulnerable to the virus enemy

Earlier this week, Governor Charlie Baker announced a partial re-opening of businesses and institutions in my State Massachusetts.  This is fine.  However, I continue to think that focus on both sides of the political divide in the US is misplaced.  When responsible, focus is on what to open up, when and under what conditions.  I continue to think that it would be much more effective to focus on who is vulnerable to COVID-19, and seek to keep the vulnerable protected, opening up businesses and institutions of all kinds to everybody else – the vast majority of us.  That is the essence of the argument Steve Buss and I put forward in the previous blog entry THE COVID-19 PANDEMIC – A THIRD WAY TO GO – CALL FOR ACTION.

That entry outlines the current social dilemma and suggests an approach for resolving it without suffering the horrible social-economic penalties of long-continuing societal and economic shutdown, or the massive hospitalizations and mega-deaths of too-rapid opening up.  It involves a shift from trying to protect everyone from exposure to the virus to identifying the vulnerable given exposure, and then focus effort on protecting them.  Since the vulnerable appears to be a tiny slice of the population compared to everybody, this could mean that most people could go back out and reboot our economy and society.

There, Steve Buss and I suggest a technical and societal approach which we believe might rescue us from a very profound societal dilemma we now face –A. open up our businesses and social institutions and encourage people to participate (perhaps economically and socially absolutely necessary, but could lead to millions of new cases of the pandemic and even to millions of new deaths) or B.  Stay mostly closed down as we have been (could prevent a flare of new cases and may be necessary to prevent disastrous overload of our health care system, but could lead to disastrous economic collapse and tens of millions of people in our country facing starvation and great suffering.)  The solution is intense analysis of existing and emerging data bases to allow us to assign Hazard Scores to individuals, which are estimates of the probability of their becoming seriously ill in case of infection with the COVID-19 virus.  If this can be successfully done, people with very low Hazard Scores could be encouraged to go out back to work and into participation with others, while those with high hazard scores could be encouraged to remain sequestered at home in relative isolation.

This approach differs from the current approach in very key respects.  The current approach attempts to protect everybody from getting the virus from anybody else– the approaches of quarantine and social isolation for essentially everybody.  This approach necessitates shutting things down and therefore massive economic restriction.  Our suggested approach is to focus protection on vulnerable individuals, those in the tiny fraction of our population who have a significant chance of getting seriously sick, require hospitalization or die if they contract the virus.  Everybody else – most of us could go out to work or socialize or play, and start restoring our economy.  In otherwise, focus on the problem where it is likely to be, with vulnerable people, focus less where the problem is unlikely to be, with relatively invulnerable people.

  1. THERE ARE ADDITIONAL WAYS YOU CAN PROTECT YOURSELVES IN THE fACE OF THE PANDEMIC

The personal risk from the pandemic in the US is generally getting worse and worse.  At the same time as I write this, perhaps half of my fellow American countrymen are faced with an imminent personal decision: A. stay cloistered at home essentially quarantined from almost everybody, B, go back out in the society and perhaps to work cautiously, practicing social distancing and wearing a face mask, or C. resume what was formally for you “normal” behavior for relating to people whether working or playing.  State-by-State and business-by business policy-makers are seeking to re-open society.  While at the same kind new cases of COVID-19 and deaths from it in the country appear to be continuing at highest levels ever.

So, so many of us wonder: “If I go back out now and resume doing the things I used to do, what is my chance of becoming seriously ill from the disease, or of becoming one of the 1,500 of us in the US who die from it every day?  I believe the decision to this key question can be based in large measure on your personal risk of getting seriously sick or confronting death if you contract the virus.  Some of the information in this blog is intended to help you estimate that personal risk.  The final section of this blog entry offers summaries of published medical information that can possibly help you make that decision in terms of your own personal risk factors for getting seriously sick or dying from COVID-19 should you get infected by the virus.

Key here is that the danger is not going away and death tolls are going up, not nice matters to contemplate when our emotions are screaming “Please Mommy, let me go out and play again.”

A.  Personal safety generalities and for you specifically

So what else can you do to protect yourself?  Multiple news sources repeat the same general wisdom about how likely you are to get sick or die from COVID-19 if you contract the virus: A. some 50% of people who test positive for it will be free of symptoms, and might not even know they are infected.  B.  most who get infected will not get seriously sick, though 10% to 20% might, C.  As many as 1% to 2% of these people may eventually die from its complications which include acute respiratory failure, pneumonia and kidney failure.  There have also been reports of longer-term consequences of virus infection, such as lung damage.  These do not appear to be documented well as yet.

We have been told in many published articles that co-morbidity factors for COVID-19 include diabetes, obesity, cardiovascular and pulmonary issues, frailty, several other chronic disease conditions, and advanced age. This is a starting list of personal health red-flags suggesting limiting your public exposure.  My suggestion is that if in any question, consult your physician.  Other personal risk factors include the nature of your job and the degree of exposure to others your job and normal lifestyle entails.  While many such risk factors have been identified, their importance has not yet been quantified.  That quantification is the essence of the approach to the pandemic we are suggesting. As we see it, if your probability of getting seriously sick from Covid-19 is very small, to that extent you can consider yourself safe if you are exposed to it.  I will refer to this vulnerability probability here as hazard level.  Low hazard level should not be confused with immunity to the virus, which technically means something else.

B.  Being Safe from Covid-19 vs. being Immune to it

We have two immune systems, a relatively fast-acting but sometimes possibly ineffective system called the innate immune system, Immunity to a virus, and a slower-acting immune system that is based on our disease experience called the adaptive immune system.  The adaptive immune system maintains a database of pathogens that the body has experienced before, and is equipped with powerful tools that often can help it fight off and defeat such a re-encountered pathogen.  If a virus or pathogenic microbe is recognized by that has been encountered and dealt with before, those tools are mobilized. That is what is meant by immunity.  Here are resources, images and videos on the innate immune system and resources, images and videos on the adaptive immune system.

Immunity depends on pattern recognition systems and can be present to various degrees.  If your body has experienced a similar pathogen, say a corona virus different than  COVID-19 (there are several including ones that give you a common cold), this can possibly give you a degree of immunity to COVID-19.  It is general knowledge that in a general population, about half the people who contract the COVID-19 virus are symptomless.  We do not know why and don’t know if this is mainly attributable to immunity or other factors.

  1. Relevant new research findings

The good news in all this is that much is being learned about the COVID-19 virus and pandemic, and about us in relationship to it.  Interesting new publications reporting these learnings are appearing with increasing frequency.  I report on only five of these here and will probably cover others in future blog entries.

A.    On hydroxychloroquine

Some small scale initial studies suggested the hydroxychloroquine may be an effective drug for lessening the impact of COVID-19 infections.  Recent more-controlled and larger-scale studies say “Not at all so.”  This drug is ineffective against the COVID-19 pathogen, and its widespread use may lead to twice as many deaths.  Yesterday a study was published in the journal The Lancet. The results reported in this news report are  “Chloroquine or hydroxychloroquine (HCQ), with or without an antibiotic, in hospitalized COVID-19 patients were associated with increased risk of death in the hospital and higher rates of arrhythmias, analysis of outcomes in nearly 100,000 patients indicated. — The 15,000 patients who received HCQ or chloroquine were about twice as likely to die compared to controls who did not receive these agents after adjusting for covariates (18.o% for hydroxychloroquine and 16% for chloroquine versus 9.3% for controls), reported Mandeep Mehra, MD, of Brigham and Women’s Hospital in Boston, and colleagues. — The drug was also associated with a higher risk of ventricular arrhythmia during hospitalization (6.1% for hydroxychloroquine, 4.3% for chloroquine versus 0.3% for controls), the authors wrote in The Lancet.  Moreover, risks for both in-hospital mortality and ventricular arrhythmia were even higher compared to controls when either drug was combined with a macrolide antibiotic, they noted.  — Mehra said in a statement these drugs should not be used as treatments for COVID-19 outside of clinical trials.”  Again, I caution that statistical correlation is not the same as causality.  For example, if hydroxychloroquine were prescribed only for those who were most desperately sick, then the enhanced death rate associated with its use would possibly reflect who it was given to, not represent causation by use of the drug.  The situation is similar to that for hospital use of ventilators, where the correlation of COVID-19 patients put on hospital ventilators and mortality is extremely high (97.5% for people my age).  Fact is that the ventilators themselves don’t kill the patients.  It is just that they often cannot protect the people put on them because they cannot breath normally any longer.

It seems fairly clear from the data that hydroxychloroquine may be harmful and either increases or is neutral with respect to mortality associated with COVID-19.  So in general, it is not a good idea to administer it except for people who need it for other reasons.

B.    On Vitamin D

A May 6 2020 study suggests that insufficient level of Vitamin D may be a major risk factor associated with COVID-19 infection.  The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality.  “The present aim was to propose an hypothesis that there is a potential association between mean levels of vitamin D in various countries with cases and mortality caused by COVID-19.  The mean levels of vitamin D for 20 European countries and morbidity and mortality caused by COVID-19 were acquired.  Negative correlations between mean levels of vitamin D (average 56 mmol/L, STDEV 10.61) in each country and the number of COVID-19 cases/1M (mean 295.95, STDEV 298.7, and mortality/1M (mean 5.96, STDEV 15.13) were observed. Vitamin D levels are severely low in the aging population especially in Spain, Italy and Switzerland.  This is also the most vulnerable group of the population in relation to COVID-19. It should be advisable to perform dedicated studies about vitamin D levels in COVID-19 patients with different degrees of disease severity.”

The study shows strong correlations severe vitamin D deficiency and mortality rates.  The study proves little however, because it on the level of national populations where many other factors can come into play.  On the other hand, the idea that Vitamin D deficiency is a co-illness and co-mortality factor for COVID-19 does not surprise me a bit.  In my mind, this has been a “usual suspect” all along.  At a microbiology level the theory definitely works.  We know D-3 deficiency leads to chronic inflammation and numerous other disease susceptibilities.  It is probably a good idea to supplement with Vitamin D-3 unless your lifestyle gives you a lot of sun exposure   Especially if you are going to venture out where you may contract the COVID-19 VIRUS,

C.  On taste and smell sensory loss symptoms

Sensory loss of taste and smell appears to be a screening criteria for determining whether someone with flu-like symptoms is infected with COVID-19 or some other pathogen, according to a very-recent study Association of chemosensory dysfunction and Covid19 in patients presenting with influenzalike symptoms.  “Background: Rapid spread of the SARS‐CoV‐2 virus and concern for viral transmission by ambulatory patients with minimal to no symptoms underline the importance of identifying early or subclinical symptoms of Covid‐19 infection. Two such candidate symptoms include reported loss of smell and taste. Understanding the timing and association of smell/taste loss in Covid‐19 may help facilitate screening and early isolation of cases.  Methods: A single‐institution, cross‐sectional study evaluating patient‐reported symptoms with a focus on smell and taste was conducted using an internet‐based platform on adult subjects who underwent testing for Covid‐19. Logistic regression was employed to identify symptoms associated with Covid‐19 positivity.  Results:  A total of 1480 patients with influenza‐like symptoms underwent Covid‐19 testing between March 3 through 29, 2020. Our study captured 59 of 102 (58%) Covid‐19‐positive patients and 203 of 1378 (15%) Covid‐19‐negative patients. Smell and taste loss were reported in 68% (40/59) and 71% (42/59) of Covid‐19‐positive subjects, respectively, compared to 16% (33/203) and 17% (35/203) of Covid‐19‐negative patients (p<0.001). Smell and taste impairment were independently and strongly associated with Covid‐19‐positivity (anosmia: adjusted odds ratio [aOR] 10.9, 95%CI:5.08‐23.5; ageusia: aOR 10.2 95%CI:4.74‐22.1); whereas, sore throat was associated with Covid‐19‐negativity (aOR 0.23, 95%CI:0.11‐0.50). Of patients who reported Covid‐19‐associated loss of smell, 74% (28/38) reported resolution of anosmia with clinical resolution of illness.  ConclusionsIn ambulatory individuals with influenzalike symptoms, chemosensory dysfunction was strongly associated with Covid19 infection and should be considered when screening symptoms. Most will recover chemosensory function within weeks paralleling resolution of other diseaserelated symptoms.”

If you find yourself with sudden loss of taste and smell, check in with your physician

D.  CAT scans appear to be the best diagnostic tool for COVID-19

I have above pointed out problems with throat-swabbing PCR tests and how very large false-negative rates make them unreliable for definitive diagnosis for infection to the virus.  The best tool appears to be CT scans.  Comparison of testing via PCR and via CT scans is discussed out in the publication Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases.  “Background : Chest CT is used for diagnosis of 2019 novel coronavirus disease (COVID-19), as an important complement to the reverse-transcription polymerase chain reaction (RT-PCR) tests.  Purpose:  To investigate the diagnostic value and consistency of chest CT as compared with comparison to RT-PCR assay in COVID-19.  Methods: From January 6 to February 6, 2020, 1014 patients in Wuhan, China who underwent both chest CT and RT-PCR tests were included.  With RT-PCR as reference standard, the performance of chest CT in diagnosing COVID-19 was assessed.  Besides, for patients with multiple RT-PCR assays, the dynamic conversion of RT-PCR results (negative to positive, positive to negative, respectively) was analyzed as compared with serial chest CT scans for those with time-interval of 4 days or more.  Results:  Of 1014 patients, 59% (601/1014) had positive RT-PCR results, and 88% (888/1014) had positive chest CT scans.  The sensitivity of chest CT in suggesting COVID-19 was 97% (95%CI, 95-98%, 580/601 patients) based on positive RT-PCR results. In patients with negative RT-PCR results, 75% (308/413) had positive chest CT findings; of 308, 48% were considered as highly likely cases, with 33% as probable cases.  By analysis of serial RT-PCR assays and CT scans, the mean interval time between the initial negative to positive RT-PCR results was 5.1 ± 1.5 days; the initial positive to subsequent negative RT-PCR result was 6.9 ± 2.3 days). 60% to 93% of cases had initial positive CT consistent with COVID-19 prior (or parallel) to the initial positive RT-PCR results. 42% (24/57) cases showed :improvement in follow-up chest CT scans before the RT-PCR results turning negative.  Conclusion: Chest CT has a high sensitivity for diagnosis of COVID-19. Chest CT may be considered as a primary tool for the current COVID-19 detection in epidemic areas.”

Another study discusses ground glass opacity as a key diagnostic features seen on CAT scans: Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study.  “Purpose: To perform a longitudinal study to analyze the serial CT findings over time in patients with COVID-19 pneumonia.  Materials and Methods: During January 16 to February 17, 2020, 90 patients (male:female, 33:57; mean age, 45 years) with COVID-19 pneumonia were prospectively enrolled and followed up until they were discharged or died, or until the end of the study. A total of 366 CT scans were acquired and reviewed by 2 groups of radiologists for the patterns and distribution of lung abnormalities, total CT scores and number of zones involved. Those features were analyzed for temporal change.  Results:  CT scores and number of zones involved progressed rapidly, peaked during illness days 6-11 (median: 5 and 5), and followed by persistence of high levels. The predominant pattern of abnormalities after symptom onset was ground-glass opacity (35/78 [45%] to 49/79 [62%] in different periods). The percentage of mixed pattern peaked (30/78 [38%]) on illness days 12-17, and became the second most predominant pattern thereafter. Pure ground-glass opacity was the most prevalent sub-type of ground-glass opacity after symptom onset (20/50 [40%] to 20/28 [71%]). The percentage of ground-glass opacity with irregular linear opacity peaked on illness days 6-11 (14/50 [28%)]) and became the second most prevalent subtype thereafter. The distribution of lesions was predominantly bilateral and subpleural. 66/70 (94%) patients discharged had residual disease on final CT scans (median CT scores and zones involved: 4 and 4), with ground-glass opacity (42/70 [60%]) and pure ground-glass opacity (31/42 [74%]) the most common pattern and subtype.”

If you have good symptomatic reasons to think you might have CODID-19, particularly pulmonary ones, even if your PCR test for the virus is negative, you can ask your physician to do a chest CT scan.

  1. FINAL COMMENTS

The main current approaches to the Coronavirus pandemic are failing miserably.  Besides the sickness and deaths and associated misery, our economic picture is probably worse than in the Great Depression of the 1930s.  “Let’s stay mostly shut down and save lives’ won’t work because of unfolding economic disaster and chaos, and become the virus is likely to come roaring back when we do open up.  “Let’s pretend things are back to normal and get people back working and playing again ASAP’’ won’t work when we see our health organizations overloaded, a sizable portion of our doctors and nurses, put out of commission by the virus and our loved ones sick and passing away in places where we can’t even visit them.  We need something much better.  We must have it.

We are in fact not helpless and I believe there is a better way

The BIG-DATA strategy we have suggested for approaching the COVID-19 pandemic is completely do-able.

  • Tools of BIG DATA are here. BIG DATA ANALYSIS is at the heart of many of the fastest growing and most profitable businesses, like Amazon and Google.  BIG DATA MEDICAL analysis is the probable key to Precision Medicine
  • Hospital records exist for millions of people who have contracted COVID-19. These convey much information about the people in relationship to the disease, including medical records, who got seriously sick or not, who had no serious symptoms and who died.  Most of these records exist in machine readable form.  Stripped of patient’s names and identifiers, with proper analysis they can tell us a tremendous amount about factors making up patient vulnerability to the virus.
  • Powerful computer programs for machine learning These can wade through such enormous compilations of data.  There are communities of machine learning enthusiasts who regularly use them.  And I bet these programs can tell us the characteristics of people who are probably vulnerable or invulnerable to covid-19, with a very high degree of statistical certainty.

The times of greatest danger are also the times of greatest opportunity

Let’s focus on how we can use the new defenses we have in our arsenal to defeat our enemy instead of having everybody trying to hide out from it.  If we can succeed doing that, we can use the same defenses to recognize and defeat future pandemics as well, and the human species can emerge stronger as a result.

YOUNGING1.0 – THE EMERGING AGING REVERSAL STRATEGY

$
0
0

By Vince Giuliano and Steve Buss

The key elements of a strategy for age reversal are emerging in the recent literature –we call it YOUNGING1.0.  This blog entry describes our understanding of that strategy, its elements, how it works and its results, and cites research evidence for its salient aspects.  This is possibly the most important blog entry published over the 12-year history of ANTI-AGINGFIREWALLS.  That is because such a strategy – where human physiological age is actually and significantly reversed –once demonstrated will be unique in our history of all humanity.  Age reversal has happened in stories and myths, such as the story of Dr. Faustus and vampire myths, and the power of Fountains of Youths, a number of which can be visited in the world today.  Vince first visited the Fountain of Youth Archeological park in Saint Augustine Florida when he was only 4, and has since visited others including the Fontana di Trevi in Italy, the Baños de Coamo in Puerto Rico and. Tambomachay in Peru.

 

 

 

 

Image source                                                                    Image source

But though much sought after, true YOUNGING approaches have never existed as the result of an actual scientific intervention.  We seek here to lay out the elements of a science-based age reversal strategy, one that works in small animals which we believe will work in humans as well, and one that is actionable now.  We draw those elements from studies by numerous specialized researchers, many of whom are unfamiliar with the work of the others.  So, we are seeking to fit together pieces of knowledge from separate sources to constitute a whole new framework.  This characterization of YOUNGING is as complete as we can make it now, and we believe it to be compelling.  True, major gaps in our knowledge are still to be filled in.   We proceed first in this Section I by listing key assertions without digressing into the backup science and literature, and in Section II back up our key points with additional information, research literature sources and citations, and identify some important still-unanswered questions.

SECTION I KEY POINTS

  1. YOUNGING is real. It has been demonstrated in small animals and by much research which characterize and validate its details.
  2. The evidence is strong that YOUNGING will work in humans. It has been demonstrated to work in rats(ref).  Of course, all statements we make here with respect to human YOUNGING are conjectural until it is actually demonstrated by well designed clinical studies.  However, the genetic and epigenetic compositions of humans and rats and associated pathways and process in humans (and in fact of all mammals) are so evolutionarily conserved and nearly identical, that we assign a high degree of certainty to the basic points made here.  The research literature citations in Section II associated with each of these points convey why we are so certain.
  3. YOUNGING is the result of an epigenetic program. In this respect it is a program like aging itself, running the aging clock backwards.  You can think of it as a program or subroutine that replaces or runs simultaneously with the aging program itself.  We have good ideas about the nature of one such program we call YOUNGING1.0, how to trigger its activation, how it works, how long it runs, and what its biological youth-generating results can be.
  4. YOUNGING1.0 as described here is a long process lasting years, not a one time event. It is not something that happens right away or overnight.  In this respect it is like aging itself, a process that goes on in our biological backgrounds that is not naturally perceptible by us moment-to-moment, or even day-by-day or month-by-month.  Rescaling of rat results suggests that YOUNGING1.0 in humans over 40 may take 10 or more years to fully play out.  This means we won’t see convincing clinical results for humans that YOUNGING exists and works until 8 or more years after a valid-scale clinical study is set up.  Until then many people may choose to deny its reality, and others like us will have to depend on the indirect but yet-powerful evidence and powerful highly personal experience.
  5. There are other epigenetic programs that foster YOUNGING besides that described here called YOUNGING1.0. We mention a few of these here.
  6. YOUNGING1.0 is a process that can be initiated by disease-free adults, intended to bring them back towards or to an epigenetic aging state of a typical 20 year old. It is known that there is a major shift in epigenetic gene regulation in humans typically centered around age 24, where numerous growth and protective genes are down-regulated and inflammatory and pro-aging genes are upregulated.   It is interesting that this timing coincides with the end of the main child-bearing years for humans as we used to be long ago.  So the shift from self-protection may have had an evolutionary purpose.  The major driver of this shift is relatively sudden methylation and consequent silencing of numerous growth, development, and protective genes.
  7. Initiation of adult aging around 24 years of age appears to be an evolutionarily conserved process triggered by histone methylation by the double and triple histone methylases H3K27me2/3. That is, di- and trimethyl-lysine 27 on histone H3.  This results in silencing of numerous genes, including many anti-inflammatory and anti-aging genes that are largely active in youth.  The results of this methylation is down-regulation or inactivation of protective genes related to this particular histone position.  These include genes that encode for protective heat shock proteins.  This may be the essence of adult aging as we know it.  This evolutionarily-conserved shift has been well-studied in nematodes where it all happens in only 4 hours.  This same histone methylation process also happens in plants as they shift from their juvenile to adult phases.   The YOUNGING1.0 process seeks to reverse this genome-wide methylation and restore the protective gene activation patterns of a much younger person, at an extreme for humans. that of a typical 20 year-old.
  1. H3K27me2/3 and its methylation/demethylation roles in growth and development are important and manifested in plants as well as animals. So, these matters appear to be very ancient and core to life cycles of most if not all living things,
  2. YOUNGING1.0 is a complex process that proceeds in well-defined stages. In outline:
    1. Initiation by introducing exogenous substances and/or processes that promote active genome-wide demethylation of histone proteins H3K27me2/3. I believe this can be accomplished many ways, rapidly or slowly.
    2. Rapid body response by downregulation of inflammatory cytokines IL-6, TNFalpha and IL1alpha. Rapid response, in a few days.  This has been observed in rats, we believe as part of YOUNGING1.0.  A great many or most serious longevity researchers agree with me (Vince) that drastic reduction of systemic inflammation is absolutely necessary for any form of cell or organ-level renewal or regeneration to take place.  It is not known however whether bringing systemic inflammation way down to 20 year-old levels and holding it down is sufficient by itself to initiating and maintaining a form of  Nor do we know for sure that this process will be free of negative side effects in humans.
    3. Global responses in re-modeling of gene regulation, including upgrading DNA repair and many other “health and longevity” genes like HO1 and NRF2 and downregulating of-inflammatory and aging” genes, like IGF-1 and MTOR. Time frames unknown but probably fairly quickly.  These first 3 steps set up and launch the program, but they are not yet the main program itself.
    4. Epigenetic, biological pathway, organ, and systems remodeling, including changes in DNA promoter methylation. Inducing such gradual changes is the main operation of the YOUNGING   In human years the process is estimated to go on for 8 or more years.

I expand on these points below.

  1. It is very difficult to know if YOUNGING1.0 is going on in someone, except after the process has gone on for four or so years. After that time DNA methylation testing should show the individual as significantly younger than expected for his or her age cohort and/or younger than before initiating the YOUNGING1.0  DNA age testing will not work as a measuring tool before that time lapse because it is predictive of biological age only with a 3 year error spread.  One could ask “YOUNGING1.0 is initiated by H3K27me2/3 de-methylation which happens right away, so why would that change not show up in a DNA methylation test?”  The answer is that DNA methylation age tests look at something else.  They look at the methylation states of the promoter regions of a  hundred or several hundred key genes , whereas H3K27me2/3 applies to only specific histone site (lysine 27 of histone 3).  So DNA methylation tests will only show a person as younger after the process has been running for several years.  [I (Vince) experienced that back in 2017 when I did DNA aging tests just before and just after infusions of plasma derived from very young blood.  Within expected margins of error, the tests, showed no differences in my DNA-predicted age.  At the time I thought that result meant the infusions did nothing, because I did not comprehend the long process nature of YOUNGING.  Only now in mid- 2020 do I understand that with those infusions a YOUNGING1.0 process may indeed have been kicked off in me, a process that is still running today and may go on for 8-10 years more.  I will soon do another DNA methylation test to check that hypothesis out.]
  2. There are many seemingly practical approaches to demethylating H3K27me2/3 and thus to initiate the YOUNGING.  The main substance that specifically demethylates H3K27me2/3 is JMJD3.  The Jumonji domain-containing protein D3 (JMJD3), specifically demethylates di- and trimethyl-lysine 27 on histone H3 (H3K27me2/3).  So we can ask “what substances can we practically use to activate JMJD3 and what other substances cab be used to demethylate H3K27me2/3?  It turns out the list of familiar substances that can do that is quite long, including:
    • Certain familiar herbal substances, including Curcumin, and High AkBA Boswellia
    • DHEA
    • Alpha keto-gluterate
    • Vitamin D
    • and dozens of others to various extents
    • And also processes such as fasting and breathing supplemental oxygen
  3. These approaches may vary in their efficacy, speed of activation initiation , side effects, and safety. We do not know which ones will really work or are best for humans right now.  The desired effect is demethylation of H3K27me2/3 and this is likely to be possible via other demethylases besides JMJD3.
  4. One approach to initiating the YOUNGING1.0 process, used for animal experiments by Harold Katcher and his colleagues used a substance they call Elixer as an activator.
    • Elixer is administered in rats as a series of two IV administrations a week apart. This is all that is required to initiate the YOUNGING of rats by multiple months equivalent to 8-12 years of human life.
    • These experiments are critical elements of the proof of the YOUNGING However the entire YOUNGING1.0 concept as outlined here is was put together by us, Vince and Steve.  Katcher’s recent paper, co-authored by Steve Horvath and many others,  covers the results of the YOUNGING of rats, but does not characterize the YOUNGING-process, or the roles of H3K27me2/3 or JMJD3 as covered here, or how it is initiated. We, Vince and Steve, are responsible for what is in this blog entry and Harold Katcher and his colleagues might take issue with some of the things we say here.
    • Pending issue of a patent, Katcher and his colleagues are keeping the content of Elixer as a trade secret. They have gone so far as to say, however, that it contains only substances that are found in the blood of younger animals
    • Because of the importance of Dr. Katcher’s work and what he and his colleagues have already published,  this Anti-agingfirewalls blog is featuring a series of video interviews that we (Vince and Steve) have had with him which we expect to publish very soon.  Steve Buss is the Producer of the series and Vince is actively participating as Executive Producer.
  5. A second approach to initiating YOUNGING, is the infusion of plasma derived from very young blood, picking up from the long-known results of hetrochronic parabiosis experiments. When old and young mice or rats are sewed together so that they share a common bloodstream, the old mice/rats get demonstrably younger and the young mice/rats get demonstrably older.  The conclusion is that there must be factors in the blood of young animals that can rejuvenate older animals.).  In my case the infused plasma was derived from blood in discarded umbilical cords of newborn human babies.  Use of plasma (which is the blood fraction left over when blood cells are removed) instead of whole blood avoids issues of blood type and graft-host rejection.
  6. A third quite different approach to initiating YOUNGING1.0 than an IV one could be to use enhanced oral delivery approaches for JMJD3 activators or combinations of JMJD3 and other HK27me demethylases. This is a speculation on our part and we have questions on the safety of activating JMJD3 which are discussed later in this blog. These are approaches that are designed to provide significantly enhanced bioavailability than that of normal pill, powder of liquid delivery. In particular, we have been considering liposomal delivery, an approach where active substance ingredients are encapsulated in nano-sized lipid (fat based) particles.  The result is greatly enhanced freedom of the carrier particles to travel through the body and get where they are needed.  Liposomal delivery technology was pioneered by the pharma industry and a number of liposomal drugs as well as liposomal dietary supplements are now being marketed..
  7. (Vince personal comment) It turns out I have also been pursuing that third approach for a number of years now, without knowing the YOUNGING1.0 reason for doing so or ever having heard anything about JMJD3 or H3K27me2/3.  Specifically, going back 5 years ago I (Vince) developed and started to consume a liposomal preparation of concentrated extracts of curcumin, high-AKBA Boswellia, ashwagandha and and ginger.  I did this to control chronic inflammation,  because I knew these four herbal ingredients were powerful suppressors of systemic inflammation, and because I knew that bioavailability  of these substances was normally very limited.  See the blog entries The Making of a Dietary Supplement and INFLAMMATION PART 6:THE SCIENCE BEHIND THE 4 HERB SYNERGY DIETARY SUPPLEMENT. 

(Disclosure: .  Regular readers of this blog know that because this product has worked so well in controlling chronic inflammation for me,  and for members if my family and friends, we have created this liposomal concoction as a commercial product, called 4 Herb Synergy.  Vince’s family supplement company SYNERGY BIOHERBALS has been marketing that supplement  for over a year now.)

What I did not know at the time I wrote these articles is that curcumin and high-AKBA Boswellia are in fact JMJD3 activators and therefore H3K27me2/3 demethylators.  I strongly suspect the ginger and ashwagandha exercise similar impact  Since I have been taking either the home-made or the commercial 4 Herb Synergy product daily for over 5 years now, and because I also take substantial daily doses of DHEA and Vitamin D, it is likely I have been in fact to some extent activating JMJD3. 

  1. (Vince comment continued) I don’t know the extent to which the blood plasma infusions or consuming the liposomal substances, DHEA and other JMJD3 activators has activated YOUNGING1 in my body. I have a number of clues however, which suggest that the answer may well be yes,  The first observable effect, drastic reduction in expression of inflammatory cytokines and inflammatory indexes was achieved years ago.  And I am free of debilitating age-related disease conditions that haunt people in my age range (now approaching 91) and I seem to be as active and productive as ever.  My medical blood tests, vision and other tests seem to show that most systems are stable.  Some measures like my lipid scores are greatly improved over what they were years ago.  Biomarkers such as resting heart rate and HRV as measured daily by my OURA ring are usually very good to excellent.  I can walk 2-3  miles on rough and hilly terrain in the woods by my house without problems.  My reading, research and thinking and writing seems as good as ever.- Have I in fact been YOUNGING?  I don’t know for sure but will soon be pursuing a new round of DNA methylation testing to help find out.
  2. Breathing oxygen in combination with exercising may promote YOUNGERING1.0. Oxygen is one of the promoters of JMJD3.  Beyond that there is an older but significant body of science behind achieving healthful results via interventions that combine exercise and breathing oxygen.  Further, this is a health and possible longevity intervention that can be pursued now by individuals without requiring any medical intervention.  Steve Buss has been experiencing the benefits of this intervention for years now.  He intends to cover this subject in detail in a follow-up blog entry.  That blog entry will cover the science and historical background of the exercise-oxygen approach, recent related research, how the practice works in detail, the equipment required and where to get it, and the benefits of the approach that Steve has personally experienced.
  3. The biggest danger for YOUNGING1.0 or any other age-reversal approach is the initiation of cancers or acceleration of growth of unknown cancers already in a person. This is because many of the genes upregulated in any cell or organ renewal approach are also the same ones commonly characterized as oncogenic (cancer-creating) genes, such as the Yamanaka stem cell renewal factors, OCT-4,SOX2, KLF4 and C-MYC – or OSKM in short for all of them.  Demethylation of H3K27me2/3 in cancer cells is not a good idea because it can lead to cancer proliferation.   The advantage of the third dietary supplement approach to JMJD3 activation Vince has been pursuing as outlined above is that each of the 4 herbal ingredients in 4 Herb Synergy is also a inhibitor of cancers, in part because they each powerfully act to inhibit NF-kB, the key protein required to activate systemic inflammation and maintain inflammasomes  Cancer processes are inherently inflammatory.
  4. There are other known natural programs that run in the bodies of normal people that can contribute to YOUNGING. For example, senescent cells exude the inflammatory cytokine IL-6. IL-6  exuded by senescent cells is a necessary trigger for nearby normal cells in the same organ to start expressing the OSKM Yamanaka  factors so they can epigenetically regress to becoming stem-cell like progenitor cells in the same lineage type, which can the differentiate to replace the senescent cells
  5. The neighboring cells in a single organ may be in quite different epigenetic states than those in neighboring cells. Some may be responding to a normal aging program.  Others may be senescent and responding to a program for senescent cells, other cells may be engaged in a YOUNGING   We think what happens to the organ depends on the relative balances of cells in these different programmed process, and perhaps on a variety of additional signaling factors as well.  Recent animal experience suggests that for normal people and most organ systems, the numbers of cells in YOUNGING decline and the numbers of cells in the senescent state increases as people move beyond middle-age.  So organs age and eventually tends towards dysfunctionality or susceptibility to disease.  On the other hand a simplistic viewpoint is that if enough of the cells in an organ are engaged in YOUNGERING, the organ itself my YOUNGER.  Harold Katcher has made a strong point that the age of a cell depends not on its history but on organ and body environmental factors which drive that age.  We think he is right about this.
  6. In addition to the approaches mentioned for initializing YOUNGING1.0, there are doubtlessly a continuum of others involving different stresses or activator of JMJD3 or other histone demethylases administered via different channels and in different doses.  It may take years to sort out which ones are safest and work best.  In particular the dosage effects may be highly nonlinear, where too-little could have only negligible effect and too much unsafe.
  7. An entirely different approach to YOUNGING has been demonstrated to work in old mice, which is simply to drain off half the blood plasma and replace it with a solution that contains albumin. A twist on the old and long discredited medical practice of bloodletting. It seems that what helps here is removal of pro-aging factors from the plasma in the bloodstreams of older animals.
  8. What is known about YOUNGING and YOUNGING1.0 leaves many open questions. For example, as already pointed out, questions include:
    • What is the best way to initiate YOUNGING1.0?
    • How can I know if YOUNGING1 is going on and the extent to which it is going on without waiting for years to see?
    • Can YOUNGING1 have undesirable side effects irrelevant for rats but important for us humans? (Vince): I am happy to experience considerible epigenetic age regression, and would love to regain some things I had earlier like thick black hair on my head and more acute hearing.  But I don’t want to lose any of my memories or give up any of the wisdom I have gained through aging.  I don’t want any basic personality changes to occur or any loss of lovingness and affection.  I would like some 45 years of epigenetic regression, but don’t  want to lose what I have learned about longevity science in just the last dozen years, not to mention last week.
    • Can the YOUNGING1 program run too long or go too far once it is started?. Can it easily be turned off?. (Vince): I don’t care to be a bumbling teenager or adolescent again.  I would like some restoration of my sex drive, but I don’t want it running me like it did when I was 22.
    • What about some of the negative consequences associated with JMJD3?. Recent literature suggests that inhibition rather than activation of JMJD3 may be helpful for treating certain conditions such as osteo-arthritis and certain auto-immune conditions.  JDJM3 promotes the differentiation of stem cells into various somatic cells.  By the same token it tends to slow down or interfere with cell de-diferentiation via the Yamanaka factors, and epigenetic regression of somatic cells into stem cells, an important natural renewal process
  9. YOUNGING approaches will in all likelihood allow many existing humans to live for many more chronological years than 123, the maximum chronological age any human being in history has been known to live. Not by strengthening us somehow so we can bulldoze through that limit, but by allowing us to get nowhere near the internal biological stress conditions that normally stop human life at or before that age.
    • This of course is a conjecture, and a hope many of us have to be one of those humans.
    • This may require triggering multiple bouts of YOUNGING while the chronological years roll on.
    • I conjecture that a few other YOUNGING approaches in addition to YOUNGING1 will be required to get past 123  This is because YOUNGING programs appear to vary in their efficacy according to organs and body systems
    • (Vince): I comment personally that until just now, I could not imagine any way for members of our species to live beyond the 123 chronical years limit.  There is a completely documented maximum chronological age for members of every known biological species, ranging from minutes or hours for some insects to thousands of years for certain tree species.  I could not imagine that we humans could find an exemption to that rule.  Now I can.  So I see this possible avenue for breaking through the chronological age limit to be very exciting
  10. A number of other interventions have been showed to extend mammalian lifespans somewhat, but our sense is that they fall short of initiating a full YOUNGING process such as that described here. These include using nicotinamide riboside to upgrade NAD+ expression, pulsed taking of rapamycin, and taking of metformin.  Some of these are interesting from the viewpoint of YOUNGING because of their mechanisms of operation.  For example, nicotinamide riboside upgrades the mitochondrial unfolded protein response (UPR), a process we think take place in YOUNGING1

SECTION II:  SCIENCE AND LITERATURE BACKING UP KEY POINTS

  1.  YOUNGING is real

Independently of the details presented here, a surprising number of researchers have come to this conclusion based on earlier evidence.  See these publications for example:

The Katcher-Horvath July 2020 publication Reversing age: dual species measurement of epigenetic age with a single clock

This publication is very important because it offers evidence that makes a number of the points cited here very clear.  The paper has many authors but two of particular importance are Harold Katcher who responsible for creating the YOUNGING intervention and the experiment administrating it to rats, and Steve Horvath who was responsible for creating the specialized DNA age testing protocols involved.  The paper is well-worth careful reading if you have not already done so.

This paper is about research with older rats who were infused with an unknown proprietary substance developed by Dr. Katcher called ELIXER, presumably related to youth-inducing factors in the blood of younger rats.  The paper describes how Dr. Horvath developed six tissue-specific epigenetic DNA methylation clocks.  Two of these clocks that can be applied for both rats and humans because of the near-identical genes of both species.  “Young blood plasma is known to confer beneficial effects on various organs in mice.  However, it was not known whether young plasma rejuvenates cells and tissues at the epigenetic level; whether it alters the epigenetic clock, which is a highly-accurate molecular biomarker of aging.  To address this question, we developed and validated six different epigenetic clocks for rat tissues that are based on DNA methylation values derived from n=593 tissue samples.  As indicated by their respective names, the rat pan-tissue clock can be applied to DNA methylation profiles from all rat tissues, while the rat brain-, liver-, and blood clocks apply to the corresponding tissue types.  We also developed two epigenetic clocks that apply to both human and rat tissues by adding n=850 human tissue samples to the training data. We employed these six clocks to investigate the rejuvenation effects of a plasma fraction treatment in different rat tissues.  The treatment more than halved the epigenetic ages of blood, heart, and liver tissue. A less pronounced, but statistically significant, rejuvenation effect could be observed in the hypothalamus. — The treatment was accompanied by progressive improvement in the function of these organs as ascertained through numerous biochemical/physiological biomarkers and behavioral responses to assess cognitive functions.  Cellular senescence, which is not associated with epigenetic aging, was also considerably reduced in vital organs.  Overall, this study demonstrates that a plasma-derived treatment markedly reverses aging according to epigenetic clocks and benchmark biomarkers of aging.”

Because of the high relevancy of this publication and Dr. Katcher’s earlier work to the life-extending Mission of this blog, Steve Bus and I have arranged to do a series of video interviews with Dr. Katcher on his thinking and this and his other publications  The videos of the first two of these interviews are being edited now.  We expect that these interviews will be announced in this blog and be made available to the public very shortly.

The results described in this publication are clearly the results of a YOUNGING program.  We think that what is involved is the YOUNGING1.0 program  as described here.  We cannot know that for sure, however, until we know what the ELIXER activator is and how it works – matters about which Dr. Katcher has been silent to protect his proprietary interest in ELIXER.

2.  YOUNGING is real and has been demonstrated in rats, and proceeds as a slow programmed process.

In particular, the paper includes a number of graphical displays and tables showing the results of what I believe to be a YOUNGING1.0 initiated by IV administration of the ELIXER substance.

The above  chart shows performance of rats in maze running.in terms of latency (time taken) over a 4-month time frame.  Since each rat month is roughly equivalent to 2.5 human years, the time frame of 4 months of these charts is equivalent to 10 human years

Focusing on the blue lines for young untreated rats, you see that these rats always go through  the maze the quickest, and that for each period there is a downward slope in the line representing rats learning about the maze.  The red lines are for untreated older control-group rats.  These curves also show a downward slope representing learning but they are far outperformed by the younger rats.  The orange curves are for older rats treated with ELIXER.  Starting on about day 20 their performance starts to beat that of the control group aged rats.  These rats perform relatively better and better over the four month period, ending up being close to as good as the younger rats.  These charts illustrate that the YOUNGING1.0 is real and that the YOUNGING1.0 does not happen all at once but proceeds slowly as a program. 

There are several other charts of interest in this publication.  For example, these charts relate to oxidative stress:

 

In each case the condition of the treated old rats approaches that of the younger rats, in many but not all cases ending up almost as good.  The charts also illustrate that the impacts of the YOUNGING treatment vary by organ and measurement.

There are many other charts in the publication illustrating these and other points I make here.

3.  Studies related to hetrochronic parabiosis

There is a rich history of studies demonstrating aspects of YOUNGING  via hetrochronic parabiosis.  Those studies involved surgically linking the bloodstreams of an older and a blood-type compatible younger mouse, and measuring a number of the resulting “objective” indictors of age in both mice.  In short, the result of the connection appeared to be that the older mouse gets biologically younger and the younger mouse gets biologically older.  For the older mouse, an astounding demonstration of age reversal.  See also these publications.

A recent May 30, 2020 paper by Irina and Michael Conboy with 10 other authors is Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albuminA principal conclusion of this study paper, appearing also in other Conboy publications is that there are pro-aging factors in the bloodstream plasma of older animals, and reducing the concentration of these may be a more impactful YOUNGING intervention than transferring in plasma with young blood factors from young animals.  They report that simply replacing half the plasma in an older mouse with a solution containing albumins is enough to kick off a powerful YOUNGING process in these mice.

“Heterochronic blood sharing rejuvenates old tissues, and most of the studies on how this works focus on young plasma, its fractions, and a few youthful systemic candidates.  However, it was not formally established that young blood is necessary for this multi-tissue rejuvenation.  Here, using our recently developed small animal blood exchange process, we replaced half of the plasma in mice with saline containing 5% albumin (terming it a “neutral” age blood exchange, NBE) thus diluting the plasma factors and replenishing the albumin that would be diminished if only saline was used.  Our data demonstrate that a single NBE suffices to meet or exceed the rejuvenative effects of enhancing muscle repair, reducing liver adiposity and fibrosis, and increasing hippocampal neurogenesis in old mice, all the key outcomes seen after blood heterochronicity. Comparative proteomic analysis on serum from NBE, and from a similar human clinical procedure of therapeutic plasma exchange (TPE), revealed a molecular re-setting of the systemic signaling milieu, interestingly, elevating the levels of some proteins, which broadly coordinate tissue maintenance and repair and promote immune responses.  Moreover, a single TPE yielded functional blood rejuvenation, abrogating the typical old serum inhibition of progenitor cell proliferation.  Ectopically added albumin does not seem to be the sole determinant of such rejuvenation, and levels of albumin do not decrease with age nor are increased by NBE/TPE.  A model of action (supported by a large body of published data) is that significant dilution of autoregulatory proteins that crosstalk to multiple signaling pathways (with their own feedback loops) would, through changes in gene expression, have long-lasting molecular and functional effects that are consistent with our observations.  This work improves our understanding of the systemic paradigms of multi-tissue rejuvenation and suggest a novel and immediate use of the FDA approved TPE for improving the health and resilience of older people.”

4.  H3K27me2/3 and JMJD3

First of all, don’t be confused because JMJD3 is half the time in the literature referred to by its other name KDM6B. “The KDM6 family includes KDM6A, KDM6B, and UTY. KDM6A (also referred to as UTX) and KDM6B (also referred to as JMJD3)(ref)”

As stated above, H3K27me2 refers to histone bi-methylation and tri-methylation specifically at lysine position 27 on histone 3.  And JMJD3 is a highly specific natural demethylator of H3K27me2

These topics and their relationships have been researched extensively and there is an extensive body of research related to them going back more tthan 20 years.  I lump these together here because most of the articles dealing with one of them at least touches on the other as well.  Here is a short  list of key citations.  A general observation is that there is widespread acknowledgment of the importance of these subjects in aging and aging processes and diseases, but relatively few publications are focused on aging or general epigenetic state reversal.

That is likely because most of this research has been in the context of cancers and disease processes.  For example, the publication Roles of H3K27me3 Demethylase JMJD3 in Inflammation and Cancers: “Histone demethylation is an important part of epigenetic modifications, involving in multiple physiological and pathophysiological processes such as proliferation, differentiation, senescence, apoptosis, reprogramming and so on. JmjC domain-containing protein D3 (JMJD3, also called KDM6B) specifically demethylates lysine 27 on histone H3 (H3K27me3), a repressive epigenetic mark, therefore modulating the expression of target genes. JMJD3 can be strongly and quickly induced by various inflammatory stimuli and cellular stresses, and can enhance pro-inflammatory reactions as well as anti-inflammatory reactions by targeting diverse transcription factors in gene promoters and bodies. Additionally, JMJD3 has a dual effect on many types of cancers through binding to promoters of oncogenes or suppressor genes. As is known to us all, in the occurrence and development of various diseases including inflammation and cancer, JMJD3 plays a crucial role, which has triggered a research boom among numerous scholars over the years. In this review, we primarily focused on the roles of JMJD3 in inflammation and cancers, and briefly discussed its application prospect, laying a theoretical foundation for further research and providing a train of thought for the prevention and treatment of related diseases.”

These factors are involved in multiple growth-and development pathways, and expression of key genes related to cell differentiation, cell senescence and cancer promotion.  An example is the 2019 publication Jumonji C Demethylases in Cellular Senescence  (JDJM3 is a Jumoni-domain demethylase, probably the one most studied).  “Senescence is a stable cell cycle arrest that is either tumor suppressive or tumor promoting depending on context.  Epigenetic changes such as histone methylation are known to affect both the induction and suppression of senescence by altering expression of genes that regulate the cell cycle and the senescence-associated secretory phenotype.  A conserved group of proteins containing a Jumonji C (JmjC) domain alter chromatin state, and therefore gene expression, by demethylating histones.  Here, we will discuss what is currently known about JmjC demethylases in the induction of senescence, and how these enzymes suppress senescence to contribute to tumorigenesis.”

The publication Critical role of histone demethylase Jmjd3 in in the regulation of CD4+ T cell differentiation is important for understanding the operation of the adaptive immune system.   “Epigenetic factors have been implicated in the regulation of CD4+ T cell differentiation.  Jmjd3 plays a role in many biological processes, but its in vivo function in T cell differentiation remains unknown.  Here, we report that Jmjd3 ablation promotes CD4+ T cell differentiation into Th2 and Th17 cells in the small intestine and colon, and inhibits T cell differentiation into Th1 cells under different cytokine-polarizing conditions and in a Th1-dependent colitis model.  Jmjd3 deficiency also restrains the plasticity of the conversion of Th2, Th17 or Treg cells to Th1 cells.  The skewing of T cell differentiation is concomitant with changes in the expression of key transcription factors and cytokines.  H3K27me3 and H3K4me3 levels in Jmjd3-deficient cells are correlated with altered gene expression through interactions with specific transcription factors.  Our results identify Jmjd3 as an epigenetic factor in T cell differentiation via changes in histone methylation and target gene expression.”

5.  Inflammation and many stresses activate JMJD3 naturally so as to suppress H3K27me2/3. 

The publication Roles of H3K27me3 Demethylase JMJD3 in Inflammation and Cancers points this out.  “Histone demethylation is an important part of epigenetic modifications, involving in multiple physiological and pathophysiological processes such as proliferation, differentiation, senescence, apoptosis, reprogramming and so on.  JmjC domain-containing protein D3 (JMJD3, also called KDM6B) specifically demethylates lysine 27 on histone H3 (H3K27me3), a repressive epigenetic mark, therefore modulating the expression of target genes.  JMJD3 can be strongly and quickly induced by various inflammatory stimuli and cellular stresses, and can enhance pro-inflammatory reactions as well as anti-inflammatory reactions by targeting diverse transcription factors in gene promoters and bodies.  Additionally, JMJD3 has a dual effect on many types of cancers through binding to promoters of oncogenes or suppressor genes.  As is known to us all, in the occurrence and development of various diseases including inflammation and cancer, JMJD3 plays a crucial role, which has triggered a research boom among numerous scholars over the years.  In this review, we primarily focused on the roles of JMJD3 in inflammation and cancers, and briefly discussed its application prospect, laying a theoretical foundation for further research and providing a train of thought for the prevention and treatment of related diseases.  — Histone modifications can alter structures and functions of genome, but the exact mechanisms remain enigmatic1. Histone methylation is dynamically regulated via methyltransferases and demethylases2. JmjC domain-containing protein D3 (JMJD3, also called KDM6B) is a member of the histone demethylase family, whose C-terminus with JmjC domain catalyzes demethylation, while the N-terminus with basic amino-acids clusters is responsible for nuclear placement3.  JMJD3 and the ubiquitously transcribed X-chromosome tetratricopeptide repeat protein (UTX, also called KDM6A) have been identified to specifically demethylate H3K27me2/3, playing key roles in the epigenetic regulation of gene expression2.  Seemingly, compared with UTX, JMJD3 is highly regulated at the transcriptional level and more susceptible to various stimuli like differentiation inducers and stress signals2. — The pivotal roles of JMJD3 and relevant mechanisms have been extensively studied for their involvement in cellular proliferation, differentiation, senescence and apoptosis4.  From the perspective of tissue responses, JMJD3 mainly embodies in embryonic development, immune system, inflammation, neurodegenerative diseases and tumorigenesis5, 6.  Herein, we primarily concentrate on the roles of JMJD3 in inflammation and cancer, aiming at laying a theoretical foundation for further research and providing a train of thought for the prevention and treatment of related diseases.”

6.  JMJD3 plays a significant role in regulating CD4+7 CELLS, a matter relevant to development of treatments for cancers, infectious and autoimmune diseases

This is laid out in the 2014 publication Critical role of histone demethylase Jmjd3 in the regulation of CD4+T-cell differentiation.  “Epigenetic factors have been implicated in the regulation of CD4+T-cell differentiation.  Jmjd3 plays a role in many biological processes, but its in vivo function in T-cell differentiation remains unknown.  Here we report that Jmjd3 ablation promotes CD4+T-cell differentiation into Th2 and Th17 cells in the small intestine and colon, and inhibits T-cell differentiation into Th1 cells under different cytokine-polarizing conditions and in a Th1-dependent colitis model.  Jmjd3 deficiency also restrains the plasticity of the conversion of Th2, Th17 or Treg cells to Th1 cells.  The skewing of T-cell differentiation is concomitant with changes in the expression of key transcription factors and cytokines.  H3K27me3 and H3K4me3 levels in Jmjd3-deficient cells are correlated with altered gene expression through interactions with specific transcription factors.  Our results identify Jmjd3 as an epigenetic factor in T-cell differentiation via changes in histone methylation and target gene expression. — A growing body of evidence suggests that CD4+Th cells play a central role in initiating and maintaining immune responses against cancer and infectious and autoimmune diseases8,9,10,11.  Dysregulation of CD4+ T-cell differentiation is associated with various autoimmune and inflammatory diseases, including myelodysplastic syndromes and systemic lupus erythematosus12,13,14.  Regulation of CD4+T-cell differentiation is essential to maintain the appropriate balance among CD4+T-cell subsets to support immune homeostasis and prevent autoimmunity.  Therefore, understanding the mechanisms regulating and controlling CD4+T-cell differentiation into various subsets is of critical importance to develop innovative treatments. CD4+T-subset differentiation is tightly regulated by many signalling molecules, including signal transducer and activator of transcription (STAT) proteins, IFN regulatory factor 4 (IRF4) and runt-related transcription factor 1 (refs 215). In addition to transcription factors, recent studies have shown that epigenetic factors control the specificity and plasticity of T-cell subsets16,17,18,19.  These transcriptional factors and epigenetic regulators bind to both shared and cell-specific regulatory regions (promoters and enhancers) among various T-cell lineages and thereby, positively or negatively regulate gene expression depending upon the cofactors present20. — Jmjd3 (also known as KDM6B) was found to catalyse the demethylation of H3K27me2/3 in vitro27,28,29,30,31,32. Jmjd3 is induced by vitamin D and proinflammatory stimuli in macrophages and is required for Ink4a-Arf, Nodal and Irf4 expression in fibroblasts, mouse embryonic stem cells and macrophages, respectively33,34,35,36,37.

7.   A thorough understanding of JKJD3 and H3Kme2/3 requires grappling with many complex factors

Underneath the simple facts that JMJD3 demethylates H3K27me2/3 producing an amazing number of biological impacts, like everywhere else in biology there is a crazy-making number of details to sort through.  For example, here are several other histone demethylases that  demethylate H3K27me2/3 .  These points are illustrated in the 2020 document Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism.  “Significance T cells control many immune functions, with Th17 cells critical in regulating inflammation.  Following activation, T cells undergo metabolic reprogramming and utilize glycolysis to increase the ATP availability.  Epigenetic mechanisms controlling metabolic functions in T cells are currently not well-defined.  Here, we establish an epigenetic link between the histone H3K27me3 demethylases KDM6A/B and the coordination of a metabolic response.  Inhibition of KDM6A/B leads to global increases in the repressive H3K27me3 histone mark, resulting in down-regulation of key transcription factors, followed by metabolic reprogramming and anergy.  This work suggests a critical role of H3K27 demethylase enzymes in maintaining Th17 functions by controlling metabolic switches.  Short-term treatment with KDM6 enzyme inhibitors may be useful in the therapy of chronic inflammatory diseases.  T helper (Th) cells are CD4+ effector T cells that play a critical role in immunity by shaping the inflammatory cytokine environment in a variety of physiological and pathological situations.  Using a combined chemico-genetic approach, we identify histone H3K27 demethylases KDM6A and KDM6B as central regulators of human Th subsets.  The prototypic KDM6 inhibitor GSK-J4 increases genome-wide levels of the repressive H3K27me3 chromatin mark and leads to suppression of the key transcription factor RORγt during Th17 differentiation.  In mature Th17 cells, GSK-J4 induces an altered transcriptional program with a profound metabolic reprogramming and concomitant suppression of IL-17 cytokine levels and reduced proliferation. Single-cell analysis reveals a specific shift from highly inflammatory cell subsets toward a resting state upon demethylase inhibition. The root cause of the observed antiinflammatory phenotype in stimulated Th17 cells is reduced expression of key metabolic transcription factors, such as PPRC1. Overall, this leads to reduced mitochondrial biogenesis, resulting in a metabolic switch with concomitant antiinflammatory effects. These data are consistent with an effect of GSK-J4 on Th17 T cell differentiation pathways directly related to proliferation and include regulation of effector cytokine profiles. This suggests that inhibiting KDM6 demethylases may be an effective, even in the short term, therapeutic target for autoimmune diseases, including ankylosing spondylitis.”  So here we have the suggestion that inhibiting JMJD3 rather than promoting it may be appropriate for some with autoimmune conditions.  The drug GSK-J4 does this. 

8.  JKJD3 inhibits natural reprogramming of normal somatic cells into stem cells via the Yamanaka OSKM FACTORS. 

I (Vince) have thought that an important aspect of YOUNGING was a natural body process where senescence cell IL-6 cytokine signaling would cause upgrading of the Yamanaka factors in some proximate cells causing them to regress epigenetically by de-differentiation (that is YOUNGER), but only part of the way so they would retain memory of their cell lineage.  There they would become progenitor cells capable of differentiation into new cells to replace the senescent ones.  I described that process in detail in my 2018 blog entry AGING, CELL AND TISSUE REPAIR, RENEWAL AND REGENERATION, INFLAMMATION AND THE SASPHowever JDJD3 promotes differentiation and inhibits de-differentiation so it inhibits that process.  That is pointed out, for example in the 2016 publication The localization of histone H3K27me3 demethylase Jmjd3 is dynamically regulated. “Jmjd3 is required for cellular differentiation and senescence, and inhibits the induction of pluripotent stem cells by demethylating histone 3 lysine 27 trimethylation (H3K27me3).” Further, this article points out the nuclear translocation is a pre=requisite for JMJD3 to exercise its histone demethylation capabilities.

“A working model to illustrate how JMJD3 negatively regulates cellular reprogramming through demethylase-dependent and independent pathways. JMJD3 upregulates Ink4a/Arf and p21 by removal of H3K27 methylation through its H3K27me2/3 demethylase activity.  Increased amounts of Ink4a and Arf induce cell senescence or apoptosis and reduce cell proliferation, which leads to decrease in efficiency and kinetics of reprogramming.   Importantly, JMJD3 protein also targets PHF20 for ubiquitination and degradation by recruiting an E3 ligase Trim26 in an H3K27 demethylase activity-independent manner.  PHF20 is required for the reactivation of key core reprogramming factors such as Oct4 through interaction with WDR5. Thus, downregulation of PHF20 protein by JMJD3 leads to the inhibition of reprogramming efficiency”

9.  JMJD3 is an important part of the cell senescence pathway

The 2019 article Jumonji C Demethylases in Cellular Senescence reports on this.  “Senescence is a stable cell cycle arrest that is either tumor suppressive or tumor promoting depending on context.   Epigenetic changes such as histone methylation are known to affect both the induction and suppression of senescence by altering expression of genes that regulate the cell cycle and the senescence-associated secretory phenotype.  A conserved group of proteins containing a Jumonji C (JmjC) domain alter chromatin state, and therefore gene expression, by demethylating histones.  Here, we will discuss what is currently known about JmjC demethylases in the induction of senescence, and how these enzymes suppress senescence to contribute to tumorigenesis.”  This diagram from the publication illustrates the mechanism.  Recall that KDM6B is an alias for JMJD3.

 

 

 

 

 

 

 

 

10.  Gene regulation shift around age 24:  time of “loss of youth”

In SECTION 1 we asserted that “there is a major shift in epigenetic gene regulation in humans typically centered around age 24, where numerous growth and protective genes are down-regulated and inflammatory and pro-aging genes are upregulated.”  The process is highly evolutionarily conserved.  How it works in nematodes was laid out in a 2015 paper by Morimoto and his colleague.  Repression of the Heat Shock Response Is a Programmed Event at the Onset of Reproduction  “The heat shock response (HSR) is essential for proteostasis and cellular health. In metazoans, aging is associated with a decline in quality control, thus increasing the risk for protein conformational disease.  Here, we show that in C. elegans, the HSR declines precipitously over a 4 hr period in early adulthood coincident with the onset of reproductive maturity.  Repression of the HSR occurs due to an increase in H3K27me3 marks at stress gene loci, the timing of which is determined by reduced expression of the H3K27 demethylase jmjd-3.1.  This results in a repressed chromatin state that interferes with HSF-1 binding and suppresses transcription initiation in response to stress.  The removal of germline stem cells preserves jmjd-3.1 expression, suppresses the accumulation of H3K27me3 at stress gene loci, and maintains the HSR.  These findings suggest that competing requirements of the germline and soma dictate organismal stress resistance as animals begin reproduction.”  It is fascinating that the methylation and loss of gene regulation happens so quickly once adulthood arrives– in 4 hours for nematodes,

Highlights 

  • Stress responses are rapidly repressed at the onset of egg laying in C. elegans
  • Transcriptional repression at stress response genes is due to increased H3K27me3
  • Reduced jmjd-3.1 expression underlies increased H3K27me3 at stress response genes
  • Repression of stress responses is regulated by germline stem cells”

The graphical abstract applies tells the story clearly

”It is thought that the progressive dysregulation of stress response pathways contributes to aging in metazoans. Here, Labbadia and Morimoto demonstrate that stress responses are rapidly repressed early in C. elegans adulthood as part of a genetically programmed event controlled by germ line stem cells through alterations in chromatin accessibility.”

Recall that a primary function of the heat shock response and upgrading of heat shock proteins like HSP70 is keeping proteins folded correctly.  However, the heat shock HSF-1 response plays a role in the activation of many cancers, so downgrading this in early adulthood could be an anti-cancer mechanism conserved by evolution.

Morimoto and his team subsequently published a 2017 paper Mitochondrial stress restores the heat shock response and prevents proteostasis collapse during agingThere, they found that “mitochondrial perturbation”, a specific kind of mitochondrial electron transport chain manipulation, restored more youthful JMJD3 and H3K27me3 expressions.  “In Caenorhabditis elegans, the programmed repression of the heat shock response (HSR) accompanies the transition to reproductive maturity, leaving cells vulnerable to environmental stress and protein aggregation with age. To identify the factors driving this event, we performed an unbiased genetic screen for suppressors of stress resistance and identified the mitochondrial electron transport chain (ETC) as a central regulator of the age-related decline of the HSR and cytosolic proteostasis.  Mild downregulation of ETC activity, either by genetic modulation or exposure to mitochondria-targeted xenobiotics, maintained the HSR in adulthood by increasing HSF-1 binding and RNA polymerase II recruitment at HSF-1 target genes. T his resulted in a robust restoration of cytoplasmic proteostasis and increased vitality later in life, without detrimental effects on fecundity. We propose that low levels of mitochondrial stress regulate cytoplasmic proteostasis and healthspan during aging by coordinating the long-term activity of HSF-1 with conditions preclusive to optimal fitness.”

A 2016 study by a different team,Two Conserved Histone Demethylases Regulate Mitochondrial Stress-Induced Longevity, addresses the question of whether the “mitochondrial perturbation” of the electron transfer chain just mentioned is an alternative path to greater youthfulness that doesn’t include or impact the JMJD3/H3K27me3 combination?  The bullet points below are the “Results” section subtitles of the study.

  • “Mitochondrial ETC-mediated longevity requires the histone lysine demethylases jmjd-1.2 and jmjd-3.1
  • There are overlapping temporal requirements of JmjC demethylase activity and ETC-mediated longevity
  • JMJD-1.2 and JMJD-3.1 regulate the mitochondrial Unfolded Protein Response (UPRmt)
  • Overexpression of jmjd-1.2 or jmjd-3.1 is sufficient for lifespan extension and UPRmt induction
  • The UPRmt is a genetic requirement for JmjC demethylase-mediated longevity
  • JMJD-1.2 and JMJD-3.1 Overexpression Recapitulates the Transcriptional Response to Mitochondrial Stress
  • Mammalian PHF8 and JMJD3 Correlate with Lifespan and UPRmt Activation”

11.  Nicotinamide riboside, the mitochondrial UPR response and extending mammalian longevity

The 2016 publication NAD⁺ repletion improves mitochondrial and stem cell function and enhances life span in mice is among those reporting on this issue.  “Adult stem cells (SCs) are essential for tissue maintenance and regeneration yet are susceptible to senescence during aging.  We demonstrate the importance of the amount of the oxidized form of cellular nicotinamide adenine dinucleotide (NAD(+)) and its effect on mitochondrial activity as a pivotal switch to modulate muscle SC (MuSC) senescence. Treatment with the NAD(+) precursor nicotinamide riboside (NR) induced the mitochondrial unfolded protein response and synthesis of prohibitin proteins, and this rejuvenated MuSCs in aged mice.  NR also prevented MuSC senescence in the mdx (C57BL/10ScSn-Dmd(mdx)/J) mouse model of muscular dystrophy.  We furthermore demonstrate that NR delays senescence of neural SCs and melanocyte SCs and increases mouse life span.  Strategies that conserve cellular NAD(+) may reprogram dysfunctional SCs and improve life span in mammals.”

12.  H3K27me3 and its methylation/demethylation status plays a similar role in the transition from youth to adulthood in plants as in animals

There are many studies about this.  A fascinating collection of diagrams showing numerous roles of H3K27me3 in plants can be found here.  For example this diagram shows loss of H27me markers in the transition from plant juvenile phase to adult phase, essentially the same thing we described here as happening in nematodes and humans.  The implication is that this is a very basic transition applicable to the life cycles and aging of living things.  And undoing it may well be the key to YOUNGING.

Image source

 

 

 

 

 

There will likely be much much more to write about all of this.

Introduction to the YOUNGING Series – Emerging Aging Reversal Strategies and Treatments

$
0
0

By Vince Giuliano and Steve Buss

Aging reversal has been the dream of humans for all of our history. It has happened in stories and myths.  For example, Hebe was the Greek Goddess of youth. “Hebe had influence over eternal youth[5] and the ability to restore youth to mortals, a power that appears exclusive to her, as in Ovid’s Metamorphoses, some gods lament their favored mortals aging. According to Philostratus the Elder, Hebe was youngest of the gods and responsible for keeping them eternally young, and thus was the most revered by them.[6]Her role of ensuring the eternal youth of the other gods is appropriate with her role of serving as cupbearer, as the word ambrosia has been linked to a possible Proto-Indo-European translation related to immortality, undying, and lifeforce.[7 She carried a cup with ambrosia.  In art, she is typically seen with her father in the guise of an eagle, often offering a cup to him. (ref Wikipedia)”

Hebe, Goddess of youth, feeding Ambrosia, elixir of youth to her father Zeus, shown in art as disguised as an eagle.  Image source Wikipedia

 

 

 

 

 

This an introduction to a series of blog entries dealing with the science of age reversal approaches.  Ambrosia existed in mythology in the 5th century BCE.  Now in 2020, established science indicates that there are substances in the blood of younger people that can restore the youth of older people.  We are now hot on the trail of understanding YOUNGING, the biological processes through which youth can be restored, and developing practical means for doing this.  This new knowledge is timely, so you may end up benefitting from it personally.  We are telling this story and the science behind it in a new series of blog entries.  The first of these is already published.  It is YOUNGING 1.0 – THE EMERGING AGING REVERSAL STRATEGY.

Over the last century, increasingly sophisticated concepts, scientific tools, and communication technologies have triggered an explosion of knowledge about Aging and how it might be slowed.  We have sought to highlight evidence of this knowledge over the last dozen years in this blog.

But this cumulative increase in evidence wasn’t significant enough that we could integrate it into a reasonably complete sketch of the causes of aging with certainty until now.  Still, “aging theories” have emerged from the certain meager knowledge we’ve had, and these theories have been much researched and discussed in the absence of more conclusive evidence.

Only very recently has experimental evidence from diverse fields hinted at explanations that, when integrated, provide a clearer view of the causes of Aging and means for slowing or reversing it.

It’s now possible to sketch a Biological-Age-Reversal-Strategy, Version 1.0, that is grounded in the evidence and settled explanations of that evidence, from a diverse set of research studies. Some of these studies are already well-known within the longevity science community. Others are less well-known, even virtually unknown, within the community but still consequential for this strategy.

We call this strategy YOUNGING 1.0 because, like Aging, it is a process rather than a sudden transformation.  It’s a kind of Aging, but in reverse. We expect our understanding of this process to broaden and deepen over time enough to merit appending a version number to each successive sketch.

In this and the next several blog posts, we will sketch this YOUNGING 1.0 strategy. Some of these posts are likely to be among the most important ever published in the 12-year history of ANTI-AGINGFIREWALLS.

We will sketch some central details of this strategy in our next post YOUNGING 1.0 – THE EMERGING AGING REVERSAL STRATEGY, which is already published.  First, we’ll address few key related issues in the remainder of this post.

About “YOUNGING

Our commitment in this blog is to convey knowledge and insight about where the sciences connected with longevity stand.  Mostly we seek to report facts and on research of others, where there is relatively little disagreement among knowledgeable scientists.  Other times, we write about topics on which there is significant disagreement or silence.  In each case, we lay out what we see to be so in our unique manner, linking up disparate pieces of research into a meaningful framework.  Other times, we relate personal commentaries on our own experiences.  Where gaps in knowledge may exist, we may speculate on what may best fill those gaps.  This YOUNGING series embodies elements of all of the above.  We think the time has come to lay out the picture now best as we can.  While we see our first sketch as compelling, major gaps in our knowledge are still to be filled in.  The total picture may not be clear for many years to come.

In scientific experiments, Intervention techniques associated with this YOUNGING 1.0 strategy have been shown to provide

  • health benefits, survival probability increases, and aging reversal in small animals
  • health and survival probability benefits in humans

There are good reasons to believe that the aging reversal they will work in humans as well.

Why now, finally, can we begin to sketch a YOUNGING Strategy with greater certainty?

I (Vince) gave a talk several years ago in which I asserted that aging-related science is like a multi-dimensional puzzle with 100,000 pieces:  A puzzle having no box cover depicting what its assembled pieces look like.  Solving the longevity puzzle is a process with many similar steps that those who have worked on large puzzles are familiar with.

  1. A good way to start is by sorting puzzle pieces into piles for general similarity, such as for sky, water, grass, woodlands and buildings. Especially look for edge pieces with straight edges. Don’t worry about pieces with strange shapes or colors portrayed on them at this point.  Just set them aside.
  2. Then start joining edge pieces and pieces of like color or pattern, looking for pieces with compatible connectors. Often It is easiest to start with like-colored edge pieces.  Start up connecting pieces two at a time, then three or more at a time when this is possible.
  3. Add to the already joined pieces, to get larger and larger chunks of the puzzle. Be on the lookout for what the chunks are likely to represent and where they are likely to end up in the assembled picture.  g. chunks of light blue and white are likely to be of sky, though they could be of reflections in water.  Another chunk of darker blue and grey is likely to be water, though it could be sky at dawn or dusk.  The chunks with bricks and spires appear to be part of some kind of building or castle, and the chunks with dark green, brown and blacks appear to be part of a forest of some kind.  Or perhaps of a forest reflected in water.  Light shades of green could be grass but are not necessarily that.
  4. Once you have some larger chunks assembled as above, build on the chunks to make them bigger. The puzzle gets easier because you have guidance as to where to connect in other pieces. 
  5. You can now work also on fitting in transition pieces, such as ones with green-brown and light blue background representing transition from forest to sky. Or pieces of castle showing sky.  The more you do the easier it gets to proceed.
  6. Finally, you get to connecting up the bigger chunks with each other and most of the edge pieces. Importantly, at this stage, you are starting to see the scene the puzzle portrays.  Now, how to fit in the oddball pieces originally set aside becomes more and more clear.  That funny collection of dark brown and black pieces?  They make up the castle gate and drawbridge.  The strange dark red pieces with blue-grey edges – they turn out to be a small boat on the lake.  And other multicolor pieces with green edges– they are festive flags planted in the grass and ladies on the lawn.
  7. At this point finishing the puzzle is easy; it just takes more patience as strange puzzle small chunks and transition pieces are fit in. And the white and the tiny yellow and speckled brown chunk with green edges? It’s a picnic tablecloth with food on it laid out on the grass.  That impossible piece with a white steak on it?  It is a feather in a ladies’ hat

When Vince started writing in this blog a dozen years ago, understanding of the longevity sciences was transitioning from Stage 2 to Stage 3 as above.  It took a lot of years to get us through most of Stages 4 and 5.  We think we are finally in what corresponds to Stage 6 of the above.  The overall gestalt of the YOUNGING picture is becoming clear.  Though there are a large number of mysterious small chunks of the puzzle yet to be filled in.

We will be detailing completion of the important puzzle of YOUNGING in the following blog entries.

How science proceeds and why many the sources of research are so disconnected

Derek de Solla Price was a brilliant and important physicist, information scientist, and historian of science who developed a deep understanding of how scientific research works.  I (Vince) interacted with him frequently on the late 60s and 70s.  To summarize a few things, he taught me:

    • Scientific research takes place via small communities of scientists (100 to 300 people) who work on a common topic, publish in the same journals, read each other’s papers and, if they are professors propagate their work via their graduate students. Leaders of such a community are well known to one another and appear of the stage together in scientific meetings.  They frequently cite each other in their publications.  And they review and support each other’s research grant requests.  An example of such a community a few years back consisted of researchers on Sirtuins as related to longevity, with Institutes at Harvard and MIT being bastions of that research community.
    • The researchers in a community with a “hot” technical focus, one where there are more and more important discoveries surfacing, are excited by their work and tend to dig deeper and deeper into their respective areas. D. students working on their mentor professor grants very often will do research that further details work of their professors on a specific topic.  In part this is because the professor is really interested in the graduate student’s research and is well-positioned to guide it. More often than not, it is also because the graduate student can be supported by a grant the professor has to study that topic.
    • When the depth, scope of interest, and growth of membership in such a community expands, a group will tend to calve off new, more specialized community instead of continuing to grow itself. For example, a community seems to have formed concerned with the mitochondrial Sirtuins SIRT3, SIRT4 and SIRT5.
    • Members of a community may be familiar with research on adjacent topics, but generally not about more remote topics that could turn out to be relevant to their central focus. Those concerned with Sirtuin research may maintain familiarity, for example, with some detailed metabolic process, and with histone acetylation/deacetylation.  But they’re probably less familiar with pathways related to glycogen synthase kinase 3 and the association of GSK3beta  with the pathogenesis and progression of many aging-related diseases.In times of significant paradigm shifts of the kind Thomas Kuhn wrote about, unfamiliarity takes on an even more dramatic character:  g. Most longevity community scientists appear completely oblivious to the ways Near Infrared Light can positively impact cognitive health via a mitochondrial mechanism of action.
      In general, there is virtually no time to become familiar with distant topics being pursued by unknown groups of other scientists.  This is understandable given the flood of some 1.3 million new publications yearly in the biological and health sciences.
    • So, the impetus among professional scientists is to dig deeper and deeper into their own, established scientific domain—stages 1 and 2 of large puzzle assembly—and not to look across to distant domains which seem on the face of it to be irrelevant. The process has been described by saying that most research falls into ever more-technical Research Silos.

Research highly relevant to YOUNGING may come from a number of disconnected research silos.  This is because YOUNGING is a multi-level, multi-organ and multi-system process. How many in the anti-aging research community have closely followed research related to the histone methylase HK27me2me3 or the particular histone demythelase JMJD3?  (Until very recently, Vince did not, despite always seeking to be very broad in his research tracking.  Steve brought the relevancy of these factors to Vince’s attention. Steve claims that the key benefit of his lack of any formal education in the life sciences is that he doesn’t know what supposed to be important and what’s not.)  Yet, these are critical elements in the YOUNGING 1.0 picture described in the next blog entry YOUNGING 1.0 – THE EMERGING AGING REVERSAL STRATEGY

Age reversal and systems biology

Understanding YOUNGING, and understanding Aging itself for that matter, can best take place if one is familiar with some rudiments of Systems Theory.  The basic idea behind Systems Theory is that the functioning of any individual component or subsystem is mutually governed by the functioning of other related components or subsystems, and that the behavior of the system itself is an emergent property.  That is, you cannot predict the behavior of the system from knowledge about the individual parts. “The whole is greater than the sum of its parts. “An easy example of this is baking a cake. If you were to lay out all of the ingredients of a cake, you would not have a cake. Instead, you would have the ingredients of cake. But, combine those ingredients in a particular way, you produce a cake.(ref)” Animal bodies, human bodies in particular, are extremely complex muti-level systems, with numerous subsystems interacting with each other in extremely complex ways.  For example, health of a heart can depend on the functioning of the vascular system which delivers blood to the heart, the lungs which deliver oxygen, and the conditions of the heart muscle, and on the operation of neuromuscular systems and in particular the Vagus 

Nerve system which drives heartbeat timing.  Going down a level, heart health can depend on the health of the cells in the heart which depend in turn on the health of the cellular components such as the cell mitochondria and integrity of the internal cell skeletal and transport systems.  And in all of these cases, a complexity of molecular mechanisms is at work.

 

Image source A limited representation of systems affecting the heart

Engineers who design extremely complex systems like a nuclear power plant or jet airplanes have developed some key systems theory concepts and principles that can be carried over directly into biology.  A few of these are:

  • For any subsystem, there are certain measurable operating parameters which must be kept within well-defined ranges for continuing functioning of that subsystem (and the system as a whole) to be possible  For example, in a nuclear power plant, in the low pressure feedwater subsystem the water pressure, temperature, salinity, acidity, and flow rate must be kept within well-defined numerical ranges.  If this is not done the pipes could crack or corrode, or the nuclear reactor could run too hot or too cold, for example.  So, gauges measure these parameters at several critical points, and feed the measurements into a computer.  If a parameter or several go out of acceptable range the computer takes steps to correct the situation if it can.  Like increasing cold water intake if the water temperature is too hot.  If those steps don’t work the computer will notify the operators and if necessary shut the reactor down.  If this system does not work well?    We know what happened at Chernobyl.   Image source

In the human body there are completely comparable situations.  Consider blood flow into the heart, for example.  Numerous parameters like blood pressure, temperature, electrolyte balance, red and white blood cell count, and heart beat rates must be kept within normal operating parameter range.

So the body continuously measures these and countless other parameters as well and is constantly making adjustments to keep them all consistently within normal operating range.  In

biology this process is known as seeking homeostasis.  Consistent fine tuning is involved.

E.g.  The   Vagus Nerve in the parasympatic nervous system accepts inputs from the major body systems and actually computes the best time for every single next heart beat.  If this is done well there is considerable heart rate variability (HRV)  in the timing of heart beats.  High HRV is an indicator of body systems resilience and general health, and low mortality. If such systems coordination is not done well, HRV is low, and this is a predictor of disease and higher mortality.  Image source  The sympathetic and parasympathetic nervious systems and the heart

  • Operations of numerous subsystems must be coordinated, again to keep all critical parameters within normal operating ranges (i.e. in a biological organism, maintain homeostasis). In the case of a typical nuclear reactor, there are radiation monitoring systems, electrical management systems, fission management systems, steam flow, high-pressure feedwater, turbine management, and wastewater management systems, to mention a few.  All are critical.  And in the human body we have the circulatory, nervous, endocrine, pulmonary, digestive, and cardiovascular systems, and all the major organ systems.  All must be managed together to keep all critical operating parameters within range (maintain homeostasis).

Image source  One of a great many of body control systems

The body’s capability to do that is incredible although we take it for normal.  As an example, consider what just happened while I took a 25 minute vigorous walk as an exercise break from this writing:  my heart started beating faster to provide more oxygen to my musculature tissues my vascular system dilated a little to accommodate the increased blood flow, my lungs started breathing deeper and more frequently, and my airways systems dilated a little to accommodate that.   I started to sweat a little as my body got hotter due to increased metabolism, and my mitochondria responded to a signal to produce more ATP for energy.  My hypothalmus gets involved in assuring temperature homeostasis as in the diagram.  And numerous secondary loops also got activated, like ones connected with the metabolic cycle, mitochondrial functioning, and neuromuscular control.  All of that activation of numerous feedback loops happened without me thinking about it at all.  And as I write this my heart is slowing to normal and other systems are going back to normal too,

  • The autonomic control systems in the body, unlike those in a nuclear power plant, exhibit an amazing additional property, known as Hormesis. That is, in response to any stress that does not exceed a certain limit, the body or body subsystem feedback loops re-tunes themselves so that the body subsystem is stronger and better off than before the stress was applied.  That, for example, is why the stress of non-excessive exercise is good for me.  And why the hypoxic stress of reducing arm blood circulation with a cuff can lead to better surgical outcomes. “Although radiation has been thought to be harmful no matter how low the dose exposure, accumulating evidence suggests that hormesis is a real phenomenon and that bioprotective functions including antioxidant capacity, DNA repair, apoptosis, and immune responses are induced by low doses of radiation (Sakai, 2006)(Wikipedia); . See this list of blog writings by Vince relating to Hormesis and its properties.
  • Underlying conditions related to homeostatic equilibrium can be very different, depending on biological age. While quick-acting feedback loops in the body work to maintain homeostasis at all times, the balance of elements and gene activation necessary to do this will vary widely depending on age and health.    My body and the bodies of my 4 year-old and 18 year-old grandchildren are in homeostasis, yet the balances in each of us are very different.  Those of us over 80, for example, will have experienced severe decline in many key hormones as well as in NAD+, sirtuins, AMPK, and many other key proteins.  And up-regulation of many other proteins such as mTOR and IGF-1. “It is well documented that the effectiveness of the immune system peaks at puberty and gradually declines thereafter with advance in age. For example, as one grows older, antibodies lose their effectiveness, and fewer new diseases can be combated effectively by the body, which causes cellular stress and eventual death.. Indeed, dysregulated immune response has been linked to cardiovascular disease, inflammation, Alzheimer’s disease (AD), and cancer(ref)” Our aging bodies may be in states of chronic inflammation and aberrant redox potential, and our thymus glands have all but disappeared.  Our DNA will have different balances of mutations, aneuploidy, methylation, and alternative splicing.  Signs of Aging are likely to be everywhere you look, in all organs and manifest on all systems levels as well as in cells.  And many of the feedback loops work a lot more slowly than the fast-acting ones I mentioned connected with exercise.
  • Aging and YOUNGING requires multiple information feedback loops on multiple systems levels interacting with each other to come into new states of equilibrium, and this can take a lot of time. Events on the molecular biology level, the level of cell organelles, the tissue-type level, the organ level and the systems level all impact each other, and these all coming into equilibrium can require complex time-consuming interactionsThis is why YOUNGING is necessarily a slow process that takes a lot of time.  As a hypothetical example, consider an older man with insufficient level of intracellular NAD+.  As a consequence he is not generating enough SIRT1 to do an adequate job of DNA repair and there is insufficient SIRT1 to produce mitochondrial proteins required for mitochondrial health.  As a result, mitochondria tend to leak reactive oxygen species (ROS), which has driven his body into an oxidative redox state.  And improperly repaired DNA is leading to his having dysfunctional and improperly folded proteins.  There are many bad consequences such as more DNA damage, a highly inflammatory general systemic state, diminished production of heat shock proteins which can properly refold proteins, and an even greater demand for the limited supply of SIRT1.  A downwards spiral is in place.  Say that person starts to take a supplement to increase the NAD+ level like nicotinamide riboside and to take resveratrol pills to increase SIRT1.  Slowly, the events in this chain of consequences may start to reverse – but it might require a long time on the supplements before the systemic inflammation starts to subside, if at all.   Basic changes associated with Aging take years to happen.  And it appears to us that they will likewise require years to be reversed in the course of YOUNGING.

We speculate now, and will flesh out details in the future, that systematic, healthful interventions at multiple levels at the same time is likely to trigger a faster process of YOUNGING.

There is much more to be said.  And we endeavor to say it.  We suggest that our readers proceed next directly to our first substantive blog entry YOUNGING 1.0 – THE EMERGING AGING REVERSAL STRATEGY.


MORE ON YOUNGING1.0 – THE EMERGING AGING REVERSAL STRATEGY

$
0
0

By Vince Giuliano

Methuselah –Methuselah lived 969 years according to Genesis 5:27, the oldest person who ever lived.  Image source

 

I believe the previous blog entry YOUNGING1.0 – THE EMERGING AGING REVERSAL STRATEGY may well turn out to be the most important one published in this blog so far.  In that blog entry, Steve Buss and I described some key elements of a strategy for age reversal which appears to be emerging in the recent literature –we call it YOUNGING1.0. To our knowledge this is the most extensive scientific characterization of a viable age reversal strategy that has appeared in the literature.

This current blog entry covers clarification, expansion and evidence for some key points that were laid out in that original blog entry.  In particular, I expand on the hypothesized scientific basis for YOUNGING1.0, which is the reversal of global H3K27 histone methylation via  JMJD2/JMJD3.  I go deeper into the biology and processes of histone methylation.  And I selectively treat a few associated topics.  For example, I note the role of vitamin C in both OSKM cell regression to younger states and inYOUNGING1.0 via JMJD2/3.

Again, this blog entry.  I take a somewhat Socratic approach, identifying key questions that could come up and our responses to these questions – to the extent I am able to formulate them.

Steve bus and I have asserted that the key feature of the particular YOUNGING approach, we focused on, YOUNGING1.0 is demethylation of H3K27 via the demethylases JMJD2/3 Why?  In the original blog entry we did not explicitly cover some of the basic reasons for this informed conjecture.  The issue was brought to my attention via an email from a well-informed colleague in the longevity science field.  He wrote me the following email.

I’ve been out of touch with you for awhile, and one of my readers just referred me to your recent work on Younging1.0. I’m glad to hear that you’re thriving and on the road to a younger body.  I’d like to talk to you when you have a chance. My general response to the science you present is this: I think of epigenetics as a highly specific program, turning some genes on and others off, and involving many mechanisms, of which 5-methyl-cytosine and H3K27 methylation are just two examples. The problem as I see it is to selectively turn on the right genes and turn off the wrong ones.  So I’m questioning whether JMJD2 can do anything selective, or whether its effect is to turn genes on globally.    If you have time for a video chat, please let me know when it’s convenient.

 We indeed did follow through with a video chat and I repeat here my responses to the points he raises here.  I generally agree with what my colleague says above, so I will address his concerns, point by point.

  1. H3K27 methylation and demethylation are global effects.  H3K27 methylation may potentially turn off or down-regulate thousands or tens of thousands of genes.  And demethylation of H3K27me loci via JMJD2 can potentially upregulate the expression of the same thousands or tens of thousands of genes.

the key to seeing this is understanding the profound difference between gene promoter site methylation and histone methylation.  Both are in the DNA.  Individual gene promoter site (or individual gene promoter site neighborhood) methylation is what is involved in the aging clocks promoted by Steve Horvath and others.  In general, when a gene is methylated its expression is inhibited.  That is, transcriptional repression is associated with DNA methylation which occurs by the covalent modification of cytosine residues in CpG dinucleotides concentrated in CpG islands.

Histone methylation is a completely different matter involving very many genes.  H3K27 is the address of a particular histone tail on a nucleosome, namely lysine27 on histone 3.  It is not the name or address of any particular gene.  When that position is methylated, or in the case of H3K27me doubly or trippily methylated, the chromatin in that neighborhood becomes closed, meaning that genes in that neighborhood cannot be expressed.  How many genes are therefore affected?  Going back to basics, “A single nucleosome consists of about 150 base pairs of DNA sequence wrapped around a core of histone proteins. The nucleosomes are arranged like beads on a string. They are repeatedly folded in on themselves to form a chromosome (ref).”

Image source

There are 21 human chrosomes and each one may have hundreds of thousands of nucleosomes(ref), and a single human cell might have 30 million nucleosome’s(ref).  So it is simple arithmetic to see that this one simple kind of histone methylation, H3K27, could potentially silence thousands or tens of thousands of our genes.  Likewise, demethylating H3K27 via JMJD2/ JMJD3 could reactivate the same genes.  So yes, one single demethylase could have a massive global effect.

  1. What does methylation and demethylation of H3K27me histones do?

In general: all Methylation and demethylation of histones turns the genes in neighboring DNA “off” and “on,” respectively, either by wrapping the DNA histone tails tightly around the DNA and thereby restricting access to it and its restricting its activation, or by loosening their tails, thereby allowing transcription factors and other proteins to access the DNA.  Put differently histone methylation results in closed chromatin where genes are not expressed and demethylation results in open chromatin where genes are expressed. 

Image source

Histone methylation is one of the several forms of post-translational modifications of chromatin.  A reminder of background on such modifications. If the DNA in a typical human cell were stretched out end to end, it would be roughly 6 feet long.  “This remarkable feat is accomplished through the intricate organization of that DNA into chromatin. The organization and structure of chromatin can control gene expression. — The fundamental unit of chromatin consists of DNA wrapped around protein octamers, termed histones, in 147 base pair segments to form nucleosome subunits. Histone octamers are made of two copies of each core histone: H2A, H2B, H3, and H4. These histones have positively charged amino (N)-terminal tails which extend from the nucleosome and can undergo several modifications, which in turn affect chromatin accessibility and gene expression.” These modifications, include acetylationmethylation, and ubiquitination, among others, and are regulated by various chromatin-modifying enzymes, frequently referred to as “writers” and “erasers,” which are responsible for incorporating or removing modifications, respectively. In addition to histones, writer and eraser proteins can also interact with transcription factors and other proteins, allowing for an incredibly intricate and multilayered system for the fine-tuned regulation of gene expression(ref).”

Going further: “This structure allows large amounts of DNA to be packaged into a relatively small nucleus. The nucleosome is highly modifiable, which allows the DNA to be accessible or inaccessible for transcription [4]. Post-translational modifications of the chromatin determine accessibility. — The histones are globular in nature except for their tails. It is in the histone tails that there can be multiple modifications of which at least eight are now known. These histone tail modifications include methylation, acetylation, phosphorylation [5], ubiquitination, citrullination, sumoylation and adenosine diphosphate ribosylation [6]. Furthermore, there are families of enzymes that mediate these histone modifications, such at the histone acetyltransferases (HATs) that catalyse the addition of an acetyl group from a donor, acetyl-CoA. Hyperacetylation of histone tails results in opening up of the DNA and thus permits access to transcription factors promoting gene expression. There are also enzymes that remove the modifications from the histone tails, such as the histone deactylases (HDACs), which remove the acetyl groups leading to a closed chromatin structure and therefore gene repression [7]. Acetylation is by far the most common histone modification.(reference: Epigenetic modulation as a therapy in systemic sclerosis).”  See also Readers, Writers, and Erasers – Chromatin as the Whiteboard of Heart Disease.

In this blog entry we are particularly concerned with histone methylation.  In general, I will continue to cite facts and publications here which indicate that JMJD2/3 and other members of the Jumonji complex result in the activation of numerous needed growth and development and health-related genes, but like so many other substances in biology, which promote growth and development are also correlated with cancer development.

Clarification of these matters can be found in the 2014 publication The Jumonji family: past, present and future of histone demethylases in cancer.

  1. JMJD2 is a highly specific histone deacetylase that localizes to H3K27me histone sites. It demethylates the gene promoters near such sites.

B.    Histone methylation, particularly that related to H3K27me has for some time been known to be related to longevity.  The 2011 review Histone methylation makes its mark on longevity relates: “How long organisms live is not entirely written in their genes. Recent findings reveal that epigenetic factors that regulate histone methylation, a type of chromatin modification, can affect lifespan. The reversible nature of chromatin modifications suggests that therapeutic targeting of chromatin regulators could be used to extend lifespan and healthspan. This review describes the epigenetic regulation of lifespan in diverse model organisms, focusing on the role and mode of action of chromatin regulators that affect two epigenetic marks, trimethylated lysine 4 of histone H3 (H3K4me3) and trimethylated lysine 27 of histone H3 (H3K27me3), in longevity.

C.    JMJD2 is essential all for the renewal of blood cells.  This is explained in the publication The KDM4/JMJD2 histone demethylases are required for hematopoietic stem cell maintenance. “Taken together, our results show that the KDM4 demethylases are required for the expression of genes essential for the long-term maintenance of normal hematopoiesis.” {Recall that KDM4 is another name for JDJM2. in fact, there are multiple proteins in both the KDM and JDJM families (ref)}.

D.    Continuing expression of JMJD2 is essential for the development of organisms and cell and organ renewal.  It is also needed for stem cell pluripotency.  This fact is central for the current blog discussion and is highlighted in the 2016 research publication Continual removal of H3K9 promoter methylation by Jmjd2 demethylases is vital for ESC self-renewal and early development“Chromatin-associated proteins are essential for the specification and maintenance of cell identity. They exert these functions through modulating and maintaining transcriptional patterns. To elucidate the functions of the Jmjd2 family of H3K9/H3K36 histone demethylases, we generated conditional Jmjd2a/Kdm4a, Jmjd2b/Kdm4b and Jmjd2c/Kdm4c/Gasc1 single, double and triple knockout mouse embryonic stem cells (ESCs). We report that while individual Jmjd2 family members are dispensable for ESC maintenance and embryogenesis, combined deficiency for specifically Jmjd2a and Jmjd2c leads to early embryonic lethality and impaired ESC self-renewal, with spontaneous differentiation towards primitive endoderm under permissive culture conditions. We further show that Jmjd2a and Jmjd2c both localize to H3K4me3-positive promoters, where they have widespread and redundant roles in preventing accumulation of H3K9me3 and H3K36me3. Jmjd2 catalytic activity is required for ESC maintenance, and increased H3K9me3 levels in knockout ESCs compromise the expression of several Jmjd2a/c targets, including genes that are important for ESC self-renewal. Thus, continual removal of H3K9 promoter methylation by Jmjd2 demethylases represents a novel mechanism ensuring transcriptional competence and stability of the pluripotent cell identity.”

E.    As usual, the situation is complex. JMJD2 is one member of the Jumonji family (Jmjc) demethylases.  Some relevant publications cited here relate to JMJD3 instead of or in addition JMJD2. “The JmjC family comprises 30 members that share a JmjC domain. To date, 18 of these have been shown to possess demethylase activity towards H3K4, H3K9, H3K27, H3K36 and H4K20 (8, 17–31). Based on their homology and the presence of different domains, the 30 members can be further classified into sub-families that often share substrate specificity. — As well as sharing a JmjC domain, all members react with α-ketoglutarate (α-KG) in an Fe(II) ion-dependent manner (Figure 2). However, not all have been shown to be catalytically active. In addition, other domains may also mediate demethylase activity independently of the JmjC domain(ref).

  1. We generally know quite a bit about the kinds of genes affected by H3K27 methylation and correspondingly by H3K27 demethylation as a result of JMJD2 or JMJD3 expression.

For one thing, this methylation has much to do with the growth and development.  l “Methylation of lysine 27 on histone 3 (H3K27me), a modification usually associated with gene repression, has established roles in regulating the expression of genes involved in lineage commitment and differentiation.(ref)” Deregulation of this methylation also appears to play a major role in cancer.

1.4.   Inflammation appears to play a major role in creating some forms of global methylation, particularly ones that can lead to forms of cancer.

See Methylation of Polycomb target genes in intestinal cancer is mediated all by inflammation and H3K27 Methylation: A Focal Point of Epigenetic Deregulation and The Jumonji family: past, present and future of histone demethylases in cancer. This is why we conjecture that suppression of systemic inflammation may be an aspect of averting global methylation. (Frequent readers of this blog know of my many published articles relating to the control of chronic inflammation as a strategy for antiaging, and my creation and promotion of a dietary substance focused on that objective.  Check out my publications in the last two years.)

  1. We know of numerous specific substances that activate the expression of JMJD2.  Many of these all are quite familiar and long-known to be health and/or longevity- producing.

I only discuss only one familiar example substance here – vitamin C. However, there are several additional old-friend substances including curcumin and high AKBA Boswellia. I expect to discuss use of these and other practical approaches to JMJD2 activation as an approach to YOUNGING in a future blog entry.

    • Vitamin C promotes the expression of See the 2017 publication  Vitamin C enhances the expression of IL17 in a Jmjd2–dependent manner“Previously, we reported that vitamin C facilitates the CpG demethylation of Foxp3 enhancer in CD4+Foxp3+ regulatory T cells (Tregs) by enhancing the activity of a DNA demethylase ten-eleven-translocation (Tet). However, it is not clear whether vitamin C affects other helper T cell lineages like T helper type 17 (Th17) cells which are related with Tregs. Here, we show that the expression of interleukin-17A (IL17) increases with the treatment of vitamin C but not with other antioxidants. Interestingly, the upregulation of IL17 was not accompanied by DNA demethylation in Il17 promoter and was independent of Tet enzymes. Rather, vitamin C reduced the trimethylation of histone H3 lysine 9 (H3K9me3) in the regulatory elements of the Il17 locus, and the effects of vitamin C were abrogated by knockdown of jumonji-C domain-containing protein 2 (jmjd2). These results suggest that vitamin C can affect the expression of IL17 by modulating the histone demethylase activity.”  Note that this is not the only reported association of vitamin C with a YOUNGING process. Vitamin C also enhances epigenetic regression of normal cells towards stem cell status via the OSKM factors(ref).
    • “Vitamin C, by enhancing the catalytic activity of JHDMs and TETs drive histone and DNA demethylation in somatic cells that allow pluripotency genes to turn on while simultaneously erasing the epigenetic memory of the adult cell state. — Vitamin C plays a pivotal role in remodeling the epigenome by enhancing the activity of Jumonji-C domain-containing histone demethylases (JHDMs) and the ten-eleven translocation (TET) proteins. By maintaining differentiation plasticity in culture, vitamin C also improves the quality of tissue specific stem cells derived from iPSCs that are highly sought after for use in regenerative medicine. The ability of vitamin C to potentiate the activity of histone and DNA demethylating enzymes also has clinical application in the treatment of cancer. Vitamin C deficiency has been widely reported in cancer patients and has recently been shown to accelerate cancer progression in disease models. Therapies involving high-dose vitamin C administration are currently gaining traction in the treatment of epigenetic dysregulation, by targeting aberrant histone and DNA methylation patterns associated with cancer progression (ref Reprogramming the Epigenome With Vitamin C).

Image sourceVitamin C promotes somatic cell reprogramming by enhancing the activity of α-KGDDs. The addition of vitamin C to the culture medium of somatic cells during reprogramming enhances the activity of α-ketoglutarate dependent dioxygenases (α-KGDDs) including Jumonji-C domain-containing histone demethylases (JHDMs/KDMs), ten-eleven translocation (TET) proteins, prolyl hydroxylases (PH) and the asparaginyl hydroxylase FIH-1. —-loci. The hypomethylation of histones by JHDMs such as KDM2 targets H3K36me3 for demethylation that suppresses the expression of senescence-inducing factors Ink4/Arf. Vitamin C also increases loss of H3K9me2/me3 by enhancing KDM3/4 activity to maintain expression at pluripotency loci during the final stages of reprogramming pre-iPSCs in to fully pluripotent iPSCs.”

5.  JMJD3 plays surprising metabolic role, acting together with SIRT1 (itself a gene deacetylase) and PPARα in certain cells under certain circumstances.

The 2018 publication Fasting-induced JMJD3 histone demethylase epigenetically activates mitochondrial fatty acid β-oxidation reports: “Jumonji D3 (JMJD3) histone demethylase epigenetically regulates development and differentiation, immunity, and tumorigenesis by demethylating a gene repression histone mark, H3K27-me3, but a role for JMJD3 in metabolic regulation has not been described. SIRT1 deacetylase maintains energy balance during fasting by directly activating both hepatic gluconeogenic and mitochondrial fatty acid β-oxidation genes, but the underlying epigenetic and gene-specific mechanisms remain unclear. In this study, JMJD3 was identified unexpectedly as a gene-specific transcriptional partner of SIRT1 and epigenetically activated mitochondrial β-oxidation, but not gluconeogenic, genes during fasting.  Mechanistically, JMJD3, together with SIRT1 and the nuclear receptor PPARα, formed a positive autoregulatory loop upon fasting-activated PKA signaling and epigenetically activated β-oxidation–promoting genes, including Fgf21, Cpt1a, and Mcad. Liver-specific downregulation of JMJD3 resulted in intrinsic defects in β-oxidation, which contributed to hepatosteatosis as well as glucose and insulin intolerance. Remarkably, the lipid-lowering effects by JMJD3 or SIRT1 in diet-induced obese mice were mutually interdependent.”

  1. The expression of JMJD2 is not always beneficial. It is highly expressed in many cancers and a cancer therapy research focus is on how to suppress the depression of JMJD2.

See, for example, the 2013 review publication KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer Cells and The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpression.  Also, the 2020 publication Advances in histone demethylase KDM4 as cancer therapeutic targets.

The 2019 publication Histone Modifications as an Intersection Between Diet and Longevity reports: ”Histone modifications are key epigenetic regulators that control chromatin structure and gene transcription, thereby impacting on various important cellular phenotypes. Over the past decade, a growing number of studies have indicated that changes in various histone modifications have a significant influence on the aging process. Furthermore, it has been revealed that the abundance and localization of histone modifications are responsive to various environmental stimuli, such as diet, which can also affect gene expression and lifespan. This supports the notion that histone modifications can serve as a main cellular platform for signal integration. Hence, in this review we focus on the role of histone modifications during aging, report the data indicating that diet affects histone modification levels and explore the idea that histone modifications may function as an intersection through which diet regulates lifespan. A greater understanding of the epigenetic mechanisms that link environmental signals to longevity may provide new strategies for therapeutic intervention in age-related diseases and for promoting healthy aging.”

I expect to include a more systematic discussion of approaches to inducing YOUNGING1.0  in a follow-up blog entry. In particular, I intend to explore the role of histone methylation in mediating the impacts of dietary interventions on aging and age reversal.  And I will suggest practical dietary interventions which I believe can contribute to YOUNGING1.0 age reversal.

ANTI-INFLAMMATORY HERBAL LIPOSOMAL PROPARATIONS FOR HEALTHY AGING

$
0
0

By Vince Giuliano

 

Frequent

 

 

 

Frequent readers of this blog know that I have invented a dietary supplement for the control of chronic inflammation, an important hallmark of aging disabilities.  The purpose of this blog entry is bring together the vital information and research about this supplement, 4 Herb Synergy, in one place.  In this blog entry, first I summarize the scientific basis for that invention.  Then I recap the events that led to the creation of the invention, why my colleagues and I brought it to the marketplace, and some of the experience we have had to date in improving the product.

This blog entry summarizes, updates and extends the information provided in two earlier entries: INFLAMMATION PART 6: THE SCIENCE BEHIND THE 4 HERB SYNERGY DIETARY SUPPLEMENT, and  On the Making of a Dietary Supplement.,

SECTION I: SUMMARY OF MAIN POINTS

Here are the main points of this blog entry.  Literature citations and discussions that validate these points are included in SECTION II.

  1. THE SCIENTIFIC BASIS FOR 4-HERBS SYNERGY

The main points are:

 Levels of chronic inflammation in humans increase with aging.

  1. Increase in chronic inflammation with aging “INFLAMMAGING” increases probabilities of multiple disease processes.  Image source
  2. Control of chronic inflammation is a key requirement for healthy aging and longevity.
  3. A central traditional approach to control of chronic inflammation, going back thousands of years, is the consumption of certain anti-inflammatory herbs.
  4. The biochemical constituents that control inflammation in those herbs are well-understood and are available in highly concentrated standardized forms.
  5. These different biochemical constituents act to control inflammation by diverse mechanisms.
  6. 4 Herb Synergy is a carefully engineered product designed to control chronic inflammation via a number of pathways that can operate synergistically.
  7. A problem with consuming some of those most important standardized anti-inflammatory herbal constituents is extremely poor bioavailability, inability of ingested substances to travel in the body and be absorbed where they are needed.
  8. Limited bioavailability and absorption of such key herbal substances can be most effectively addressed by using contemporary technologies of nano-particle delivery. In particular encapsulation of ingredients in liposomes, is a well-understood technique used in making 4 Herb Synergy. 
  1. THE ORIGIN AND HISTORY OF 4 HERB SYNERGY – a personal story

The original invention of 4 Herb Synergy was a step in a 47-year personal struggle to control my own chronic inflammation, originally of arthritic origin.

  1. Starting in my 20s, I was beset by aches, pains and stiffness in certain joints making sleep and some forms of movement uncomfortable. In 1972 (aged 32) I first sought to limit such inflammatory symptoms. I got my advice back then by reading popular health articles in magazines and, once in a great while, from consulting with an alternative health practitioner.  The first step was to limit my coffee consumption, which then was up to 6-8 cups a day.  That worked and the symptoms went completely away for about 10 years.  Image source
  2. And then the inflammatory pains gradually returned. In 1982 (aged 42) had read some of Linus Pauling’s early works and started taking large doses of Vitamin C. This worked and the pains went away again for about 15 more years.
  3. Then I got a worse-than-ever attack of arthritic pains in 1997 (age 67). I found and read several books on the use of herbal medicines to treat arthritis.  That was before much could be found on the subject on Internet.  I came up with a dietary supplement regimen which I have continued to modify and improve ever since.  Central to this regimen, in addition to the usual suspects like fish oils and vitamin C and D, were four herbs of Ayurvedic origin that were also each touted by book authors to be powerful anti-inflammatories that could just by themselves control RA symptoms – Curcumin, Ginger, Ashwagandha and Boswellia.  These raw ingredients were all readily available in pill form as dietary supplements, so I decided to take them all. After taking this pill regimen for about 3 months my arthritic symptoms all but vanished again.
  4. I give a lot of credit to this supplement regimen for keeping me agile for my age and largely free of inflammatory aches and pains for some 16 more years, until about 2013, when I was 83. The knuckle joint in the small finger in my left hand, my usual early inflammation alarm indicator, was starting to act up again. When arthritic symptoms were starting, it would become stiff and click when I I worked it, a situation known as “trigger finger,”.   By then I knew a lot more about the longevity sciences and about these herbs, and so I set about in the next step in my campaign to remain free of inflammatory aches, and pains and immobility.  My conjecture, which turned out to be correct, was that the 4 herb combination I was taking was an excellent one for controlling systemic inflammation, but that not enough of these substances were getting into my body tissues where they were needed to do that job effectively.  I needed to up the absorbability of the ingredients.
  5. That is when I developed the first formulation of 4 Herb Synergy in my kitchen, a liposomal version of the same combination of 4 herbs. At first, I thought I was pursuing a temporary personal health and longevity hack.   (In fact, I have been consuming the latest versions of it daily ever since as a central part of my personal longevity campaign.)  At the time, I knew I was growing older and increasingly vulnerable to the infirmities of old age.  As a dedicated longevity science researcher, I also knew that my continuing wellbeing and energy level depended on control of systemic inflammation.  I had already learned about the powerful anti-inflammatory impacts of certain key herbal chemical components in the four herbs. I had the pill-form experience with the 4 herbs.  I knew how these could be combined for synergistic impact.    And I knew how poor absorbability of these herbal chemicals could be overcome using a high-technology process of encapsulating the components into liposomal nano-particles.  And I knew how to make liposomal concoctions using mechanical sheer and ultrasound.  So I did that.
  6. Making a new batch of the supplement every 2 weeks or so became a pattern and soon Melody my wife started taking it too. Back then we called our kitchen-made product lipomix.  Our basic tools were a powerful high-sheer blender and an ultrasound tool cleaner unit.  If I neglected to make or take lipomix, after a week or two, the inflammatory symptoms like the trigger finger would begin to creep back.  Resuming taking the supplement would cause symptoms to vanish again.   So I learned the supplement was working for me.   As the months and then years rolled by, we knew the supplement gave us a certain vitality, and never wanted to stop.  The kitchen hacking turned into a process of continuing improvement of both process and product, switching from raw herbs to more-concentrated herbal extracts and improving the liposomal formulation process.   We did rounds of external laboratory testing to confirm liposomal content. Soon we were making batches for more and more friends and family members and this started to consume too much of our time and kitchen space.
  7. So, in 2017 we decided to make our liopmix into a commercial product which we renamed 4 Herb Synergy.  And my family partners Mike and Melody and I set up our Synergy Bioherbls LLC and we went into business.
  8. To create 4 Herb Synergy as a marketable product, we have conducted two rounds of R&D together with our manufacturer partner – a small but highly reputable company owned by a biologist. The first was to develop our first generation Gold commercial product, and the second in 2020 to develop our second-generation Gold II product,  Each round yielded significant Improvements in concentration, taste, added supporting anti-inflammatory ingredients, viscosity  and shelf life.  Gone are the quart sized bottles we used to fill up in our kitchen-hacking days, and our manufacturer is using a proprietary process which includes smaller liposomes in larger ones.  And taste is significantly improved.
  9. Meanwhile, in the last six years I have focused much of my longevity research on understanding the cellular mechanisms of chronic inflammation, and you can read several articles I have written about this subject in my blog.

I tell the earlier part of this story in greater length in the blog entry On the Making of a Dietary Supplement

 MY BASIC MOTIVATION FOR SELLING A PRODUCT

In deciding to launch a dietary supplement business, the possibility of enhancing our family income was certainly a consideration.  But it was not the most critical one. We have been living for a number of years on retirement income and could continue to do so. And at age 87 in 2017 why would I be willing to take on all the demands and hassles of going into a new business?

Perhaps the key consideration was that by creating a product I could likely do a lot more to enhance the health and longevity of people then simply by writing about it.   Most of the content of this blog is highly technical and, unfortunately, not understandable by people who do not have a background in biology and molecular biology. This has frustrated me since my intention all along has been to enhance the healthy longevity of as many people as I could. But the menu is not a meal. And while I have said a great deal about the science of longevity, I had to acknowledge that few people could translate this into actions which would benefit themselves.

The question for me has been what can I do to actually help foster a transformation of society so that the average healthy fully active lifespan is increased by 20 or 30 years? After large number years of intensive study of the scientific topics related to longevity, I thought I understood how a reasonably healthy individual could do that starting now. Without waiting for further scientific breakthroughs or paying thousands to go to shady offshore longevity clinics.  Part of my confidence in this understanding was knowing I have actually been doing that successfully for myself.

Thinking about it, I came to realize that the way our world works is that people benefit greatly from scientific knowledge and advanced technologies that are embodied in products, even though they do not begin to understand how or why those products work.

  • Modern electronic devices and technologies like TV sets, computers and Internet are based on the electromagnetic series of Maxwell, and effects explainable only through the quantum physics of Max Planck, Niels Bohr, Dirac, Einstein and their colleagues. But ordinary people use these all them time without any understanding of how and why they work. Actually, it is quite miraculous how a tremendous cacophony of sounds, images and messages are constantly passing through the space around us without us sensing anything at all.  But we do not have to think about that at all to use a cell phone or TV.
  • The list of such science and technology-based products which we use and benefit from every day without understanding how they actually work goes on and on. Hundreds of millions of us enjoy relative immunity to the COVID19 pandemic because we are vaccinated.  But only a tiny handful of us understand how and why the vaccines work.   How many drivers of cars can characterize the operation of an internal combustion engine?  How many people who flip a light switch understand the technology of electrical generation and transmission? How many users of microwave ovens can explain how they work? How many users of refrigerators and air conditioners can describe how they work?  We don’t have to understand how a product works to get the benefits of the knowledge built into the product.

Realizing the above became fairly clear to me that I could possibly have a much bigger impact on longevity of others by packaging some of my most-central scientific knowledge into a product that people could easily buy.  Users of the product could realize health and longevity benefits due to taking it, even if they did not understand how it works Around 2016 I realized that I actually had invented and was using such a product, our lipomix.  And that I could create a commercial counterpart of it that I could sell.   That, in a nutshell, has been my central motivation.

 SECTION II – RESEARCH BACKUP

in this section I offer more detailed discussions and literature citations that are directly supportive of the main points in SECTION I.

  1. Scientific Basis for 4-Herb Synergy
    1. the aging process is characterized by chronic inflammation. Chronic inflammation is at the heart of multiple disease processes that emerge with advanced aging

I have generated multiple blog entries related to these facts, and they continues to be of central concern in the aging literature.

An example of the extensive literature on the subject is the 2020 publication Senoinflammation: A major mediator underlying age-related metabolic dysregulation”Chronic inflammation is a complex and unresolved inflammatory response with low-grade multivariable patterns that aggravate systemic pathophysiological conditions and the aging process. To redefine and delineate these age-related complex inflammatory phenomena at the molecular, cellular, and systemic levels, the concept of “Senoinflammation” was recently formulated. In this review, we describe the accumulated data on both the multiphase systemic inflammatory process and the cellular proinflammatory signaling pathway. We also describe the proinflammatory mechanisms underlying the metabolic molecular pathways in aging. Additionally, we review age-related lipid accumulation, the role of the inflammatory senescence-associated secretory phenotype (SASP), the involvement of cytokine/chemokine secretion, endoplasmic reticulum (ER) stress, insulin resistance, and autophagy. The last section of the review highlights the modulation of the senoinflammatory process by the anti-aging and anti-inflammatory action of calorie restriction (CR). Evidence from aging and CR research strongly suggests that SASP from senescent cells may be the major source of secreted cytokines and chemokines during aging. A better understanding of the mechanisms underpinning the senoinflammatory response and the mitigating role of CR will provide insights into the molecular mechanisms of chronic inflammation and aging for potential interventions.”

This diagram speaks to the role of chronic inflammation in various age-related disease processes:

Image source

Again, inflammation itself is not the problem.  Acute inflammation is an important natural body response necessary for wound healing. Without it, we would die. The problem with inflammaging addressed by our supplement is chronic inflammation – overall systemic inflammation that grows worse with aging.  “Inflammation is actually the bodys normal response to conditions such as infection, toxins, and trauma.

Under normal conditions, once the negative event is over, the body will produce an anti-inflammatory response to restore balance. In cases of chronic pain, however, the body is not able to regulate the inflammatory response. The result is chronic imbalance and chronic pain(ref).”

 

Image source

  1. Inflammatory cytokine levels in plasma increase with age in humans

This has been a theme frequently reiterated in this blog. As summarized in the 2010 publication Plasma Cytokine Levels in a Population-Based Study: Relation to Age and Ethnicity, “BackgroundAging is one factor believed to contribute to processes that underlie chronic low-grade inflammation in older adults. Moreover, more recent studies have suggested that cytokine levels are influenced by ethnicity.  Methods: In this study, we determined plasma cytokine profiles in a population-based sample (n = 1,411; aged 25–91 years) to determine the relationship between circulating cytokine levels, aging, and ethnicity. We measured interleukin-1 receptor antagonist (IL-1ra), interleukin (IL)-6, -10, C-reactive protein (CRP), and tumor necrosis factor-receptor 1 (TNF-r1).  Results: IL-6 and TNF-r1 significantly increased with age, whereas IL-1ra, IL-10, and CRP did not significantly increase with age. After adjusting for age, non-Hispanic whites had significantly higher levels of IL-1ra than Mexican Americans, whereas non-Hispanic blacks had significantly higher levels of IL-6 and CRP than Mexican Americans as well as non-Hispanic whites. CRP levels in non-Hispanic blacks were no longer significantly higher after adjusting for body mass index (BMI), indicating that BMI is an important predictor of this inflammatory marker.  Conclusions: These results demonstrate that cytokine levels are influenced by both age and ethnicity. Furthermore, these results show that inflammatory profiles for Mexican Americans are lower than non-Hispanic whites and non-Hispanic blacks.”

Image source  Mikel Izquierdo

  1. The inflammaging hypothysis

This relationship between chronic inflammation and aging, often called the “inflammaging hypothysis” applies to numerous disease conditions.  It is discussed in a large number of publications such as those in this list of Pubmed publictions. Steven Austad has offered a webinar on the subject accessible here. Webinar | Inflammation And Aging – Bing video.

 

 

 

 

Image source

 

 

As an example, consider the relationship of aging and inflammation in cardiological diseases, a topic discussed in several recent publications including this 2020 one: Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease. “The ongoing worldwide increase in life expectancy portends a rising prevalence of age-related cardiovascular (CV) diseases in the coming decades that demands a deeper understanding of their molecular mechanisms. Inflammation has recently emerged as an important contributor for CV disease development. Indeed, a state of chronic sterile low-grade inflammation characterizes older organisms (also known as inflamm-ageing) and participates pivotally in the development of frailty, disability, and most chronic degenerative diseases including age-related CV and cerebrovascular afflictions. Due to chronic activation of inflammasomes and to reduced endogenous anti-inflammatory mechanisms, inflamm-ageing contributes to the activation of leucocytes, endothelial, and vascular smooth muscle cells, thus accelerating vascular ageing and atherosclerosis. Furthermore, inflamm-ageing promotes the development of catastrophic athero-thrombotic complications by enhancing platelet reactivity and predisposing to plaque rupture and erosion. Thus, inflamm-ageing and its contributors or molecular mediators might furnish targets for novel therapeutic strategies that could promote healthy ageing and conserve resources for health care systems worldwide. Here, we discuss recent findings in the pathophysiology of inflamm-ageing, the impact of these processes on the development of age-related CV diseases, results from clinical trials targeting its components and the potential implementation of these advances into daily clinical practice.”

Image source

 

 

 

 

 

 

 

 

Other recent research publications relating inflammaging to cardiovascular disease risks are.

A central traditional approach to control of chronic inflammation, going back thousands of years, is the consumption of certain anti-inflammatory herbs.

Research studies asserting this can be found in the ancient Chinese and Aryuvedic literature.  Modern scientific studies confirm the biological mechanisms and pathways through which herbal substances operate to control chronic inflammation(ref).  This list contains many items in the current literature to this effect.

Image source

The central mechanisms through which herbal substances can control inflammation are increasingly understood

These Include inhibition of expression of NF-kappaB, the central cellular mechanism for triggering inflammatory signaling, inhibition of formation and therefore inactivation of inflammasomes such as the NLRP3 inflammasome, deacetylation and therefore inactivation of pro-inflammatory genes, acetylation and therefore deactivation of anti-inflammatory genes, strong promotion of the NRF2 protein which activates hundreds of anti-inflammatory and “anti-oxidant response genes like heme oxygenase, suppression of histone methylation via JMJD3, selective gene and histone modifications which have anti-inflammatory impacts, activation of autophagy, cox-2 inhibition that directly targets cyclooxygenase-2, and inhibition of 5-lipoxygenase.  Also, inhibition of other inflammatory pathways can be involved including JAK/STAT, AP-1, Hsp90, and HIF-1, and upgrading of tonic pathways such as PPARγ and Nrf2.

Over the years, I have written about most of these in this blog.  A Google search combining any of these with anti-agingfirewalls.com  should lead to what I have written.  A search of the national library of medicine data base using the search terms inflammation and herbal medicine leads to the 1424 entries on this list.

Further, a great deal is known about what particular anti-inflammatory chemicals can be found in which herbs and how those chemicals work.

I confine my discussion here to brief discussions of the key anti-inflammatory chemicals known found in the four herbal ingredients in 4 Herb Synergy

  1. Curcuminoids, found in curcumin found in turmeric root. “Curcuminacts as an antiinflammatory by inhibiting cyclooxygenase 2 (COX-2), inducible nitric oxide synthase (ins) and lipoxygenase (COX). INOs, LOX, and COX are key enzymes that mediate inflammatory(ref)”  Further, curcumin inhibits the expression of NF-kb and pro-inflmmatory cytokines like TNF-alpha, (GM-CSF), IL-4, IL-5, and IL2 (ref).  “Curcumin also reduces the expression of genes being regulated by NF-κB, including 5-lipoxygenase (5-LOX), tumor necrosis factor (TNF), adhesion molecules, interleukins (IL-1, IL-6, IL-8), chemokine receptor type 4 (CXCR-4), and C-reactive protein (Rao, 2007Skommer et al., 2007)(ref).” Also, curcumin increases mitochondrial biogenesis and mitophagy(ref).

Image source: Cellular and molecular mechanisms of curcumin in prevention and treatment of disease

  1. Boswellic acid (AKBA), acetyl-11-keto-beta-boswellic acid (AKBA) found in the herb Boswellia.  “Boswellic acids (BA), a natural mixture isolated from oleo gum resin of Boswellia serrata comprised of four major pentacyclic triterpene acids: b-boswellic acid (the most abundant), 3-acteyl-b-boswellic acid, 11-keto-b-boswellic acid, and 3-acetyl-11-keto-b-boswellic acid, is reported to be effective as anti-inflammatory, immunomodulatory, antitumor, anti-asthmatic and in Chron’s disease. It inhibits pro-inflammatory mediators in the body, specifically leukotrienes via inhibition of 5-lipoxygenase(ref).” “KBA and AKBA, have been shown to decrease production of proinflammatory cytokines including IL-1, IL-2, IL-6, IFN-γ and TNF-α which finally are directed to destroy tissues such as cartilage, insulin producing cells, bronchial, intestinal and other tissues. NFĸB is considered to be the target of AKBA.(ref)”

Image source,  Illustrates the signaling cascade for the impact of AKBA on the 5-LOXIN inflammatory pathway

 

 

 

 

 

  1. Withanolides, found in the herb ashwagandha (Withania somnifera), also known as Indian ginseng).In this chapter we identify and describe the major withanolides with anti-inflammatory properties, illustrate their role within essential and supportive inflammatory pathways (including NF-κB, JAK/STAT, AP-1, PPARγ, Hsp90 Nrf2, and HIF-1), and then discuss the clinical application of these withanolides in inflammation-mediated chronic diseases (including arthritis, autoimmune, cancer, neurodegenerative, and neurobehavioral)(ref)”

Image source  Neuroprotective inpacts of withania somnifera (ashwagandha)

 

 

 

 

  1. Gingerols, found in ginger (Zingiber officinale RoscoeZingiberaceae). Gingerols can activate autophagy(ref), “The findings of this study demonstrate that S-[6]-gingerol protects HuH7 cells against IL1β-induced inflammatory insults through inhibition of the ROS/NFκB/COX2 pathway — Our findings show that S-[6]-gingerol protects HuH7 cells against an IL1β-induced inflammatory response by inhibiting the reactive-oxygen-species- (ROS-) activated NFκB/COX2 pathway. (ref).” “Gingerols inhibit the production of inflammatory mediators such as nitric oxide and Prostaglandin E2 (PGE2) in a dose-dependent manner(ref).50

Image source Anti-inflammatory and other impacts of gingerols

The Synergy in 4 Herb Synergy

The synergy in 4 Herb Synergy exists because of the multiplicity of overlapping biological mechanisms against chronic information just listed in the previous section. 4 Herb Synergy is made out of the most-concentrated and highest quality available standardized herbal extracts of exactly the substances described just above, Curcuminoids, Boswellic acids (AKBA), Withanolides and Gingerols. Much of our high cost for manufacturing the product is associated with the relatively high costs of the standardized extracts.

The liposomal bodies in 4 Herb Synergy are more than just neutral carriers of the herbal extracts.  Since they are made out of phosphatidylcholine, the liposome containers are also contributors to the supplement’s anti-inflammatory synergy.  “Phosphatidylcholine, a major component of biological cell structures, itself can exercise a number of anti-inflammatory capabilities including limiting nuclear translocation and phosphorylation of p65 in IEC-6 cells, limiting the expression of NF-kB and TNF-α,  and further inhibiting inhibited the protein phosphorylation levels in MAPK signaling pathways(ref).”  Many of the articles cited in this list relate to implications of the anti-inflammatory properties of phosphatidylcholine in various organ and disease contexts.

Additional substances included in the latest Gold II version of 4 Herb Synergy are also contributors to the supplement’s anti-inflammatory capabilities, including:

  • Vitamin C (ref),
  • Magnesium (ref),
  • Myristoleic acid (kombo nut oil extract) (ref), and
  • Hyaluronic acid (ref).

The above (ref) links point to discussions of anti-inflammatory properties)

The problem of bioavailability (absorbability)

4-Herb Synergy is a liposomal preparation, encapsulating the active ingredients in nano-sized carriers known as liposomes.  The reason is to multiply the absorbability and bioavailability of those ingredients and therefore the biological effectiveness of the product.

A longstanding problem with certain herbal substances is that very little of the most health-benefiting components can get through after ingestion to where they are needed in the body to do their good work.   This particularly holds for some of the best anti-inflammatory herbal components such as those in Curcumin and Boswellia.  Curcumin’s health impacts are most impressive, but most of these are not realizable by simply consuming the substance because of poor absorbability.  “Curcumin has been confirmed to exhibit very poor bioavailability, with many studies showing very low, or even undetectable, concentrations in blood and extraintestinal tissue. Major reasons postulated are due to its poor absorption, rapid metabolism, chemical instability, and rapid systemic elimination (11).(ref)” “Major reasons contributing to the low bioavailability of curcumin appear to be owing to its poor solubility, low absorption, rapid metabolism and rapid systemic elimination(ref).”  See these links as to poor bioavailability of curcumin, and these links as to poor bioavailability of Boswellia.

Bioavailability is normally a measure of how much of an ingested substance ends up in the bloodstream. But when considering biological impacts of certain molecules, many additional barriers may be involved. Consider an anti-inflammatory substances like a curcuminoid that addresses brain inflammation, for example.  The ingested substance must 1. Evade neutralization by stomach acids and gut bacteria, 2 be able to successfully penetrate the gut lumen and enter the portal vein, 3. must avoid neutralization by the liver, whose job it is to neutralize foreign substances, 4. Must avoid being collected and peed out by the kidneys. 5. must be capable of crossing the blood brain barrier, 6 must be capable of crossing brain cell outer membranes. If the molecule’s mode of operation is in the cell nucleus or mitochondria it must also be capable of penetrating the membranes of these organelles.  No wonder that almost none gets through to where it is needed.   Similarly, timing, amount, and nature of food intake can have a profound effect on the absorbability of a substance like AKBA(ref).

Why not simply amplify the dose to overcome poor absorbability?  Because the heavy dose could be toxic and dangerous.  Heavy doses of substances like curcumin can overload and damage the liver, whose job is to remove unrecognized substances from the blood stream.

One strategy for increasing absorbability ot dietary supplements has been to add substances such as piperene, a pepper extract.  This approach has widely been used in commercial preparations of curcumin(ref) and bosewellia(ref). However its effectiveness is relatively low.

Nanodelivery of supplements

Problems of poor absorbability have been recognized for a long time for certain drugs.  Effective delivery of certain cancer drugs all the way into cancer cells is a paramount consideration, for example.  Major pharma companies have worked on strategies to address the bioavailability and internal body delivery issue, starting long before such issues were widely recognized to be of concern also for certain dietary supplements.  Pharma companies have researched and explored numerous techniques to enhance drug bioavailability and absorbability(ref).  The same techniques are in principle also applicable for delivery of dietary supplements in cases when bioavailability and absorbability is a major concern.

Perhaps the most promising category of soutions appear to be nanodelivery, the encapsulation of the substances to be delivered in tiny nano-scale carriers – microvesicles 50 to a few hundred nanometers in size, where the carrier material is itself biologically neutral.   Such nanoparticles can easily pass through many of the body barriers such as those mentioned above.

Multiple kinds of nano-sized vesicles have been tried for drug delivery including micelles, ones based on polymers, carbon-based materials, and of particular concern here liposomes. “The application of liposomes to assist drug delivery has already had a major impact on many biomedical areas. They have been shown to be beneficial for stabilizing therapeutic compounds, overcoming obstacles to cellular and tissue uptake, and improving biodistribution of compounds to target sites in vivo.(ref)”  Nano-encapsulation of vitamin C, curcumin, DHA and other key nutrients is slowly being embraced by segments of the dietary supplement industry. using liposomes made out of phosphatidylcholine.  Because:

  • Phosphatidylcholine, such as made from sunflower seeds is a completely natural substance, a major ingredient in body cell membranes.
  • Compared with use of other vesicles, reliable manufacturing of liposomal preparations at reasonable cost is relatively easy.
  • Liposomes offer additional advantages, such as protection of encapsulated ingredients from degradation due to light exposure.

Image source.  A simple liposome.  Hydrophobic substances can be contained in the bilayer, hydrophilic ones in the core.

 

 

 

 

Nano-delivery occurs naturally in our bodies

Cells in the body itself utilize such a nanocarrier delivery system of particles called exosomes. Exosomes “mail” minute quantities of many important kinds of molecules to other cells in the body.   “Exosomes are defined as nanometre-sized vesicles, being packages of biomolecules ranging from 40-150 nanometres in size that are released by virtually every cell type in the body. — The exosomes released by regenerative cells such as stem cells, for example, are potent drivers of healing and repair.”  “Exosomes have been shown to be key mediators of cell to cell communication, delivering a distinct cargo of lipids, proteins and nucleic acids that reflects their cell of origin. — The exosomes released by regenerative cells such as stem cells, for example, are potent drivers of healing and repair. Whereas exosomes secreted from diseased cells could be used to detect and diagnose conditions such as cancers at their earliest and most readily treatable phase. — Every exosomes’ contents typically include lipids; genetic information, in the form of various types of ribonucleic acid (RNA); and proteins including enzymes, growth factors, receptors and cytokines. This cargo is contained within a phospholipid bilayer membrane, the same substance cell membranes are made from. (The same being true for liposomes) — Exosomes are found in all body fluids, and play a key role in carrying messages and molecules from one cell to another, in a target-specific manner. The recipient cell may be proximal to the sender, or at a distant site in the body(ref).”

The biomedical literature discusses the use of liposomal preparations of herbal anti-inflammatories for the treatment of rheumatoid arthritis.  The following diagram is from the 2014 review article Application of Liposomes in Treatment of Rheumatoid Arthritis: Quo Vadis. It shows “Etiology of rheumatoid arthritis and potential therapeutic agents and their sites of action..” Three of the anti-inflammatory herbal ingredients shown in the diagram are the same as those in 4 Herb Synergy: boswellic acid, curcumin and withanolides .

 

 

 

 

 

 

 

 

 

 

 

Please note the disclaimer at the end of this article.  My colleagues and I make no claim that 4 Herb Synergy is effective for prevention, diagnosis or cure for arthritis or any other disease.

I celebrated my 91th birthday in November 2020 and expects to be fully active professionally at least until age 100, leading a great life.  I remain in good health and remain physically and mentally active, benefiting from what I have learned about health and longevity and the longevity interventions I have been pursuing – a main one being taking 4 Herb Synergy.  For more intimate detail on me, you can read some of my more-personal recent blog entries such as Funny things are happening to me on the way to 100. And UPDATE ON LONGEVITY INTERVENTIONS – MAINLY PERSONAL.’

 

—————————————————

MEDICAL AND PERSONAL  DISCLAIMER

 

THE AUTHOR IS A PARTNER IN SYNERGY BIOHERBALS LLC, THE COMPANY MARKETING 4 HERB SYNERGY.

 

THE PURPOSE OF THIS BLOG ENTRY IS TO PRESENT GENERIC AND PERSONAL INFORMATION RELATED TO A DIETARY SUPPLEMENT RECENTLY DEVELOPED BY THE AUTHOR AND HIS COLLEAGUES.  WE HEREIN WISH TO CONTINUE THE LONG-ESTABLISHED POLICY OF THIS BLOG , WHICH IS TO PRESENT ESTABLISHED SCIENTIFIC FACTS AND PERSONAL COMMENTARIES RELATED TO WELLNESS AND HEALTH, NOT TO  PROVIDE MEDICAL ADVICE OR ADVOCATE ANY TREATMENT FOR CURE, PREVENTION OR DIAGNOSIS OF ANY DISEASE.

 

THE STATEMENTS IN THIS BLOG ENTRY HAVE NOT BEEN REVIEWED OR APPROVED BY THE FDA.

 

FROM TIME TO TIME, THIS BLOG MAY DISCUSS RESEARCH DEVELOPMENTS RELATING TO DISEASE PROCESSES.  THE INTENTION OF THOSE DISCUSSIONS IS TO CONVEY CURRENT RESEARCH FINDINGS AND OPINIONS, NOT TO GIVE MEDICAL ADVICE.  THE INFORMATION IN POSTS IN THIS BLOG IS NOT A SUBSTITUTE FOR A LICENSED PHYSICIAN’S MEDICAL ADVICE. IF ANY ADVICE, OPINIONS, OR INSTRUCTIONS HEREIN CONFLICT WITH THAT OF A TREATING LICENSED PHYSICIAN, DEFER TO THE OPINION OF THE PHYSICIAN. THIS INFORMATION IS INTENDED FOR PEOPLE IN GOOD HEALTH.  IT IS THE READER’S RESPONSIBILITY TO KNOW HIS OR HER MEDICAL HISTORY AND ENSURE THAT ACTIONS OR SUPPLEMENTS HE OR SHE TAKES DO NOT CREATE AN ADVERSE REACTION.

 

YGD YOUNGING1.0 PART 4: UNDERLYING MECHANISMS OF YOUNGING 1.0. HSC STEM CELL DIFFERENTIATION

$
0
0

By Vince Giuliano

Art KOUKOU by Vince Giuliano

I.   INTRODUCTION AND BACKGROUND

YOUNGING processes in the human body are like AGING processes in reverse. I have suggested that there are natural YOUNGING processes normally going on in mature humans, along with AGING processes. What we experience is normal aging is the result of how the YOUNGING and AGING processes balance against each other over time. Normally of course we seem to get older, though we all accept that aging can be greatly accelerated by certain disease and stress conditions.

I have asserted that the scientific basis now exists for creating conditions which can induce YOUNGING processes sufficient to outweigh aging processes in healthy mature and older persons. In other words it is likely that some of us can soon cast ourselves into mostly aging in reverse, on a temporary basis at least. As I have asserted previously, I believe I’m already doing that. The suggestion is radical, but is supported by very real science.  I do not think YOUNGING and its implications are yet adequately grasped within the longevity research community. So I have been devoting a series of blog entries devoted to the science of this topic. This is the fourth such entry, as I continue to study the vast probably-relevant literature and learn new things.

For those of you who are completely new to this line of discussion I suggest you start by reading the less technical introductory blog entry YGA Introduction to the YOUNGING Series – Emerging Aging Reversal Strategies and Treatments.  After that, the next thing I suggest you read is the substantive blog YGB YOUNGING1.0 – THE EMERGING AGING REVERSAL STRATEGY.  Then you can read the blog entry just prior to this one  YGC MORE ON YOUNGING1.0 – THE EMERGING AGING REVERSAL STRATEGY.

In these blog entries, I proposed at least three key hypotheses.  The second of these is unique in the published literature related to longevity.

First, that humans and other advanced biological organisms enjoy in their adult years a number of mechanisms of systemic age reversal, these going on simultaneously with aging processes. I call these YOUNGING processes. While the existence of such mechanisms is acknowledged in the longevity research community, I think it is fair to observe that they are not being treated there now as very important. Evidence suggests that these processes range from ones imperceptible in their operation to long-term processes which can reverse many of the landmarks of aging to much younger states. These may require a decade or more for their operation.

Second, I have asserted that H3K27me2-3 histone demethylation via expression of JMJD3 is the fundamental basis for one or more key YOUNGING processes in advance organisms including humans.

Third, controlling and limiting chronic systematic inflammation is also necessary for essential YOUINGING processes to happen.

The purpose of this present blog entry is to further expand on these hypotheses, providing further science background and expressing them in deeper and more precise ways. In particular, my intent is to identify the biological mechanisms underlying the second assertion above. And, to provide published research evidence for each key step of my argument. In this discussion I will cover background related to Polychrome Repressive Complexes and highlight the importance of stem cells for rejuvenation.  I will discuss some of the critical demethylase-dependent and demethylase-independent rules of JMJD3 for chromatin reorganization required to allow cell lineage differentiation.  I dig further into on the the critical roles of histone methylation and JDJM3 in phases of aging, and discuss the companion roles of UTX with JMJD3.  I will also discuss other age-related histone modifications including methylation of other histone sites besides H3K27me2-3  And I touch on other important epigenetic histone post-translational modifications including acetylation, phosphorylation,  ubiquitylation, and sumoylation.

II.   RECAP OF PREVIOUS BLOG ENTRIES IN THIS SERIES

 Re. expression of JMJD3 and consequent repression of H3K27me2-3 is the basis for one or more key YOUNGING processes in humans.

Previous blog entries in this series support the key proposition that expression of JMJD3 and consequent repression of H3K27me2-3 play in the development in a wide variety of biological organisms, including us Homo Erectus.  In short:

    • Early development of organisms absolutely requires the turning on of a number of key growth and development genes, ones whose expression is otherwise inhibited by. H3K27me2-3 methylation which is inherited from parents, must be turned off early in development to enable expression of a wide variety of genes required for growth and development. The developing organism therefore inhibits H3K27me2-3 methylation via expression of JMJD3, allowing expression of those genes. Later, after reproductive maturity is achieved there is a rather abrupt period where the expression of JDJM3 is turned significantly down initiating adult aging.  This two-step process appears to be very fundamental for most if not all species of living organisms. It is observed in insects and plants as well as vertebrates. A profound YOUNGING process is required for the development of advance organisms including humans. That process is normally dialed way down as childbearing years come to an end. This happens in part because of H3K27me2-3 histone methylation which dials down the activity the activities of numerous developmental genes.
    • If we, much later in life, want to foster longevity associated with cell rejuvenation, we must discover means for turning complexes of the same genes back on in limited and controlled ways. I am suggesting that a best way to turn those genes back on as part of initiating a basic YOUNGING process is the same way they were originally turning on, by inhibiting H3K27me2-3 methylation via expression of JMJD3.
    • Recall, that YOUNGING01 as we have characterizred it is a reverse epigenetic aging process in mature adults back towards an early adult stage such as may be experienced typically in someone’s mid 20s. It is definitely is not intended or purport to revert a human back to childhood or infancy as in The Curious Case of Benjamin Button  A very important implication is that epigenetic age regression at a cellular level is a vital part of what is wanted and needed, but epigenetic regress all the way back to pluripotency (ie all the way back to stem cell level). is neither needed or wanted.  Specifically, cellular regession must not go so far back that cell lineage markers are lost.  Specifically, epigenetic age regression of adult somatic cells is needed to regress them back into precursor cells capable in turn of turning into young and vital cells in the same lineage.

III.  AN UNDERLYING MECHANISM BEHIND THE YOUNGING 1.0 HYPOTHESIS

In summary, polychrome repressive complex (PRC2) hypermethylation of histones (H3K27me) increases with advanced age in stem cells, and is responsible for decreasing efficiency of stem cells to achieve their routine tasks of differentiating and replacing other senescent or dead somatic body cells. The result is that lifelong processes of cell renewal via stem cells slows down and is impaired. JDJM3 reverses the aging cell epigenetic signature due to PRC2 histone hypermethylation, particularly in HSC stem cells responsible for most body cell renewal.  Couple this reversal of hyper methylation with improving NF-KB and NRF2 signaling and reducing ROS levels by controlling chronic inflammation, the result is that old stem cells behave a lot more lot younger ones – the YOUNGING 1.0 age reversal effect.  I herein lay out the logical steps that lead to these conclusions. And I cite a variety of recent research results related to these steps.

  1. Body cells mature, die and are replaced by newly-differentiated stem cells on an ongoing process.  Without this happening advanced organisms could not survive; life for us would be impossible.  Red blood cells in humans, for example, have a lifespan of only about 4 months.  Unlike other cell types, they cannot reproduce by cell division and must be replaced by differentiated stem cells.  Essentially all cell types are ultimately subject to such replacement, although expected cell lifespans may vary radically by type.
  2. Of particular interest are hemopoietic stem cells (HSCs) which live in bone marrow niches and are responsible for replacement for all blood cell types, a process known as hematopoiesis.  HSCs may be responsible for replacement of many other body cell types as well as blood-line ones.
  3. All stem cells themselves reproduce via normal cell division and have relatively long lifespans. However with advanced aging the structure and composition of stem cells change significantly and their ability to differentiate into their destination somatic cell types becomes compromised.
  4. This effect may just by itself explain many of the manifestations of advanced aging as organs become starved of healthy replacements for senescent or morbid cells.
  5. Among the known age-related impacts of HSCs are epigenetic shifts that significantly down regulate their accurate reproduction and differentiation into their designated body cell types. Included among these shift are A. Hyper histone methylation at the sites resulting from rising levels of PRC2, B Hypo histone acetylation at the H4K16 site. And C. Unrepaired or under-repaired DNA damage associated with cell reproduction.
  6. Some of the most significant aging related shifts in stem cells can be reversed by known interventions that affect the epigenome. One of these, highlighted in the YOUNGING 1.0 approach is global histone demethylation at the H3K27me2-3 sites via induction of the demethylase JMJD3. Among its effects, JMJD3 accelerates the differentiation of stem cells.

IV.   MORE DETAILED DISCUSSION AND RESEARCH CITATIONS

  1. Body cells, whether of dividing types or not, mature, die and are replaced by newly-differentiated stem cells as an ongoing life-long process. About hemopoietic stem cells (HSCs)

The necessary replacement of normal body (somatic) cells by newly differentiated stem cells has been studied for some time.    The natural renewal of blood cells is a case in example.  From the 2017 publication On the Mechanism of Human Red Blood Cell Longevity: Roles of Calcium, the Sodium Pump, PIEZO1, and Gardos Channels,In a healthy adult, the transport of O2 and CO2 between lungs and tissues is performed by about 2 · 1013 red blood cells, of which around 1.7 · 1011 are renewed every day, a turnover resulting from an average circulatory lifespan of about 120 days — Human red blood cells (RBCs) have a prescribed lifespan of about 4 months before being cleared from the circulation. During this period, RBCs devoid of organelles and biosynthetic capacity experience irreversible age-related changes in metabolism, membrane transport, ionic composition, cortical cytoskeleton, and immune-reactivity, among others (Beutler, 1985b; Clark, 1988; Romero and Romero, 1999; Lew et al., 2007; Tiffert et al., 2007; Lutz, 2012; Franco et al., 2013; Lutz and Bogdanova, 2013). Nevertheless, under the microscope, the appearance of RBCs from healthy adults remains remarkably uniform, regardless of cell age. — . That such manufacturing precision can be maintained by a bone marrow producing about 7 · 109 cells per hour in a normal adult is a truly remarkable feat of evolutionary bioautomation. And no less remarkable is the mechanism that enables the homeostatic stability of the RBCs throughout senescence. — We suggest that the need to maintain optimal circulatory performance has driven the evolution of a remarkably costefficient compensation strategy to preserve RBC volume and to extend RBC lifespan.”

Image source

Constant renewal of all blood cell types depend on constant differation and regeneration of blood stem cells,  long known as hematopoietic stem cells (HSCs). In fact research suggests that HSCs may in fact be the stem cell source of all the body’s cell types.  The 2013 publication Hematopoietic Stem Cells Are Pluripotent and Not Just “Hematopoietic” reports “Over a decade ago, several preclinical transplantation studies suggested the striking concept of the tissue-reconstituting ability (often referred to as HSC plasticity) of hematopoietic stem cells (HSCs). While this heralded an exciting time of radically new therapies for disorders of many organs and tissues, the concept was soon mired in controversy and remained dormant for almost a decade. This commentary provides a concise review of evidence for HSC plasticity, including more recent findings based on single HSC transplantation in mouse and clinical transplantation studies. There is strong evidence for the concept that HSCs are pluripotent and are the source for the majority, if not all, of the cell types in our body.  — Many tissues and organs in our body possess variable but significant regenerative capacity. Some organs such as bone marrow (BM), skin, and the mucosa of the gastrointestinal tract are characterized by life-long cell turnover. In these organs the mature cells have finite life spans and are continually replaced by more primitive progenitor cells. Others such as skeletal muscle and liver are characterized by limited cell turnover in the steady-state, but are capable of significant regeneration following tissue injury and loss of constituent cells. To account for the cell turnover in these organs, the concept of stem cells, cells that can self-renew and generate progeny committed to differentiation in specific pathways, emerged decades ago. Further, it was generally held that stem cells possess organ/tissue specificity; for example, hematopoietic stem cells (HSCs) generate only blood cells. — Against this long-held belief, striking tissue-reconstituting capability of HSCs (often referred to as HSC plasticity) was reported about a decade ago and suggested exciting new avenues of therapy for disorders of many organs and tissues. However, these reports were soon followed by others with negative results and papers offering different interpretations, as exemplified in the disputes among a number of major laboratories [13]. Our laboratory has also been engaged in the studies of HSC plasticity using single-cell HSC transplantation and has obtained unequivocal evidence for the HSC-origin of fibroblasts/myofibroblasts, adipocytes, and osteo-chodrocytes, major cell types comprising connective tissue. This commentary consists of a brief summary of our studies of connective tissue and of studies reported from other laboratories indicating an HSC-origin of other major cell types. We believe these findings strongly support the concept that HSCs are the source for the majority, if not all, of the cell types in our body.”  This concept, of the capability of HSCs to differentiate into many if not all cell types has been widely picked up In the literature, as exemplified  by these documents.

2.     Many of the manifestations of advanced aging could be due simply to decline in differentiation and functionality of stem cells, HSCs in particular.

If stem cells can no longer function  so as to satisfy ongoing needs for replacement of normal body cell types (somatic cells), many if not most of the normal symptoms of advanced aging might be explained by that fact alone. The 2007 publication Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation reports: “Age-related defects in stem cells can limit proper tissue maintenance and hence contribute to a shortened lifespan. Using highly purified hematopoietic stem cells from mice aged 2 to 21 mo, we demonstrate a deficit in function yet an increase in stem cell number with advancing age. Expression analysis of more than 14,000 genes identified 1,500 that were age-induced and 1,600 that were age-repressed. Genes associated with the stress response, inflammation, and protein aggregation dominated the up-regulated expression profile, while the down-regulated profile was marked by genes involved in the preservation of genomic integrity and chromatin remodeling. Many chromosomal regions showed coordinate loss of transcriptional regulation; an overall increase in transcriptional activity with age and inappropriate expression of genes normally regulated by epigenetic mechanisms was also observed. Hematopoietic stem cells from early-aging mice expressing a mutant p53 allele reveal that aging of stem cells can be uncoupled from aging at an organismal level. These studies show that hematopoietic stem cells are not protected from aging. Instead, loss of epigenetic regulation at the chromatin level may drive both functional attenuation of cells, as well as other manifestations of aging, including the increased propensity for neoplastic transformation.”

Also highly relevant in this regard is the 2015 publication Epigenetic Control of Stem Cell Potential during Homeostasis, Aging, and Disease  “Stem cell decline is an important cellular driver of aging-associated pathophysiology in multiple tissues. Epigenetic regulation is central to establishing and maintaining stem cell function, and emerging evidence indicates that epigenetic dysregulation contributes to the altered potential of stem cells during aging. Unlike terminally differentiated cells, the impact of epigenetic dysregulation in stem cells is propagated beyond self; alterations can be heritably transmitted to differentiated progeny, in addition to being perpetuated and amplified within the stem cell pool through self-renewal divisions. — Tissue-specific stem cells are imbued with self-renewal potential and the capacity for differentiation to generate mature effector cells, and thus they are responsible for sustained function of tissues throughout life. Aging is associated with the progressive inability to maintain tissue homeostasis or robustly regenerate tissue after injury or stress. These processes are mediated by tissue-specific stem cells, suggesting that impaired stem cell function may underlie central cellular pathophysiologies associated with aging. Indeed, mounting evidence indicates that degenerative aging-associated changes in adult stem cells are a central driver of many age-related phenotypes (reviewed in Oh et al., 2014Liu and Rando, 2011Behrens et al., 2014Rossi et al., 2008). The mechanistic basis for aging-associated stem cell decline is not completely understood, but numerous studies have shown that loss of polarity (Florian et al., 2012), mitochondrial dysfunction (Bratic and Larsson, 2013), altered autophagy (Warr et al., 2013), replicative stress (Flach et al., 2014), and accrual of DNA damage (Rossi et al., 2007Rübe et al., 2011Yahata et al., 2011Wang et al., 2012Beerman et al., 2014) all contribute to stem cell aging. In addition, increasing evidence suggests that epigenetic dysregulation is also an important mechanistic driver of stem cell aging.

A central hypothesis being proposed in this blog entry is that restoring a more youthful profile of epigenetic regulation in HSC stem cells via global histone deacetylation of H3K27me2-3 via JDJM3 is a central mechanism of the age reversal processes I have called YOUNGING 1.0

Among its effects, JMJD3 accelerates the differentiation of stem cells. The 2016 publication Transient ectopic expression of the histone demethylase JMJD3 accelerates the differentiation of human pluripotent stem cells reports: “Harnessing epigenetic regulation is crucial for the efficient and proper differentiation of pluripotent stem cells (PSCs) into desired cell types. Histone H3 lysine 27 trimethylation (H3K27me3) functions as a barrier against cell differentiation through the suppression of developmental gene expression in PSCs. Here, we have generated human PSC (hPSC) lines in which genome-wide reduction of H3K27me3 can be induced by ectopic expression of the catalytic domain of the histone demethylase JMJD3 (called JMJD3c). We found that transient, forced demethylation of H3K27me3 alone triggers the upregulation of mesoendodermal genes, even when the culture conditions for the hPSCs are not changed. Furthermore, transient and forced expression of JMJD3c followed by the forced expression of lineage-defining transcription factors enabled the hPSCs to activate tissue-specific genes directly. We have also shown that the introduction of JMJD3c facilitates the differentiation of hPSCs into functional hepatic cells and skeletal muscle cells. These results suggest the utility of the direct manipulation of epigenomes for generating desired cell types from hPSCs for cell transplantation therapy and platforms for drug screenings.

  1. The histone code, the epigenetic regulation of stem cells, and the interplay between epigenetic modifications

There is increasing recognition in the research community of the importance of epigenetic histone modifications for the global activation and in the activation of families of genes. And, of the profound importance of the gene-regulating impact of such modifications in both early developments and advanced aging. “Such modifications include acetylation, methylation, phosphorylation and ubiquitination The functional consequences of histone modifications can be direct, causing structural changes to chromatin, or indirect, acting through the recruitment of effector proteins. All histone modifications are removable, which may therefore provide a flexible way for regulation of gene expression(ref).”

Further, there can be significant interaction between methylation, acetylation, and ubiquititination processes, as pointed out in the document Epigenetic interplay of histone modifications and DNA methylation mediated by HDA6.    “Our studies demonstrate that HDA6 integrates DNA methylation and histone modifications in gene silencing by interacting with MET1 and FLD (Fig. 1). More recently, OTU6 was found to directly interact with the histone lysine demethylase LDL1/KDM1C in plants,25 suggesting that regulatory crosstalk between histone demethylation and deubiquitination through the direct interaction between LDL1/KDM1C and OTU6. Taken together, data described above indicate that the crosstalk among different epigenetic modifications could be mediated by the interaction of various histone modification proteins and complexes.” This diagram from that publication  shows how a histone deacetylase can lead to an altered methylation profile.

Gene silencing mediated by HDA6. The gene activation markers, H3 acetylation, H4 acetylation and H3K4 tri-methylation are associated with active chromatin. HDA6 can mediate gene silencing through interacting with MET1 and FLD, resulting in DNA methylation, histone deacetylation and histone demethylation.”

 

4.  With advanced aging the structure and composition of stem cells change significantly and their ability to differentiate into their destination somatic cell types becomes compromised

This theme, for example is elaborated within the 2020 research publication Understanding intrinsic hematopoietic stem cell aging. “Aging is the largest risk factor for many chronic diseases and disabilities. Not surprisingly, aging is also the major risk factor for several hematologic syndromes and malignancies, such as myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).1 Moreover, aging has a negative impact on HSC regenerative capacity, and for this reason, cell-intrinsic mechanisms of aging are important putative targets for therapeutic interventions in order to ameliorate the consequences of aging on HSC and on the hematopoietic system.2 Understanding the mechanisms of HSC aging will provide the scientific community with new tools to improve the regenerative capacity of healthy HSC and thus the function of the hematopoietic system in the elderly.”  I have found the following diagram from that publication to be particularly helpful in illustrating the multiple cell-specific aspects of aging stem cells.

Off particular interest in the present discussion is histone hypermethylation due to increasing PRC2 expression, which can be reversed using the JDJM3 histone 27 decatylase. Other impacts of aging shown in the diagram include “Increase in phenotypic HSC number and decrease regenerative capacity, Myeloid skewing, DNA damage, Clonality, Epigenetic drift, Cell polarity, Metabolic alterations and impaired autophagy, Altered proteostasis, Alterations in intrinsic signaling pathways”

This following diagram compares histone acetylation/deacetylation impacts at the H4K16 position in plants as well as in mammals, illustrating how the impacts if ancient histone modifications have been evolutionarily conserved across plant and animal species.

 

 

 

 

 

 

 

 

Image source  “H4K16 versus H4K16Ac. The acetylation status of lysine 16 in histone H4 (represented as a blue circle) has a critical role in multiple functions in chromatin regulation throughout evolution as shown. Whereas acetylation of K16 is involved in active transcription and open chromatin, non-acetylated K16 is associated with gene silencing and heterochromatin compacted structure.”

5.  Underlying HSC stem cell aging and its negative effects are alterations in the DNA methylation landscape resultant from the proliferation history of the HSCs

The 2014 publication Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging reports “The functional potential of hematopoietic stem cells (HSCs) declines during aging, and in doing so, significantly contributes to hematopoietic pathophysiology in the elderly. To explore the relationship between age-associated HSC decline and the epigenome, we examined global DNA methylation of HSCs during ontogeny in combination with functional analysis. Although the DNA methylome is generally stable during aging, site-specific alterations of DNA methylation occur at genomic regions associated with hematopoietic lineage potential and selectively target genes expressed in downstream progenitor and effector cells. We found that age-associated HSC decline, replicative limits, and DNA methylation are largely dependent on the proliferative history of HSCs, yet appear to be telomere-length independent. Physiological aging and experimentally enforced proliferation of HSCs both led to DNA hypermethylation of genes regulated by Polycomb Repressive Complex 2. Our results provide evidence that epigenomic alterations of the DNA methylation landscape contribute to the functional decline of HSCs during aging.”

V.  ADDITIONAL CHARACTERISTICS OF H3K27me2-3 HISTONE METHYLATION, POLYCHROME REPRESSIVE COMPLEXES, AND JDJM3

Basic to our YOUNGING1 hypothysis is the proposition that the age reversal process involves the global demythelation of doubly or triply methylated lysine 27 on histone 3, that is of H3K27me2-3.  We have suggested that YOUNGING in mature adults can be triggered by upgrading expression of a significant demethylase for H3K27me2-3, of which there are two, known as JDJM3 and UTX,  What typically happens is that there is a lifelong dance of double and triple methylation at this histone site and demethylation.  To start, what initiates such methylation?

  • Introducing the Polycomb Repressive Complex2 (PRC2). The 2020 publication  Methylation of H3K27me2-3 is induced by the specific methylase PRC2:  Post-translational modifications of PRC2: signals directing its activity.  “Polycomb repressive complex 2 (PRC2) is a chromatin-modifying enzyme that catalyses the methylation of histone H3 at lysine 27 (H3K27me1/2/3). This complex maintains gene transcriptional repression and plays an essential role in the maintenance of cellular identity as well as normal organismal development. The activity of PRC2, including its genomic targeting and catalytic activity, is controlled by various signals. Recent studies have revealed that these signals involve cis chromatin features, PRC2 facultative subunits and post-translational modifications (PTMs) of PRC2 subunits. Overall, these findings have provided insight into the biochemical signals directing PRC2 function, although many mysteries remain.”
  • JMJD3 plays a critical role in this lifelong dance of aging methylation and demethylation.  This is reflected in the title of the 2014 publication  Histone demethylase Jumonji D3 (JMJD3/KDM6B) at the nexus of epigenetic regulation of inflammation and the aging process“Histone methylation is involved in the epigenetic control of immune responses and cellular senescence. Jumonji domain-containing protein 3 (JMJD3), also called lysine-specific demethylase 6B (KDM6b), is an inducible histone demethylase which enhances immune responses and can trigger cellular senescence. JMJD3 potentiates gene expression by demethylating repressive H3K27me3 epigenetic marks in promoters and gene bodies. Moreover, JMJD3 also stimulates transcription in a demethylase-independent manner by mediating interactions between chromatin modifiers. JMJD3 can enhance both pro-inflammatory and anti-inflammatory responses by targeting distinct transcription factors in a context-dependent manner in gene promoters. For instance, JMJD3 can induce macrophage M2 polarization via STAT6 signaling. JMJD3 also interacts with T-bet factor and induces Th1 differentiation of CD4(+) T cells. Moreover, JMJD3 can activate TGF-β signaling through the SMAD3 pathway. Conversely, JMJD3 displaces polycomb complexes from the INK4 box, which induces the expression of INK4a and triggers cellular senescence. JMJD3 can also enhance the nuclear localization of p53 and thus regulate its function. The control of INK4 box and p53 is closely related to the regulation of the aging process. We will briefly review the inducible properties of JMJD3 expression and then focus on the role of JMJD3 in the regulation of inflammation and senescence through different signaling pathways. We emphasize that an inflammatory milieu and cellular stress can enhance immune responses and provoke cellular senescence via epigenetic regulation through JMJD3 activation.”
  • JMJD3 and early development.  From the 2015 publication JMJD3 as an epigenetic regulator in development and disease “— 1.1. JMJD3 and development Embryonic stem cells (ESCs) repress developmental genes by utilizing H3K27 trimethylation, but ESC deficiency in JMJD3 does not seem to affect stem cell maintenance and self-renewal capacity (Mansour et al., 2012Ohtani et al., 2013). During differentiation, H3K27 methylation is removed in a tissue- and cell-specific manner, and the demethylases, JMJD3 and UTX, are directly involved in embryogenesis into the three germ layers, endoderm, mesoderm, and ectoderm, of a developing vertebrate.1.1.1. Endoderm JMJD3 and UTX drive the formation of the germ layer, endoderm, which gives rise to the gastrointestinal tract, respiratory tract, endocrine glands, and the auditory and urinary systems. Endoderm commitment is controlled by the WNT signaling pathway. — 1.1.2. Mesoderm  JMJD3 and UTX are also involved in the formation of the germ layer, mesoderm, but JMJD3 can partially compensate for the loss of UTX during ESC differentiation into mesoderm (Morales Torres et al., 2013). Mesodermal development leads to the formation of muscle tissue, spleen, cartilage, bone, skin, kidneys, gonads, heart, blood vessels, and blood cells. Jmjd3 deficiency in ESCs significantly increases repressive H3K27me3 marks on the promoter of the mesodermal regulator, Brachyury and decreases its expression, leading to impaired recruitment of β-catenin (Ohtani et al., 2013), which is a prerequisite for WNT-induced mesoderm differentiation. During late mesoderm differentiation, JMJD3 is also essential for normal organ development. Jmjd3 knockout in ESCs reduces endothelial cell differentiation as well as cardiac progenitor cell differentiation (Ohtani et al., 2013). In addition, Jmjd3 knockout mice at E17.5 demonstrate impaired spleen development, with smaller size and hyperemic areas (Li, 2014a). Furthermore, JMJD3 affects bone formation. Endochondral bone formation and ossification begins with multipotent mesenchymal stem cell (MSC) differentiation into chondrocytes. This cartilage maturation during endochondral bone formation is regulated by JMJD3 and its association with the transcription factor, RUNX2, promoting proliferation and hypertrophy of chondrocytes (Zhang et al., 2015). JMJD3 can also direct MSCs to differentiate preferentially into one lineage over another lineage. — 1.1.3. Ectoderm  Formation of the germ layer, ectoderm, is also regulated by JMJD3 and partially by UTX (Morales Torres et al., 2013). The ectoderm can differentiate into the nervous system, including the spine, peripheral nerves, and brain. Key regulators in neurogenesis, Pax6Sox1, and Nestin, harbor bivalent marks, H3K4me3/H3K27me3, which are dynamically regulated during differentiation, and Jmjd3 can directly regulate expression of these key regulators in neurogenesis (Burgold et al., 2008). Jmjd3 is also a key regulator in Shh-dependent neural tube development (Shi et al., 2014). In fact, Jmjd3 is essential for ESC commitment into neural lineages. In the developing spinal cord, trimethylation of H3K27 also regulates BMP activity, which, in turn, leads to JMJD3 interaction with the transcription factors, SMAD1/4, to activate the notochord-derived BMP antagonist, Noggin (Akizu et al., 2010) (Fig. 1C). This negative feedback loop ensures rigorous and anatomically defined spinal cord formation. —. Overall, the important role of JMJD3 in the formation of all three germ layers suggests that JMJD3 is fundamental in cell fate and plasticity.”
  • JDMJ3 is modulated by the polychrome repressive complex so as to control a network of genes related to puberty.  A  part of the dance. Recalling that KDM6b is the gene expressing JMJD3, the 2021 publication Polycomb represses a gene network controlling puberty via modulation of histone demethylase Kdm6b expression tells this story: “Female puberty is subject to Polycomb Group (PcG)-dependent transcriptional repression. Kiss1, a puberty-activating gene, is a key target of this silencing mechanism. Using a gain-of-function approach and a systems biology strategy we now show that EED, an essential PcG component, acts in the arcuate nucleus of the hypothalamus to alter the functional organization of a gene network involved in the stimulatory control of puberty. A central node of this network is Kdm6b, which encodes an enzyme that erases the PcG-dependent histone modification H3K27me3. Kiss1 is a first neighbor in the network; genes encoding glutamatergic receptors and potassium channels are second neighbors. By repressing Kdm6b expression, EED increases H3K27me3 abundance at these gene promoters, reducing gene expression throughout a gene network controlling puberty activation. These results indicate that Kdm6b repression is a basic mechanism used by PcG to modulate the biological output of puberty-activating gene networks.”

JDJM3 and H3K27me3 histone methylation play mutiple roles in lifelong normal and advanced aging  as exemplified by the following discussions of tissue repair, the longevity factors KLOTHO and foxo3a.

  • JMJD3 and lifelong tissue repair From the 2016 publication JMJD3 as an epigenetic regulator in development and disease1.2. JMJD3 and cell plasticity  Not only does JMJD3 play a role in cellular differentiation in the developing embryo, it regulates cellular processes in differentiated tissues. Specifically, Jmjd3 is intimately involved in tissue repair. Following bone injury, osteoclasts are responsible for bone resorption, and abnormal osteoclast differentiation can lead to osteoporosis. RANKL stimulation of the osteoclast cell surface receptor, RANK, leads to osteoclast differentiation. This is accompanied by JMJD3-mediated demethylation of H3K27me3 at the Nfatc1 gene, a gene responsible for bone mass (an). These studies suggest that JMJD3 mediates osteoclast differentiation after bone injury and may limit the onset of osteoporosis. JMJD3 has also been implicated in skin repair (Shaw and Martin, 2009). Whereas Polycomb genes, which are involved in histone methylation, are significantly downregulated during murine skin repair, the demethylases, Jmjd3 and Utx, are markedly upregulated, leading to less Polycomb-mediated silencing of the wound repair genes, Myc and Egfr (Shaw and Martin, 2009). Whether JMJD3 is directly involved in other types of tissue repair is not yet known, but JMJD3 is likely involved in the cellular plasticity involved in tissue repair (ref).”
  • In fact, JMJD3 may play a direct role in the reprogramming of adult cells into a pluripotent state. The ability to revert differentiated cells back into a pluripotent, embryonic stem cell-like state has been a breakthrough for patient-specific disease modeling and drug testing. This cellular reprogramming is induced by the exogenous addition of the transcription factors, Sox2Oct4c-Myc, and Klf4. OCT4 is critical for generating induced pluripotent stem cells (iPSCs) and maintaining pluripotency (Lowry et al., 2008Pesce and Scholer, 2001). Activation of OCT4 occurs in parallel with the recruitment of JMJD3 to chromatin, suggesting that JMJD3 is involved in cellular reprogramming (Apostolou and Hochedlinger, 2013). Our own research has shown that JMJD3 is a potent negative regulator of cellular reprogramming (Zhao et al., 2013) (Fig. 4). Ablation of Jmjd3 in mouse embryonic fibroblasts increases iPSC formation, whereas, ectopic Jmjd3 expression inhibits reprogramming by both histone demethylase-dependent and -independent mechanisms (Zhao et al., 2013). Further understanding of the role of JMJD3 in cellular reprogramming and tissue repair may lead to therapeutic test-beds of iPSCs and enhance wound repair(ref).”
  • One mechanism of aging is down-regulation of the longevity proteins klotho and foxo3a consequent to increasing h3k27me3 with aging.  At least this is observed in mouse kidney cells.  The 2020 publication Epigenetic Regulation of KL (Klotho) via H3K27me3 (Histone 3 Lysine [K] 27 Trimethylation) in Renal Tubule Cells  reports: “KL (klotho) levels decline with age, which is an important mechanistic driver of aging. KL gene deficiency is associated with hypertension. The purpose of this study is to investigate the potential role of H3K27me3 (histone 3 lysine [K] 27 trimethylation) in the regulation of KL gene expression and examine the related molecular pathways that may drive kidney cell aging. Kidneys were collected from 6-month-old WT (wild type; young WT), 30-month-old WT (aged WT), and 6- (young) and 20-month-old (aged) KL mutant mice, respectively. We demonstrated that the H3K27me3 level was increased in kidneys of aged WT and KL mutant mice versus young WT mice. Elevation of H3K27me3 levels was likely due to downregulation of the H3K27 (histone H3 Lys 27)-specific demethylase JMJD3 (the Jumonji domain containing-3) in the aged kidneys. Inhibition of PRC2 (polycomb repressive complex C2; histone trimethyltransferase) decreased the H3K27me3 levels leading to an increase in the expression of KL in cultured primary renal tubule cells assessed by Western blot and KL promoter activity assays. The chromatin immunoprecipitation qPCR assay revealed that H3K27me3 was physically associated with the KL promoter region. Furthermore, aging impaired the SGK1 (serum- and glucocorticoid-induced protein kinase 1)/FOXO3a (the forkhead box class O 3a) signaling leading to upregulation of p53 and p16 (aging markers) in the kidney of aged WT mice. KL may regulate the SGK1/FOXO3 signaling, which was decreased due to KL deficiency. Thus, aging-associated downregulation of KL gene expression may be partly attributed to upregulation of H3K27me3 levels. Downregulation of KL may impair the SGK1/FOXO3 signaling contributing to kidney cell aging.”  Of course. The YOUNGING01 response to this situation is downregulation of H3K27me3 via JDJM3.
  • JMJD3 is recruited by the Yamanaka pluripotency factor KLF4.  As reported in the 2020 publiction JMJD3 acts in tandem with KLF4 to facilitate reprogramming to pluripotency   “The interplay between the Yamanaka factors (OCT4, SOX2, KLF4 and c-MYC) and transcriptional/epigenetic co-regulators in somatic cell reprogramming is incompletely understood. Here, we demonstrate that the histone H3 lysine 27 trimethylation (H3K27me3) demethylase JMJD3 plays conflicting roles in mouse reprogramming. y JMJD3 also promotes enhancer-promoter looping through the cohesin loading factor NIPBL and ultimately transcriptional elongation. This competition of forces can be shifted towards improved reprogramming by using early passage fibroblasts or boosting JMJD3’s catalytic activity with vitamin C. Our work, thus, establishes a multifaceted role for JMJD3, placing it as a key partner of KLF4 and a scaffold that assists chromatin interactions and activates gene transcription.”  Note here the interesting observation that JMJD3 “induces the pro-senescence factor Ink4a” which would seem to lead cells down the path to senescence, the opposite direction from regression to “stemness” and pleuripotency.  True. But only a problem if we fall into the trap of thinking of all similar cells in an organ as doing the same thing.  As I have pointed out, different cells in an organ can healthily be in different epigenetic states, most in a mature but healthily functioning state, some in senescence, and sone in epigenetic regression, i.e. undergoing YOUNGING.  Recall that the Yamanaka OSKM cell-level YOUNGING journey to pluripotency absolutely requires senescence signaling to trigger it.  So the fact that a non-histone related impact of JMJD3 promotes cell senescence is part of its action which fosters cell-level reprogramming to pluripotency.
  • JDJM3 expression can be dysregulated so as to induce inflammatory signaling in the case of alcohol dependence.  The 2019 publication Dysregulation of the histone demethylase KDM6B in alcohol dependence is associated with epigenetic regulation of inflammatory signaling pathways reports “Through quantitative mRNA expression analysis of over 100 epigenetic enzymes, we identified 11 that are dysregulated in the brain of alcohol dependent rats. The histone 3, lysine 27 (H3K27me3) demethylase KDM6B, was found to have region‐specific dysregulation in the prefrontal cortex and nucleus accumbens and also in human alcoholic brain tissues. A ChIP‐sequencing analysis showed that alcohol‐induced changes in H3K27me3 were enriched at genes in the IL‐6 signaling pathway, thereby implicating a novel KDM6B‐mediated epigenetic signaling pathway integrated with inflammatory signaling pathways that underlie alcohol addiction.”
  • JDMJ3 plays an important role in cancer processes. In this respect it is like many other substances involved in growth and development such as IGF1 and OCT4.  The 2016 publication The roles of histone demethylase UTX and JMJD3 (KDM6B) in cancers: Current progress and future perspectives reports: “Aberrant epigenetic reprogramming occurs frequently in the development of tumors. Histone H3 lysine 27 trimethylation (H3K27me3) exerts a repressive epigenetic mark on a large number of genes. UTX and JMJD3 are the only two histone demethylases which activate gene expression via demethylating H3K27me3 to H3K27me2 or H3K27me1. Current studies show that dysregulation of these two proteins are heavily linked to oncogenesis in various tissue types. Accumulating evidence suggested that there is remarkable therapeutic potential of targeting JMJD3 or UTX in different types of cancer. Herein, we shall give a brief review on the functional roles of JMJD3 and UTX in cancers and evaluate the available compounds and agents targeting UTX and JMJD3. Finally, we also discuss the several modalities that target UTX and JMJD3 for cancer therapy. This review will help to develop novel strategies to abolish or restore effects of UTX and JMJD3 in the pathogenesis of cancer.”

This is the published list of Highlights for the 2016 publication Histone demethylase JMJD3 at the intersection of cellular senescence and cancer

      • Different studies demonstrate JMJD3 as a tumor suppressor and oncogene.
      • Tumor suppressor pathways controlled by JMJD3 help to coordinate growth arrest.
      • JMJD3 activates the senescence-associated secretory phenotype (SASP) observed in aging.
      • Senescent-like cancer cells undermine normal tissue

This dual role of JMJD3 suggests that it’s activation for longevity purposes be done in a carefully regulated way.

VI.  AGING INFLAMMATION AND STEM CELL RENEWAL PROCESSES

Regular readers of this blog by now know the importance I assign to control of chronic inflammation for health in advanced aging, and for the possibility of living a very long life. You know I have written a number of blog entries related to this topic and in fact have created a dietary supplement for the control of chronic inflammation.  Related to this current blog entry, there appears to be strong evidence that control of chronic inflammation is critical for maintenance of healthy stem cell reproduction and hematopoiesis.  A number of recent research publications have focused on this.  One of these is Inflamm-Aging of hematopoiesis, Hematopoietic stem Cells and the Bone Marrow Microenvironment.  All hematopoietic and immune cells are continuously generated by hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) through highly organized process of stepwise lineage commitment. In the steady state, HSCs are mostly quiescent, while HPCs are actively proliferating and contributing to daily hematopoiesis. In response to hematopoietic challenges, e.g., life-threatening blood loss, infection, and inflammation, HSCs can be activated to proliferate and engage in blood formation. The HSC activation induced by hematopoietic demand is mediated by direct or indirect sensing mechanisms involving pattern recognition receptors or cytokine/chemokine receptors. In contrast to the hematopoietic challenges with obvious clinical symptoms, how the aging process, which involves low-grade chronic inflammation, impacts hematopoiesis remains undefined. Herein, we summarize recent findings pertaining to functional alternations of hematopoiesis, HSCs, and the bone marrow (BM) microenvironment during the processes of aging and inflammation and highlight some common cellular and molecular changes during the processes that influence hematopoiesis and its cells of origin, HSCs and HPCs, as well as the BM microenvironment. We also discuss how age-dependent alterations of the immune system lead to subclinical inflammatory states and how inflammatory signaling might be involved in hematopoietic aging. Our aim is to present evidence supporting the concept of “Inflamm-Aging,” or inflammation-associated aging of hematopoiesis.”

Also relevant is the January 2021 review publication Inflammation and hematopoietic stem cells aging.  “Hematopoietic stem cells (HSCs) replenish all lineages of blood cells throughout the lifespan. During aging, the repopulation capacity of HSCs declined, and aged HSCs display a tendency for myeloid differentiation. Several intrinsic and extrinsic factors have been identified to promote HSCs aging. In this review, we focus on the contribution of aging-associated inflammation in provoking HSCs aging and discuss the future research direction of inflammation and HSC aging.”

VII.  YOUNGING PROCESSES AT A CELLULAR LEVEL CAN INVOLVE DEMETHYLATION OF DOUBLE OR TRIPPLE METHYLATED HISTONE LYSINES IN ADDITION TO OR BESIDES LYSINE 27

While I have focused specifically on H3K27me2-3 methylation up to this point, YOUNGING processes may require demethylation of other histone lysines such as H3K9me3.  This is discussed for example in the following publications:

  • The 2015 publication Histone Demethylase Expression Enhances Human Somatic Cell Nuclear Transfer Efficiency and Promotes Derivation of Pluripotent Stem Cells is another supporting the role of demethylation of trimethylated histones for cell reprogramming to younger more pluripotent states, this time related to lysine 9 instead of 27.  “The extremely low efficiency of human embryonic stem cell (hESC) derivation using somatic cell nuclear transfer (SCNT) limits its potential application. Blastocyst formation from human SCNT embryos occurs at a low rate and with only some oocyte donors. We previously showed in mice that reduction of histone H3 lysine 9 trimethylation (H3K9me3) through ectopic expression of the H3K9me3 demethylase Kdm4d greatly improves SCNT embryo development. Here we show that overexpression of a related H3K9me3 demethylase KDM4A improves human SCNT, and that, as in mice, H3K9me3 in the human somatic cell genome is an SCNT reprogramming barrier. Overexpression of KDM4A significantly improves the blastocyst formation rate in human SCNT embryos by facilitating transcriptional reprogramming, allowing efficient derivation of SCNT-derived ESCs using adult Age-related Macular Degeneration (AMD) patient somatic nuclei donors. This conserved mechanistic insight has potential applications for improving SCNT in a variety of contexts, including regenerative medicine.”
  • This closely related publication The Histone Demethylases Jhdm1a/1b Enhance Somatic Cell Reprogramming in a Vitamin-C-Dependent Manner relates a similar theme, this time involving trimethylation of  histone lysine36.  “Reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) resets the epigenome to an embryonic-like state. Vitamin C enhances the reprogramming process, but the underlying mechanisms are unclear. Here we show that the histone demethylases Jhdm1a/1b are key effectors of somatic cell reprogramming downstream of vitamin C. We first observed that vitamin C induces H3K36me2/3 demethylation in mouse embryonic fibroblasts in culture and during reprogramming. We then identified Jhdm1a/1b, two known vitaminC-dependent H3K36 demethylases, as potent regulators of reprogramming through gain- and loss-offunction approaches. Furthermore, we found that Jhdm1b accelerates cell cycle progression and suppresses cell senescence during reprogramming by repressing the Ink4/Arf locus. Jhdm1b also cooperates with Oct4 to activate the microRNA cluster 302/367, an integral component of the pluripotency machinery. Our results therefore reveal a role for H3K36me2/3 in cell fate determination and establish a link between histone demethylases and vitamin C induced reprogramming.”

This publication also highlights a couple of other important factors: first that different histone lysine positions require different but closely related demethylases.  E.g. demethylating H3K36me2/3 takes place via JHDM1a/1b while, as we have previously discussed, how demethylating H3K27me2/3 takes place via JDJM3.  So, positioning YOUNGING as involving only H3K27me2/3 and JDJM3 has been an over-simplification. Second, that vitamin C is an important factor as far as cell-level YOUNGING is concerned.  I have pointed this out in earlier blog entries.  For example I devoted a section to discussing this topic mentioning additional literature citations and a diagram in the blog entry YGC More on YOUNGING1.0  – the emerging aging reversal strategy. A practical consequential inference is that any practical approach to initiating YOUNGING might benefit from generous self-dosage with vitamin C or actually require vitamin C to be effective.  Please note that I am not at this point suggesting that vitamin C by itself is sufficient to initiate YOUNGING as I may hae hoped decades ago.

VIII.  IS THE WHOLE YOUNGING 01 HYPOTHESIS SO RADICAL AS TO BE OUT OF STEP WITH MAINLINE SCIENCE?

I have to finally comment on this because I have learned that intelligent educated people may think that I have gone a bit off my rocker when I tell them that significant age reversal is now possible, that I am starting to understand how it works, that in fact I am doing it, and that it is likely working for me. I have discovered the secret of the Fountain of  Youth?  Me?  Right now after so many thousands of years of failure to do so in the course of human history? Give me a break.

Most people with this reaction don’t know enough about biology or longevity to discuss the topic intelligently. So they mainly seek to change the subject, politely of course. On the other hand there is a growing number of key longevity scientists who believe like I do that aging is optional, like David Sinclair who wrote the seminal book Lifespan: Why We Age―and Why We Don’t Have To.

I do not believe the YOUNGING concept is radical, although it would have been so only only 5 years ago.  Researchers are increasingly believing in the possibility of age-reversal via epigenetic reprogramming.  By 2017, publications where appearing with titles like The Emerging View of Aging as a Reversible Epigenetic Process. As time rolls by, there have been more and more of them.  A latest is the April 2021 publication A ride through the epigenetic landscape: aging reversal by reprogramming.

Another quite relevant April 2021 publication is Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trialThis paper describes a small clinical trial that demonstrates limited epigenetic epigenetic age reversal age reversal; The endpoint of the study is epigenetic age as measured by a Horvath DNA  methylation clock.   +“– Herein we report on a randomized controlled clinical trial conducted among 43 healthy adult males between the ages of 50-72. The 8-week treatment program included diet, sleep, exercise and relaxation guidance, and supplemental probiotics and phytonutrients. The control group received no intervention. Genome-wide DNA methylation analysis was conducted on saliva samples using the Illumina Methylation Epic Array and DNAmAge was calculated using the online Horvath DNAmAge clock (2013). The diet and lifestyle treatment was associated with a 3.23 years decrease in DNAmAge compared with controls (p=0.018). DNAmAge of those in the treatment group decreased by an average 1.96 years by the end of the program compared to the same individuals at the beginning with a strong trend towards significance (p=0.066). Changes in blood biomarkers were significant for mean serum 5-methyltetrahydrofolate (+15%, p=0.004) and mean triglycerides (-25%, p=0.009). To our knowledge, this is the first randomized controlled study to suggest that specific diet and lifestyle interventions may reverse Horvath DNAmAge (2013) epigenetic aging in healthy adult males. Larger-scale and longer duration clinical trials are needed to confirm these findings, as well as investigation in other human populations. — Manipulations to slow biological aging and extend healthspan are of interest given the societal and healthcare costs of our aging population. Herein we report on a randomized controlled clinical trial conducted among 43 healthy adult males between the ages of 50-72. The 8-week treatment program included diet, sleep, exercise and relaxation guidance, and supplemental probiotics and phytonutrients. The control group received no intervention. Genome-wide DNA methylation analysis was conducted on saliva samples using the Illumina Methylation Epic Array and DNAmAge was calculated using the online Horvath DNAmAge clock (2013). The diet and lifestyle treatment was associated with a 3.23 years decrease in DNAmAge compared with controls (p=0.018). DNAmAge of those in the treatment group decreased by an average 1.96 years by the end of the program compared to the same individuals at the beginning with a strong trend towards significance (p=0.066). Changes in blood biomarkers were significant for mean serum 5-methyltetrahydrofolate (+15%, p=0.004) and mean triglycerides (-25%, p=0.009). To our knowledge, this is the first randomized controlled study to suggest that specific diet and lifestyle interventions may reverse Horvath DNAmAge (2013) epigenetic aging in healthy adult males. Larger-scale and longer duration clinical trials are needed to confirm these findings, as well as investigation in other human populations.”

This current blog series about YOUNGING is intended to be a meaningful contribution to this stream.

My current intention is that Part 5 of this YOUNGING series will be about practical ways for inducing YOUNGING 01, including combinations of activating JDJM3 and limiting chronic inflammation.


WARNING: AS POINTED OUT IN THIS BLOG ENTRIES, IMPROPER OR ABERRANT ACTIVATION OF JDJM3 MAY LEAD TO CANCER PROCESSES OR OTHER ILLNESSES.  NOTHING WRITTEN IN THIS BLOG ENTRY IS INTENDED AT THIS POINT TO RECOMMEND OR ENCOURAGE SELF OR OTHER HUMAN EXPERIMENTATION INVOLVING SUCH JMJD3 ACTIVATION.

YGE YOUNGING 1.0 PART 5: PRACTICAL INITIATION OF YOUNGING 1.0 VIA HYPOXIC INTERVENTIONS

$
0
0

By Vince Giuliano and Steve Buss

 Image source – retinal neuron

This is the fifth blog entry on a natural process of aging in reverse we have called YOUNGING 1.0.  It is about a category of practical interventions that humans can use to initiate YOUNGING 1.0 processes in themselves – interventions based on oxygen scarcity in cells, known as hypoxia. The blog entry also identifies a hitherto undiscussed underlying mechanism explaining hypoxic hormesis – a process that involves remarkable health benefits flowing from various temporary conditions of hypoxia in the body, such as wearing a pressure cuff that limits circulation in an arm for a short period of time.

We suggest that readers new to the YOUNGING 1.0 concept review some of the earlier entries for context before seeking to digest this one.  We suggest you start by reading the less technical introductory blog entry YGA Introduction to the YOUNGING Series – Emerging Aging Reversal Strategies and Treatments.  After that, the next thing we suggest you review is the substantive blog YGB YOUNGING1.0 – THE EMERGING AGING REVERSAL STRATEGY.  Then you can look at the blog entry YGC MORE ON YOUNGING1.0 – THE EMERGING AGING REVERSAL STRATEGYAnd finally, the previous entry YGD YOUNGING1.0 PART 4: UNDERLYING MECHANISMS OF YOUNGING 1.0. HSC STEM CELL DIFFERENTIATION.

SUMMARY

These previous blog entries have been mainly focused on the underlying biological mechanisms through which YOUNGING 1.0 processes produce a variety of phenomena that collectively can be described as a form of aging in reverse.  However, these blog entries have not focused on how YOUNGING 1.0 can be reliably and safely initiated in mammals such as ourselves. This particular blog entry is focused on a class of interventions which result in body cells experiencing a lack of oxygen and responding as they are evolutionarily programmed to do, by upgrading a certain cellular signaling pathway known as Hypoxia Induced Factor 1alpha (HIF-1 α).

Since oxygen is so essential for survival of animal cells and bodies, evolution has provided us with a number of mechanisms to protect our cells against real or perceived oxygen insufficiency.  The HIF-1α pathway is primary among these.  Given a bodily perception of drop in the environmental oxygen level or oxygen insufficiency, the pathway leads to the rapid activation of numerous protective and health-promoting genes – a situation known as hypoxic hormesis.  Studies have revealed many possible benefits including hippocampal neurogenesis, strengthend immune response, lessened inflammation, decreased arterial hypertension, improved wound healing, better capacity to exercise and enhanced spatial learning and memory)(ref).

“Eventually, HIF-1 acts as a master regulator of numerous hypoxia-inducible genes under hypoxic conditions. The target genes of HIF-1 encode proteins that increase O2 delivery and mediate adaptive responses to O2 deprivation. Despite its name, HIF-1 is induced not only in response to reduced oxygen availability but also by other stimulants, such as nitric oxide and hydrogen sulfide, and various growth factors.(ref HIF-1 Signaling Pathway

Among the known impacts of activation of that pathway is genome-wide demethylation of the H3K27me2-3 histone via expression of JMJD3.  And that, in turn has been argued in previous blog entries to be the central activating mechanism of YOUNGING 1.0. JMJD3 activation can results in the re-activation of literally thousands of genes, including many involved in growth and development as well as DNA repair and other kinds of cellular damage remediation. Finally, in laying this all out, it becomes evident that the YOUNGING process itself may be responsible for the health benefits longer known to result from intermittent hypoxia (hypoxic hormesis)(ref).

Temporary Induction of hypoxia is increasingly recognized in the research literature as being at the nexus of epigenetic regulation for numerous biological aging as well as growth and development and regenerative phenomena, including inflammation, hematopoiesis, wound healing, angiogenesis, inflammation, aging, and cell senescence.  We believe that is because hypoxia induces expression of JMJD3, which leads to H3K27me2-3 histone demethyation which turns on thousands of genes as part of a YOUNGING 1.0 process.

ON THE EVOLUTIONARY DEVELOPMENT OF BIOLOGICAL MECHANISMS TO PROTECT OXYGEN AVAILABILITY

From the 2020 publication The Hyperoxic-Hypoxic Paradox “Oxygen is the third-most abundant element in the universe, after hydrogen and helium, and it is the most dominant effector of most living creatures on earth. About 300 million years ago, during the Carboniferous period, atmospheric oxygen levels reached a maximum of 35%, which may have contributed to the large size of animals and insects at this time [1,2]. Today, oxygen constitutes 20.8% of the earth’s atmosphere, and any slight change in its concertation will have a dramatic impact on all levels of mammalian physiology. The ability to maintain oxygen homeostasis is essential for survival, and all mammalian physiological systems evolved to ensure the optimal level of oxygen supplied to all cells in each organism. This has transpired through the evolution of a complex physiological infrastructure for oxygen delivery (the lungs), oxygen transport carriers (erythrocytes and plasma), oxygen transport pathways (vascular system), and the pump (heart). Both the development and regulation of these systems in organisms provide the basis for oxygen homeostasis —   Accordingly, low levels of oxygen, or hypoxia, are one of the most powerful inducers of gene expression, metabolic changes, and regenerative processes, including angiogenesis and stimulation of stem-cell proliferation, migration, and differentiation.”  The mechanisms of the hypoxic response include basic ones of gene regulation moderated, as we shall see, by histone methylation as a way of simultaneously affecting large numbers of genes.  This diagram from the same publication illustrates the oxygen delivery chain.

JMJD3 IS ACTIVATED BY HYPOXIA

A central message of this blog entry is that hypoxia leads to expression of JMJD3 and consequent demethylation of H3K27me3,.  We therefore strongly suspect that hypoxia is an important initiator of YOUNGING 1.O. The 2014 publication HIF-1-Dependent Induction of Jumonji Domain-Containing Protein (JMJD) 3 under Hypoxic Conditions reports: “Jumonji domain-containing proteins (JMJD) catalyze the oxidative demethylation of a methylated lysine residue of histones by using O2, α-ketoglutarate, vitamin C, and Fe(II). Several JMJDs are induced by hypoxic stress to compensate their presumed reduction in catalytic activity under hypoxia. In this study, we showed that an H3K27me3 specific histone demethylase, JMJD3 was induced by hypoxia-inducible factor (HIF)-1α/β under hypoxia and that treatment with Clioquinol, a HIF-1α activator, increased JMJD3 expression even under normoxia. Chromatin immunoprecipitation (ChIP) analyses showed that both HIF-1α and its dimerization partner HIF-1β/Arnt occupied the first intron region of the mouse JMJD3 gene, whereas the HIF-1α/β heterodimer bound to the upstream region of the human JMJD3, indicating that human and mouse JMJD3 have hypoxia-responsive regulatory regions in different locations. This study shows that both mouse and human JMJD3 are induced by HIF-1.” —

“In response to hypoxia, cells express several genes to maintain homeostasis. More than 500 genes, including vascular endothelial growth factor (VEGF), erythropoietin (EPO), phosphoglycerate kinase-1 (PGK-1), glucose transporter-1 (glut-1), and BCL-2/adenovirus E1B 19 kDa interacting protein 3 (Bnip3) are induced under hypoxia in MCF7 cells (Elvidge et al., 2006). These diverse target genes are transcribed by a common transactivator, the hypoxia-inducible factor 1-α/β (HIF-1α/β) heterodimer (Semenza, 2012). Under normoxic conditions, HIF-1α is ubiquitinated and rapidly degraded whereas HIF-1β is constitutively expressed. HIF-1β is identical to the Aryl hydrocarbon receptor nuclear translocator (Arnt) that is a dimerization partner protein of the dioxin receptor, Aryl hydrocarbon receptor. The 403rdand 564th proline residues of human HIF-1α are hydroxylated by prolyl hydroxylase domain protein (PHD) (Bruick and McKnight, 2001). The hydroxylated prolines are recognized by the E3 ubiquitin ligase von Hippel-Lindau protein (pVHL), which triggers the ubiquitination-dependent degradation of HIF-1α (Maxwell et al., 1999). The 803rd asparagine residue of HIF-1α is also hydroxylated by an oxygen-dependent asparagine hydroxylase, referred to as Factor-Inhibiting HIF-1 (FIH-1). The hydroxylated asparagine residue hinders the recruitment of the CREB-binding protein (CBP)/p300 coactivator. PHD and FIH-1 require molecular oxygen, α-ketoglutarate, vitamin C, and Fe(II) for their catalytic activities.  The trans-active form of HIF-1α is stabilized under hypoxia because the activities of these two oxygen-dependent hydroxylases decrease (Hewitson et al., 2002).” —

“More than 100 JMJDs have been identified, and most of them have demethylase activity with different substrate specificities (Shi and Whetstine, 2007). JMJD1A/JHDM2A/KDM3A demethylate H3K9me2 and me1, JMJD2 isozymes demethylate H3K9me3, Jarid1 isozymes demethylate H3K4me3, and JMJD3/KDM6B demethylate H3K27me3. Histone methylation affects gene expression in distinct localized patterns. The tri-methylation of H3K4 and acetylation of H3 in the promoter region are associated with actively transcribed genes, whereas the methylation of H3K9 and H3K27 in the promoter region are associated with inactive genes (Kooistra and Helin, 2012). The fact that JmjC proteins need molecular oxygen for their catalytic activities suggests that their activities can be inhibited under hypoxic conditions. Recent findings that hypoxia induced several JmjC proteins imply that their induction compensates their reduced catalytic activity under hypoxia (Beyer et al., 2008; Pollard et al., 2008; Wellmann et al., 2008Xia et al., 2009). Thus, in response to hypoxic stress, histone methylation of individual genes can be dynamically regulated by the net change in the activity and expression of the JmjC proteins.” —

JMJD2s, JMJD1A, and Jarid1B have been identified as HIF-1α target genes (Beyer et al., 2008; Pollard et al., 2008; Xia et al., 2009). This study first demonstrated that hypoxia also induces an H3K27me3 demethylase, JMJD3, by a HIF-1α dependent mechanism. Together with the recent findings that JMJD3 is involved in in breathing, inflammation, cardiac development, neural development, and senescence, this study suggests that hypoxia can influence these diverse biological processes by changing the expression level of JMJD3”

IMPACT OF JMJD3 ON GENE ACTIVATION

As discussed in previous blog entries of this series. JMJD3 demethylates H3K27me2-3 histones activating thousands of silenced genes.  The actions of jmjd3 are illustrated in this diagram from the publication JMJD3 in the regulation of human diseases:

“A graphical illustration on the mechanisms of JMJD3 in the regulation of enhancing gene transcription. JMJD3 promotes gene transcription in a demethylase-dependent or independent manner. JMJD3 enhances the initiation of transcription through three ways. Firstly, JMJD3 demethylate H3K27me3 on the promoter of targeted genes. Secondly, JMJD3 releases suppressive PRC2 complexes. Thirdly, JMJD3 binds to the Pol II elongation complex, enhancing its progression through H3K27me3-enriched gene bodies to enhance transcription elongation. This is the demethylase-dependent process. JMJD3 recruits co-activators to targeted gene promoters by interacting with both the co-activator and transcription factors in gene promoters. This co-activation process does not require demethylase activity. This is the demethylase-independent manner.”

CONTEXT OF HYPOXIC JDJM3 ACTIVATION

The impacts of hypoxia and JDJM3 activation can be either detrimental as in the case for several disease conditions and/or quite positive, dependent on site and locale, timing, duration, periodicity and intensity.  A small scrape on the skin or insect bite may initiate a strictly local activation associated with local inflammation, as part of a normal wound healing response.   Hypoxic Stress on a particular organ or body system such, for example, as induced by strenuous leg exercise may induce a response only or mainly in the legs involved.  General hypoxic stress associated with insufficient oxygen while breathing may be communicated by the circulatory system to a multiplicity of body systems and locales leading to a whole body response.  The hypox situation in blood cells is carried everywhere the circulatory system goes.  Likewise, JMJD3 activation paths associated with the blood circulatory system such as might be encountered in the case of heterochronic parabiosis or umbilical cord plasma infusions will likely produce whole body responses. 

The YOUNGING 01 response I we originally characterized in the first blog entry of this series was such a whole-body response.  YOUNGING 01 is envisaged as being triggered by whole-body stress lasting from a few minutes to a maximum of a few hours that activates JMJD3,  This could be a general hypoxic stress due to, for example. a transition from breathing concentrated oxygen to breathing normal air while exercising. We view this YOUNGING01 activation phase to be transient although it could be repeated periodically.  Animal experiments suggest that the YOUNGING 01 process itself is a consequence of the whole body activation of thousands of genes by JMJD3, leading to forms of reverse aging that could take years to play out.

BENEFICIAL INDUCTION OF INTERMITTENT HYPOXIA

It has been known for many years that many actions which temporarily limit oxygen supply to cells and activate hypoxia induced factors can induce a wide variety of health benefits in mammals such as ourselves.  This is because hypoxia activates a very large number of genes involved in growth and development including ones connected with angiogenesis, erythropoiesis, cell differentiation and proliferation as illustrated in this diagram.  The genes listed are representative; many more are actually involved:

Image and following text source  Hypoxia Signaling by Novus Biologicals The cellular response to hypoxia is predominantly shaped by HIF signaling. HIFs, primarily HIF-1, HIF-2 and to a less-defined extent HIF-3, control the expression of hundreds of genes involved in key cellular processes that facilitate adaptation to low-oxygenation. — HIFs are considered “Master Regulators of Hypoxia”, because they control the expression of hundreds of genes which help cells to survive under low oxygenation. However, several alternative pathways have been identified to contribute to the overall hypoxia response and cellular adaptations. Often these signaling pathways intersect HIF signaling.”  —

HYPOXIA HIF1-INDUCING INTERVENTIONS

Here are some of the most important possible hypoxia HIF1-inducung interventions:

  • aerobic exercise
  • measures which temporarily restrict blood flow within limbs, such as pressure cuffs and bands
  • high altitudes such as above 9000 feet
  • stays in decompression chambers
  • body accommodation to hyper oxygenation which is suddenly discontinued
  • inhibitors of steps in the mitochondrial respiratory chain such as by certain drugs
  • vascular constriction induced by drugs or other effects
  • a limb “going to sleep” accompanied by loss of sensation and muscular control due to circulatory restriction
  • holding one’s breath

Intermittent hypoxia can also result from multiple disease and environmental situations, such as

  • obstructive sleep apnoea (OSA)
  • diseases such as COPD
  • lack of hemoglobin, anemia
  • insufficient microvascular dilation due to drugs or insufficient expression of nitric oxide
  • environments without sufficient ventilation
  • presence of carbon monoxide or cyanide which inhibit normal oxygen conveying functions of hemoglobin
  • Serious infection with COVID can impact breathing and can create a life-threatening hypoxic situation

Conversely, actions to ensure an adequate oxygen supply (which tend to preclude expression of HIF-1α) include

  • breathing supplemental oxygen
  • being enclosed in a hyperbaric chamber
  • being on a ventilator machine
  • taking Viagra, Cialis or Levitra to induce expression of nitric oxide which promotes micro vascular dilation

Known Health Benefits of Intermittent Hypoxia

There is an extensive body of literature associated with both positive and negative health effects of intermittent hypoxia. The  detrimental effects can be associated with multiple disease processes.  An example is the case of SARS-COVID as illustrated by this diagram:

Image source

In this blog entry we are mainly be concerned with positive impacts of temporarily induced by intermittent hypoxia.

THERE IS A GROWING AWARENESS OF THE RELEVANCY OFTHE BENEFITS OF INTERRMITTANT HIF-1α EXPRESSION FOR PROCESSES OF REGENERTIVE MEDICINE

Esentially every process of organ regeneration studied in the field of regenerative medicine requires epigenetic modifications of hundreds of genes from normal steady-as-you-go state into growth-and-development state.  Evolution provides central mechanisms for bringing this about. Central to those mechanisms is global H3K27me2-3 demethylation through the expression of JDJM3. And one of the practical ways of inducing this expression is via inducing temporary hypoxia. Therefore it is not surprising that temporary hypoxia is increasingly being recognized as an important tool in the domain of regenerative medicine. The 2021 publication Unlocking mammalian regeneration through hypoxia inducible factor one alpha signaling reports.  “Historically, the field of regenerative medicine has aimed to heal damaged tissue through the use of biomaterials scaffolds or delivery of foreign progenitor cells.  Despite 30 years of research, however, translation and commercialization of these techniques has been limited.  To enable mammalian regeneration, a more practical approach may instead be to develop therapies that evoke endogenous processes reminiscent of those seen in innate regenerators.  Recently, investigations into tadpole tail regrowth, zebrafish limb restoration, and the super- healing Murphy Roths Large (MRL) mouse strain, have identified ancient oxygen-sensing pathways as a possible target to achieve this goal.  Specifically, upregulation of the transcription factor, hypoxia-inducible factor one alpha (HIF-1α) has been shown to modulate cell metabolism and plasticity, as well as inflammation and tissue remodeling, possibly priming injuries for regeneration. Since HIF-1α signaling is conserved across species, environmental or pharmacological manipulation of oxygen-dependent pathways may elicit a regenerative response in non-healing mammals. In this review, we will explore the emerging role of HIF-1α in mammalian healing and regeneration, as well as attempts to modulate protein stability through hyperbaric oxygen treatment, intermittent hypoxia therapy, and pharmacological targeting. We believe that these therapies could breathe new life into the field of regenerative medicine.”Historically, the field of regenerative medicine has aimed to heal damaged tissue through the use of biomaterials scaffolds or delivery of foreign progenitor cells. Despite 30 years of research, however, translation and commercialization of these techniques has been limited. To enable mammalian regeneration, a more practical approach may instead be to develop therapies that evoke endogenous processes reminiscent of those seen in innate regenerators. Recently, investigations into tadpole tail regrowth, zebrafish limb restoration, and the super-healing Murphy Roths Large (MRL) mouse strain, have identified ancient oxygen-sensing pathways as a possible target to achieve this goal. Specifically, upregulation of the transcription factor, hypoxia-inducible factor one alpha (HIF-1α) has been shown to modulate cell metabolism and plasticity, as well as inflammation and tissue remodeling, possibly priming injuries for regeneration. Since HIF-1α signaling is conserved across species, environmental or pharmacological manipulation of oxygen-dependent pathways may elicit a regenerative response in non-healing mammals. In this review, we will explore the emerging role of HIF-1α in mammalian healing and regeneration, as well as attempts to modulate protein stability through hyperbaric oxygen treatment, intermittent hypoxia therapy, and pharmacological targeting. We believe that these therapies could breathe new life into the field of regenerative medicine.”

What we have to add to this and similar discussions are two important new pieces: 1. HIF-1α does its global gene activation job by H3K27me3 demethylation via JMJD3, and 2. Organ regeneration involves a profound aging-reversal process we call YOUNGING 01.

HIF-1 AND ITS BENEFITS (OR PROBLEMS) CAN BE ACTIVATED NOT ONLY BY ACTUAL HYPOXIA BUT ALSO BY ABRUPT CHANGES IN OXYGEN AVAILABILITY.

Again from the 2020 publication The Hyperoxic-Hypoxic Paradox:  “Effective metabolism is highly dependent on a narrow therapeutic range of oxygen. — The sensing of decreased oxygen levels (hypoxia) or increased oxygen levels (hyperoxia), occurs through specialized chemoreceptor cells and metabolic changes at the cellular level, which regulate the response. Interestingly, fluctuations in the free oxygen concentration rather than the absolute level of oxygen can be interpreted at the cellular level as a lack of oxygen. Thus, repeated intermittent hyperoxia can induce many of the mediators and cellular mechanisms that are usually induced during hypoxia. This is called the hyperoxic-hypoxic paradox (HHP).”

The following diagram from the publication The Hyperoxic-Hypoxic Paradox illustrates how HIF-1 can be triggered by transitions from normoxia to hypoxia or from hyperoxia to normoxia. Intermittent hyperoxia can trigger HIF-1 multiple times.

 

“As summarized in the f0llowing figure (from the same publication)  most of the cellular cascades initiated by hypoxia can be induced by intermittent hyperoxia, the so-called “hyperoxic-hypoxic paradox”. HIF, VEGF, SIRT, mitochondrial biogenesis, and stem cell proliferation and migration could all be induced by “biological fooling” the cells with certain protocols of repeated intermittent hyperoxia. Even though the exact dose response-curve has yet to be discovered in clinical practice, certain HBOT protocols have already demonstrated induction of damaged tissue regeneration.”

The same theme is supported by  other studies, such as reported in the 2012 publication Pulsed high oxygen induces a hypoxic-like response in human umbilical endothelial cells and in humans: “It has been proposed that relative changes of oxygen availability, rather than steady-state hypoxic or hyperoxic conditions, play an important role in hypoxia-inducible factor (HIF) transcriptional effects. According to this hypothesis describing the “normobaric oxygen paradox”, normoxia following a hyperoxic event is sensed by tissues as an oxygen shortage, upregulating HIF-1 activity. With the aim of confirming, at cellular and at functional level, that normoxia following a hyperoxic event is “interpreted” as a hypoxic event, we report a combination of experiments addressing the effects of an intermittent increase of oxygen concentration on HIF-1 levels and the activity level of specific oxygen-modulated proteins in cultured human umbilical vein endothelial cells and the effects of hemoglobin levels after intermittent breathing of normobaric high (100%) and low (15%) oxygen in vivo in humans. Our experiments confirm that, during recovery after hyperoxia, an increase of HIF expression occurs in human umbilical vein endothelial cells, associated with an increase of matrix metalloproteinases activity. These data suggest that endothelial cells “interpret” the return to normoxia after hyperoxia as a hypoxic stimulus. At functional level, our data show that breathing both 15 and 100% oxygen 30 min every other day for a period of 10 days induces an increase of hemoglobin levels in humans. This effect was enhanced after the cessation of the oxygen breathing. These results indicate that a sudden decrease in tissue oxygen tension after hyperoxia may act as a trigger for erythropoietin synthesis, thus corroborating the hypothesis that “relative” hypoxia is a potent stimulator of HIF-mediated gene expressions.”

Careful attention must be paid to timing, frequency and intensity of doses.  “An understanding of proper dosage is needed in order to design an effective intermittent hypoxia protocol, particularly due to the comorbidities associated with hypoxia. For example, intermittent hypoxia has been shown to induce LTF in rats while continuous hypoxia does not.[15] And acute IH shows no evidence of the hippocampal cell death found in rats while chronic intermittent hypoxia exposure does[16]   Though intermittent hypoxia has been used for various therapeutic applications across a number of physiological system, there is a general consensus in what can be considered a safe and beneficial amount of intermittent hypoxia. Such a protocol would involve a fraction of inspired oxygen (FiO2) ranging between 0.09 – 0.16 with 3 – 15 episodes per day with comorbidities found in the range of a FiO2 of 0.03 – 0.08 and 48 – 2400 episodes per day.[2] (From Wikipedia)”

THE MASTER INITIATOR OF INFLAMMATION NF-kB IS ACTIVATED BY HYPOXIA

Again ,from Hypoxia Signaling by Novus Biologicals: “NF-kB is a main regulator of inflammatory signaling, orchestrating the induction of proinflammatory proteins including adhesion molecules, cytokines and chemokines. NF-kB signaling is activated via three mechanisms including canonical (dependent on inhibitor of kB kinase -IKK beta), non-canonical pathways (dependent on IKK-alpha) and atypical (IKK-dependent or -independent) pathways. Hypoxia activates NF-kB via the canonical pathway leading to the induction or repression of various target genes.”   This table is also from that publication:

Hypoxia/NF-kB Regulated Genes
Cytokines/Chemokines TNF-alphaIL-1 betaIL-6IL-8
Enzymes COX-2iNOS
Adhesion Proteins ICAM-1VCAM-1
Transcription Factors HIF-1 alpha
Immunoreceptors TLR-3

While the initialtion of inflammation by hypoxia may seem contra-intuitive, actually it is not surprising since inflammation is the first step in the restorative process of wound healing.  Again, I remind you my personal battle against inflammation is not at all against initiation of inflammation; it is against persistent chronic locked-in inflammation typically present in advanced aging.

PRO-INFLAMMATORY CONSEQUENCES OF HYPOXIA ARE DUE IN SOME MEASURE TO JMJD3 ACTIVATION BY HYPOXIA

We know this because knock-down of JMJD3 reduces expression of NF-kB and inflammatory markers.  See the articles on this list.

JMJD3 AND NF-kB COOPERATE FOR WOUND HEALING

The 2015 publication Histone H3K27 Demethylase JMJD3 in Cooperation with NF-κB Regulates Keratinocyte Wound Healing reports “Histone H3K27me3 demethylase JMJD3 has been shown to be involved in keratinocyte differentiation and wound healing. However, the exact molecular mechanism underlying JMJD3-mediated keratinocyte wound healing has not been fully elucidated. In this study, we report on the biological function of JMJD3 in keratinocyte wound healing using in vitro cell and in vivo animal models. Our results indicate that JMJD3 up-regulation and NF-κB activation occur in the region of the wound edge during keratinocyte wound healing. We also found that JMJD3 interacts with NF-κB, resulting in increased expression of the inflammatory, matrix metalloproteinase, and growth factor genes via demethylation of H3K27me3 at the gene promoters. Consistently, inactivation of JMJD3 or NF-κB resulted in aberrant keratinocyte wound healing. Our study suggests that regulation of JMJD3 may provide a new therapeutic intervention for treating the chronic skin wound.”

HYPOXIA AND CONSEQUENT EXPRESSION OF JDJM3 IS A MAJOR DRIVER OF ANGIOGENESIS

One of the body’s key regenerative processes is angiogenesis, the development of new vasculature.  JMJD3 (KDKM4B) is actively involved and activated by hypoxia, The 2020 publication Hypoxia-Mediated Regulation of Histone Demethylases Affects Angiogenesis-Associated Functions in Endothelial Cells reports: “Objective: Previous studies have demonstrated that the expression of several lysine (K)-specific demethylases (KDMs) is induced by hypoxia. Here, we sought to investigate the exact mechanisms underlying this regulation and its functional implications for endothelial cell function, such as angiogenesis. Approach and Results: We analyzed the expression changes of KDMs under hypoxia and modulation of HIF (hypoxia-inducible factor) expression using GRO-Seq and RNA-Seq in endothelial cells. We provide evidence that the majority of the KDMs are induced at the level of nascent transcription mediated by the action of HIF-1α and HIF-2α. Importantly, we show that transcriptional changes at the level of initiation represent the major mechanism of gene activation. To delineate the epigenetic effects of hypoxia and HIF activation in normoxia, we analyzed the genome-wide changes of H3K27me3 using chromosome immunoprecipitation-Seq. We discovered a redistribution of H3K27me3 at ≈2000 to 3000 transcriptionally active loci nearby genes implicated in angiogenesis. Among these, we demonstrate that vascular endothelial growth factor A (VEGFA) expression is partly induced by KDM4B- and KDM6Bmediated demethylation of nearby regions. Knockdown of KDM4B and KDM6B decreased cell proliferation, tube formation, and endothelial sprouting while affecting hundreds of genes associated with angiogenesis. These findings provide novel insights into the regulation of KDMs by hypoxia and the epigenetic regulation of VEGFA-mediated angiogenesis.  Conclusions: Our study describes an additional level of epigenetic regulation where hypoxia induces redistribution of H3K27me3 around genes implicated in proliferation and angiogenesis. More specifically, we demonstrate that KDM4B and KDM6B play a key role in modulating the expression of the major angiogenic driver VEGFA.”

NITRIC OXIDE AND HYDROGEN SULFIDE ADMINISTRATION ARE AMONG THE OTHER APPROACHES TO ACTIVATING HIF-1AND GLOBAL HISTONE DEMETHYLATION ON HISTONE SITES, HORMETIC IMPACTS AND POSSIBLY A VERSION OF YOUNGING

The 2018 publication Endogenous hydrogen sulfide regulates histone demethylase JMJD3-mediated inflammatory response in LPS-stimulated macrophages and in a mouse model of LPS-induced septic shock reports: “Overproduction of inflammatory mediators contributes to uncontrolled inflammation during  endotoxin shock  Cystathionine-γ-lyase (CSE), an enzyme involved in hydrogen sulfide (H2S) biosynthesis, has potential anti-inflammatory activity in a variety of inflammatory diseases. Jumonji domain-containingprotein 3 (JMJD3), a histone 3

Lys27 (H3K27) demethylase, has been implicated in macrophage activation, but its function in CSE-mediated anti-inflammatory activities remains unknown. In the present study CSE was found to be upregulated in macrophages and mouse lipopolysaccharide (LPS) challenge models. LPS stimulation also enhanced the activation of JMJD3 and decreased H3K27me3 levels. JMJD3 knockdown upregulated H3K27me3 levels and attenuated the LPS-mediated inflammatory response. CSE knockout amplified the inflammatory cascade by increasing JMJD3 expression in septic mice. Similarly, enhanced production of inflammatory mediators by macrophages was mitigated by CSE overexpression via inhibition of JMJD3 expression. This is the first report indicating that inflammation enhanced CSE/H2S system biosynthesis, that in turn attenuated the LPS-triggered inflammatory response by regulating JMJD3 expression. Thus, the CSE/H2S system represents an epigenetic-based modification mechanism to prevent uncontrolled inflammation.”

The 2013 publication Nitric oxide modifies global histone methylation by inhibiting Jumonji C domain-containing demethylases reports “Methylation of lysine residues on histone tails is an important epigenetic modification that is dynamically regulated through the combined effects of methyltransferases and demethylases. The Jumonji C domain Fe(II) α-ketoglutarate family of proteins performs the majority of histone demethylation. We demonstrate that nitric oxide ((•)NO) directly inhibits the activity of the demethylase KDM3A by forming a nitrosyliron complex in the catalytic pocket. Exposing cells to either chemical or cellular sources of (•)NO resulted in a significant increase in dimethyl Lys-9 on histone 3 (H3K9me2), the preferred substrate for KDM3A. G9a, the primary methyltransferase acting on H3K9me2, was down-regulated in response to (•)NO, and changes in methylation state could not be accounted for by methylation in general. Furthermore, cellular iron sequestration via dinitrosyliron complex formation correlated with increased methylation. The mRNA of several histone demethylases and methyltransferases was also differentially regulated in response to (•)NO. Taken together, these data reveal three novel and distinct mechanisms whereby (•)NO can affect histone methylation as follows: direct inhibition of Jumonji C demethylase activity, reduction in iron cofactor availability, and regulation of expression of methyl-modifying enzymes. This model of (•)NO as an epigenetic modulator provides a novel explanation for nonclassical gene regulation by (•)NO.”

EXPLAINING HORMESIS

It is interesting that over 10 years ago, I (Vince) became interested in hormesis (Processs through which a mild a and temporary body stress activates a body response leaving the organism healthier), and I wrote a number of blog entries on the topic which remain online.  Among the stress activators concerned were heat shock and HIF-1, nitric oxide, and hydrogen sulphide.   See these earlier publications, for example.  Jim Watson and I even suggested in 2013 that these substances might be served at hormesis health bars.  What was not known then was the mechanism of action underlying these hormetic effects, which is herein described as global histome H3K27 me2-3 demethylation via JDJM3 and its close cousin Jumanji domain demethylases.  I (Vince) was among the researchers strongly suspecting all along that hormetic effects might be life-extending.  I did not appreciate their possible linkage to an actual age-reversal process, however, which Steve Buss and I have now identified as YOUNGING 1.0.  In 2013 I generated a blog entry Prospectus for a Grand Unified theory of Biology, Health and Aging in which I asserted that hormesis is so fundamental to biology it will be an important feature of a Grand Unified Therory (GUT) of biology when that emerges.  I believe that now even more and that YOUNGING will be part of that GUT.

Inflammation Part 9: The inflammatory Reflex, an evolutionary leap forward

$
0
0

By Vince Giuliano and Steve Buss

It is now generally accepted that the brain inhibits inflammation induced by an immune challenge resulting in the release of inflammatory cytokines or TNF in two main ways: biochemically, by activating the hypothalamic-pituitary-adrenal axis to release glucocorticoids; and neurally, via a mechanism that has been termed the ‘inflammatory reflex’.  This blog entry is about the later.

Image source

The Inflammatory Reflex (IR) is an autonomous nervous system mechanism for detecting and correcting conditions of inflammation,  It is an ancient evolutionarily preserved response found in mammals and important for us. In fact, neural regulation of immune cell activation is an ancient mechanism dating back to nematode worms,   IR is a whole-body response that takes place unconsciously in the background via the afferent (incoming) and efferent (outgoing) branches of the autonomous nervous system.  Most other causes of and responses to inflammation discussed in this blog and in the literature have been based on cell-level molecular interactions or purely molecular signaling.  My colleagues and I have focused so far on matters like NF-kb and other inflammatory and anti-inflammatory cytokines and inflammasomes, and mainly on activities that go on within individual cells.  By contrast the IR is a calculated intercellular brain-driven response. It utilizes long-distance electrical links that work in concert with chemical messaging.  It is a mechanism coordinating the nervous and immune systems that explains key aspects of the mind-body connection. It opens the door to basically new forms of preventative and active therapies for multiple inflammation-related conditions, such as via electric stimulation of the vagus nerve. Finally, and fascinatingly, it appears that a requirement for the IR to function is the presence of JDJM3, the key histone deacetylase substance that activates the YOUNGING1 pathway that we have written so much about recently.  It now appears to us that JDJM3 activation is required for ALL key biological renewal pathways in us.  (“A substance (or ligand) is cholinergic if it is capable of producing, altering, or releasing acetylcholine, or butyrylcholine (“indirect-acting”), or mimicking their behaviors at one or more of the body’s acetylcholine receptor (“direct-acting”) or butyrylcholine receptor types (“direct-acting”)(ref).”

THE INFLAMMATORY REFLEX AND SURVIVAL PROBABILITY

Our interest in The Inflammatory Reflex is driven by experiment evidence showing that it dramatically increases Survival Probability in the face of certain lethal inflammatory challenges.

Images from two studies are shown in the image below. In both studies, survival probability was profoundly higher when The Inflammatory Reflex Motor Arm (aka, the Cholinergic Anti-Inflammatory Pathway) was triggered.

In the study on top, a drug that triggers the Muscarinic-Acetylcholine receptors in the brain, Xanomeline, was administered to mice in 2 doses along with a control group getting saline. Soon after, a lethal dose of LPS was administered to all three groups. No mice died who got the highest Xanomeline dose.

In the study at the bottom, the Hegu and Neguan acupoints were stimulated with Electro-Acupuncture. The Hegu acupoint was shown to trigger the IR Motor Arm in a way comparable to Xanomeline in the brain. Lethal LPS was administered to the 2 acupoint groups and the 2 control groups. The survival probability results are comparable to the remarkable results demonstrated in the Xanomeline experiment.

The IR mechanism is the most potent longevity promoting mechanism that most longevity science enthusiasts know nothing about.

WHAT IS THE INFLAMMATORY REFLEX?

From The inflammatory reflex (2002) by Kevin J. Tracey, one of the first papers on the topic: “Inflammation is a local, protective response to microbial invasion or injury. It must be fine-tuned and regulated precisely, because deficiencies or excesses of the inflammatory response cause morbidity and shorten lifespan. The discovery that cholinergic neurons inhibit acute inflammation has qualitatively expanded our understanding of how the nervous system modulates immune responses. The nervous system reflexively regulates the inflammatory response in real time, just as it controls heart rate and other vital functions. The opportunity now exists to apply this insight to the treatment of inflammation through selective and reversible ‘hard-wired’ neural systems.”

From the 2005 publication  Autonomic neural regulation of immunity,  co-authored by Kevin J. Tracey: “The inflammatory reflex is a physiological pathway in which the autonomic nervous system detects the presence of inflammatory stimuli and modulates cytokine production. Afferent signals to the brain are transmitted via the Vagus nerve, which activates a reflex response that culminates in efferent Vagus nerve signaling. Termed the ‘cholinergic anti-inflammatory pathway’, efferent activity in the Vagus nerve releases acetylcholine (ACh) in the vicinity of macrophages within the reticuloendothelial system. ACh can interact specifically with macrophage alpha7 subunits of nicotinic ACh receptors, leading to cellular deactivation and inhibition of cytokine release.

Image source

Illustration legend: Operation of the Inflammatory reflex: The functional anatomy of the inflammatory reflex: Inflammatory mediators, such as cytokines, are released by activated macrophages and other immune cells when TLRs and NLRs are activated upon immune challenge. These mediators are detected by sensory components of the afferent arm of the inflammatory reflex (red). Neuronal interconnections between the NTS, AP, DMN, NA and higher forebrain regions (not shown) integrate afferent signaling and efferent vagus nerve-mediated immunoregulatory output.  Efferent vagus nerve cholinergic output to the spleen, liver and gastrointestinal tract (blue) regulates immune activation and suppresses pro-inflammatory cytokine release (dotted red lines). Efferent vagus nerve fibers interact with the splenic nerve to suppress pro-inflammatory cytokine release in spleen—a major organ source of TNF and other pro-inflammatory cytokines in endotoxemia and other inflammatory conditions. This efferent cholinergic arm of the inflammatory reflex is termed the cholinergic anti-inflammatory pathway and can be activated in the brain through mAChR-mediated mechanisms triggered by M1 mAChR agonists and other mAChR ligands, and AChE inhibitors, such as galantamine. Abbreviations: AChE, acetylcholinesterase; AP, area postrema; DMN, dorsal motor nucleus of the vagus nerve; LPS, lipopolysaccharide (endotoxin); mAChR, muscarinic acetylcholine receptor; NA, nucleus ambiguus; NLRs, nucleotide-binding oligomerization domain-like receptors; NTS, nucleus tractus solitarius; TLR4, Toll-like receptor 4. (Adapted from [6] )”

From another early (2005) publication on the topic The cholinergic anti-inflammatory pathway. “The regulation of the innate immune response is critical for controlling inflammation and for the prevention and treatment of diseases. We recently demonstrated that the efferent vagus nerve inhibits pro-inflammatory cytokine release and protects against systemic inflammation, and termed this vagal function “the cholinergic anti-inflammatory pathway.” The discovery that the innate immune response is regulated partially through this neural pathway provides a new understanding of the mechanisms that control inflammation. In this review, we outline the cholinergic anti-inflammatory pathway and summarize the current insights into the mechanisms of cholinergic modulation of inflammation. We also discuss possible clinical implications of vagus nerve stimulation and cholinergic modalities in the treatment of inflammatory diseases.”

BACKGROUND ON THE VAGUS NERVE ANDTHE PARASYMPATHETIC AND SYMPATHETIC NERVOUS SYSTEMS

Although the vagus nerve is regarded to be part of the autonomic nervous systems, many of its actions interface with activities that are to some extent also under conscious brain control.  It regulates breathing, for example, and we can to some extent override the autonomous operation  to control our breathing.  From Everything you need to know about the vagus nerve:  “The vagus nerve is the longest and most complex of the 12 pairs of cranial nerves that emanate from the brain. It transmits information to or from the surface of the brain to tissues and organs elsewhere in the body. — The name “vagus” comes from the Latin term for “wandering.” This is because the vagus nerve wanders from the brain into organs in the neck, chest, and abdomen.  It is also known as the 10th cranial nerve or cranial nerve X. — The vagus nerve has two bunches of sensory nerve cell bodies, and it connects the brainstem to the body. It allows the brain to monitor and receive information about several of the body’s different functions. — There are multiple nervous system functions provided by the vagus nerve and its related parts. The vagus nerve functions contribute to the autonomic nervous system, which consists of the parasympathetic and sympathetic parts.  – The nerve is responsible for certain sensory activities and motor information for movement within the body.  Essentially, it is part of a circuit that links the neck, heart, lungs, and the abdomen to the brain. The vagus nerve has a number of different functions. The four key functions of the vagus nerve are:

  • Sensory: From the throat, heart, lungs, and abdomen.
  • Special sensory: Provides taste sensation behind the tongue.
  • Motor: Provides movement functions for the muscles in the neck responsible for swallowing and speech.
  • Parasympathetic: Responsible for the digestive tract, respiration, and heart rate functioning.

Its functions can be broken down even further into seven categories. One of these is balancing the nervous system.  The nervous system can be divided into two areas: sympathetic and parasympathetic.

  • The sympathetic side increases alertness, energy, blood pressure, heart rate, and breathing rate.
  • The parasympathetic side, which the vagus nerve is heavily involved in, decreases alertness, blood pressure, and heart rate, and helps with calmness, relaxation, and digestion. As a result, the vagus nerve also helps with defecation, urination, and sexual arousal.”

Image and legend source:  Cholinergic Agonists and Antagonists  –  “FIG. 16.1 Parasympathetic responses. Stimulation of the parasympathetic nervous system or use of parasympathomimetic drugs will cause the pupils to constrict, bronchioles to constrict and bronchial secretions to increase, heart rate to decrease, blood vessels to dilate, peristalsis and gastric secretions to increase, the bladder muscle to contract, and salivary glands to increase salivation.”

Key Vagus nerve functions include:

  • Memory formation and consolidation, including via release of the neurotransmitter norepinephrine into the amygdala, which consolidated memories.
  1. Communication between the brain and the key organs: g. The vagus nerve delivers information from the gut to the brain. “Your gut uses the vagus nerve like a walkie-talkie to tell your brain how you’re feeling via electric impulses called “action potentials.” Your gut feelings are very real(ref).”
  1. Managing heart rate and blood pressure:  The vagus nerve controls heart pumping action via electrical impulses to specialized muscle tissue.  The heart does not work like a metronome and regular timing of heart beat is bad.  Exact time of triggering each individual heart beat is calculated based on instantaneous values of inputs to the vagus system from multiple organs.  Difference in such timing is known as heart rate variability, HRV, which is a measure of the effectiveness of vagus nerve operation and an important measure of general health and predicted longevity.  HRV is a measurement of the reseliance of one’s heart and vagus nerve.   High HRV is predictive of good health and longevity, while consistently low HRV is predictive of high mortality.

[[Personal note: I (Vince) wear an Oura ring which samples and monitors my HRV along with heart rate and other bioindicators 24-7.  Every morning I check what the overnight HRV pattern has been and the average overnight HRV score.  This represents the average variation of heart beat timing for R to R intervals measured in milliseconds.  My overnight average varies up over 150 to on a very good day down to less than 70 on a so-so day, and averages out to 119.  It was 136 for last night.  Given that the average HRV value for males my age is under 54, I think I am doing very well in this regard.  The Oura software on my cell phone computes a daily measure of my readiness to meet the coming day’s challenges, in significant part based on my recent HRV pattern.  My readiness score this morning was 90, which is regarded to be optimal.

 

Images source  Data for Elite HRV users.  “Chart 2 – This chart shows Elite HRV scores statistics for 8,873 males over different age ranges. The data is presented as box plots that represent the medians, 1st and 3rd quartiles, and extreme values (minimums and maximums). There are also markers for means at each age range.”  However note from the following scatter-graph that he Elite data does not include anybody as old as me, now close to 92.  My average score of 119 would be high off the chart.

You might also note that nobody in my age range of 92 was sampled in this chart of Elite users and that for some reason my personal score is high off their charts.  Some of the difference between these scores and mine could possibly be explained by differences between Elite and Oura HRV measurement approaches.]]

 

 

 

 

Health-inducing and stress-lowering functions of the vagus system include

  1. Relaxation through deep breathing: The vagus nerve communicates with the diaphragm. With deep breaths, a person can feel more relaxed.
  2. Decreasing systemic inflammation: The vagus nerve sends anti-inflammatory signal to other parts of the body. (The Inflammatory Reflex)
  3. Anxiety and fear management: The vagus nerve sends information from the gut to the brain, which is linked to dealing with stressanxiety, and fear – hence the saying, “gut feeling.” These signals help a person to recover from stressful and scary situations.”  They also let you know when you are hungary.
  1. Initiating relaxation after stress: “When your ever-vigilant sympathetic nervous system revs up the fight or flight responses—pouring the stress hormone cortisol and adrenaline into your body—the vagus nerve tells your body to chill out by releasing acetylcholine. The vagus nerve’s tendrils extend to many organs, acting like fiber-optic cables that send instructions to release enzymes and proteins like prolactin, vasopressin, and oxytocin, which calm you down. People with a stronger vagus response may be more likely to recover more quickly after stress, injury, or illness(ref).”

“Overstimulation of the vagus nerve is the most common cause of fainting.  If you tremble or get queasy at the sight of blood or while getting a flu shot, you’re not weak. You’re experiencing “vagal syncope.” Your body, responding to stress, overstimulates the vagus nerve, causing your blood pressure and heart rate to drop. During extreme syncope, blood flow is restricted to your brain, and you lose consciousness. But most of the time you just have to sit or lie down for the symptoms to subside(ref).”

Electrical stimulation of the vagus nerve can reduce unwanted inflammation and might stop it altogether, according to an emerging body of experimental evidence. See this list of recent publications related to therapeutic electric stimulation of the vagus nerve.  As a matter of fact “A burgeoning field of medical study, known as bioelectronics, may be the future of medicine. using implants that deliver electric impulses to various body parts, including the vagus nerve, scientists and doctors hope to treat illness with fewer medications and fewer side effects(ref).”

M1 AND M2 MACROPHAGES AND CONTROL OF INFLAMMATION

Source of the following quote and image is the 2018 publication Phytochemicals as modulators of M1-M2 macrophages in inflammation“Macrophages are critical mediators of the innate immune response against foreign pathogens, including bacteria, physical stress, and injury. Therefore, these cells play a key role in the “inflammatory pathway” which in turn can lead to an array of diseases and disorders such as autoimmune neuropathies and myocarditis, inflammatory bowel disease, atherosclerosis, sepsis, arthritis, diabetes, and angiogenesis. Recently, more studies have focused on the macrophages inflammatory diseases since the discovery of the two subtypes of macrophages, which are differentiated on the basis of their phenotype and distinct gene expression pattern. Of these, M1 macrophages are pro-inflammatory and responsible for inflammatory signaling, while M2 are anti-inflammatory macrophages that participate in the resolution of the inflammatory process, M2 macrophages produce anti-inflammatory cytokines, thereby contributing to tissue healing. Many studies have shown the role of these two subtypes in the inflammatory pathway, and their emergence appears to decide the fate of inflammatory signaling and disease progression. As a next step in directing the pro-inflammatory response toward the anti-inflammatory type after an insult by a foreign pathogen (e. g., bacterial lipopolysaccharide), investigators have identified many natural compounds that have the potential to modulate M1 to M2 macrophages. –”

Continuing: “Macrophages form an essential component of innate immunity by inhibiting or promoting cellular proliferation and tissue repair [1]. They are highly plastic and dynamic in nature, which has been attributed to their ease in adapting alternate phenotypes in response to various external stimuli [2]. Macrophages are distinctly subdivided into the classical M1 and alternative M2 categories, which in turn correspond to the Th1–Th2 polarization of T cells respectively (Figure ​(Figure1).1). This process represents the extremes of the dynamic changing state of macrophage activation [2]. Pro-inflammatory M1-macrophages release cytokines that inhibit the proliferation of malignant cells [3] and counter various pathogens [4]. In contrast, M2-macrophages or tumor-associated macrophages (TAM’s) release cytokines that promote tumor growth and dissemination along with tissue repair [5]. The M1–M2 macrophage polarization process is tightly regulated by key signaling events. The classical activation of macrophages occurs following an injury or infection by agents such as microbial products or pro-inflammatory cytokines including bacterial lipopolysaccharides (LPS), interferon-γ (IFN-γ) or tumor necrosis factor-α (TNF-α) [6]. M1 macrophages are characterized by the production of pro-inflammatory cytokines, the release of interleukin (IL)-12 and IL-23, and high levels of reactive oxygen intermediates (ROIs) and nitric oxide (NO). By contrast, M2 macrophages are activated by entirely different stimuli and are observed in the healing phase without the prevalence of infection [7]. These stimuli include IL-4 and/or IL-13, immune complexes and toll-like receptor (TLR), IL-1 receptor ligands, and IL-10. They are further characterized by the secretion of anti-inflammatory cytokines such asIL-10, chemokine (C-C motif) ligands (CCL)18 and CCL22, and the upregulation of dectin-1, mannose receptor CD206 (MRC1), scavenger receptor A, scavenger receptor B-1, CD163, C-C chemokine receptor type 2 (CCR2), C–X–C motif chemokine receptor (CXCR) 1,CXCR2 and dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) [89]. Moreover, M2 macrophages produce ornithine and polyamines through the arginase pathway [10] while M1 macrophages generate hazardous NO or ROI. To summarize the molecular agents released by classical M1 macrophages, pro-inflammatory cytokines such as TNF-α, IL-1, IL-6, IL-12, Type I IFN, C–X–C motif chemokine ligand (CXCL) 1–3, CXCL-5, and CXCL8–10 form the major pool [11]. On the other hand, the alternative M2 macrophages generate an array of anti-inflammatory cytokine such as IL-10, IL-4 and very low levels of pro-inflammatory cytokines such as IL-12 among others [12]. An optimum balance between M1 and M2 macrophage is very important at the basal, as well as advanced level, of immune regulation as any imbalance in the two states would be expected to cause the dysregulation of the immune pathway. The plasticity of macrophage transition might be attributed to the complex signaling pathways associated with the two phenotypes.”

Macrophages can be converted from one form to the other depending on environmental stimuli, a process refered to as changing the polarization of the macrophage.  “Macrophage polarization has profound impacts on various physiological and pathological conditions, such as angiogenesis, wound repair, inflammation, and tumorigenesis. Regardless of physiological or pathological process, a serial of signaling pathways and diverse mediators (e.g., cytokines, chemokines, transcriptional factors) are heavily implicated in macrophage polarization. Signals from the local microenvironment are modulated by various receptors on the macrophages to initiate multiple pathways of macrophage polarization(ref).”

 Maintaining proper balance of M1 and M2 polarization is important for health and some auto-immune diseases like lupus result in favoring M1 polarization which leads to constitutional states of inflammation. “In pathological conditions, chronic persistent inflammation could induce an aberrant response of macrophage and cause a shift in their phenotypes. Moreover, this shift would result in the alteration of macrophage polarization in some vascular dermatoses; e.g., an increase in proinflammatory M1 emerges from Behcet’s disease (BD), psoriasis, and systemic lupus erythematosus (SLE), whereas an enhancement in anti-inflammatory M2 appears in infantile hemangioma (IH).”

ROLE OF JDJM3 IN THE INFLAMMATORY REFLEX

So, for the Inflammatory Reflex operating via the cholinergic anti-inflammatory pathway to do its job on controlling inflammation, there has to be adequate M1 to M2 polarization.  This is where JDJM3 comes in. Again, we recall that JDJM3 specifically relates to a specific histone position.  It demethylates HK27me2-3, activating thousands of genes silenced by this methylation.  There is evidence that the presence of JDJM3 is a necessary condition for adequate M1 to M2 polarization to take place.  The 2010 publication The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection reports: “Polarization of macrophages to M1 or M2 cells is important for mounting responses against bacterial and helminth infections, respectively. Jumonji domain containing-3 (Jmjd3), a histone 3 Lys27 (H3K27) demethylase, has been implicated in the activation of macrophages. Here we show that Jmjd3 is essential for M2 macrophage polarization in response to helminth infection and chitin, though Jmjd3 is dispensable for M1 responses. Furthermore, Jmjd3 (also known as Kdm6b) is essential for proper bone marrow macrophage differentiation, and this function depends on demethylase activity of Jmjd3. Jmjd3 deficiency affected trimethylation of H3K27 in only a limited number of genes. Among them, we identified Irf4 as encoding a key transcription factor that controls M2 macrophage polarization. Collectively, these results show that Jmjd3-mediated H3K27 demethylation is crucial for regulating M2 macrophage development leading to anti-helminth host responses.”

While the above result may seem specific to helminth infection, the demethylation OF H3K27 and consequent activation of the Irf4 transcription factor seems to be a key factor given other pathologies as well, and we think it is fundamental for M2 macrophage polarization.  For example the 2016 publication Epigenetic Modulation in Periodontitis: Interaction of Adiponectin and JMJD3-IRF4 Axis in Macrophages reports: “Emerging evidence suggests an important role for epigenetic mechanisms in modulating signals during macrophage polarization and inflammation. JMJD3, a JmjC family histone demethylase necessary for M2 polarization is also required for effective induction of multiple M1 genes by lipopolysaccharide (LPS). However, the effects of JMJD3 to inflammation in the context of obesity remains unknown. To address this deficiency, we firstly examined the expression of JMJD3 in macrophage isolated from bone marrow and adipose tissue of diet induced obesity (DIO) mice. The results indicated that JMJD3 was down-regulated in obesity. Adiponectin (APN), a factor secreted by adipose tissue which is down-regulated in obesity, functions to switch macrophage polarization from M1 to M2, thereby attenuating chronic inflammation. Intriguingly, our results indicated that APN contributed to JMJD3 up-regulation, reduced macrophage infiltration in obese adipose tissue, and abolished the up-regulation of JMJD3 in peritoneal macrophages isolated from DIO mice when challenged with Porphyromonas gingivalis LPS (pg.lps). To elucidate the interaction of APN and JMJD3 involved in macrophage transformation in the context of inflammation, we designed the loss and gain-function experiments of APN in vivo with APN(-/-) mice with experimental periodontitis and in vitro with macrophage isolated from APN(-/-) mice. For the first time, we found that APN can help to reduce periodontitis-related bone loss, modulate JMJD3 and IRF4 expression, and macrophage infiltration. Therefore, it can be inferred that APN may contribute to anti-inflammation macrophage polarization by regulating JMJD3 expression, which provides a basis for macrophage-centered epigenetic therapeutic strategies.”

There are several additional ways of promoting macrophage M2 polarization, for example by key transcription factors such as the anti-inflammatory STAT6 and the Yamanaka epigenetic cell reprogramming factor KLF4.  The 2015 publication Transcription Factors STAT6 and KLF4 Implement Macrophage Polarization via the Dual Catalytic Powers of MCPIP reports: “Macrophage polarization plays a critical role in tissue homeostasis, disease pathogenesis, and inflammation and its resolution. IL-4–induced macrophage polarization involves induction of STAT6 and Krüppel-like factor 4 (KLF4), which induce each other and promote M2 polarization. However, how these transcription factors implement M2 polarization is not understood. We report that in murine macrophages MCP-1–induced protein (MCPIP), induced by KLF4, inhibits M1 polarization by inhibiting NF-κB activation and implements M2 polarization using both its deubiquitinase and RNase activities that cause sequential induction of reactive oxygen species (ROS), endoplasmic reticulum (ER) stress, and autophagy required for M2 polarization. MCPIP also induces C/EBPβ and PPARγ, which promote M2 polarization. Macrophages from mice with myeloid-targeted overexpression of MCPIP show elevated expression of M2 markers and reduced response to LPS, whereas macrophages from mice with myeloid-specific deletion of MCPIP manifest elevated M1 polarization with enhanced phagocytic activity. Thus, both in vivo and in vitro experiments demonstrate that the transcription factors STAT6 and KLF4 implement IL-4–induced M2 polarization via the dual catalytic activities of MCPIP.”Another example of an intervention promoting M2 polarization is administration of the drug  Macrophage polarization plays a critical role in tissue homeostasis, disease pathogenesis, and inflammation and its resolution. IL-4–induced macrophage polarization involves induction of STAT6 and Krüppel-like factor 4 (KLF4), which induce each other and promote M2 polarization. However, how these transcription factors implement M2 polarization is not understood. We report that in murine macrophages MCP-1–induced protein (MCPIP), induced by KLF4, inhibits M1 polarization by inhibiting NF-κB activation and implements M2 polarization using both its deubiquitinase and RNase activities that cause sequential induction of reactive oxygen species (ROS), endoplasmic reticulum (ER) stress, and autophagy required for M2 polarization. MCPIP also induces C/EBPβ and PPARγ, which promote M2 polarization. Macrophages from mice with myeloid-targeted overexpression of MCPIP show elevated expression of M2 markers and reduced response to LPS, whereas macrophages from mice with myeloid-specific deletion of MCPIP manifest elevated M1 polarization with enhanced phagocytic activity. Thus, both in vivo and in vitro experiments demonstrate that the transcription factors STAT6 and KLF4 implement IL-4–induced M2 polarization via the dual catalytic activities of MCPIP.”

Another example of an intervention promoting M2 polarization is administration of the drug Azithromycin.  The 2015 publication  Azithromycin protects mice against ischemic stroke injury by promoting macrophage transition towards M2 phenotype reports: “To develop novel and effective treatments for ischemic stroke, we investigated the neuroprotective effects of the macrolide antibiotic azithromycin in a mouse model system of transient middle cerebral artery occlusion. Intraperitoneal administration of azithromycin significantly reduced blood-brain barrier damage and cerebral infiltration of myeloid cells, including neutrophils and inflammatory macrophages. These effects resulted in a dose-dependent reduction of cerebral ischemic damage, and in a remarkable amelioration of neurological deficits up to 7 days after the insult. Neuroprotection was associated with increased arginase activity in peritoneal exudate cells, which was followed by the detection of Ym1- and arginase I-immunopositive M2 macrophages in the ischemic area at 24-48 h of reperfusion. Pharmacological inhibition of peritoneal arginase activity counteracted azithromycin-induced neuroprotection, pointing to a major role for drug-induced polarization of migratory macrophages towards a protective, non-inflammatory M2 phenotype.”

PHYTOSUBSTANCE PROMOTERS OF THE M2 MACROPHAGE POLARITY

I think ingestion of certain plant-based substances (phytosubstances) is the most practical and most important class of interventions to promote the M2 macrophage phenotype.  I am talking about substances much discussed previously in this blog like, resveratrol, quercetin, bacopa, and milk thistle– my old herbal anti-inflammatory friends.   They especially include curcumin, ashwagandha, Boswellia, and  ginger, the key ingredients in the anti-inflammatory liposomal herbal preparation I have invented and which we are now selling, 4 Herb Synergy.  Hitherto I have discussed the anti-inflammatory properties from numerous viewpoints, and this blog entry adds another such viewpoint which is M2 macrophage activation.

The 2018 article Phytochemicals as modulators of M1-M2 macrophages in inflammation.  “In this review, we provide a focused discussion of advances in the identification of natural therapeutic molecules with anti-inflammatory properties that modulate the phenotype of macrophages from M1 to M2.”  The article concludes “On exposure to external stimuli, macrophages can differentiate into pro-inflammatory (M1) or anti-inflammatory (M2) phenotypes. However, the molecular mechanisms arising from or leading to these diversions are still only partially understood. It is a common knowledge that microbial products such as LPS or Th1 cytokines including TNF and IL-6 polarize macrophages toward the M1 type thereby releasing pro-inflammatory cytokines responsible for initiating an inflammatory cascade that clears the invading microbes. In contrast, the Th2 cytokines including IL-4 and IL-13 polarize the macrophages to the M2 type, which release anti-inflammatory cytokines, thereby contributing to tissue repair and remodeling [12]. Recently, many breakthrough discoveries have been made in which investigators have identified therapeutically important natural compounds and molecules that have the ability to pharmacologically modulate this interconversion, particularly towards the M2 phenotype. These natural modulators include chemical entities from various classes, including stilbenes, polyphenols, flavonoids, terpenes, anthraquinones and various others from diverse origins. Investigators around the world have independently verified their pharmacological activities for M1–M2 polarization, with clear-cut roles as anti-inflammatory agents. Apart from the natural sources, few studies have also successfully demonstrated the pharmacological activities of compounds isolated from fungi and other microbes as well as laboratory synthesized compounds and known drugs. These miscellaneous compounds also modulate the M1 to M2 phenotypic conversion by varied pathways. In summary, the contribution of natural products as anti-inflammatory agents via the modulation of M1 and M2 phenotypes is unquestionable. Although their potent role in M1–M2 phenotypic modulation is clear, there is an unmet need for a clear-cut understanding of the exact molecular mechanisms involved in this modulation. Hence, an in-depth investigation of the molecular pathways as well as the key players involved in modulating the M1–M2 phenotypes by these agents are needed. This would pave the way not only for a better understanding of the M1–M2 phenotypic changes but would also result in the discovery of novel analogs that may be more potent in inhibiting inflammation via M1–M2 modulation.”

So where does this discussion on the Inflammatory Reflex leave me (Vince) in terms of my earlier emphasis on controlling age-related systemic inflammation using targeted plant-based phytochemicals for this purpose?  And where does it leave me in terms of understanding the underlying mechanisms of operation of my 4 Herb Synergy anti-inflammatory concoction?  It reinforces these.

THE ROLE OF ACETYLCHOLINE IN M1-M2 POLARIZATION AND IN THE INFLAMMATORY REFLEX

To recap, numerous publications have pointed out that in the inflammatory reflex, efferent neurons carry signals that result in acetylcholine production in specialized T cells which results in M2 polarization of macrophages resulting in control of the inflammation.  Detailing this process somewhat further, from the 2011 publication α7 Nicotinic Acetylcholine Receptor (α7nAChR) Expression in Bone Marrow-Derived Non-T Cells Is Required for the Inflammatory Reflex: “ —  stimulation of the vagus nerve protects from excessive cytokine production and ameliorates experimental inflammatory disease. This mechanism, the inflammatory reflex, requires the α7 nicotinic acetylcholine receptor (α7nachr), a ligand-gated ion channel expressed on macrophages, lymphocytes, neurons and other cells.” – “Recent insights in protective mechanisms have revealed that neural circuits suppress release of damaging cytokines and that neural regulation of immune cell activation is an ancient mechanism dating back to nematode worms, a primitive animal with rudimentary nervous and immune systems (1012).  — A prototypical antiinflammatory neural mechanism is the inflammatory reflex (11,1315). Action potentials arising in the brain stem are transmitted in the cholinergic vagus nerve to terminate in the celiac ganglion, the site of origin of the adrenergic splenic nerve. Signals through the splenic nerve terminate on specialized T cells that respond to norepinephrine by producing acetylcholine, the terminal neurotransmitter in the circuit. Acetylcholine interacts with cytokine producing macrophages in the red pulp and marginal zone to suppress TNF release (15). The cytokine-suppressing mechanism of the inflammatory reflex requires the α7 nicotinic acetylcholine receptor (α7nAChR), as evidenced by the observation that the inflammatory reflex is impaired in α7nAChR-deficient mice (16). Furthermore, deleting α7nAChR from isolated macrophages impairs the ability of acetylcholine to suppress TNF and other cytokines.”

The liposomal bodies in 4 Herb Synergy and most other liposomal supplements consist of acetylcholine.  However in my discussions of the impacts of the 4 Herb Synergy supplement in controlling inflammation, I (Vince) have only discussed the roles of the herbal substances carried by the liposomes.  I have never hitherto mentioned the additional possible anti-inflammatory role of the acetylcholine in the liposomal bodies, although this could be very significant.

We note for completeness here that synthesis of acetylcholine by macrophages can go on in other contexts besides the Inflammatory Reflex, contexts not involving the vagus nerve or neurons but relying only on chemical signaling instead.  For example this 2021 article is about how cold induces certain macrophages in adipose fat to synthesize acetylcholine for purposes of getting beige fat cells to give off heat: Acetylcholine-synthesizing macrophages in subcutaneous fat are regulated by β2-adrenergic signaling.   “Non-neuronal cholinergic signaling, mediated by acetylcholine, plays important roles in physiological processes including inflammation and immunity. Our group first discovered evidence of non-neuronal cholinergic circuitry in adipose tissue, whereby immune cells secrete acetylcholine to activate beige adipocytes during adaptive thermogenesis. Here, we reveal that macrophages are the cellular protagonists responsible for secreting acetylcholine to regulate thermogenic activation in subcutaneous fat, and we term these cells cholinergic adipose macrophages (ChAMs). An adaptive increase in ChAM abundance is evident following acute cold exposure, and macrophage-specific deletion of choline acetyltransferase (ChAT), the enzyme for acetylcholine biosynthesis, impairs the cold-induced thermogenic capacity of mice. Further, using pharmacological and genetic approaches, we show that ChAMs are regulated via adrenergic signaling, specifically through the β2 adrenergic receptor. These findings demonstrate that macrophages are an essential adipose tissue source of acetylcholine for the regulation of adaptive thermogenesis, and may be useful for therapeutic targeting in metabolic diseases.

The process is illustrated by this image and legend from that publication:

“Immune cells secrete acetylcholine to activate beige adipocytes during adaptive thermogenesis, yet the identity of these acetylcholine-secreting cells is unclear. This study shows that a subpopulation of adipose macrophages—named cholinergic adipose macrophages (ChAMs)—is responsible for β2 adrenergic receptor-dependent secretion of acetylcholine upon acute cold to stimulate thermogenesis in neighboring beige adipocytes within murine subcutaneous fat.”

We intend at some point to publish a separate blog entry specifically focused on the many health-inducing roles that can be played by acetylcholine supplementation.

A QUESTION WE ASK OURSELVES

Where does it leave us in understanding the triggering and operation of the YOUNGING 01 aging-in-reverse process we have so much discussed recently?  It lends even more credence to the proposition that JDJM3 is fundamental to probably all natural body and cell-level rejuvenation processes.  And that activation on JDJM3 is a necessary condition for just about any form of whole-body or whole-organ YOUNGING to take place.  JDJM3 activation must be one thing going on.  We are continuing our research to identify a practical sufficient condition for triggering basic multi-year YOUNGING 01.  That is, what in addition must be done to assuredly trigger a 10 or 15 year process of whole-body YOUNGING 01? And Why?  We will be reporting on that as we go on.  We are currently delving deeper into certain transcription factors as well as molecular pathways known to be involved in body renewal processes including the Yamanaka Factors themselves, the WNT, SHH, BMP, Sonic Hedgehog, TGF-beta T-box genes and SMAD3 pathways.  We are also looking deeper into growth and development factors known the be present in umbilical cord blood plasma.

 

 

 

Online meetup – YOUNGING – Triggering Ancient Mechanisms For Rejuvenation

$
0
0

By Vince Giuliano

Dear blog readers:

You might be interested in participating in this Zoom Meetup which will take place Saturday, November 20, 2021 11:00 AM to 12:30 PM EST. The Meetup is under the auspices of London Futurists, a 8,864 person group organized by David Wood and concerned with important new trends likely to have profound impacts on our lives. Steve Buss and I will be covering the essentials of our recent identification of a new paradigm in biology impacting all natural body rejuvenation processes as well as aging itself.  And, helping to explain processes of reverse aging which we call YOUNGING processes. The materials covered will summarize essentials of the previous seven entries published in this blog

The meeting notice on the London Futurists site: Recent times have seen an explosion in the number of scientific studies documenting evidence about biological processes related to aging and rejuvenation. Many different theories attempt to explain that evidence. One complication, however, is that several new intervention techniques have emerged that appear to provide longevity benefit, sometimes profound, that aren’t explained by any of these existing theories.

Independent longevity researchers Vince Giuliano and Steve Buss believe that the number and content of scientific-study puzzle pieces have approached a critical threshold. It is now possible, they claim, to assemble a good explanation, in which natural body rejuvenation processes play a vital role. This comprehensive new explanation integrates existing theories and also highlights an age-reversal process they have identified and named ‘YOUNGING’.

Vince and Steve believe that this emerging explanation constitutes a paradigm shift for the longevity science movement. Already-proven rejuvenation explanations and interventions can ONLY be properly understood to fit together via understanding recent evidence of ancient, evolutionarily-conserved mechanisms.

During this meetup, Vince and Steve will reveal and discuss a single epigenetic process underlying all known natural body rejuvenation processes as well as YOUNGING..

======

This event will consist of three parts: 1.  a 45-minute summary Powerpoint Presentation by Vince and Steve, 2. A 45-minute curated question-and answer session.  Users will be able to post questions and other users may vote on them before they are posed and answered.  And 3.  A followup Zoom session of open conversational interactions among users who choose to participate.

This event will be hosted on Zoom. To register, visit https://us02web.zoom.us/webinar/register/WN_D3XBj1ycQLmZdWduLFl_rA

The Zoom registration fee (UKP £2.50) helps cover London Futurists running costs, such as Zoom licensing. The webinar can also be viewed, without charge, on the London Futurists YouTube channel, but without the option to participate in the live Q&A.

(If you cancel your registration before the start time of the webinar, Zoom will automatically issue a refund for your registration fee.)

ONLINE PRESENTATION – Extensions to Triggering Ancient Mechanisms For Rejuvenation — Online user comments, questions asked, and selected post-Meetup responses

$
0
0

By Vince Giuliano and Steve Buss

As announced previously, on November 20 2021 Steve Buss and I were featured in an online Meetup of the London Futurist group.  We focused on delivering a coherent presentation of our research reported in a number of our recent YOUNGING-SERIES blogs.  And, on how we believed that this work initiates a new paradigm for aging in all organisms including us, the prospect for reverse aging, and practical YOUNGING interventions.  You can see the vide of the first hour of that meetup presentation on YouTube by clicking HERE.  Further, as extensions to what is in the video, below we 1.  list a number of viewer comments made during the presentation, in some cases with remarks of my own and Steve’s evoked in response to the comments, and 2. List a number of questions posted by viewers and addressed after the presentation. And also ,selectively responding with remarks of my own and Steve’s.  These comments, questions and responses to them are not in the viewable only in this blog entry.

To view video, click above on original meeting announcement poster

The Meetup was under the auspices of London Futurists, a 8,864 person group organized by David Wood and concerned with important new trends likely to have profound impacts on our lives. Steve Buss and I covered the essentials of our recent identification of a new paradigm in biology impacting all natural body rejuvenation processes as well as aging itself.  And, helping to explain processes of reverse aging which we call YOUNGING processes. The materials covered summarize essentials of the previous seven entries published in this blog

The original meeting notice on the London Futurists site: Recent times have seen an explosion in the number of scientific studies documenting evidence about biological processes related to aging and rejuvenation. Many different theories attempt to explain that evidence. One complication, however, is that several new intervention techniques have emerged that appear to provide longevity benefit, sometimes profound, that aren’t explained by any of these existing theories.

Independent longevity researchers Vince Giuliano and Steve Buss believe that the number and content of scientific-study puzzle pieces have approached a critical threshold. It is now possible, they claim, to assemble a good explanation, in which natural body rejuvenation processes play a vital role. This comprehensive new explanation integrates existing theories and also highlights an age-reversal process they have identified and named ‘YOUNGING’.

Vince and Steve believe that this emerging explanation constitutes a paradigm shift for the longevity science movement. Already-proven rejuvenation explanations and interventions can ONLY be properly understood to fit together via understanding recent evidence of ancient, evolutionarily-conserved mechanisms.

This event consisted of three parts: 1.  a hour and 12 minute summary Powerpoint Presentation by Vince and Steve., This is the only part recorded and presented in the video you can see on YouTube. User comments on these and in some cases responses by me are listed below in this blog entry.  2. A 35-minute or so curated question-and answer session.  Users were able to post questions and other users could vote on them before they are posed and answered.  The questions raised are also listed below in this blog.  Responses online were not recorded, but in some cases Steve and I also provide brief responses here. And 3.  A followup Zoom session of open conversational interactions among users who choose to participate. Altogether we were at it for more than 3 hours.  Session 3 was not recorded.

About 98 people participated in the meetup.  25 interested people persisted through the open Zoom interactions until the very end.  After 3 hours of interaction, the 25 participants did not want to sign out.  Finally, David Wood had to forcibly terminate the meeting.

The following brief viewer chat comments made during Part 1 don’t show in the YouTube presentation and are complimentary to it.  They appeared temporarily during the presentation  in tiny text windows.  I list all the relevant chat comments but have stripped out the names of most of the comment originators . In selected cases I remark in response to a comment, in plain red text like this.  Steve’s responses are in green like this.

Substantive chat comments in Part1  Time stamps indicate when made

I have deleted a number of administrative remarks as well as ones that seem to make no sense or have no relevant context.  Please be aware that many remarks are not responsive to immediately previous ones in this listing.

16:18:10      While some of my aging markers range from 25-35 yo.in late middle age my skin seems to be aging much faster.  Does Younging also “reverse” skin aging, and if so, do we know the mechanism, as I understand elastin (for example) is very difficult to replenish.

I think that some form or forms of Younging must include reversal of skin aging.   But I know relatively little about that now and am not sure about what interventions might work best.  Recent research and anecdotal experience suggests that red and infrared light might underlie effective approaches.  Also skin cryotherapy may be relevant. I expect to review the research literature related to these topics soon.

I have used red and near infrared light, near infrared heating, and other substances on my face and have achieved effects which are noticeable to me, if not others. Here’s a link to a study showing the positive effects of light.  If you do a search for studies about “retinoid jmjd3 epigenetic”, you’ll get a long list of studies.  I’ve used the “Medix 5.5 Retinol Cream”, available at Amazon, and can feel the positive difference in my skin almost immediately.

16:22:34      Hi. Will the slides be available?

Right now you can pause on the individual slides while viewing the YouTube presentation

Is there a way to get copies of the slides to be able to look at the figures more closely.

Right now you can pause on the individual slides in the YouTube presentation and copy them with screen shots.

16:56:37      This is a ridiculously crazy and exciting presentation! What could be more important?

That happens to be the way we feel too.

17:09:08      I have driven my SpO2 down below 55 via Tummo breathing

17:09:41      I take Occam’s razor and see the following: Whenever the body is damaged or put into an emergency mode we see a repair or rejuvenation process.

Yes, the essence of this presentation

There’s a move afoot within the Longevity Science Movement to try to remove as many senescent cells as possible. But senescent cells have an important roleSenescent IL-6 signaling is essential to triggering rejuvenation through epigenetic reversion and regeneration via the OSKM Yamanaka factors

17:21:25      @MB- most Oxygen is good

17:24:17      Oxidation in general isn´t

Not quite so simple.  Oxidatiive damage is generally not good, but oxidative conditions may play key signaling roles in restorative processes.

17:25:09      Thanks to Vince and Steve, for giving me a major piece to the puzzle. You’ve confirmed a lot of ancient Taoist and Yogic texts with this work. Thanks!

You are welcome

17:26:36      Infra Red light works big time!!

It indeed appears to.  I have been reading the research about it in recent days and hope to publish a blog entry on this soon.

I have used near infrared light, via several different interventions, for years now. Among them, I have the Vielight Neuro Duo product and try to use it 4 to 6 days a week. I can tell the difference when I miss using it for a week or two.

17:28:03      I just opened a window to Vince’s supps list

Look at the most recent.  I intend do to update this list again soon.

17:28:34 to   👍✌☮☯😁 I’ve been doing and teaching Tai Chi Quan and Qigong for over 20 years. it works! 😁

I bet it does.  Although I used to practice Tai Chi some, this  was years ago.

17:28:        But I know how much better pure Oxygen is

17:29:42      Best presentation I have seen in a long time!  …Maybe ever.

17:29:58      This has been a truly profound presentation on a better understanding of the underlying processes of aging and a potential regeneration of a human body.

17:30:16      Indeed.

17:30:31      Absolutely

17:30:46      Been reading Vince’s blog for years – highly recommended

17:31:11      Same here. Amazing work.

17:31:31      yes! I am looking for some good products!

17:32:02      Where the mind leads the body will follow, Aging is an attitude of the mind, so are the genes, genes express where the mind is set in its ways- William Young / London

17:32:35      The NRF2 pathway is not only evolutionarily highly conserved in humans.  There are rodents like the naked mole rats and a special bat that live 10 times longer than they should. They have extremely high nrf2 levels.  Could it not simply be the ratio between inflammation level and nrf2 level that is encoded in the organism and determines life span?

I think the question is a good one that deserves discussion. NRF2 expression and expression of inflammation as evidenced by NF-kb have a teeter-totter relationship.  When one goes up the other goes down. As mentioned in our presentation, limiting chronic inflammation appears to be required for effective expression of JDJM3.  You can activate NRF2 via multiple natural phytochemicals and thereby keep chronic inflammation down. So the ratio of NRF2/NF-kb can be under of conscious control, and therefore the same is roughly true for lifespan up to a point.  See all the articles in my blog www.agingsciences.com about chronic inflammation and NRF2. And about my anti-inflammatory supplement 4 Herb Synergy.  I think limiting chronic inflammation has been a central longevity measure that got me to this point and will keep me personally active and productive to age 100+.

NRF2 expression has a critically central intimate relationship with various states of oxygen concentration in cells. For example, in the study abstract diagram below, NRF2 is shown to mediate hypoxia-inducible HIF-1a activation in epithelial cells.

We have only just begun to understand the relationship of NRF2 to HIF-1.

Illustration source: Nrf2 mediates hypoxia-inducible HIF1α activation in kidney tubular epithelial cells

 

 

 

 

 

 

 

 

 

 

This YOUNGING work is bringing all our old friends together in amazing ways around the same health and longevity table: NFF2, phytosubstances to enhance expression of NRF2 and minimize chronic inflammation, oxygen therapies, hormesis, antioxidant response elements,  HIF1alpha, vagus nerve operations, acetyl choline, mitochondrial processes. And recently JDJM3,  This great meeting will possible be the subject of our next blog entry.

17:34:35       Have you looked at adding CO2 to the O2 bag?

As far as I know, there’s no reason to add co2 to the oxygen bag when doing Exercise With Oxygen Therapy (EWOT) exercise. Manfred von Ardenne doesn’t mention it in his book, Oxygen Multistep Therapy.  If you have a study link suggesting that it could be useful, please let us know.

17:35:47      That is the ultimate truth, but most people aren’t willing to do the work necessary for that to work for the majority. so interventions like the ones being discussed will work for them. Great comment. Cheers!

17:36:52      I totally agree. Higher Nrf2 consistently could lead to longer lifespan. It would neutralize the hyper activity of mTOR

Yes yes.

17:37:34      Rapamycin, metformin both lead to higher activation of Nrf2

Yes yes.  And both promote JDJM3

17:38:24      Intentionality

Yes.  Those of you familiar with my extended writings know that I believe intentionality is the source of creativity.  It has guided most of my adult life.  See my ON BEING AND CREATION treatise and recent entries in my Being and Creation blog.

My experience with my friend, Vincent, has convinced me of the value of practicing Intentional Reality Creation.

7:38:57 Epigenetic factors cause most aging. Mindset, diet, exercise, stress, environmental toxins, etc.

Yes.

17:40:29 The Law of One is the law of the many as the one, and therefore the law of nature is purposefully the law of the many, so holistically we are making it.

17:42:53 overspecialization.

17:43:13 We as part of the law of one, are responsible for the Law of Nature, it is all about not arriving at critical mass to change the paradigm to have what is desired by the whole. William Young / London

And now it is possibly the time for arriving at that critical mass and changing the paradigm.  That thought excites and motivates me endlessly.

17:44:17 The cures to everything are in Pubmed. Except world peace.

If significantly increasing longevity could lead to a greater societal expression of wisdom (as I think could be the case), and this enhances the prospects for world peace, then perhaps some of the cures that lead to world peace are in Pubmed!

17:44:48 The problem also has to do with political pressure to parrot the wear-and-tear/damage-repair approach to treat age related decline.

Basic paradigm shifts are difficult and usually meet fierce resistance from the established order.  We have come a long way already though, and I do not expect to be boiled in oil or burned at the stake if I don’t recant.  Truth ultimately prevails.

17:46:31 Appreciation and gratitude to Vince and Steve. Finally a view of the forest!

17:47:06 Thank you!  Unfortunately I can’t stay for the panel session, but thanks to Vince and Steve for a fascination presentation. Looking forward to other researchers picking it up.

We hope this will happen soon.  We invite critical examination of what we have presented here.

18:00:            activating nrf2 decreases epigenetic age. I tracked this over 430 Days with 12 Tests lowering the epigenetic age around 5 years

Yes yes.  Fascinating.  See my earlier remark about that in this list.  And Martin, Please get in direct touch with me about this important data of yours.  I would like to know more about it.

18:03:40      I have a spreadsheet I track of about 30 physiological and functional factors to reflect healthy aging, based on quantitative aspects where possible

I would love to see this too.

18:06:22 agingintervention.org

18:14:33 You can get Hamblin’s books off of Amazon.

18:15:30 FYI, it is simple and cheap to buy far-red/near-IR light arrays online.

True, there is quite a selection on Amazon.com.  I now have four of them,  Most of those devices seem to be imported from China.

18:16:39 Low-Level Light Therapy: Photobiomodulation (Tutorial Texts) https://www.amazon.com/dp/151061415X/ref=cm_sw_r_apan_glt_fabc_0KMHDVDQGGWH5S18KZBS

8:19:28   Would the writer need to be a medical doctor?

I assume this refers to a possible book related to YOUNGING as covered in this presentation. No the writer does not have to be a medical doctor

18:20:17 She has the credentials,  and has written a book ( The Kauffmann Protocol).

18:20:50 I think I got it

18:22:15 Wow! I love it!

18:23:29 Steve and Vincent: have you had an epigenetic age test? What were the results?

I had three DNA methylation age tests 4 1/2 years ago, all off of a single blood draw.  One showed me at about my actual age, another showed me a year younger than actual age and he third showed me as a year older than actual age.  This represents about the expected variance in these age tests. I had a blood draw for such an age tests today  and should know the results any day now.  I intend to publish them along with a number of my health biomarkers in a forthcoming blog entry.

18:27:04 hi David this is Akshay Sanghavi Can you announce my name and I will speak?

Good to hear from you Akshay

18:27:26 Ah, that makes sense. Will do…

18:29:17 Thank you very much gentlemen for the great session. Please make sure to repeat this!!

Steve and I are planning for a follow-up session on London Futurists, now aiming for Feb or Mar 2022

18:32:13 From  Johnny Adams  to  Hosts and panelists:

Volunteer rat #2 here to  Hosts and panelists:.  In my rambling attempt to answer David’s question about my personal age management program (stack) MUCH was omitted.  It is all here

https://www.aginginterventionfoundation.org/AgingInterventionProgram.pdf

Thanks Johnny

18:33:25 USG/NIH is near to agreeing aging is a disease, opening up funding?

This may be good news, though I believe certain kinds of needed aging research may not be funded this way.  For example, It will take a 40-50 year study of tens of thousands of participants, like the Framinham Heart Study, for us to determine which of the large number of life extension approaches now being practiced really work, and how well they work.  More immediately, a lot of the longevity approaches being tried could be partially validated or invalidated by rat studies.  But who will sponsor such studies if proprietary drugs and patented molecules are not involved?  E.g. who will sponsor carefully designed studies to validate or invalidate life-extension properties of systemic oxygen therapy? Infrared light therapies?  Vagus nerve therapies?, therapies that limit systemic age-related inflammation?

18:33:57 From       try to get rid of your senescence cells, then make sure your nrf2 level is high

That is a common viewpoint but are you sure? Il-6 senescent cell signalling is necessary to trigger Yamanaka factor OSKM cell-level epigenetic reversionin-vivo, leading to production of renewed cells.

18:35:09 From  Chris Wikman  to  Everyone:   Are we talking about a multi-faceted Younging experiment with most all known interventions, on human(s)?

I see such as a needed ongoing study

18:35:24 From  David Wood  to  Everyone:       Now speaking: Akshay Sanghavi – partner of Harold Katcher

18:39:56 for me, it is something radically different to see animals living longer than others but with a normal lifespan for their species and mimicking a specific aspect of this species for people to live longer.

Indeed so

18:44:26 Pranayama breathing techniques (I presented a webinar on this earlier this year..)

Yes, this too needs serious looking into given what is being discovered

18:46:27 Stellar!

18:46:45 You do great work, David.  Much appreciated!

18:47:17 Bravo, gentlemen!

18:47:56 Pranayama in Yoga, Tai Hsi in Taoism. They work.😁

18:48:12 excellent discussion

18:48:28 Indeed.

18:49:40 A seminal discussion. kudos to all!! Cheers!!👍✌☮☯😁

18:49:47 thank you so much David!

18:49:52 Thank you!

18:50:14 Thanks !

18:50:33 Nobody wants to leave!

18:56:06 Senescent Cells and the incidence of age-realted diseases“

 Questions in Part 2 of the Meetup, and selected responses

While some of my aging markers range from 25-35 yo, in late middle age my skin seems to be aging much faster.  Does “Younging” also “reverse” skin aging, and if so, do we know the mechanism, as I understand elastin (for example), is very difficult to replenish?

I assume whole body Younging will revese skin aging.  But now I only know about some of the previously known interventions purported to impact on skin aging. See earlier discussion here.

See my comments above.

 

Do you know exactly which genes are affected by JMJD3?

No.  There are thousands of them.   But we have a good idea of the gene families involved.  See for example this publication https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447479/

What about safety?

Depends on the intervention and side effects.  Based on animal experiments showing whole-body YOUNGING, and based on the many natural processes involving JDJM3 expression, I surmise that we will probably be able to clarify the safety of several whole body YOUNGING approaches.  Oxygen therapies could well be among these.

I believe (and I think Vince does to) that the major risk of deliberate increased JMJD3 expression is cancer risk. But that cancer requires significant inflammation to develop. That’s why profound reductions in inflammation are required as part of a JMJD3 focused regimen.

 

Hi. Will these slides be available?

You can pause on them in the YouTube presentation

 

Do you have a book that explains these concepts for “general audiences?”

Not yet, but we are now organizing to get one or more written.

 

Okay, great. Thanks for asking. Great work. I’m big on infra red, so that part was VERY interesting.
Does the JDJM3 literature to date fit with Dr. Harold Katcher’s work ?

I think it probably does very well, though Harold has been careful so far in not revealing what his ELIXER substance is.  Knowing nothing about his treatment substance except that it is present in young blood, little can be said.  However, his publication on the slow multi-year younging processes experienced by his small animals is part of the basis for my believing that whole-body YOUNGING is possible and demonstrated.

Is it possible that longevity was “bred out” in early humans based on how tribes distributed possibly scarce resources to elders vs. reproducing-age members? (Tribes with fewer long-lived members could provide more resources to reproducing members…?)

 Possibly, but all our antecedent species (in fact almost all species as far as i know) have well-defined maximum lifespans, so having a maximum life span was passed on to humans by evolution.

As far as I know, there is no evidence for the Programmed Aging Theory of Aging. There’s just an argument based wholly in conjecture.

Meanwhile….

1… profound evidence exists that the impulse of evolution is focus on life, regeneration, rejuvenation, renewal, by many processes, including JMJD3.

2… Digest the science of what evolution accomplished in establishing the Cholinergic Anti-Inflammatory Pathway (CAP) in detail. It’s incredible.

The suggestion that adaptions based on scarce resources are even roughly comparable in scope and effect vis-à-vis the Cholinergic Anti-Inflammatory Pathway is folly and cannot be taken seriously.

And notice… No promoters of the Programmed Aging Theory of Aging have tried to explain how their “Theory” explains the fact of the existence of the CAP in humans.

 

Is there any research on the impact of trauma on JMJD3?

Yes there appears to be a fair amount as can be revealed by Google and PubMed searches.  A broad generalization of special cases suggests that upregulation of JMJD3 results from serious stresses, including ones related to trauma.  See the article at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881266/

 

Can you give examples of food rich with DHEA?

I know of no natural food sources of DHEA.

How can we be sure that HDR doesn’t turn on genes not required in that type of cell?

I don’t think we can be sure, just as we can’t be sure that all kinds of other interventions turn on genes incidentally.  If we find an intervention is harmful, the usual approach is to discontinue using it, not to explore its gene activation impact profile which can be very complex.

In whose image and likeness was the human body created? It is still unclear. For example, a single-cell organism is arranged in the image and likeness of an atom. What about a human body? Thank you.

I strongly prefer the conventional evolutionary explanation as attested by a long sequence of studies and documentation. The others do not make much sense to me. A recent online lecture to your point, outlining our 300,000 years of history as Homo sapiens, is at https://www.youtube.com/watch?v=USMY3SvqEws

Can you let us know from where we can get good Oxygen?

Steve uses a system that extracts oxygen from the air and stores it in a very large bag where it can be breathed later.  See the photo of this in our online Powerpoint presentation

 

100 years ago, researchers Lorande Loss Woodruff, Rhoda Erdmann (1879-1947), Alexis Carrel (Nobel laureate), Sergey Metalnikov (1870-1946) received thousands of healthy generations from single cells and were forced to stop their healthy division. The degeneration of cells, they explained, is due to a decrease in the supply of received oxygen from the surrounding nutrient medium as a result of its pollution with waste products. We can say that degeneration, aging and decay of the cell organism is the result of self-poisoning and suffocation of the cell. Can you comment on their claim about the nature of aging? Thank you.

Appealing though this may sound I don’t think that makes sense.  Cells have finite natural lifecycles whose length may vary drastically by cell type.  And in the interest of the organism concerned, cells are replaced by differentiated stem cells. I  think some natural cell purifying processes such as the existence of natural killer cells and autophagy are very important as are interventions like oxygen therapy.  But, I don’t think it is correct to say that the aging and decay of cells is due to self-poisoning and suffocation. 

Are there any drugs for histone demethylation or for inflammation reflex apart from rapamycin?

Yes there are several that could be considered, including metformin and galantamine.  I would recommend caution, however, given the side effects that could be encountered.

Is Steves o2 machine commercially available or did he build it?

I understand that machines like his are commercialy available from several vendors.

Question to Steve: What is your HWOT training schedule?

A question for Steve to answer.  My impression is that he uses it several times a week.

Do you think that new techniques, such as those used for the mRNA vaccines can be used to more efficiently increase JMJD3 by directly increasing it in cells better than using these round about techniques.

Quite possibly.  I do not know for sure, but suspect that mucbetter techniques for the controlled induction of episodic enhanced expression of JDJM3 will be developed.

The NRF2 pathway is not only evolutionarily highly conserved in humans.
There are rodents like the naked mole rats and a special bat that live 10 times longer than they should. They have extremely high nrf2 levels.
Yes.  I commented on this earlier in this listing.  We have been looking for any research that ties NRF2 expression to expression of JDJM3.  I think that is now showing up as illustrated in the diagram in the above list.  Look for a new blog entry on this soon.
Could it not simply be the ratio between inflammation level and nrf2 level that is encoded in the organism and determines life span?
I commented on that point earlier in this listing.  I think both can have a profound influence on lifespan.
Question to Mr. Giuliano: Do you know that a person can restore the young structures and functions of his old body? The human body has powerful repair mechanisms for this. They create the substance of the body, heal its injuries, make the weak body athletic. They can make the old young again. Thank you.

Exactly, the gist of our presentation and the essence of our recent work has been identifying how the natural restorative processes in the body work and discovering ways of utilizing them to create health and significantly longer healthy lives.

 Are you not worried about the creation ROS (Reactive Oxygen Species) when increasing oxygen with excercise, how about doing the opposite, reducing oxygen?

Yes.  The positive impacts of oxygen therapy are realized when there is an increase in oxygen level, and this can be realized by temporarily reducing oxygen level and creating hypoxia, and then increasing it to normal level again.  We refer to the overall process as Varoxia.

 

Is it that the mechanisms have not been found by evolution, or is it that evolution decided we need to die and be replaced?

Evolution is definitely not decided that we need to die and be replaced. We have been eminently successful as a species. Rather, social evolution has strongly augmented and empowered biological evolution.  For example, sanitary systems cleaner air, automobile seatbelts, safer automobiles and modern medicine are social developments which have contributed significantly to our longevity.  So also is a recent development of the vaccines protective against COVID.  Finally, what is most exciting about our recent work involving JDJM3 and the inflammatory reflex is that there are common mechanisms underlying natural restorative processes and health and longevity interventions.

 

have you seen any reduction in bio age through methylation tests personally?

I addressed this question above.  Awaiting results any day now.

Steve re doing experiments – do you measure the results of your own EWOT for example?  What are the biomarker and objective results?

 

Thanks guys

 

Why do you think that BIOLOGY is responsible for our aging, and not PHYSICS, which explains the nature of aging and indicates the way to rejuvenate the old with the help of the art of medicine?

Aging is a property of living things and the science of living things is biology. A physicist myself by university training, I know that there are many phenomena of physics that contribute to biology. However, There appears to be a hierarchy of Sciences. Although physics is fundamental the laws of chemistry cannot be derived from knowledge of physics.  Similarly, the laws of biology cannot be derived from the laws of physics or those of Chemistry; they are their own things based on studies of living things.

I apologize but could not configure my ZOOM. You have correctly noted that OXIGEN deficiency is noted in senile processes. But why do you ignore the physical processes? Biological objects are victims of these physical processes. Don’t you think so?

Of course physical processes must be considered, an example being that oxygen deficiency can lead to impaired microvasculature.  In turn, if the microvasculature delivering oxygen to organs or parts of organs is inadequate, the affected cells may be oxygen deficient. So, a deteriorative feedback situation can result

 

 


PRACTICAL INTERVENTIONS FOR YOUNGING1.0 – Introduction to the series

$
0
0

By Vince Giuliano and Steve Buss

INTRODUCTION

This blog entry serves as an Introduction to a planned series of blog entries focused on interventions for maintaining a healthy state while aging and initiating natural processes for reversal of aging – what we have called YOUNGING1.0 in a series of previous blog entries.

State of longevity interventions that promote YOUNGING 1.0

The efficacy of longevity interventions can and has been studied in small animal models, but is unknown for humans.  Because we humans live so long, It will take a very large 50 year longitudinal study similar to the Framingham Heart Study or the Nurses’ Health Study 1,2 and 3 for us to be able to definitively document “best” protocols of longevity interventions in terms of efficacy, ease of pursuit, and costs.  That is, if there actually exists a clear set of “best” protocols for everybody.  It may well be the case that individual differences should continue to dictate individual protocols.  Such a study may not produce useful predictive results until its 10th year.  So we are stuck with a situation where there is no standard accepted protocol of interventions for promoting longevity.  Rather, the choice of wellness and longevity-promoting interventions tends to be quite different for every individual pursuing or recommending them.  So, any recommendations in this blog series represent our opinions, Steve’s and Vince’s.  As time goes on we should have more complete experimental evidence of the longevity impacts of interventions on small animals to guide us.  But now we have to often go on the basis of quite incomplete evidence.  This includes choices based on scientific knowledge of mechanisms, feelings and personal experience from employing the interventions, anecdotal experience of others, and commercial hype.

Interventions we plan to cover further in this blog series

A substantial number of known interventions induce health benefits, and to varying extents are thought to promote human longevity.  They also activate the expression of the histone deacetylase JDJM3, indicating that they fall under the umbrella of age-reversal which we have called YOUNGING1.0 in recent blog entries.  There are so many of these and so much to be said about each one, that we have chosen to cover the most important ones in a series of blog entries.  The current blog entry serves as an introduction to that series.  The interventions we plan to cover in the series are:

  1. Red and near-infrared light biomodulation, the subject treated in the following Part 1 blog entry, to be published together with this one.
  2. Dietary supplements which activate the expression of JDJM3 and also control and limit chronic inflammation. Vince will generate this.
  3. VARIOXIA. Induction of variations in systemic oxygen levels.  Steve Buss has been pursuing this intervention personally, knows more about it, and will be creating the blog entry for it.
  4. Infusions of umbilical cord blood plasma. Vince has experienced this intervention, has assembled and studied literature citations relating to it, and will generate a blog entry on it soon.
  5. VAGUS nerve stimulation, electrical or physical, including applications of the Inflammatory Reflex. Steve has particularly focused on this topic and will generate  a blog entry for it.
  6. Criteria for picking these particular interventions:

These interventions meet the following criteria for our treatment in the immediate future

  • The interventions have been extensively researched and are well-known to produce multiple health as well as possible longevity impacts.
  • The biomolecular pathways through which they operate are fairly well understood
  • Each of them activates JDJM3 and therefore falls under the scope of interventions for what we have described as YOUNGING1.0.
  • The interventions are not as well known and familiar as the “of course” ones like good diet, dietary restriction and systematic exercise
  • there exists a significant community of dedicated people that have been pursuing each type of intervention
  • The interventions have been sufficiently practiced that we are quite sure how they can be administered so that they are safe and do no harm.
  • The interventions are practical and can be pursued affordably now at home without access to expensive high-technology equipment or special laboratory access or medical expertise.
  • Each of the interventions have been and are still being pursued by one or both of us authors, Steve and Vince. And, in so far as we can tell have been producing important personal benefits for us,  We are able to relate direct personal experience with them

Additional relevant interventions

To be clear, there are numerous additional interventions which promote YOUNGING1.0, some of which are both efficacious and important components of any total personal longevity intervention protocol: exercise, good diet and dietary restriction are primary among these.  Also worth consideration are activation of heat shock and cold shock proteins, additional forms of mitochondrial perturbations, and hormetic doses of radiation at various frequencies and hormetic doses of many toxic substances such as carbon monoxide and hydrogen sulfide.  Some of these have been discussed extensively in the popular literature, and others have been treated previously in this blog.  See for example Jim Watson’s 2013 blog entry The Hormesis Bars.  We may post additional information to YOUNGING 1.0 on these topics as we further assess their importance.

Characterizations

For each of the four interventions covered, in the appropriate blog entry we will characterize:

  • Known health and longevity benefits,
  • the biomolecular pathways through which the intervention operates, and how these explain the known health and longevity benefits
  • The major administration options which can be pursued for the intervention. for example the main equipment and options connected with photobiomodulation are described in the forthcoming Part 1 entry.  And we will identify the associated personal investment requirement.
  • Some biomarkers which can be practically used to help evaluate the efficacy of the interventions. For example, daily, hourly and in some cases instantaneous data provided by wearables like smart health watches and rings.
  • We will characterize personal experience that Steve and Vincent has from pursuing each intervention covered and what we believe it has done for us. (Vince and Steve both have experience with 1., Vince has long-been intensely involved in 2 and has had experience with 4.  Steve has extensive experience in 2,and 3 and has followed 5 for some time.

We will suggest how these five interventions could best be combined with other established interventions such as exercise and dietary restrictions.  We would also suggest that people seriously interested in experiencing YOUNGING1.0 pursue at least three out of the suggested five interventions together with other important ones.  In thenext and final part of this current blog enry, I put my use of the five interventions described here in context by characterizing all the  longevity interventions I have been pursuing

Vince’s longevity program

In summary, conditions, habits and interventions that I believe contribute to my longevity include:

  • Daily exercise at a moderate cardiovascular pace of at least 30 minutes a day
  • Daily physical therapy exercises designed to impact on various muscular systems
  • Family diet intensive in vegetables, fruits, fish, EV olive oil, grains, adequate protein
  • Hormetic cold shock therapy, usually involving my body becoming chilled both in the mornings and evenings
  • Dietary restriction, where most days I eat only a late breakfast and a 6 o’clock supper with minimal possible snacks in between
  • Full use of the conventional medical system, including periodic consultation with multiple specialists, and evaluation of vision, hearing, neurological state, MRI’s and CAT-scans
  • Living and interacting daily with younger people including my wife who is 17 years younger than me and four grandchildren under 8 years
  • Careful observance of public health measures such as assuring that I breathe clean air, seeking full vaccinations and following recommended measures to protect against COVID and other pathogens
  • Morning monitoring a number of dynamic key biomarkers using wearables, an OURA ring, and a Fitbit Health Watch
  • Frequently monitoring conventional health laboratory biomarkers such as lipid scores. Inflammatory indices, and the status of blood components
  • Occasional personal DNA biological age testing
  • I have had infusions of umbilical cord blood plasma, the last four years ago, and am planning for additional ones
  • On occasion, using an Apollo Neuro wearable sonic device to stimulate my vagus nerve and for stress relief
  • On occasion, using a jacket that combines a massager and redlight therapy for my lower back
  • Consuming twice daily 4 Herb Synergy, the liposomal dietary supplement I have developed for control of chronic inflammation
  • One or two daily 20-minute exposures to a PBM light pad on my lower back and spleen area
  • Daily onsuming a substantial variety of dietary supplements for specific purposes, including and going beyond control of chronic inflammation

PRACTICAL INTERVENTIONS FOR YOUNGING1.0 – Part 1 PHOTOBIOMODULATION

$
0
0

By Vince Giuliano

INTRODUCTION

This blog entry is concerned with PHOTOBIOMODULATION, the first topic to be covered in a series of blog entries characterizing interventions for initiating natural processes for revers

The introduction to this series in provided in the previous blog entry PRACTICAL INTERVENTIONS FOR YOUNGING1.0 – Introduction to the series.  It mentions the interventions we plan to cover in this blog series, identifies our criteria for selecting them, additional highly relevant interventions, what we expect to say about each intervention, and a list of the interventions I (Vince) am personally pursuing.

The concept of using light therapy for diseases is far from new.  Colors were strongly associated with specific healing properties in ancient Egypt, China, India and Greece(ref).  “In the 19th century, the chronic and progressive nature of this disease (Lupus Vulgaris) was particularly marked: it remained active for ten years, twenty years, or even longer and, proved resistant to all treatment until the breakthrough by Niels Ryberg Finsen using a form of “concentrated light radiation” now known as Photobiomodulation (PBM) which won him a Nobel Prize.  Queen Alexandra of Great Britain, (1844–1925), consort to Edward the VII, as the inscription on the bronze statue of her at the London Hospital, notes, “Introduced to England the Finsen light cure for Lupus, and presented the first lamp to this hospital(Wikipedia)”.  Later, around 2001 the theory and practice of PBM was greatly accelerated by the availability of appropriate medical-grade lasers, and starting around 2016 further accelerated by the availability of inexpensive LED devices that emit near-infrared and red light at therapeutic frequencies.

RED AND NEAR-INFRARED LIGHT PHOTOBIOMODULATION

A number of forms of electromagnetic radiation are known to produce positive health effects when doses are within hormetic ranges.  We are concerned here particularly with red light in the 660 nm range and near infrared light in the 880 nm range.  I (Vince) have long been aware of photobiomodulation (PBM) as a technique for achieving positive biological impacts.  But it is not until recently, as part of my YOUNGING explorations, that I have seriously paid attention to it.  I find myself blown away by the extent and depth of research related to bio modulation, the incredible array of health benefits it can produce, and the availability of inexpensive home equipment for PMB.  “Photobiomodulation (PBM) therapy is a rapidly growing approach to stimulate healing, reduce pain, increase athletic performance, and improve general wellness(ref)”.

A.  Known health and longevity benefits

Studies on the impacts of PBM have included rapid wound healing, tissue repair, treatment for scleroderma, Raynaud’s Syndrome, reduction and elimination of chronic pain, rejuvenation and proliferation of bone marrow, activation and renewal of adipose and dental stem cells, reduction of chronic inflammation, promotion of angiogenesis and neovascularization, reversal of age-related thymic involution, reversal of cell senescence markers, expansion and improvement of function of cells (like hematopoietic stem cells, embryonic stem cells, natural killer cells, islet-like cell clusters, neurons and glial cells), natural tissue repair, reversal of hair loss, protection of red blood cells, dialation of capillary vessels and associated cardiovascular and pulmonary benefits, enhancing angiogenesis in cases of injury recovery, triggering expression of nitric oxide in cases of spinal cord injury, treatment of ischemic stroke, treatment of acute spinal cord injury, reduction in auto-immune disease symptoms, treatment of fibromyalgia, treating eye injuries, enhancing cognitive function, creating immunotherapy against small cell lung cancer, reduction in edema, increasing blood flow to the brain, treating PTSD, treating restless leg syndrome, ophthalmic benefits like protection of the retinal barrier and reduction of age-related macular degeneration and retinal pathologies, treating all kinds of sports injuries, reduction of fibrosis, treatment of dermatitis, remedying SAD, enhancing HRV, increase endurance, ——

The list goes on and on and could fill an entire page.  Far too many benefits to be believable?  Snake oil?  Too good to be true?  Those are natural skeptical reactions.  But the supportive research literature is there in plain sight for anyone who wants to pursue it.  The National Library of Medicine database lists 13,417 publications for the term near-infrared therapy and 2002publications for the term photobiomodulation.  The vast majority of these have been published in the lst seven years.  A search in clinicaltrrialss.gov using the term near infrared therapy reveals 1,009 clinical trial studies and a search for photobiomodulation reveals 211 studies(As I review this document prior to publication, I note that each of these numbers is higher than it was yesterday.)

The following images suggest applications of PBM

 

PBM applications Image source

 

 

 

 

 

 

 

 

 

 

 

PBM applications Image source

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Applications of PBM Image Source

B.    Literature citations supporting health and longevity benefits

Following is a small sample list of recent research publications beginning to show the range of PBM applicability.  You may click to read any of interest.

 

C.  Biomolecular Pathways

Several biomolecular mechanisms have been proposed for explaining the biological activities of PBM and near infrared light.  Some or most of these may work together synergistically.  I review a few of the most familiar ones here, and then go on to review how quantum effects, unfamiliar for most biologists, may be key.

Conventional explanations

The most popular explanation revolves around a purported role of cytochrome c oxidase (COX) in mitochondria, as illustrated in this graphic.

Image source  “Schematic diagram of the mechanisms of photobiomodulation near infrared light within wavelengths (630-1000 nm) targets the mitochondrial enzyme cytochrome oxidase C resulting in (i) direct stimulation in mitochondrial respiration and (ii) dissociation of nitric oxide which indirectly increases mitochondrial respiration.  These processes result in elevation of ATP, cAMP, reactive oxygen species and intracellular calcium which impact downstream signalling pathways that triggers increase in anti-inflammatory processes, protein synthesis, anti-apoptotic protein production, cellular repair/metabolism/proliferation/migration and antioxidants.”

This explanation has been seriously challenged, for example in the publication What Lies at the Heart of Photobiomodulation: Light, Cytochrome C Oxidase, and Nitric Oxide—Review of the Evidence

Objective: The underlying mechanisms of photobiomodulation (PBM) remain elusive.  The most attractive hypotheses revolve around the role of cytochrome c oxidase (CCO) and cellular energetics.  — Background: No reliable demonstration of any PBM-related light-induced mechanistic effect on CCO has been reported.  Studies on PBM have proven to be either nonreproducible, of questionable relevance, or involve wavelengths unlikely to be operative in vivo.  The literature reveals very few demonstrable mechanistic light effects of any sort on CCO.  Nitric oxide (NO) is involved in a number of the reported light effects on CCO.  NO inhibits CCO at high reductive pressures by binding to the heme a3 moiety.  This complex is white light labile.  – Methods: The reported photolability of the heme–NO complex seems to be a prime target for PBM studies, as removal of inhibiting NO from the active site of CCO could restore normal activity to inhibited CCO.  Another aspect of CCO–NO chemistry has been revealed that shows intriguing possibilities.  — Results: A novel nitrite reductase activity of solubilized mitochondria has been demonstrated attributable to CCO.  NO production was optimal under hypoxic conditions.  It was also found that 590 nm irradiation increased NO production by enhancing NO release.  The presence of cellular NO has usually been considered metabolically detrimental, but current thinking has expanded the importance and the physiological roles of NO.  Evidence shows that NO production is likely to play a role in cardioprotection and defenses against hypoxic damage.  — Conclusions: Studies combining PBM and hypoxia also point to a connection between light irradiation, hypoxia protection, and NO production.  This leads the authors to the possibility that the intrinsic nature of PBM involves the production of NO.  The combination of CCO and hemoglobin/myoglobin NO production with photorelease of NO may constitute the heart of PBM.”

Another of the conventional explanations for how PBM works via mitochondria is illustrated in this diagram.

“The mitochondrial electron transport chain has been shown to be photosensitive to red and near-infrared (NIR) light.  — mitochondrial photostimulation has been shown to increase ATP production and cause transient increases in reactive oxygen species (ROS).  In some cells, this process appears to participate in reduction/oxidation (redox) signaling.  Redox mechanisms are known to be involved in cellular homeostasis and proliferative control(ref: Low-Intensity Light Therapy: Exploring the Role of Redox Mechanisms).”  The production and expression of mitochondrial ROS involve extremely complex biomolecular mechanisms and depend on many factors.  For those who care to pursue it, this topic is treated in detail in the publication, Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers.  Among the factors determining mitochondrial ROS production is mitochondrial membrane potential state, Δψm in the following diagram.  This is possibly responsible for the major action of PBM on mtROS.

Image source “Regulation of mtROS production

“A number of factors including mitochondrial membrane potential (Δψm), metabolic state of mitochondrial, O2 concentration regulate the production of mtROS.  Non-mitochondrial generated ROS can also augment mtROS production, a process known as “ROS-induced ROS”.  Meanwhile, transcription factor STAT3 has recently been found to suppress mtROS production independent of its nuclear factor activity.), metabolic state of mitochondrial, O2 concentration regulate the production of mtROS.  Non-mitochondrial generated ROS can also augment mtROS production, a process known as “ROS-induced ROS”.  Meanwhile, transcription factor STAT3 has recently been found to suppress mtROS production independent of its nuclear factor activity.”

Evidence for need for an alternative explanation is set forward in the 1919 publication Mitochondrial cytochrome c oxidase is not the primary acceptor for near infrared light—it is mitochondrial bound water: the principles of low-level light therapy.  “According to the mainstream theory the root cause for mitochondrial ATP upregulation in response to irradiation of cells with red-to-near infrared (R-NIR) light is the absorption of R-NIR photons by cytochrome c oxidase (CCO). Here, I show that this theory is inadequate for an explanation of the experimental results obtained in LLLT. Putting a model on a wrong concept will automatically limit its predictive capability, leading to results in disagreement with observation—as it happens today in LLLT. Excellent clinical and experimental results are contrasted by an underlying concept, i.e., the light/cell-interaction mechanism assumed in the majority of reports, which originates from a handful of articles showing incorrect data. Instead, a new theoretical basis for LLLT is presented. The resulting model describes experiments correctly and allows us to predict their outcome, thereby safeguarding future progress in LLLT.”

Another, probably more accurate explanation which depends on the role of nano-scale water layers in mitochondria is laid out in the 2017 publication Aging Is a Sticky Business.  “Objective: The objective of this work is to put forward a mechanism by which low-level light [red-to near infrared (NIR) laser or light emitting diodes (LED)] is instrumental in the process of accelerating the healing of wounds. — Background data: Interaction modalities of low-level light with oxidatively stressed cells and tissues are the focus of intense research efforts. Several models of the light/cell-interaction mechanism have been proposed. In the most popular model, cytochrome c oxidase is believed to play the role of the principal acceptor for red-to NIR photons.  — Methods: Using as an illustrative example the successful LED treatment of an edematous limb ulcer, the results of recent in vitro tests and complementary laboratory experiments are presented and discussed. — Results: The most plausible mechanism of biostimulatory effect of red-to NIR light consists of its impact on the nanoscopic interfacial water layers in mitochondria and the extracellular matrix (ECM) where mitochondrial reactive oxygen species (ROS) induce an increase in the viscosity of the water layers bound to the predominantly hydrophilic surfaces in the intramitochondrial space as well as the ECM, where the process progressively propagates with age. The biostimulatory effect of red-to NIR light consists of counteracting the ROS-induced elevation of interfacial water viscosities, thereby instantly restoring the normal mitochondrial function, including the synthesis of adenosine triphosphate (ATP) by the rotary motor (ATP synthase). — Conclusions: An understanding of the mechanism of interaction of red-to NIR light with mitochondria, cells, and tissues safeguards progress in the field of low-level light therapy (LLLT) and puts us in the position to design better therapies.”

Quantum theory explanation

The conventional explanations of the physical mechanisms through which PBM generates its health effects share a crucial flaw.  They are only in terms of molecular and ordinary biology, whereas the interaction of radiation and matter is governed by a more-fundamental and absolutely validated body of science, quantum physics.  This is possibly because very few scientists versed in molecular biology are familiar with quantum theory and its strange effects.  Imagine how lame explanations of astronomy would be by scientists who ignore observations by telescopes, or how lame discussions of infectious diseases would be by scientists who ignore microscopic evidence.  So when biologists who do not understand the quantum physics involved in the interaction of red/near infrared light and human tissues try to explain what happens that is really a quantum effect, what can we expect?

The 2020 publication Quantum biology in low level light therapy: death of a dogma amplifies on this theme and points out how the quantum effect of electron tunneling may play an important role when red/near infrared light is shined on human tissues.  It picks up on the idea of PBM changing the viscosity of nano-scale water layers in mitochondria, and goes on to describe the quantum mechanism. .  “Background: It is shown that despite exponential increase in the number of clinically exciting results in low level light therapy (LLLT), .  Progress in LLLT is currently realized by a trial and error process, as opposed to a systematic approach based on a valid photon-cell interaction model.  — Methods: The strategy to overcome the current problem consists in a comprehensive analysis of the theoretical foundation of LLLT, and if necessary, by introducing new interaction models and checking their validity on the basis of the two pillars of scientific advance (I) agreement with experiment and (II) predictive capability.  The list of references used in this work, does contain a representative part of what has been done in the photon-cell interaction theory in recent years, considered as ascertained by the scientific community.  — Results: Despite the immense literature on the involvement of cytochrome c oxidase (COX) in LLLT, the assumption that COX is the main mitochondrial photoacceptor for R-NIR photons no longer can be counted as part of the theoretical framework proper, at least not after we have addressed the misleading points in the literature.  Here, we report the discovery of a coupled system in mitochondria whose working principle corresponds to that of field-effect transistor (FET).  The functional interplay of cytochrome c (emitter) and COX (drain) with a nanoscopic interfacial water layer (gate) between the two enzymes forms a biological FET in which the gate is controlled by R-NIR photons.  By reducing the viscosity of the nanoscopic interfacial water layers within and around the mitochondrial rotary motor in oxidatively stressed cells R-NIR light promotes the synthesis of extra adenosine triphosphate (ATP).  — Conclusions: Based on the results of our own work and a review of the published literature, we present the effect of R-NIR photons on nanoscopic interfacial water layers in mitochondria and cells as a novel understanding of the biomedical effects R-NIR light.  The novel paradigm is in radical contrast to the theory that COX is the main absorber for R-NIR photons and responsible for the increase in ATP synthesis, a dogma propagated for more than 20 years.”

According to this publication, Quantum electron tunneling may be involved in what amounts to near-infrared light being the controlling element in a field effect transistor effect which governs the efficacy of the electron transport chain in affected mitochondria.

Image source

“Principle of the biological field-effect transistor (FET): The tunneling of electrons (not shown in the image) across the gate comprising the nanoscopic interfacial water layer formed by three monolayers of H2O (blue), confined between the enzymes cytochrome c acting as emitter (red) and cytochrome c oxidase (COX) acting as drain (green), is controlled by R-NIR photons.  The expectation that exposure of the enzyme complex to biostimulatory intensities of R-NIR light induces an instant drop in the viscosity of the nanoscopic interfacial water layer confined in the space between emitter and drain, complemented by a spatial separation (volume expansion) is based on the results described in (44,49), respectively.  The working principle of the FET can be understood on the basis of Eq.  [1] and [2].  Image inspired by (48).”

In other words, in human tissues, levels of near infrared light level may control the flow of electrons between cytochrome c and cytochrome C oxidase, a key process in step IV of the mitochondrial electron transfer chain A powerful amplification effect.  Far out science fiction? Actually very mundane.  All modern electronic devices depend crucially on the same electron tunneling and FET process.  Without them there would be no computers, cell phones, internet or TV, or pubmed for this blog you are reading for that matter.  Engineers got used to this 50 years ago.  Biologists, it is time for you to get on board to the underlying nature of reality. Read the document and the ones it cites for evidence.

D.  How PBM activates JDJM3

As discussed above, PBM near-inrared and near red light perturbs mitochondrial functioning as well as generates excess mtROS, having a particular effect it is thought on Complex IV of the mitochondrial electron transfer chain.  The 2019 publication Two Conserved Histone Demethylases Regulate Mitochondrial Stress-Induced Longevity describes the links between such mitochondrial perturbations and JDJM3 expression.  “We identify the conserved histone lysine demethylases jmjd-1.2/PHF8 and jmjd-3.1/JMJD3 as positive regulators of lifespan in response to mitochondrial dysfunction across species.  Reduction-of-function of the demethylases potently suppresses longevity and UPRmt induction while gain-of-function is sufficient to extend lifespan in an UPRmt-dependent manner. — These findings illustrate an evolutionary conserved epigenetic mechanism that determines the rate of aging downstream of mitochondrial perturbations.”  The effect seems tp be mediated by the mitochondrial unfloded protein response (mtUPR).  “We demonstrate that both jmjd-1.2 and jmjd-3.1 are necessary and sufficient for activation of the UPRmt in C. elegans. Moreover, our experiments identify jmjd-1.2 and jmjd-3.1 as positive regulators of a longevity response that genetically requires UPRmt signaling. Using transcriptome analysis, we demonstrate that jmjd-1.2 and jmjd-3.1 coordinate the transcriptional response to mitochondrial stress. Furthermore, using a systems genetics approach, we find that the mammalian orthologs exhibit positive genetic correlations with UPRmt core components in the BXD mouse genetic reference population (Andreux et al., 2012; Wu et al., 2014). Together, these data reveal a conserved epigenetic mechanism that determines longevity and stress signaling in response to mitochondrial dysfunction.”

Physical effects of heat

Another important physical process associated with red/near infrared radiation is which in terms leads to microvascular dilation associated with the expression of nitric oxide (NO) and  the generation of elevated temperatures in the outer layers of the tissues irradiated,  This can mean that growth and health factors generated in cells as a result of the radiation that can be released into the blood stream – say via being packaged in exosomes – can more effectively be carried by the circulatory system to more-distant organs.

E.  Technology for PBM, red and near infrared light therapy

In the early recent history of PMB, starting in the 1960s the light sources used consisted mainly of lasers and the concept of low-level light therapy emerged.  Starting about 2015, LED-based devices started to be used.  Recent consumer-level therapy devices may embody arrays of  hundreds of LEDs.  The 2018 publication Photobiomodulation: lasers vs. light emitting diodes? reports: “Photobiomodulation (PBM) is a treatment method based on research findings showing that irradiation with certain wavelengths of red or near-infrared light has been shown to produce a range of physiological effects in cells, tissues, animals and humans. Scientific research into PBM was initially started in the late 1960s by utilizing the newly invented (1960) lasers, and the therapy rapidly became known as “low-level laser therapy”. It was mainly used for wound healing and reduction of pain and inflammation. Despite other light sources being available during the first 40 years of PBM research, lasers remained by far the most commonly employed device, and in fact, some authors insisted that lasers were essential to the therapeutic benefit. Collimated, coherent, highly monochromatic beams with the possibility of high power densities were considered preferable. However in recent years, non-coherent light sources such as light-emitting diodes (LEDs) and broad-band lamps have become common. Advantages of LEDs include no laser safety considerations, ease of home use, ability to irradiate a large area of tissue at once, possibility of wearable devices, and much lower cost per mW. LED photobiomodulation is here to stay.”

There is a wide variety of consumer-accessible LED PMB devices now available, These exist in a number of form factors, ranging from mini-flashlight sized devices to devices with arrays of LCDs to devices that fit in body orifices to panels, blankets or saunas that irradiate the entire body. To get an idea of devices marketed to consumers, you can start by checking on amazon,com for red light therapy lamps and near infrared therapy devices.

To start, here are the ones I have at home and have been using recently,

Bulbs    54 watt– These with 18 LEDs. 9pcs 660nm deep red leds 9pcs 850nm +  A From $25 to $40 at amazon.com.  I (Vince)have a couple of these.  I find their use relatively inconvenient because it is awkward to position them on some area of my body in a way that I can benefit from a therapy session while doing something else.  The bulbs are so heavy that if put in a gooseneck table lamp they will bend it over so it shines straight downward or causes the entire lamp to fall over.  But they [rovide a very low cost way to get started

Smaller semi-flexible LED pads    “Gospel’s” Equine & Canine Medium Light Therapy Pad 9-1/2″ X 12″  (30.5cm X 24.1cm) and has 132 LEDs!    60 visible red (660nm) and 72 near-infrared (850nm).  Although marketed for animial use, they appear to work well for humans.  I have found this pad useful for medium-small body parts like a hand or knee $424.  Made in the US.

 

Wraparound therapy sash  DGYA) RLT-s21 -WT  More area coverage than the smaller pad and physically flexible, like a heavy cloth.  You can wrap it around your waist or an arm or leg and read, watch TV or work on your computer or rest during a 20 minute therapy session.

After using this device daily for two weeks, I can declare it has reduced my lower back pain and discomfort by AT LEAST80%.  Cost on Amazon,com $180 – $200

Here are some of the other device form factors

Mini-flashlight,   Helmet, Panel light 

 

 

Hat,   Face mask,  Hand enclosure

 

 

Foot LED device,  joint pad, “full-body” panels

 

Infrared sauna blanket     Intranasal therapy light

 

 

Infrared therapy saunas

 

 

Whole body PBM laser light pod

 

 

A recent trend is that all over the country is that some local tanning salons are starting to acquire whole-  body PBM treatment devices and offer PBM therapy.  For randomly selected example see the web pages for Sun City Tanning in Pembroke MA, Superior Tanning in Kingston RI, and Sun Haven Tanning in Billings Montana.  I find this interesting because of the very real benefits of PBM vs the mixed health benefits of UV for tanning, which can be of cosmetic value but can include promotion and inductions of skin cancers.

F.  Limitations of current knowledge

In general, the field of PMB therapy has  been driven much more by widespread practice and the delivery of positive health effects than by theory.  Relatively little attention has been given to understanding of underlying mechanisms.  “It works!” and that has led to widespread commercialization and popular use.  So the weakest areas of understanding about it are 1.  The fundamental physical and biological mechanisms through which it works, which I have focused on here,,and  2.  Validated treatment protocols and dosage parameters for various disease and pathological conditions: What are the best frequencies of light to be used? Where should the light be shined?  With what intensity?  For how big an area?  For how long?  Repeated how often? And for how many times?

 For most treatment purposes we simply don’t know the best answers to these treatment-related questions.  Bur we also don’t know how big a problemef that is.  The research and experience suggests that exactitude of these parameters may not be that critical.  That is, therapy may be successful for a wide variety of conditions using standard default values.  Manufacturers of most of the PBM devices mentioned above suggest using default values.  For example, a medium sized LED therapy pad such as my Equine unit described above is applied directly to the skin; it enables therapy coverage of about 100 square inches, offers the same dose of red and near-infrad light at the same frequencies to whatever skin area it is applied to, and times itself out in 15 minutes

 

 

 

 

 

 

PRACTICAL INTERVENTIONS FOR YOUNGING1.0 – Part 2: Electromagnetic health stimulation approaches and devices

$
0
0

By Vince Giuliano

Image source  The photo shows Nikola Tesla sitting in a building with giant Tesla coils of his own making in 1899, seemingly oblivious of the giant bolts of electricity zapping all around him.  This demonstrated the relatively harmless nature of the specific kind of electric current being generated.  Later, medical therapy devices were based on the same Tesla technology.  See the final photo in this blog entry.

INTRODUCTION

This is a first writeup regarding my recent efforts to seek better understanding the roles of various forms of electromagnetic stimulation on health, longevity and biological processes in general.  I focus here centrally on PEMF (Pulsed electromagnetic frequencies) because I have known some things about this technology and its use since the 1970s, and am generally familiar with its purported mechanism of action.  I mention my current self-experimentation with PEMF, and have used standard PEMF therapies daily for about a month now.  Then, I go on to identify and briefly comment on the alphabet-soup of the other main approaches to electric body simulation.  Throughout, I refer to specific systems used.  Finally, I relate an anecdote about my first deep involvement with a medical electrical stimulation device.

As context, Steve Buss and I have been concerned with a family of health-inducing and age reversal processes which we have called YOUNGING1.0.  We have generated a number if blog entries about this and it has been the subject of our recent webcast on YOUNGING -Triggering Ancient Mechanisms For Rejuvenation

We have hypothysized and are close to establishing that a common mechanism is found in nearly all living organisms that is part of all restorative and regenerative natural body process.  That is the demethylation of the double and triple methylated histone H3K27me2-3 by the histone deacetylase JMJD3.  Further, we have asserted that this same mechanism also a necessary aspect of all effective measures that are life-extending.  That is, any effective intervention that promotes rejuvenation will necessarily include enhanced expression of JDJM3.  We have, however, yet to establish that expression of JDJM3 is sufficient to induce aspects of age-reversal or YOUNGING1.0.

A number of techniques are known to promote healthfulness and expected longevity and promote the expression of JDJM3.  These include systematic exercise, calorie restriction, certain herbal supplements like curcumin, DHEA, infusions of umbilical cord blood plasma, and a few drugs like metformin and rapamycin.  We do not yet know the best way to induce expression of JDJM3 so as to safely trigger expression of JDM3 to induce YOUNGING1.0 as a systematic, long-lasting whole-body process.

We do have some strong clues however, and that is to look at techniques that enhance the functioning of the vagal nervous system.  Two families of health-generating approaches that that seem underexplored to us in this regard relate, among other matters, to vagal nerve stimulation: 1.  Photobiomodulation – the use of red and near and far infrared light, and 2. electromagnetic body stimulation.  The results of a round of research on 1. Is reported in the blog entry PRACTICAL INTERVENTIONS FOR YOUNGING1.0 – Part 1 PHOTOBIOMODULATION.  This current blog entry reports on a first round of research on 2, focusing on PEMF.

As a general non-technical intro, see The Best Brain Wave Tech Of 2021, part pf the commercial site of one of the equipment vendors.  Also you can see History of the most effective PEMF therapy, a YouTube video

PART 1 – PEMF

PEMF Pulsed electromagnetic frequencies–  unlike other electrical therapies, PEMF does not involve electrical connections or direct electrical current flow from the device into the body.  Instead, what is involved is transmission of dynamic magnetic variations into the body from electrical coils which do not require direct skin contact. Wound coils, somewhat similar to those found in traditional loudspeakers, are driven by the PEMF device and emanate electrical pulses with programmed frequencies, pulse shapes, durations and intensities for specific therapeutic purposes. the idea here is that there are a number of particular pulse frequencies and characteristics that represent states of the nervous system, and that such states can to significant extents be induced by external pulse applications at those frequencies.  Natural brain and nervous system signals combine with those of the PEMF device so as to become entrained, that is to become synchronized in period and phase so as to reinforce one another.

Particularly there are certain well known brain wave frequencies

Frequency band Frequency Brain states
Gamma 30-100Hz problem solving, deep thinking, happiness
Alpha (α) 8–12 Hz Very relaxed, passive attention
Theta (θ) 4–8 Hz Deeply relaxed, inward focused
Delta (δ) 0.5–4 Hz Sleep

In a nutshell, Alpha brainwaves relate to creativity and daydreaming, Beta waves are produced in the middle of deep thinking, Delta/Theta waves can be found during deep sleep, and Gamma waves are associated with problem solving, happiness, and compassion.

Source of following materials on brain waves is NeuroHeath Brainwaves – The Language

“DELTA (0.1 to 3.5 Hz)

The lowest frequencies are delta. These are less than 4 Hz and occur in deep sleep and in some abnormal processes. It is the dominant rhythm in infants up to one year of age and it is present in stages 3 and 4 of sleep. It tends to be the highest in amplitude and the slowest waves.  We increase Delta waves in order to decrease our awareness of the physical world.  We also access information in our unconscious mind through Delta. Peak performers decrease Delta waves when high focus and peak performance are required.  However, most individuals diagnosed with Attention Deficit Disorder, naturally increase rather than decrease Delta activity when trying to focus.  The inappropriate Delta response often severely restricts the ability to focus and maintain attention.  It is as if the brain is locked into a perpetual drowsy state.  Another way to look at Delta is to imagine you are driving in a car and you shift into 1st gear….you’re not going to get anywhere very fast.  So Delta would represent 1st gear,

DELTA (0.1-3 Hz): Distribution: generally broad or diffuse; may be bilateral, widespread.  Subjective feeling states: deep, dreamless sleep, non-REM sleep, trance, unconscious.  Associated tasks & behaviors: lethargic, not moving, not attentive.  Physiological correlates: not moving, low-level of arousal.  Effects of training: can induce drowsiness, trance, deeply relaxed states

THETA (4-8 Hz)  The next brainwave is theta.  Theta activity has a frequency of 3.5 to 7.5 Hz and is classed as “slow” activity. It is seen in connection with creativity, intuition, daydreaming, and fantasizing and is a repository for memories, emotions, sensations.  Theta waves are strong during internal focus, meditation, prayer, and spiritual awareness.  It reflects the state between wakefulness and sleep and relates to the subconscious mind.  It is abnormal in awake adults but is perfectly normal in children up to 13 years old.  It is also normal during sleep.  Theta is believed to reflect activity from the limbic system and hippocampal regions.  Theta is observed in anxiety, behavioral activation and behavioral inhibition.  When the theta rhythm appears to function normally it mediates and/or promotes adaptive, complex behaviors such as learning and memory.  Under unusual emotional circumstances, such as stress or disease states, there may be an imbalance of three major transmitter systems, which results in aberrant behavior.  Back to our car example, Theta would be considered 2nd gear. Not as slow as 1st gear (Delta) but still not very fast.

THETA (3.5-7.5 Hz):  Distribution: usually regional, may involve many lobes, can be lateralized or diffuse.  Subjective feeling states: intuitive, creative, recall, fantasy, imagery, creative, dreamlike, switching thoughts, drowsy; “oneness”, “knowing.”  Associated tasks & behaviors: creative, intuitive; but may also be distracted, unfocused.  Physiological correlates: healing, integration of mind/body.  Effects of Training: if enhanced, can induce drifting, trance-like state. If suppressed, can improve concentration, ability to focus attention

ALPHA (8-12 Hz):  Alpha waves are those between 8 and 12(Hz).  Alpha waves will peak around 10Hz.  Good healthy alpha production promotes mental resourcefulness, aids in the ability to mentally coordinate, enhances overall sense of relaxation and fatigue. I n this state you can move quickly and efficiently to accomplish whatever task is at hand.  When Alpha predominates most people feel at ease and calm.  Alpha appears to bridge the conscious to the subconscious.  It is the major rhythm seen in normal relaxed adults – it is present during most of life especially beyond the thirteenth year when it dominates the resting tracing.  Alpha rhythms are reported to be derived from the white matter of the brain.  The white matter can be considered the part of the brain that connects all parts with each other.  Alpha is a common state for the brain and occurs whenever a person is alert (it is a marker for alertness and sleep), but not actively processing information.  They are strongest over the occipital (back of the head) cortex and also over frontal cortex.  Alpha has been linked to extroversion (introverts show less), creativity (creative subjects show alpha when listening and coming to a solution for creative problems), and mental work.  When your alpha is within normal ranges we tend to also experience good moods, see the world truthfully, and have a sense of calmness.  Alpha is one of the brain’s most important frequency to learn and use information taught in the classroom and on the job.  You can increase alpha by closing your eyes or deep breathing or decrease alpha by thinking or calculating.  Alpha-Theta training can create an increase in sensation, abstract thinking and self-control.  In our car scenario, Alpha would represent neutral or idle.  Alpha allows us to shift easily from one task to another.

ALPHA (8-12 Hz): Distribution: regional, usually involves entire lobe; strong occipital w/eyes closed.  Subjective feeling states: relaxed, not agitated, but not drowsy; tranquil, conscious associated tasks & behaviors: meditation, no action.  Physiological correlates: relaxed, healing.  Effects of Training: can produce relaxation.  Sub band low alpha: 8-10: inner-awareness of self, mind/body integration, balance.  Sub band high alpha: 10-12: centering, healing, mind/body connection

BETA (above 12 Hz)   Beta activity is ‘fast’ activity. It has a frequency of 14 and greater Hz.  It reflects desynchronized active brain tissue.  It is usually seen on both sides in symmetrical distribution and is most evident frontally.  It may be absent or reduced in areas of cortical damage.  It is generally regarded as a normal rhythm and is the dominant rhythm in those who are alert or anxious or who have their eyes open.  It is the state that most of brain is in when we have our eyes open and are listening and thinking during analytical problem solving, judgment, decision making, processing information about the world around us.  Beta would represent overdrive or hyperdrive in our car scenario.  The beta band has a relatively large range, and has been divided into low, midrange and high.

LOW BETA (12-15HZ): Distribution: localized by side and by lobe (frontal, occipital, etc).  Subjective feeling states: relaxed yet focused, integrated.  Associated tasks & behaviors: low SMR can reflect “ADD”, lack of focused attention.  Physiological correlates: is inhibited by motion; restraining body may increase SMR.  Effects of Training: increasing SMR can produce relaxed focus, improved attentive abilities,

MID BETA (15-18hz): Distribution: localized, over various areas.  May be focused on one electrode.  Subjective feeling states: thinking, aware of self & surroundings.  Associated tasks & behaviors: mental activity.  Physiological correlates: alert, active, but not agitated.  Effects of Training: can increase mental ability, focus, alertness

HIGH BETA (above 18hz): Distribution: localized, may be very focused.  Subjective feeling states: alertness, agitation.  Associated tasks & behaviors: mental activity, e.g. math, planning.  Physiological correlates: general activation of mind & body functions.  Effects of Training: can induce alertness, but may also produce agitation.

GAMMA (above 30 Hz)  Distribution: very localized.  Subjective feeling states: thinking; integrated thoughts.  Associated tasks & behaviors: high-level information processing, “binding.”  Physiological correlates: associated with information-rich task processing.  Effects of Training: not known.  Gamma is measured between 30 and 44 (Hz) and is the only frequency group found in every part of the brain.  When the brain needs to simultaneously process information from different areas, its hypothesized that the 40Hz activity consolidates the required areas for simultaneous processing.  A good memory is associated with well-regulated and efficient 40Hz activity, whereas a 40Hz deficiency creates learning disabilities.”

SEE https://omnipemf.com/product/neorhythm/?wcpbc-manual-

The NeoRhythm PEMF device offers these custom frequencies and predefined programs:

Custom Frequencies (NeoRhythm)

Predefined Programs (NeoRhythm)

The Neorhythm device also allows advanced users to create their own custom PEMF program through specifying a dominant frequency and associated magnetic flux density and an accompanying frequency and associated magnetic flux density,  For example, these values for four of the default Neorhythm programs are:

PAIN CONTROL

Dominant frequency: 303 Hz
Magnetic flux density: 2.0 mT
Accompanying frequency: 12.5 Hz
Magnetic flux density: 0.25 mT

ENERGY & VITALITY

Dominant frequency: 40.5 Hz
Magnetic flux density: 2.5 mT
Accompanying frequency: 54 Hz
Magnetic flux density: 0.5 mT

DEEP RELAXATION

Dominant frequency: 10 Hz
Magnetic flux density: 2.5 mT
Accompanying frequency: 3 Hz
Magnetic flux density: 0.25 mT

LUCID DREAMING

Dominant frequency: 40 Hz
Magnetic flux density: 0.5 mT
Accompanying frequency: 4 Hz
Magnetic flux density: 0.5 mT

Two small-scale double blind placebo-controlled clinical studies related to the NeoRhythm device are:

The Hapbee PEMF device appears to offer a different kind of flexibility, but at additional cost for a Hapbee membership.  Hapbee claims to associate PEMF signal patters with bioactive molecules.

 

 

See https://hapbee.com/pages/blendpedia.  “A Hapbee Signal is a recording of a molecule’s unique magnetic frequency (such as caffeine).  Just choose the blend you’d like to play, and Hapbee projects a low-energy frequency that’s designed to help influence how you feel. Each Blend is designed to imitate the magnetic effects of molecules that people use every day to enchance their mood, get work done, and relax.”

And there are a lot of blends that can be mixed and matched using Hapbee, such as sleep and rest-inducing blends, an alcohol blend, a CBD blend, a chocolate blend, and a nootropic nicotine blend.  The idea is that to get access to the effects of a blend of substances to put you in a certain state, say one of being ready for intensive work concentration.  Just dial into the PEMF signal pattern that puts you in that state.  To get access to the blends you need a Hapbee membership, $19 a month normally although you initially get a month’s access to all blends and choice of two of them when you buy the device.  In this regard going with Hapbee is different than going with other devices since your membership costs go on and on and may soon dwarf your original equipment cost.

The Neorhythm and Hapbee devices seem similar and both are currently discounted deeply to the same $249 price point.  However the Neorhthtm device puts out significantly higher magnetic flux density:  NeoRhythm uses medium-intensity magnetic fields with a maximum magnetic flux density of 20,000-25,000 milliGauss. Hapbee’s peak signal strength is 40 milliGauss–extremely lower although still possibly effective.

PUBLISHED RESEARCH ON THE THERAPEUTIC EFFICACY OF PEMF

When it comes to biological mechanisms of action of PEMF, electromagnetic biological impacts are so ubiquitous and diverse that it is difficult to decide where to start.  It is even more difficult to conclude on which impacts are most fundamental and deserve further intense investigation.  It is important to bear in mind that all of chemistry, and by extension all of biochemistry, is about electron shells, electrical binding potentials, and electric fields – and therefore is subject to perturbance or modification by EMF fields.  So, on the most basic level the impact of PEMF may be extremely complex.  Numerous publications have sought to grapple with the complexity and associated possibilities.

For example, back in 2014 the publication BIOLOGICAL EFFECTS OF PULSATING MAGNETIC FIELDS: ROLE OF SOLITONS reported “In this paper, we analyze biological effects produced by magnetic fields in order to elucidate the physical mechanisms, which can produce them.  We show that there is a hierarchy of such mechanisms and that the mutual interplay between them can result in the synergetic outcome.  In particular, we analyze the biological effects of magnetic fields on soliton mediated charge transport in the redox processes in living organisms.  Such solitons are described by nonlinear systems of equations and represent electrons that are self-trapped in alpha-helical polypeptides due to the moderately strong electron-lattice interaction.  They represent a particular type of dissipative=less large polarons in low-dimensional systems.  We show that the effective mass of solitons is different from the mass of free electrons, and that there is a resonant effect of the magnetic fields on the dynamics of solitons, and, hence, on charge transport that accompanies photosynthesis and respiration.  These effects can result in non-thermal resonant effects of magnetic fields on redox processes in particular, and on the metabolism of the organism in general.  This can explain physical mechanisms of therapies based on applying magnetic fields.”

Major impacts of PEMF treatments are thought to be mediated via mitochondria,  The 2019 publication Ambient and supplemental magnetic fields promote myogenesis via a TRPC1-mitochondrial axis: evidence of a magnetic mitohormetic mechanism reports: ”We show that both supplemental and ambient magnetic fields modulate myogenesis.  A lone 10 min exposure of myoblasts to 1.5 mT amplitude supplemental pulsed magnetic fields (PEMFs) accentuated in vitro myogenesis by stimulating transient receptor potential (TRP)-C1–mediated calcium entry and downstream nuclear factor of activated T cells (NFAT)-transcriptional and P300/CBP-associated factor (PCAF)-epigenetic cascades, whereas depriving myoblasts of ambient magnetic fields slowed myogenesis, reduced TRPC1 expression, and silenced NFAT-transcriptional and PCAF-epigenetic cascades.  The expression levels of peroxisome proliferator–activated receptor γ coactivator 1α, the master regulator of mitochondriogenesis, was also enhanced by brief PEMF exposure. Accordingly, mitochondriogenesis and respiratory capacity were both enhanced with PEMF exposure, paralleling TRPC1 expression and pharmacological sensitivity.”   This image from that publication illustrates the effect.

Image source

Applications of PEMF therapies

The 2016 publication Biological Effects of Pulsed Electromagnetic Field (PEMF) Therapy reports:“Introduction Pulsed electromagnetic field (PEMF) therapy is effective because time-varying or pulsed electromagnetic fields create microcurrents in the body’s tissues.  These microcurrents elicit specific biological responses depending on tretment parameters such as amplitude, frequency, and waveform.  The body contains multiple electromagnetic fields with each tissue and organ having a unique electromagnetic signature.  Computerized Axial Tomography (CAT) scans and Magnetic Resonance Imaging (MRI) scans take advantage of these unique signatures to create a map of the body’s tissues using pulsed electromagnetic fields.  While the diagnostic benefits of PEMFs are accepted and widely used, medical practitioners are still realizing the therapeutic benefits of PEMFs.  In 1954, Japanese scientists first reported on the piezoelectric properties of bone.  This finding led to further research showing that damaged bone responded therapeutically to electric fields and pulsed electromagnetic fields.  Then in 1995, scientists at the University of Kentucky found that each type of soft tissue responds favorably to specific electromagnetic frequencies.1  Since then, peer reviewed clinical research documenting the biological and therapeutic effects of PEMFs has increased dramatically.  Despite this research contributing to the development of many types of effective PEMF devices, the Food and Drug Administration (FDA) has cleared relatively few of these devices for treating specific conditions.  However, as clinical evidence continues to mount, and as patients drive the demand for effective but safer medical therapies, this will likely change.  Since the FDA cleared the first therapeutic PEMF device over 30 years ago, there have been no postmarketing safety alerts issued for any of these devices.  This reflects the overall safety of short sessions of therapeutic PEMFs.  The benefits of PEMF therapy have been documented in multiple peer-reviewed clinical studies for a wide range of medical conditions. Randomized double-blind, placebo controlled clinical trials using PEMF therapy have shown beneficial effects for chronic low back pain, fibromyalgia, cervical osteoarthritis, osteoarthritis of the knee, lateral epicondylitis, recovery from arthroscopic knee surgery, recovery from interbody lumbar fusions, persistent rotator cuff tendinitis, depression, and multiple sclerosis.2,3,4,5,6,7,8,9,10,11 PEMF therapy and current FDA status In 1979, the FDA cleared PEMF therapy in the form of electrical bone growth stimulators for use in treating non-union fractures.  Subsequently, the FDA cleared PEMF therapy for failed joint fusion following arthrodesis, failed spinal fusion, and congenital pseudoarthrosis. In 1987, the FDA formally “grandfathered” 510(k) marketing clearance to a high frequency PEMF device for adjunctive therapy in the palliative treatment of postoperative edema and pain in superficial soft tissue.  A similar device was given FDA approval in 2008 to deliver what its company calls “targeted microcurrent therapy.”  Most recently, in October of 2008, the FDA cleared a PEMF device using repetitive transcranial magnetic stimulation (rTMS) for the treatment of Major Depressive Disorder in adult patients who failed to achieve satisfactory improvement from prior antidepressant medication.  In a multicenter clinical trial, approximately half of the patients experienced significant improvement in depression symptoms, and approximately a third of the patients experienced complete symptom relief at the end of six weeks.12  The future of PEMF therapy The future of PEMF therapy is exciting given the findings of early research in a wide variety of health conditions.

For example, preliminary data in clinical studies shows rTMS has promise in treating schizophrenia, post-traumatic stress disorder, obsessive-compulsive disorder, Alzheimer’s disease, and Parkinson’s disease.13,14,15,16,17  In relation to cardiovascular disease, studies show how PEMF therapy may reduce blood glucose levels, blood viscosity, total cholesterol, and triglycerides, while raising high-density lipoprotein (HDL).18,19  These studies will hopefully serve as an impetus for further investigation given that heart disease is the leading cause of death in the United States.  Another study shows how PEMF therapy may accelerate the healing of damaged brain tissue following acute stroke. 20 In light of the emergence of drug resistant bacteria, clinical studies show how PEMF therapy could one day become part of the standard of care in inhibiting Staphylococcus aureus infections and augmenting antibiotic therapy.21,22 Complicating the issue of antibiotic resistance are biofilms, dynamic mucous-like cities in which bacteria live and thrive.  Biofilms protect bacteria and assist in bacterial cell-to-cell communication and in the exchange of genetic information.  The same bacterium living outside a biofilm is less susceptible to antibiotics when living in a biofilm. Studies indicate PEMF therapy may effectively address this dangerous bacterial diversity.23,24

Studies also suggest that PEMF therapy may one day be used to treat cancer. Findings show PEMF therapy induces apoptosis of cancer cells, inhibits the growth of malignant tumors, modulates the immune system via cytokines as an anti-tumor effect, and may act synergistically with chemotherapy and photodynamic therapy to combat tumor growth.25,26,27,28  PEMF therapy and osteoporosis The scientific evidence is accumulating regarding how PEMF therapy may one day gain FDA approval for the prevention and treatment of osteoporosis.29,30 PEMF therapy improves bone mineral density, increase growth of osteoblasts, and positively influence bone remodeling via cytokines, prostaglandins and cell growth factors.31,32,33,34 In the clinical setting, it is important to document objective measures of improvement based on the therapy chosen. Bone density test scores are used to monitor the response to therapy for osteoporosis and osteopenia over the long term. Over the short term, clinicians can use urine deoxypyridinoline (uDPD) levels to monitor response to therapy. Deoxypyridinoline cross links Type 1 collagen found in bone. In conditions where bone turnover is high, deoxypyridinoline spills into the urine in high levels. As bone turnover decreases, uDPD levels drop. In my preliminary analyses, I find that PEMF therapy lowers uDPD in patients with osteoporosis. In one patient, uDPD decreased by 53% in two months with weekly sessions, and the reduction was sustained with once-monthly sessions. If this finding is reproducible in a double-blind, placebocontrolled clinical trial, this would affirm the ability for PEMF therapy to positively impact bone remodeling in osteoporosis.”

The database clinicalrials.gov shows 90 studies for the search term PEMF.  Perusing the studies in this list indicates the breadth of conditions that appear to respond to PEMF therapies.

PEMF MECHANISMS OF ACTION

The following diagram from the 2020 publication Promising application of Pulsed Electromagnetic Fields (PEMFs) in musculoskeletal disorders,   I think it illustrates some but by far not all of the impacts of PEMF

Fig. 1.”The underlying molecular mechanisms of biological effects induced by PEMFs. PEMF stimulation is involved in the regulation of cell proliferation and differentiation as well as immune modulation and inflammation response through a variety of underlying molecular mechanisms.

Abbreviation: PEMFs Pulsed electromagnetic fields; PKC Protein kinase C; MAPK Mitogen-activated protein kinase; ERK Extracellular signal-regulated kinases; RANKL Receptor activator of nuclear factor kappa-B ligand; RANK Receptor activator of nuclear factor kappa-B; JNK c-Jun N-terminal kinase; TRK Tyrosine kinase receptor; PI3K Phosphatidylinositide 3-kinases; PDK1 Phosphoinositide dependent protein kinase-1; AKT Protein kinase “B; mTOR mechanistic target of rapamycin; AC Adenylyl cyclase; cAMP cyclic adenosine monophosphate; PKA Protein kinase A; CREB cAMP response element-binding protein; NF-KB Nuclear factor-kappa B.”

RELATIONSHIP OF PEMF THERAPY TO YOUNGING01

In our writings, Seve Buss and I have characterized YOUNGING01 by a distinctive feature of its mechanism of operation, and that is global histone demethylation of the doubly and triply methylated sites H3K27me3-2 by the specific histone demethylase JDJM3.  Large numbers of growth and-development, inflammation-related and other genes related to age-reversal are thus activated.  A directly relevant publication is the 2020 Specific low-frequency electromagnetic fields induce expression of active KDM6B associated with functional changes in U937 cellsRecall that KDM6B is a synonym for JDJM3.  “In this study, we investigated the effects of specific low-frequency electromagnetic field sequences on U937 cells, an in vitro LFMF model of human monocyte/macrophage differentiation. U937 cells were exposed to electromagnetic stimulation by means of the SynthéXer system using two similar sequences, XR-BC31 and XR-BC31/F. Each sequence was a time series of 29 wave segments, equal to a total duration of 77 min. Here, we report that exposure (4d, once a day) of U937 cells to the XR-BC31 setting, but not to the XR-BC31/F, resulted in increased expression of the histone demethylase KDM6B along with a global reduction in histone H3 lysine 27 tri-methylation (H3K27me3). Furthermore, exposure to the XR-BC31 sequence induced differentiation of U937 cells towards a macrophage-like phenotype displaying a KDM6B dependent increase in expression and secretion of the anti-inflammatory interleukins (ILs), IL-10 and IL-4. Importantly, all the observed changes were highly dependent on the nature of the sequence. Our results open a new way of interpretation for the effects of low-frequency electromagnetic fields observed in vivo. Indeed, it is conceivable that a specific low-frequency electromagnetic fields treatment may cause the reprogramming of H3K27me3 and cell differentiation.”

The U937 call line is a familiar laboratory strain, and the transformation to the m2 anti-inflammatory macrophage phenotype is another aspect of YOUNGING01 we have discussed at length in our blogs.  I see two major takeaways from this study: 1.  Yes, under certain circumstances PEMF can initiate YOUNGING01 processes, and 2. Careful choice of PEMF parameters such as the difference between XR-BC31 and the XR-BC31/F settings may be required for HOUNGING01 to be activated.  We need to understand these a lot better.

Although successful PEMF therapy has been thought to require careful selection of treatment parameters, in most cases how to optimize such parameters to treat a specific disease condition or issue is simply not known.  Such parameters include positions of radiating units on the body, pulse waveform (e.g. sinusoidal, sawtooth, triangular, square) pulse frequency and spacing, magnetic field strength, length of treatment sessions, and number of sessions required.  As a result, most therapeutic uses of PEMF have been based on heuristic protocols, and we have no idea of how optimal they are.

With respect to PEMF and natural bodily regenerative processes, it appears that there is a fair amount to be said.  For example, the 2019 review article The Use of Pulsed Electromagnetic Field to Modulate Inflammation and Improve Tissue Regeneration: A Review reports “Pulsed electromagnetic field (PEMF) is emerging as innovative treatment for regulation of inflammation, which could have significant effects on tissue regeneration.  PEMF modulates inflammatory processes through the regulation of pro- and anti-inflammatory cytokine secretion during different stages of inflammatory response.  Consistent outcomes in studies involving animal and human tissue have shown promise for the use of PEMF as an alternative or complementary treatment to pharmaceutical therapies.  Thus, PEMF treatment could provide a novel nonpharmaceutical means of modulating inflammation in injured tissues resulting in enhanced functional recovery. This review examines the effect of PEMF on immunomodulatory cells (e.g., mesenchymal stem/ stromal cells [MSCs] and macrophages [MΦ]) to better understand the potential for PEMF therapy to modulate inflammatory signaling pathways and improve tissue regeneration.  This review cites published data that support the use of PEMF to improve tissue regeneration. Our studies included herein confirm anti-inflammatory effects of PEMF on MSCs and MΦ.”

The publication goes on to cover territory we have covered in other blog entries relating to m1 (pro-inflammatory) and m2 (anti-inflammatory macrophage), pointing out that timely activation of both phenotypes is important for key matters like wound healing and suggesting that PEMF signaling may be key for timely switching of macrophage type expression.

Continuing the selective quote from the document: “The immune system plays an essential role in tissue regeneration following tissue damage as well as during cell signaling homeostasis.  The immune response to tissue injury is crucial in determining the efficacy and rate of the healing process, including the extent of scarring and the restoration of organ function.1  To integrate the immune system into regenerative strategies, one of the first challenges is to modulate the precise functions of the different immune components during the tissue healing process.  The regulatory interactions of the immune system with tissue regeneration are not unidirectional, and stem cells, as key players in regeneration, can modulate the immune system in several ways to facilitate regeneration.1,2

However, the immune system does not always perform a complementary role in regeneration, and several reports have suggested that increased inflammation can inhibit the regeneration process.  An argument can be made that there are immune-mediated mechanisms of regeneration and repair that can be modulated by pulsed electromagnetic field (PEMF) therapy to improve the ability of tissue to regenerate.  Until recently, allopathic medicine rejected the possibility that an electromagnetic field (EMF) could affect biochemical mechanisms with weak electrical fields.  Biochemistry, however, is based on an understanding of the flow of energy that drives chemical reactions.3

Physical properties of molecules can be combined to express internal energy and thermodynamic potentials, which are necessary for equilibrium and homeostasis in spontaneous processes.4  New models of biophysics emphasize cooperative electrical activity of highly ordered elements at all levels of physiology: cells, tissues, organs, organ systems, as well as the entire human organism.  Research has shown that effects caused by low-frequency or weak EMF therapies can induce changes in cell proliferation, alterations in membrane structure and function, changes in nucleic acids, protein phosphorylation and adenosine triphosphate (ATP) synthesis, as well as entrainment of brain rhythms and conditioned brain response in vitro and in vivo.5–7  Parameters of these EMFs include frequency, intensity (field strength), waveform, and time of exposure. Recognition of physiological sensitivities to exogenous EMF came from the observation of endogenous internal electrical processes.4  For example, the piezoelectric properties of bone use electromechanical control to determine either osteoblastic or osteoclastic phenotype of cells.8  However, biophysical properties of cell function have mostly been ignored when choosing treatments for inflammation/immune modulation and regenerative medicine therapies.

Using PEMF to regulate cell signaling mechanisms involved in the inflammatory/immune response pathways of different cell types has become an innovative alternative treatment in the pursuit of regenerative therapies.9,10  Several studies have reported that PEMF can modulate both cell surface receptor expression/activation and downstream signal transduction pathways, thereby restoring homeostatic cell functions such as viability, proliferation, differentiation, communication with neighboring cells, and interaction with components of the extracellular matrix (ECM).11–18  PEMF can activate multiple intracellular pathways, including numerous processes and biochemical mechanisms within both the immune system and tissue regenerative processes, such as the musculoskeletal system7,19,20 and the nervous system.21–23 PEMFs are physical stimuli that affect biological systems through the production of coherent or interfering fields that modify fundamental electromagnetic frequencies generated by living organisms.7,24 These endogenous frequencies are ubiquitous in tissue, for instance, frequencies from 5 to 30 Hz have been found during postural muscle activity (quiet standing) and 10 Hz during walking.25  Successful regeneration requires a balanced immune cell response, with the recruitment of accurately polarized immune cells in an appropriate quantity.2  Here is where PEMF could have an influential role in the inflammatory process and thereby support tissue regeneration.”

PART 2 OTHER ELECTRICAL/ELECTROMAGNETIC STIMULATION APPROACHES

Decoding abbreviations for electrical/electromagnetic stimulation approaches –

E-STIM –  E-stim is a general term for the  electrical pulses to mimic the action of signals coming from neurons (cells in your nervous system). These mild electrical currents target either muscles or nerves. This is a very generic term.  My purpose here is to list the mainline e-stim approaches.  I have not studied nor used these approaches so cannot responsiby comment of their efficacy.

Specific types of E-STIM beyond PEMF include:

TENS – transcutaneous electrical nerve stimulationTENS therapy involves the use of low-voltage electric currents to treat pain.  TENS may be used for chronic (long-term) pain as well as for acute (short-term) pain. Electrodes are placed on the skin near the source of the pain.  Signals are sen t through nerve fibers to block or at least reduce the pain signals traveling to the brain.

EMSelectrical muscle stimulation.   EMS uses a slightly stronger current than TENS to get muscles to contract.  The unit’s electrodes (also placed on the skin near the affected muscles) cause rhythmic contractions.  This can improve muscle strength if the user attempts to contract the muscle simultaneously.  E-stim therapy for muscle recovery sends signals to targeted muscles to make them contract. (Flexing your biceps is a form of muscle contraction.)  By causing repeated muscle contractions, blood flow improves, helping repair injured muscles.  I own but have not useda VERVE unit that combines TENS and EMF which can be purchased from Amazon.com for $65.

ESTRElectrical stimulation for tissue repair helps reduce swelling, increase circulation, and speed up wound healing.(ref)

IFC – (Interferential current) stimulates nerves to reduce pain.  “Interferential current therapy works by sending small amounts of electrical stimulation to damaged tissues in the body.  The therapy is meant to boost the body’s natural process for responding to pain, increase blood flow and the production of hormones that promote healing. — ICT delivers stimulation through two different frequencies, one of about 4000Hz and the other varies up to 400Hz.  When the two currents cross, the difference in frequency creates interference, which is where the name for the therapy originates.  The exact frequencies, and resulting interferential frequency, can be controlled by the physical therapists during the session. — Interferential current therapy usually requires sessions with a duration of about 9 to 15 minutes.  During this time, the physiotherapist will attach four electrode pads to the area which will be treated.  Wires connect the pads to the current intensity regulator device which delivers the frequencies required. (ref)

NMES –  Neuromuscular electrical stimulation stimulates the nerves in muscles to restore function and strength, prevent muscle atrophy, and reduce muscle spasms. This $65 registered device requires a prescription.  Controlled by knobs. From the look of it, suggests a technology of 40 years ago,

FESFunctional electrical stimulation is intended to restore functionality to injured neuromuscular systems, such as due to spinal cord injury.  It involves long-term muscle stimulation aimed at restoring function and motor skills. “Functional electrical stimulation (FES) uses small electrical impulses to activate specific muscles and nerves. These impulses trigger the desired function, such as contracting muscles to move a foot or lift an arm. FES is also used to block pain signals and restore or improve bodily functions, such as bowel and bladder control(ref).”  FES can involve a number of different hardware approaches, including entire units and/or electrodes implanted in the body.  See this document.

SCS Spinal cord stimulation uses an implantable device to relieve pain.

RSWT  radial shockwave therapy  See https://www.amazon.com/dp/B082F6HMX1?tag=amz-mkt-chr-us-20&ascsubtag=1ba00-01000-org00-win10-other-smile-us000-pcomp-feature-scomp-feature-scomp&ref=aa_scomp    “Radial shockwave therapy (RSWT) is the use of short, intense energy waves travelling faster than the speed of sound. These energy waves stimulate the breakdown of scar tissue and fibroblasts. This process increases blood circulation and initiates metabolic activity, causing an inflammatory response that promotes and stimulates healing.  Over the past several years numerous articles and abstracts have been published regarding the effectiveness of RST. Shockwave is clinically proven to have success rates of 91 per cent for calcific tendonitis, 90 percent for plantar fasciitis and 77 percent for tennis elbow.(ref)”  My impression is that the shockwaves invove physical molecular movement and not electrical currents, akin to the waves produced by PEMF

ulRFEultra low radio frequency  “Ultra low frequency (ULF) is the ITU designation for the frequency range of electromagnetic waves between 300 hertz and 3 kilohertz, corresponding to wavelengths between 1000 to 100 km.(ref)”  See https://neurohacker.com/the-science-behind-using-ulrfe-technology-to-improve-focused-attention-and-make-you-more-productive.

tDCS – Transcranial Direct Current Stimulation“  Transcranial Direct-Current Stimulation (tDCS) is a portable, wearable brain stimulation technique that delivers a low electric current to the scalp.  A fixed current between 1 and 2 mA is typically applied1.  tDCS works by applying a positive (anodal) or negative (cathodal) current via electrodes to an area.  tDCS is a neuromodulation technique that produces immediate and lasting changes in brain function. The position of the anode and cathode electrodes on the head is used to set how current flows to specific brain regions.  The current delivered by tDCS is NOT strong enough to trigger an action potential in a neuron; instead its “sub-threshold” changes the pattern of already activity neurons. Think of the brain as active, trying to do or learn something, and tDCS coming along to boost this ongoing activity.  At the cellular level2,  tDCS changes neuronal firing and by strengthening synaptic transmission between neurons by augmenting synaptic plasticity3 which is, in turn, the cellular basis of learning. tDCS is often combined with training.  Training in itself produces learning (synaptic plasticity), and concurrent tDCS amplifies these effects (enhances synaptic plasticity). Some clinical applications tDCS is currently being explored for are depression, schizophrenia, aphasia, addiction4, epilepsy, chronic pain (migraine, fibromyalgia), attention, and motor rehabilitation. tDCS is also used for non-medical wellness applications, for example accelerated learning5, focus, relaxation, and meditation(ref).6”  Also see https://www.google.com/search?q=TDC+devices&oq=TDC+devices&aqs=chrome..69i57.18907j0j15&sourceid=chrome&ie=UTF-8

WB-EMS – whole body electrical myostimulation   Suggested for use to halt or reverse sarcopenia, age-related muscle loss.  See this page for articles on WB-EMS and devices that induce it. This page points to scientific publications pointing to the benefits and risks of WB-EMS

Clinical multifunctional electrotherapy units – A number of electrical stimulation devices are designed to be used in clinical and professional  settings.  They maybe used for multiple applications and may cost up to $3,700.  For example, this unit offers many electrical as well as sound wave stimulation options

My experience using the Neorhythm PEMF device

About 5 weeks ago when I first started working this blog entry, I surveyed candidate PEMF devices for for my personal use. I was interested in acquiring a practical low-cost device that was known to be efficacious for stimulating the Vagus nerve system and wanted to develop some first-hand experience using PEMF.  After looking over the sites for a dozen different brands I ordered a NeoRhythm unit from omnipemf.   It was to be used along with my near-infrared and red light belts and Apollo Neuro units.  I knew the results I want, which included more concentrated and effective sleep, ability to enhance focus and cognition, and personal energy.  I also planned to assess its effectiveness in enhancing HRV and other overnight scores measured by my Oura ring..

The result has been what seems to be very good ability to focus, to be there with family through whatever is going on, and, combined with evening use of my infrared pad, consistently sound sleep.  These results appear to be consistent with changes in longstanding patterns observable on my Oura Ring app, namely:

Monthly overnight average Nov 2021 Dec 2021 Jan 2022 Feb 1-15 2022
Resting heart rate 56 54 55 53
Heart Rate Variability 58 72 65 94
Sleep score 84 87 87 88
Next-day readiness 72 80 81 92

Higher is better for all scores except resting heart rate where lower is better

Not bad at all,given the results I have been looking for “ which included more concentrated and effective sleep, ability to enhance focus and cognition, and personal energy.”  I will see if these results keep continuing with passing time.  And I will be looking for additional health benefis of combining therapies with my infrared -red light units, and with my Apollo Neuro unit.

My First Use of a Medical E-Stim Devices

This is a brief historical anecdote about my first personal encounters with a medical e-stim device, 82 years ago when I was ten years old (1940). At the time, a deal friend and family member, had suddenly died, Dr. Joseph DeHoratis, my Godfather.  I had occasionally got to rummage unsupervised in the deserted basement in his medical office on Gratiot Ave in Detroit.  My grandfather was executor of the Doctor’s estate and I gladly accompanied him when he visited the office to inventory its contents.  I headed directly down into the basement, a dark cavernous place full of wonders like a large collection of old medical books with astounding illustrations describing every variety of ailment, immense glass flasks for delivery of IV treatments and who knows what else, and other strange medical contraptions.  This time I discovered a mahogany case perhaps weighing 45 pounds which contained an early diathermy machine.  Opening the case revealed a marble top, multiple dials and knobs,, and an adjustable spark gap assembly.  My grandfather regarded everything in that basement to be junk, and let me take the machine home, where it quickly became part of my developing attic electronics laboratory. The unit generated very high-voltage low-amperage currents in the radiofrequency range.  It was based on use of a primitive spark gap and tuning coil apparatus, similar to the first Marconi wireless units used on ocean liners like the Titanic, a version of a Tesla coil.  (see initial photo in this blog entry).  The high-frequency high-voltage current the unit generated could throw a fat 1.5 inch spark which was harmless to the body because the high-frequency current flowed along the skin.  If you held in electrode from the unit in one hand and a fluorescent tube in the other hand, the tube would light up.  And anyone touching you would also receive a prickly spark.  It was a scary machine worthy of Dr. Frankenstein’s laboratory.  The unit I has was a lot like but not quite identical with the one illustrated below here.  The knob in the center controlled the adjustable spark gap.   One thing the unit could definitely do is destroy all radio reception in the neighborhood.  I used the machine often for various “experiments,” and demonstrations to visitors to my laboratory, but never for any actual medical purpose.  Later but still when I was a kid, I built more-powerful Tesla machines using both spark-gap and vacuum tube technologies.

Image source

Biometrics and Aging

$
0
0

By A. Christopher Wikman, March 2022

INTRODUCTION

Over the years, this weblog has brought to light, integrated and presented the science of aging and the healthy practices and interventions (see the post PRACTICAL INTERVENTIONS FOR YOUNGING1.0 – Introduction to the series), which can seemingly slow, halt and even reverse the aging process.  Many readers have adopted such practices and interventions, and wonder the extent to which they are working, or whether some of them might not be working at all.  This blog post reviews key biometrics, or biomarkers, associated with assessing healthy aging, which may help answer the reader’s question of “how am I doing?”

 

 

Table 1. Various individual biomarkers.

From Biomarkers of Aging: From Function to Molecular Biology, June 2016, Nutrients

Up until recent times, various measures have been predominantly utilized by medical professionals to assess patient health and diagnose illness.  These range from non-invasive, traditional measures such as weight and blood pressure, to blood-based tests such as glucose levels, to complex imaging studies.  The concept “Biological Age”, which has been in the literature since at least the 1980s (see Methods for the determination of psycho-social performance within the scope of a model for objectivizing biological age, Pöthig, et all, full article is in German), has arisen to use these measures, individually or in combination with others, to arrive at a proxy score in years which reflects healthy aging, or not, when compared to one’s chronological age, and now widely used in intervention studies.  (This blog has previously covered some of these measures – see  Telomere lengths, Part 2: Lifestyle, dietary, and other factors associated with telomere shortening and lengthening from 2010, and Aging, health and disease – view from the DNA Methylome from 2016.) We all know someone who seems to have aged slowly, or conversely, prematurely aged, due to various factors such as lifestyle and genetics.  The best methods with which to determine Biological Age are an active area of research, and herein we will review some of the more prominent and interesting methods.  To be useful as an aging biomarker, suggested criteria mentioned in the literature include 1) changes in levels of the biomarker indicate changes in aging and/or mortality risk, 2) they are reliable and repeatable, and 3) they can be affected by interventions.

Further, the research is looking at how well the measure can predict mortality and time-to death.  Some earlier models, though apparently having strong predictive powers and correlation, were found not so strongly predictive of mortality risk.

Figure 1. Telomere length, gene expression, blood chemical parameters and DNA-methylation status all undergo age-associated changes, which can be measured and used to predict chronological age with a varying error rate. From Biohorology and biomarkers of aging: Current state-of-the-art, challenges and opportunities.

 

 

 

 

Figure 2.  This wonderful figure by Moskalev covers some of the complexity of this topic.   See the reference to his book.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table 2 – A selection of biomarkers associated with nine hallmarks of aging.  Image source: A Framework for Biomarkers of Aging in Clinical Trials to Extend Healthy Lifespan Jamie N. Justice, PhD Wake Forest School of Medicine, Gerontology & Geriatric.

Before we delve into the more complex Biological Aging models, which are based upon multiple measures, we’ll cover the various types of individual measures which are commonly used to assess health, and notably those which are well correlated with aging (such as gait speed), but not those measures which may be elevated even in younger years, such as total cholesterol and graying hair, and thus are not as strongly correlated with age.  For many of these aging indicators, there are published norms by age group, so patients may be able to assess their own results without requiring clinician support.

Also consider that measures can be looked at in at least these three ways: 1) the number of different assays required – how many things are being measured, 2) how is the measure being looked at – longitudinally vs. cross-sectionally (is one looking at how their own values are changing with time, or are they comparing the measure to aged matched norms – perhaps both?), and 3) the biological level of the measure, whether cell-based, organ-based, or patient whole-body level.

Physical performance measures

Gait speed is another term for walking speed, and is correlated with age (Association between walking speed and age in healthy, free-living individuals using mobile accelerometry–a cross-sectional study).  Curiously, the study did not find a significant correlation between gait speed and Body Mass Index (BMI), though BMI has been used in several aging models.  HW Jung in the study Functional Age Predicted by Electronic Short Physical Performance Battery Can Detect Frailty Status in Older Adults used gait speed, along with stand-up time and a balance score in a model to calculate a person’s functional age.

Grip strength is another often used measure to assess aging, wherein the patient squeezes a hand-held dynamometer.  The results and applicability of this measure may be skewed if the patient has emphasized forearm resistance/strength training in relation to other healthy lifestyle factors, but otherwise is a significant factor in frailty.

VO2max is a measure of cardiovascular fitness and training – the amount of oxygen in liters per kg of body weight a person can utilize per minute of intense cardio exertion, typically steady state, over perhaps a 20 minute period (although there is an aspect of this which seems to slowly decline as the exertion continues).  Various fitness devices, exercise equipment and their associated apps can provide an estimation, though more accurate values typically require a clinical setting.  Calculated values range from the 10s and 20s for older, untrained individuals up to 80s and 90s for elite athletes.  It is well known to decline with age, but can be significantly improved with cardio training.

Functional measures of physiology (other than physical performance)

Lung function is an intriguing measure.  A follow-up review associated with the well-known Framingham study later found that lung capacity (or FVC – Forced Vital Capacity, in liters) was a better predictor of mortality than the well-known cardiovascular risk factors.  Lung capacity decreases on average rather steadily beginning around 25-35 years old, and pulmonary issues are common in the elderly.  (See the section below on Biological Age assessment for younger patients.)  For years it was thought that this decline could not be significantly affected.  However, freedivers and others have now shown this not to be true.  Other relevant measures here are FEV1/FVC – FEV1 being the liters of air forcibly blown out in the first 1 second, and in relation to total lung capacity, and PEFPeak Expiratory Flow, in liters of air/min. These are measured in a spirometry, commonly used by pulmonologists and allergists in the doctor’s office.

Interest in Heart Rate Variability (HRV) has been growing rapidly in recent years, further enhanced by the wide availability of wearable fitness devices such as the Oura ring, Apple watch, and Whoop wrist strap.  This measure reflects the variation in time intervals between heartbeats, and a wider range of variation during a “data collection”, typically from 5 minutes to overnight monitoring, and at rest, generally indicates better, more adaptive autonomic response to stress.  So higher values can indicate greater levels of health.  After age 11-12, HRV typically declines with age (perhaps related to the onset of puberty) (see The effect of age and sex on the heart rate variability of healthy subjects).  Blood pressure has long been established as a risk factor when elevated (or too low), and is used in some aging models.  Resting heart rate, which is often lower than average in trained individuals, does not correlate well with age, and in fact seem to follow a U-shape in predicting all-cause mortality (The impact of time-updated resting heart rate on cause-specific mortality in a random middle-aged male population: a lifetime follow-up), with the lowest mortality risk found in the 60-70 bpm range.  Cardiac output, which is the volume of blood being pumped per unit of time, also does not seem well correlated with age.  Abnormally low or high values are more likely associated with disease.

Several neurocognitive measures are associated with aging, including memory and processing speed, and even physical measurements based on brain imaging.  These have found their way into Biological Age models, but their use by patients would typically require physician support and be costly, and thus not easily accessible.

Anthropometric measures

Anthropometric measures are those which relate to measuring the human body, such as BMI, waist and hip circumferences, and waist-hip ratio.  These measures generally increase with age after the 20s and 30s, though the correlation is not particularly as strong as other biomarkers we cover here, and as such, models to predict Biological Age based solely on these types of markers are not very useful.  More complex body shape measures such as ABSI and SBSI, which reflect body surface area and may more accurately reflect unhealthy lifestyles, have found some application in models based upon deep learning sets.

Another external, non-invasive measure are the facial features related to aging, which have been used by apps to estimate one’s Biological Age.  However, most of these apps seem not very useful, at least yet.  Research using two different apps in the 2017-published study Age estimation by facial analysis based on applications available for smartphones found very poor performance for female subjects, while values for male subjects seemed somewhat better correlated with age.  By 2018 however, the study PhotoAgeClock: deep learning algorithms for development of non-invasive visual biomarkers of aging claimed a MAE of 2.3 years, based upon eye corner images.  Although not freely available, the plastic surgeon Dr. Richard Baxter offers a (licensed) PhotoAgeClock assessment to his patients.  And while most app-based methods of predicting age are not very accurate, the perceived age of facial images (face-age) (as performed by human evaluators) is associated with all-cause mortality and other aging-associated traits.  Note that facial aging does not generally correlate with epigenetic clocks or blood-based DNAm measures (Association of facial ageing with DNA methylation and epigenetic age predictions) – see more on this below.

Blood-based measures

There are numerous blood-based measures which correlate well with aging, and which are directly relevant to the hallmarks of aging (see Tables 2 above and 3 below).  We will review some of these here, and then discuss some of the Biological Age models which are based on these measures.  Further, we will focus mainly on those blood-based markers which are available in clinics or direct to the public, vs. those still in research settings only.

Table 3 – Blood-based markers and associated underlying biological processes.  Image source: A Framework for Biomarkers of Aging in Clinical Trials to Extend Healthy Lifespan Jamie N. Justice, PhD Wake Forest School of Medicine, Gerontology & Geriatric.

Factors associated with red blood cells themselves include RDW (red blood cell distribution width) and MCV (mean corpuscular volume). Higher levels of RDW and MCV both correlate with aging, although these can also indicate disease such as a type of anemia.  The PhenoAge model (see below), for example, makes use of these two measures.

The interest in telomere length as a predictor of aging has recently declined, somewhat due to the finding that it is weakly predictive of mortality and CVD.  This measure is commonly obtained from white blood cells (but also from other types of cells), and reflects the amount of accumulated cell division, which is limited (see the Hayflick limit).  It has been established though that not all cells, and organs, age at the same rate, and so telomere length based on white blood cells may not accurately reflect full body aging.

Reduced immune system function is another hallmark of aging.  Relevant blood-based markers include WBC, CD8 and B-cell counts, which decline with age, lymphocyte % of total WBCs, and neutrophil counts, which increase.  Clinically available direct measures of thymus health do not yet seem available.  The thymus begins a life-long decrease in size after puberty, attributed to the decreasing levels of sex hormones.

Endocrine measures which are affected by aging (or vice versa?) include growth hormone, IGF-1 (part of the insulin-IGF-1-signaling system), and testosterone.

Systemic and chronic inflammation has been established as another hallmark of aging, leading to the term inflammaging.  (This topic has been reviewed extensively in previous blog posts here.)  CRP is a common marker for inflammation, and has found its way into several Biological Age models.  Other markers not as common but also included in models include IL-15, IL-6 and TNF-α.

Cellular senescence occurs when otherwise healthy cells stop the normal cell cycle, and rather than dying off and being recycled as intended, they may release toxic substances which damage other healthy tissues.  This is an active area of research, including the objective to identify relevant strong markers highly correlated with aging and mortality risk.  IL-15, mentioned above, was found to be one of the stronger markers of senescence in the study The senescence-associated secretome as an indicator of age and medical risk, as well as GDF-15.

The growing awareness of and interest in anti-aging interventions has brought great interest in numerous natural substances previously either unknown or of low interest.   Some of these can be assayed, and others implied by assaying related metabolites or pathways.  Along with this has come patient interest in measuring one’s levels, which may be used to inform whether to supplement and with how much.  Healthy levels of NAD, NMN, and NR, all related to vitamin B3, and the sirtuins, have been associated with anti-aging and popularized in best-selling books.  Recently NAD assays have become available to the public, in the form of a home test kit which is returned to the lab for results, such as from the US-based Jinfiniti. The results provide a few very broad age-based ranges for what is “normal”.  Other substances such as the hormone DHEA, the fatty acid GLA (which has anti-inflammatory properties), and the mineral lithium (in very low doses) have been associated with increasing longevity, and can be assayed by labs available to a doctor’s office, and in the US with increasing availability direct to the public.

Other measures include fasting glucose and triglycerides, which are elevated with age, and HDL, which declines.  Interestingly, total cholesterol is not well correlated here, and some controversial but professional opinions have stated that better health is associated with higher levels of cholesterol, and that it is the combination of high cholesterol with the oxidation of the deposits which leads to cardiovascular disease.  One may think of the analogy of high-speed driving combined with careless or reckless driving habits.  In isolation, high speed driving can be safe under the right conditions, but it increases the risk of injury and mortality when coupled with other factors.

Aging markers of proteostasis (autophagy, UPR, folding and processing proteins, etc.) are still not well established.  However, the common blood chemistry markers albumin and creatinine are correlated with aging and have found their way into models.  Note that creatinine levels are affected by both external supplements (creatine), and by kidney disease.

Technological developments such as metabolomics, proteomics, etc. and AI techniques such as deep learning and deep neural networks (DNN) have enabled research to assay, analyze and determine the aging correlations of large sets of potential aging markers.  Some of these measures are clinically available, such as albumin, leptin, PAI and cystatin C, while availability of others such as GDF-15 and B2M is either very limited (e.g. Mayo Clinic) or not at all.

Besides obtaining samples via blood draw, buccal swabs from the inside of the cheek can be used to obtain DNA samples for use in some of the various DNA methylation assessments (covered below), and urine samples have also been used in studies.  Tissue biopsy and CSF draws are utilized in a research setting but are considered too expensive and invasive for widespread purposes at this time.

Geriatric-focused measures

Some biomarkers are focused on the middle-aged, elderly and geriatric populations.  These include bone mineral density, hormones (such as DHEA and Testosterone), and frailty indices.  As such, these measures may not be useful for assessing aging (as opposed to disease) until the ages of 60-65 and older.  For example, in the study Age- and Gender-Specific Prevalence of Frailty and Its Outcomes in the Longevous Population: The Chinese Longitudinal Healthy Longevity Study, frailty incidence in the age group 65-79 was 4.8% (reaching 59% for those older than 100 years).  So it seems unlikely that this measure would be useful for those much younger than 65 and generally healthy, due to limited population study data and very small distribution in the frail category.  Unfortunately there is a younger population who suffer from chronic debilitating diseases in which those diseases are not strongly correlated with aging.  For example, a Canadian 2017 study Prevalence of frailty in Canadians 18–79 years old in the Canadian Health Measures Survey found that 4.3% of all those aged 35-49 were already frail, with conditions ranging from liver disease, kidney disease, and asthma, among others.  There exist other and specific measures for such diseases which are used to gauge disease severity, and these fall beyond the scope of this article.

Nonetheless, indicators for the category known as pre-frail may be helpful in identifying those at risk and for whom interventions can be utilized with the objective of delaying frailty.  Which leads us to the next section….

Measuring aging in younger patients

The aging processes seem to take hold around 25-35 years of age.  These processes include the onset of cardiovascular diseases, sarcopenia, neurological issues, and others.  Given this, a key question is “how well can this be measured”, and further, does aging measured during one’s younger years accurately predict lifespan, and possibly healthspan.  Can interventions be applied and be lastingly effective beginning at these “young” ages?  Perhaps this will eventually lead to population-wide interventions beginning during these younger years and result in healthspans in the range of 100-120 years for the majority of the public, even assuming that we’re not yet able to extend lifespan beyond that range.

Consider that a single estimate of Biological Age is a point estimate.  Lifestyle changes and interventions may take a few years to have a measurable or noticeable effect.  Therefore, it may be useful to have a Biological Aging baseline established near the time one begins to make significant changes.  A significant and ongoing longitudinal study (using data from the Dunedin Study) looks at the aspect of measuring aging in younger people over a long period of time.  (See Quantification of biological aging in young adults (2015) and Disparities in the pace of biological aging among midlife adults of the same chronological age have implications for future frailty risk and policy (2021).  Biomarkers from multiple systems were included – cardiovascular, metabolic, renal,  this will eventually lead to population-wide interventions beginning during [the ages of 25-35 years old] and result in healthspans in the range of 100-120 years for the majority of the public immune, dental, and pulmonary (see Figures 3 and 4).  Young adults were assessed at the ages of 26, 32, 38, and 45 years.  As the authors had a data set which included the levels of many potential biomarkers over a 19-year period (and thus the changes in those levels), they developed a Pace of Aging for each member of the cohort.   Note that the pace of changes in the model’s markers were generally non-linear.  Larger values in Pace of Aging correlated with eventual and more significant changes in aging factors such as physical limitations, brain health, and facial appearance.  So those with calculated higher rates of aging also looked and acted like they were older.  A limitation of that study is that, being based upon a controlled age of the cohort, who were still only middle-aged, there was limited data on disability and mortality.

Figure 3 – Normalized measures and their trends from age 26 to 38, in the study Disparities in the pace of biological aging among midlife adults of the same chronological age have implications for future frailty risk and policy (2015)

 

Figure 4 – Normalized measures (with some changes from earlier list) and their trends from age 26 to 45, in the follow-up study Disparities in the pace of biological aging among midlife adults of the same chronological age have implications for future frailty risk and policy, 2021

Younger readers may be interested to note that the study A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study published in 2018 concluded that many aging measures, at least up to that time, overestimated the age of younger adults.

Biological Age models based upon combinations of measures and other information

A concern with most any single biomarker is that it typically reflects a limited aspect of the patient.  Studies have found that various biomarkers which are correlated with aging often have low correlations between them individually.  For example, an individual could have excellent triglyceride levels while having poor lung function.  Taking either in isolation would probably not provide an accurate estimate of full-body biological age.  The models reviewed below are based upon multiple measures which thus typically reflect more than one aspect of the patient’s condition.

Another possible concern is whether the indicator is applicable to a wide range of ages.  A survey by the review Biohorology and biomarkers of aging: Current state-of-the-art, challenges and opportunities found that lower bounds among Biological Age models ranged from 0 to 46 years old, and upper bounds from 70 to 103.  One would like a model which is able to predict age over a wide range.

The model RealAge projects your biological age based upon an extended series of questions generally about your lifestyle, illnesses, and a few blood test results such as cholesterol. The Q&A takes about 15-20 minutes, and is free after you register on the website.  The prediction was found more accurate than chronological age (see Prediction of Mortality Using On-Line, Self-Reported Health Data: Empirical Test of the Realage Score).  This may be one of the easiest or most accessible Biological Age predictors – however the accuracy depends upon self-reported data which is expected to be truthful.

VitalScan is an autonomic function test conducted in a doctor’s office, which takes about 15 minutes to conduct.  The sensors used include blood pressure cuffs, oximeters, and EKG pads.  This test also evaluates cardiometabolic risk, and generates a 15-20 page detailed physician’s report and a 2 page simplified summary for patients.  One of the reported items is an equivalent age.  As the test is somewhat focused, the predicted age must be understood in that limited context and not as accurate as models based upon a broader range of factors.

Similarly, the NeuPT-HRV scan can be used in a physicians’ or therapists’ office to evaluate a patient’s nervous system (presumably autonomic), focusing on HRV (see above), but also generates an extensive report, including predicted age.

Epigenetic clocks, based upon DNA methylation, were pioneered by Horvath and others, first published in 2013.  Two which currently stand out are PhenoAge and GrimAge (see DNA methylation GrimAge strongly predicts lifespan and healthspan, Horvath, 2019).  These tests are not available to the public at this time, but other variations are offered such as TruAge by TruDiagnostic, and myDNAge by Epimorphy, using lancet-based home blood draw kits and cost a few hundred dollars in the USA.  TruDiagnostic now also offers a DunedinPACE pace of aging report (see more below on this).  Another option is AgelessRx, which offers 4 different age prediction options across standard blood test results to DNA methylation, ranging from free to $495 in the USA.

There is by now a large variety of these epigenetic clocks, and further, there is a wide range in the number of CpG sites used in their models, ranging from 3 to over 1000, as shown in Figures 5 and 6.  Curiously, there has been little overlap in the CpG sites used among the models, which would seem to suggest there is further work to be done to establish the “best” set of markers, or at least that perhaps there are multiple good solutions?  (See more below.)  Another area of study seeks to establish how a particular DNA methylation profile is linked to the root cause(s) of aging.

 

 

 

 

 

 

 

 

Figure 5 – Venn diagram of the CpG sites used in Hannum, Horvath and two Weidner clocks (all have <5 years of error […]. The intersection between their features is rather thin and indicates that DNAm clocks can achieve similar accuracy while relying on different sets of methylation sites.  Source: Biohorology and biomarkers of aging: Current state-of-the-art, challenges and opportunities

 

 

Figure 6 – Aspects of various epigenetic clocks

 

 

Figure 6 source: DNA Methylation Biomarkers in Aging and Age-Related Diseases   – Another comparison of epigenetic clocks I.mage source (including imaged caption): The Institute of Regenerative Medicine: Biomarkers of Health and Aging: Is There a Paradigm Shift Coming in Their Measurements?  (Author’s note: This diagram may have been originally sourced from a medical research paper).

Using blood test results often ordered by physicians such as for an annual physical, there are multiple websites, usually free of charge to use, which will generate a predicted age.  Given the relative affordability of blood chemistry testing, availability of data sets, and accessibility, it’s interesting that these types of aging clocks did not appear until 2016. Aging.ai, offered by Insilico Medicine, has four variations which use 41, 33, 19, and 1066 inputs, and claims a mean average error of 5.5 to 6.2 years among the models.  Several of the more commonly available blood chemistry markers mentioned above are used in their 19-input Aging.AI 3.0 model, as well as a few electrolyte and protein markers, geographical location and sex.  This model was shown to be useful for assessing mortality risk in the study Population Specific Biomarkers of Human Aging: A Big Data Study Using South Korean, Canadian, and Eastern European Patient Populations.  

Accuracy and repeatability of Biological Aging models – What’s the best?

The accuracy claims of various models seem to range from 3 to 6 years, with GrimAge currently considered the best available, with an MAE of about 3.6 years per Horvath.  His team’s research concluded that GrimAge is 18% more accurate than chronological age.  So GrimAge seems to be the best as of 2022.  See the study DNA methylation GrimAge strongly predicts lifespan and healthspan, which concluded this model better than DNA Age and PhenoAge.   Regarding repeatability, the Dunedin Pace of Aging studies noted continuously increasing predicted biological age, as expected.  However, I am not yet aware of studies on the degree of repeated measures correlation in these clocks.  Relevant to these models’ standard deviations or ranges of value, another likely question is how well do different models compare to each other.  In this regard my personal experiences have shown a very wide range of predictions (see below).  The 2017 paper Eleven Telomere, Epigenetic Clock, and Biomarker-Composite Quantifications of Biological Aging: Do They Measure the Same Thing? found little correlation among various DNAm, telomere, and biomarker-based aging clocks.  The study also concluded that none of the clocks in the study were strongly associated with healthspan-related aspects such as balance, motor coordination, cognitive decline, and facial aging.

Alternately, the 2021 paper An integrative study of five biological clocks in somatic and mental health found small but still significant correlations between their epigenetic and transcriptomic clocks, and between their metabolomic and proteomic clocks (these two reflecting the inter-related inflammatory and metabolic issues), but little otherwise.  The five clock models, epigenetic, telomere, proteomic, metabolomic, and transcriptomic, were new models developed for this study, and did not use pre-existing models.  This study also points out that “Hastings et al., 2019 showed relatively strong correlations (r > 0.50) between three physiological composite biological clocks (i.e. homeostatic dysregulation, Klemer and Doubal’s method and Levine’s method), but not with telomere length”.  The 2021 paper also looked at whether somatic and mental health issues were associated with aging.  The proteomic clock age was associated with digestive and endocrine diseases, the metabolomics clock with cardiovascular disease, and metabolic syndrome associated with four of the five clocks.  Mental health issues were picked up by the epigenetic and proteomic clocks and somewhat by the transcriptomic (RNA) clock.  The epigenetic clock was effective at picking up the accumulated effects of cigarette smoking.  Very curiously, the lifestyle factor physical activity, in mean MET minutes per week, was not associated with any of the five aging clocks.  A sixth, composite clock was also developed by this team, combining the five others, and this model had stronger associations with disease and lifestyle factors.  A conclusion was made that “…the correlates of chronological age in different molecular layers were not strongly correlated, suggesting that biological aging may be differently manifested at certain cellular levels”, and that “being biologically old at multiple cellular levels has a cumulative multi-systemic effect”.  What’s not fully clear yet is whether and how aging precedes and is a risk factor for disease, and whether those aging aspects can be elucidated before middle age.

The 2020 paper Underlying features of epigenetic aging clocks in vivo and in vitro looked at 11 different existing epigenetic clocks and various sources for the DNAm samples.  Not surprisingly, the clocks had overlaps but also significant differences.  Five of the eleven clocks showed links between epigenetic aging and metabolism, immunity and autophagy.  Two of the clocks showed links with cellular senescence and mitochondrial dysfunction. The team went on to extract features from each clock to create a meta-clock, which was highly correlated with aging across diverse tissues (better than any individual clock), better at predicting mortality risk, and better at capturing aging cell states.  Unfortunately, as the team explained, they were unable to compare this meta-clock to GrimAge.  Though since neither clock is available at this time to the general public, to many this will be a moot point.

So perhaps, while all aging clocks are correlated with aging, they may reflect different but partially overlapping areas.  It seems likely that a “best” clock is going to need to reflect the aging of a large number of aspects.  Nonetheless, aging clocks do reflect increasing risk of disease and death, and their development has been a major accomplishment.

There do not seem to be any single-sample biomarkers which are a reasonable predictor of whole-body biological age.  However, this doesn’t mean they are to be ignored.  I maintain a personal assessment chart of about 30 aspects of my health and physiology, which helps me focus on specific areas which may need improvement.  For example, my lung function has been less than optimal, and by incorporating healthier breathing practices over the last year, my lungs’ functional age has improved by 5 years, much to the surprise of both myself and my physician. (Future articles will cover more on this.)  One approach could be to concentrate on the markers related to the most prevalent diseases in old age and morbidity – cardiovascular, cancer, neurological (such as Alzheimer’s and Parkinson’s), diabetes, and chronic lower respiratory (such as bronchitis), and then closely watch the trends in these markers.  These combined account for over two-thirds of disease after age 65, and much of this is already covered in annual physical checkups.

How often? Considering the utility and effectiveness timeframes of interventions

We’ll only touch briefly on this related topic here, but further thinking about the results of Biological Age estimates inevitably leads to the question of how quickly can interventions “move the needle”, and thus how much time to allow before obtaining a new estimate of aging.

The TRIIM study (Reversal of epigenetic aging and immunosenescent trends in humans) measured blood chemistry on average every two months for a 12 month period.  Alternately, suggestions in the media are that DNA methylation changes may not become significant until 3 years or so have elapsed, and thus frequent testing is not warranted.  To this point, one may think about the monthly or yearly variations in commonly ordered blood chemistry results.  Some markers seem very stable, while others may vary significantly within the lab’s “normal” reference range.  These variations can be due to many factors, such as time of day, season of the year, fasting or not, recent intake of supplements and meds, changes in the dosage of maintenance medications, assay kit used, etc.  For those who require or have available several assay values within the timeframe of a single year, for example, and considering the above factors, a patient might consider averaging the values which they have available, and not “cherry-picking”.

BMI and similar measures can be somewhat quickly modified by diet and exercise, though it’s likely that the accumulated long term effects of having excess visceral fat cannot be quickly undone.  So just because you may have recently lost weight doesn’t mean you should get checked to see if you’ve now become “younger”.

Functional and physical performance-based measures may change significantly in a matter of months due to exercise, therapies, and lifestyle changes.  As mentioned above, I experienced a 5-year reduction in “lung age”, as measured in a spirometry, seemingly due to 5-6 months of practicing healthier breathing practices, such as nostril vs. mouth breathing.  To put that into context, my prior results had been somewhat steadily increasing (getting worse) in 1-2 year increments over the prior 5-6 years, and the same spirometry system was being used.  This is not to say that my biological age improved by 5 years, but at least this aspect, and an important one regarding mortality risk in future years, was now improved.

HRV is another measure which seemingly can be “quickly” improved through training and therapy, but again, this is one aspect of your autonomic nervous system, and thus, to the extent we yet understand, improving it does not (at least quickly) result in a “younger” full-body and mind.  (Note – the relationship between interventions to improve HRV and the Cholinergic Anti-inflammatory Pathway (CAP), which can be triggered by stimulating the vagus nerve, part of the autonomic nervous system, is an area of interest.)

To wrap up this section, and which has been reviewed previously in this blog, the following interventions seem to have the most impact system-wide: exercise, selected natural supplements and some medications, pulsed electromagnetic fields, varoxia, therapeutic plasma exchange, and stem cell treatments.  None of these appear to be quick fixes.

Personal experiences

I’ve obtained age predictions from telomere assays, Aging.ai, DNAge, RealAge, facial apps, and others.  The variation in predicted ages has in some aspects been discouraging, ranging from almost 30 years younger to 10 years older.  One of those on the older side was a facial aging app, which was quite surprising, as most new people whom I meet assume that I’m 10-20 years younger than I really am!

Further references

Biomarkers of Human Aging, 432 page book, edited by Alexey Moskalev, 2019

Biomarkers of Longevity – Analytical Report, 145 page PDF presentation, Aging Analytics Agency, 2019

=============================================

Note by Vince Giuliano.  With this timely and relevant first blog entry, I welcome Chris Wikman as a researcher and writer for this blog.  I expect Chris will offer important additional contributions as we seek to expand on the nature and scope of our YOUNGING01 hypothesis.

Online Presentations About Younging Available as YouTube Videos

$
0
0

In the last two months, Vincent and I have given 3 talks about YOUNGING that can now be viewed on YouTube.

The first two talks emphasize the two major biological mechanisms central to YOUNGING. In the 3rd talk, we discuss Interventions based in the science of YOUNGING.

Two Talks at Oregon State University (OSU)

We were invited by Dr. Deborah Coehlo to give two March 2022 lectures in her course called Health Psychology.

OSU Talk # 1 About YOUNGING via the Cholinergic Anti-Inflammatory Pathway

In the first OSU talk, we discussed some important longevity science basics and then reviewed the science of the Cholinergic Anti-Inflammatory Pathway.

 

OSU Talk # 2 About YOUNGING via Histone Demethylases, including JMJD3

In the second OSU talk, we discussed some important epigenetic variables driving aging and rejuvenation and some interventions we can make related to YOUNGING.

 

London Futurists Meetup Talk about YOUNGING-related Interventions

We gave a 2nd talk for the London Futurists Meetup about YOUNGING-related Interventions on April 9th.

 

Viewing all 150 articles
Browse latest View live